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1. Background of the research project 
 
Children with bilateral spastic Cerebral Palsy (CP) present with a varying degree of lower limb 
impairments, including increased muscle tone and weakness. These primary problems generally 
cause secondary impairments of muscle contractures and bony deformities and result in functional 
problems of gait and gross motor function.
1
 Treatment of children with bilateral CP is usually situated 
within a multidisciplinary context, including physiotherapy as a key component. 
2
 Controlling primary 
problems and prevention of secondary problems are thereby overall treatment aims to improve, 
stimulate and optimize motor function.
3
  
The International Classification of Functioning, Disability and Health (ICF) provided a useful framework 
to categorize assessment results and treatment approaches.
4,5
 However, development of this 
framework has also confronted the paediatric physiotherapist with the heterogeneity and the 
complexity of the pathology. It thereby opened many discussions regarding the entry point in 
treatment. The interactive dynamics within the ICF suggests that a combination of interventions 
targeting the different levels of the model may be required.
5,6
   
In the last decades, research in physiotherapy treatment of children with CP has increased 
remarkably. Many intervention studies so far have evaluated the effectiveness of individual techniques 
with promising results.
7,8
 However, as highlighted by the ICF, daily clinical practice most likely requires 
a mixture of individual techniques, each targeting a specific problem. Still, there is lacking insight in the 
effectiveness of multifaceted physiotherapy approaches tailored to the individual needs of the child 
and thereby addressing more adequately the heterogeneity of the pathology.   
Therefore, the current doctoral project will focus on an evidence-based, individually defined and 
targeted physiotherapy approach for children with bilateral CP.   
The first part of the general introduction describes the definition and classification of CP with specific 
attention to the prevalence and clinical presentation of bilateral spastic CP. The second part of the 
introduction elaborates on problems of gait and gross motor function of these children and the 
rationale behind related treatment. Finally, the aims and outline of this doctoral thesis are described. 
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2. Bilateral spastic Cerebral Palsy 
2.1 Definition, classification and prevalence  
Cerebral Palsy (CP) describes a group of permanent disorders of the development of movement and 
posture causing activity limitations, which are attributed to non-progressive disturbances in the 
developing fetal or infant brain. 
9,10
 With an incidence of 2-4 per 1000 newborn children, it is the most 
common cause of physical disability in childhood.
1
 As stated in the definition, CP is considered as an 
umbrella term, covering a wide range of clinical presentations and degrees of severity. Therefore, 
many research groups have attempted to categorize children with CP, with different purposes, such as 
description, prediction, comparison and evaluation of change. 
In 2000, the Surveillance group of Cerebral Palsy in Europe (SCPE) reached a consensus on the 
definition, classification and description of children with CP.
11
 The SCPE thereby identified wide 
variations in the use of terms such as spastic diplegia and quadriplegia and therefore, proposed a 
more reliable system (Fig 1). This innovative hierarchical classification system differentiated the 
subtypes of children with spasticity into only two categories, namely bilateral and unilateral 
involvement.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Hierarchical classification tree of Cerebral Palsy subtypes according to the Surveillance 
Group of Cerebral Palsy in Europe (Source: Cans et al. 2000
11
)  
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In 2005, Bax et al. proposed four major dimensions of classification.
10
  
The first dimension considers the nature of their motor abnormalities, including the observed tonal 
abnormalities and the diagnosed movement disorders. For the classification based on the observed 
tone abnormalities, the strategy of the SCPE has been adopted. This divides CP into the spastic, 
dyskinetic or ataxic type. Spastic CP is characterized by increased muscle tone and/or pathological 
reflex activation. Dyskinetic CP is characterized by involuntary, uncontrolled, recurring, occasionally, 
stereotyped movements and ataxia represents the loss of normal muscle coordination. For the key 
function of ambulation, the Gross Motor Function Classification System (GMFCS) is proposed, 
grouping individuals with CP into one of the five levels based on functional mobility.
12
 A parallel 
classification for upper limb function is provided by the Bimanual Fine Motor Function (BFMF) Scale
13
 
or the Manual Ability Classification Scale (MACS)
14
. 
The second component considered other, associated impairments that interfere with the ability to 
function in daily life and may at times produce even greater activity limitation than the other 
impairments. Himmelmann et al. reported that 32% of the children with spastic diplegia showed more 
than two accompanying impairments.
15
 Learning disabilities (49%), epilepsy (34%) and visual 
impairments (21%) were most commonly reported in this group of children. 
As a third component, the anatomic distribution and radiologic findings are identified as the basis 
for classification.  
As a fourth component of classification, Bax et al. identified timing and causation of the insult.
10
  
The third and fourth component will be discussed in the section describing the pathogenesis of CP. 
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GMFCS BFMF 
Level I 
Walks without restrictions 
Limitations in more advanced gross motor skills 
Level I 
One hand manipulates without restrictions 
The other hand manipulates with restrictions or 
limitations in more advanced fine motor skills 
Level II 
Walks without restrictions, limitations walking 
outdoors and in the community 
Level II 
(a)  One hand manipulates without restrictions, 
       Other hand is only able to grasp or hold 
(b)  Both hands: Limitations in more advanced 
      fine motor skills 
Level III  
Walks with assistive mobility devices, limitations 
walking outdoors and in the community 
Level III 
(a) One hand manipulates without restrictions. 
       The other hand has no functional ability 
(b) One hand has limitations in more advanced 
fine motor skill. The other hand has only the 
ability to grasp or worse 
Level IV 
Self-mobility with limitations, children are 
transported or use power mobility outdoors and in 
the community 
Level IV 
(a) Both hands have only the ability to grasp 
(b) One hand has only the ability to hold or worse 
Level V 
Self-mobility is severely limited, even with the use 
of assistive technology 
Level V 
Both hands only have the ability to hold or worse 
 
Figure 2. The Gross Motor Function Classification System (GMFCS)
12
 and the Bimanual Fine Motor 
Function (BFMF)
13
 (Source: Himmelman et al. 2006
15
)  
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According to the SCPE, 85% of the children with CP can be classified as spastic.
16
 Bilateral spastic 
CP thereby accounts for 46% of the children with CP. The population-based study by Himmelmann et 
al observed that children with spastic diplegia represented 39,2 % of the total population. The latter 
study also expressed gross motor function and bimanual fine motor function over the different CP 
types.
15
 Of the 144 children with spastic diplegia, 54% were classified at GMFCS level I to II, and 15% 
at GMFCS level III, representing the ambulant population amongst the bilaterally involved children 
(Fig 3).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. A. Distribution of the Gross Motor Function Classification System levels by type of CP in 367 
children ; B. Distribution of the Bimanual Fine Motor Function levels by type of CP in 345 children with 
CP (Source: Himmelmann et al., 2006
15
). 
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2.2 Pathogenesis 
CP results from an injury in the developing central nervous system, which can occur in utero, during 
delivery or in the first year of life. The patterns of brain lesions depend on the stage of brain 
development and can be divided into congenital or acquired brain lesions. Congenital lesions are 
usually caused by different types of events occurring the 28
th
 day of life and can be categorized into 
malformations, periventricular lesions and cortical-subcortical lesions. Malformations usually develop 
during the first or second trimester of gestation and include predominantly cortical maldevelopments in 
bilateral distribution. In addition, different genetic conditions can also interfere with early brain 
development. Periventricular lesions generally occur during the late second and early third trimester. 
An insult during the early third trimester will mostly lead to periventricular white matter disease or 
leucomalacia (PVL). Insults at the end of the third trimester or around birth usually affect the cortical 
and/or deep grey matter.
17
 Acquired lesions appear after the 28
th
 day of life and before the age of 
three years. These lesions generally occur as a postnatal event like a trauma or an infection.  
According to the SCPE however, abnormal MRI findings were found in only 90% of the children with 
bilateral spastic CP. Around 60% of the children showed PVL and only 10 to 15% showed grey matter 
lesions.
18
 Fig 4 provides a schematic and MRI view of PVL. Several authors have demonstrated the 
relationship between spastic diplegia and prematurity. 
16,19,20
 Himpens et al. observed significantly 
different distributions of the type of CP over the different groups of gestational age.
19
 Spastic diplegia 
dropped down from 85% in the extremely preterm group to 23% in the term group. 
 
 
       B 
  
 
 
 
 
Figure 4. Periventricular leucomalacia (PVL): A Coronal sections from the brain of a 28-week-old 
premature infant. The dorsal cerebral subventricular zone (SVZ), the ventral germinative epithelium of 
the ganglionic eminence (GE), thalamus (T), and putamen (P)/globus pallidus (GP) are shown. The 
focal necrotic lesions in cystic PVL (small circles) are macroscopic in size and evolve to cysts. The 
focal necrotic lesions in non-cystic PVL (black dots) are microscopic in size and evolve to glial scars. 
The diffuse component of both cystic and non-cystic PVL (pink) is characterised by the cellular 
changes (Source: Volpe 2009)
21
 B Weighted MRI scan of a 26 week premature infant. (Source: 
Blumenthal 2004)
22
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2.3 Clinical characteristics of children with bilateral Cerebral Palsy 
2.3.1 The framework of the International Classification of Functioning, Disability and Health 
To describe the clinical characteristics of bilateral spastic Cerebral Palsy, the International 
Classification of Functioning, Disability and Health (ICF) as defined by the World Health Classification 
(WHO) can be used (Fig 5). 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. The conceptual framework of the International Classification of Functioning, Disability and 
Health (Source: WHO, 2001) 
 
In the ICF, disability and functioning are viewed as outcomes of interactions between health conditions 
(diseases, disorders and injuries) and contextual factors.  
Body functions are physiological functions of body systems (including psychological functions). Body 
structures are anatomical parts of the body such as organs, limbs and their components. 
Impairments are problems in body function or structure such as a significant deviation or loss.  
Activity is the execution of a task or action by an individual. Participation is involvement in a life 
situation. Activity limitations are difficulties an individual may have in executing activities. Participation 
restrictions are problems an individual may experience in involvement in life situations.  
Environmental Factors make up the physical, social and attitudinal environment in which people live 
and conduct their lives. (e.g. school and home environment). Internal personal factors influence how 
the individual experiences his/her disability (e.g. gender, age, coping styles, social background, 
education). 
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The International Classification of Functioning, Disability and Health – Children and Youth version 
(ICF-CY) is a WHO approved “derived” classification based on the ICF that includes further detailed 
information on the application of the ICF when documenting the relevant aspects of functioning and 
health in children and youth. The ICF-CY shares the same classification properties as its reference 
classification the ICF. However, in the interest of a streamlined, comprehensive ICF, which adequately 
addresses all aspects of functioning across the lifespan, the relevant stakeholders have recently 
agreed to merge the two classifications back into one while completing other updates and revisions. 
As the overall conceptual framework of the ICF-CY is the same for both the ICF and the ICF-CY, this 
will further be referred to as ‘ICF’.  
 
2.3.2 Problems at the level of body structure and function 
Spasticity 
One of the main primary problems in children with bilateral spastic CP is spasticity. Following the 
definition by Lance (1980), spasticity is defined as a motor disorder characterized by a velocity 
dependent increase in tonic stretch reflexes (muscle tone) with exaggerated tendon jerks, resulting 
from hyper-excitability of the stretch reflex, as one component of the upper motor neuron syndrome.  
In children with bilateral involvement, spasticity is usually higher in the lower limbs compared to the 
upper limbs and most commonly affects m.Gastrocnemius, the Hamstrings, m.Rectus Femoris, 
mm.Adductores and m.Iliopsoas. In clinical practice, spasticity is usually evaluated using the Modified 
Ashworth Scale (MAS), complemented by the Tardieu Scale.
23-26
  
 
Weakness  
Muscle weakness has long been considered as a secondary problem in CP. It was considered as a 
result of co-activation of antagonistic muscles, reducing the net forces acting to rotate a joint. Although 
this lack of reciprocal inhibition causing excessive co-contractions has been confirmed
27,28
, more 
recent investigations have identified muscle weakness as being more a primary problem in children 
CP. 
26-30
 Reduced muscle volumes throughout the lower limbs up to 50% were observed
31
 and 
thereby, children with CP were less able to activate their target muscles maximally. 
26,29,32
 Although 
many questions regarding the pathophysiology of muscle weakness remain unanswered, muscular 
changes can probably not only be explained by classic interpretations of the effects of neural changes 
alone.
33
 Table 1 summarizes the facts regarding histological and physiological consequences 
regarding muscle strength problems in children with CP. 
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Table 1. Histological and physiological adaptations in the spastic muscle and consequences for 
children with Cerebral Palsy 
Structural changes  
 Altered distributions between type I (slow-twitch) muscle fibres and type II (fast twitch) fibres with 
generally, a predominance of type I fibres
34,35
 
 Reduced muscle belly length and increased tendon length
26,33,36
 
 Increased fibres size variability
30,35
  
 Increased modulus of elasticity
37
  
 Increased sarcomere length at the hamstrings
38
  
 Reduced number of fibres, increased intramuscular fat and connective tissue
38
 
 Inefficient recruitment of motor units
28
 
 Reduced muscle cross-sectional area
39-42
  
 Cross-bridge stiffness at muscular and collagen level
43
 
Consequences 
 Children with CP demonstrate a slower rate of maximal force production
28
 
 Children with CP are less able to activate their muscles maximally
26,32
 
 Children with CP show reduced half-relaxation time and disturbances in reciprocal inhibition
28,39
  
 Children with CP show reduced muscle volumes
29,31,36,39,42,44-46
 
 
In general, alterations at the spastic muscles cause the muscle to exert maximum force at a different 
point along the length-tension curve. Because of this biomechanical disadvantage, the muscle no 
longer works optimally for gross motor functions and walking. Muscle weakness thereby contributes 
for a great extend to functional capacity in these children.
27
 
47-54
 
Muscle strength is most commonly evaluated using manual muscle testing. 
55,56
 Although manual 
muscle testing has limited sensitivity, no other evaluation tools provide an equal, easy-to-use 
screening tool. Controversial results are available regarding the use of handheld dynamometry.
57
 
Additionally, handheld dynamometry does not provide an outcome measure that can be used to define 
training-intensity. Isokinetic measurements show reasonable reliability, but are limited to 
measurements of the knee-flexors and extensors and are known to be expensive and time-
consuming.
58
 During the last years, the use of functional muscle testing has increased, as it is a useful 
and reliable means to measure muscle strength over multiple joints and muscles.
57
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Muscle contractures and skeletal deformations 
As spasticity interferes with normal muscle stretch during growth, it is thought to contribute to the 
development of secondary muscle and soft tissue contractures and to skeletal deformations. Stiffening 
of the extra-cellular matrix with increased collagen, an increase of in vivo sarcomere length and 
reduced relaxation half-time can lead to higher passive stresses. The increased and unbalanced 
muscle tone sets off a cascade of bone and muscle responses. The combination of the changes in 
muscle architecture together with alterations in muscle use associated with spasticity results in 
stiffness. Combined with altered spontaneous limb movement, these cause reduced muscle length 
and limited joint function. The altered muscle forces cause abnormal forces on the growing bone, 
which as such can cause lever-arm dysfunctions.
59
 Range of motion and muscle lengths are usually 
measured clinically, by goniometer. The measurements show moderate reliability.
25
 In addition, as 
tone reduction became more successful in the last years, the role of muscle weakness in the 
development of bony deformities became more obvious. 
60,61
 
 
Selectivity 
As a direct result from the brain lesion, children with CP are known to show typical movement 
patterns. These patterns, in combination with the spasticity and muscle weakness, attribute to the 
limited ability for the children to selectively activate specific muscles. Selective motor control involves 
isolating movements upon request, appropriate timing and maximal voluntary contraction without 
overflow movement. Different motor control tests are available for children with CP, most of them with 
limited reliability. 
59,62-64
  
 
Postural control 
Impaired trunk control is one of the key features of children with CP. 
65,66
 Especially in children with 
PVL and children with diplegia, impaired trunk control is known as a major reason for postural 
problems.
67
 Fig 6 overviews the percentage of submaximal scores for the different items of the Trunk 
Control Measurement Scale, indicating trunk deficits for the different topographies.  Literature on the 
evaluation of trunk control in children with CP is scarce and only a limited number of clinical tools are 
available to measure trunk control in children with CP. More static evaluations are the Seated Postural 
Control Measure (SPCM)
68
 and the Spinal Alignment and Range of Motion Measure (SAROMM).
69
 
More recent and dynamic evaluation tools are the Segmental Assessment of Trunk Control (SATCo)
70
 
and the Trunk Control Measurement Scale (TCMS)
71
.  
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Figure 6. Percentage of submaximal scores for the different items of the Trunk Control Measurement 
Scale, indicating trunk deficits for the different topographies. (Source: Heyrman et al. 2013
71
) 
 
2.3.3 Problems at the level of activity and participation 
Gait problems 
The combination of pathological movement patterns, weakness and impaired muscle lengths in CP 
are known to cause a wide variation of pathological gait patterns.  Children with CP usually walk 
independently but most have reduced speed, increased walking speed and increased energy 
expenditure. 
72,73
 The most commonly used classification in clinical practice and research is the 
classification of Rodda and Graham.  It is based on a systematic review of literature and provides a 
description of the pathological patterns, as well as the potential underlying mechanism and 
strategies.
74
  
 
 
 
 
 
 
 
 
 
Figure 7. Visual representation of the sagittal gait patterns during mid-stance in spastic diplegia. 
Source: Rodda et al. 2004 
74
  
Static sitting balance Selective movement control Dynamic reaching 
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Normal gait has several attributes. Because of the neuromuscular problems that occur in CP, all these 
attributes are lost in varying degrees. Pathological gait is a combination of cause and effect. The brain 
injury can interfere with gait in several ways. The primary effects of the brain injury (loss of selective 
motor control of muscles, difficulties in balance and abnormal muscle tone) arise from the brain as a 
direct result from the brain injury. These impose abnormal forces on the skeleton, causing secondary 
effects of musculoskeletal deformities. A child will cope with its primary and secondary problems using 
compensation strategies, which can be seen as tertiary problems. Pathological gait is always a results 
or a mixture of these primary, secondary and tertiary problems. Three-dimensional gait analysis 
usually includes joint kinematics (the quantitative three-dimensional measurement of motion), joint 
kinetics (the measurements of moments and power production occurring in the major articulations of 
the lower extremities) and dynamic electromyography (muscle activity patterns, frequently expressed 
as on-off signals of individual muscles and/or muscle groups). This allows integration of all these 
components and can thereby support the clinician in unravelling these problems and consequently, 
improve the understanding in the child’s problems.
59
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Summarized sagittal plane kinematic data for the typical gait patterns in spastic diplegia. 
The light-grey wave-forms represent the average gait pattern for a typically developing child; curves in 
dark-grey the typical gait patterns for children with spastic diplegia. (Source: Rodda et al. 2004
74
)   
  
19 
The Movement Assessment Profiles (MAPS) and the Gait Profile Score (GPS) have been developed 
to summarize much of the complex information within the kinematic data.
75
 Movement Analysis 
Profiles (MAPS) can be calculated as the root mean square error (RMSE) between the point-by-point 
comparison of the lower limb joint angle and the averaged joint angle of the reference group. 
Calculation of the average of all lower limb joint angles results in the GPS, which summarizes the 
overall severity of gait pathology. 
59,75
  
When analysing group data however, the heterogeneity of CP and the variety of gait patterns in 
children with spastic diplegia, might cause the phenomenon of ‘regression to the mean’. As not all 
children show the same gait deviations, determining group improvements based on gait data is 
challenging.  Z-scores represent a standardized deviation from a reference group.
76
 Z-scores are non-
dimensional and therefore, allow comparison of individual pathological parameters. The use of z-
scores therefore provides the possibility to compare individual improvements within a group of children 
with different gait pathologies.  
 
Limitations in gross-and fine motor function 
The majority of children with bilateral spastic CP has moderate to severe problems in gross motor 
function and mobility. 
1,13,15
 The disorder in the development of gross motor function thereby 
represents the hallmark of these conditions. 
52,77
 Many different outcome measures are available to 
evaluate gross motor function in these children. A systematic review by Ketelaar et al.,
78
 concluded 
that especially the Gross Motor Function Measure
79
 and the Pediatric Evaluation of Disability 
Inventory
80
 fulfilled the criteria of reliability and validity with respect to responsiveness to change.    
The Gross Motor Function Measure 88 (GMFM-88) and 66 (GMFM-66) version are standardized 
observation measures to evaluate gross motor function changes in children with CP.
79
 The tests as 
such have no age-limits, but the test items are selected with reference to a five-year-old with normal 
motor abilities, that can usually accomplish all items. The GMFM-88 is the oldest version, consisting of 
88 items, divided into five dimension: lying and rolling (dimension A), sitting (dimension B) crawling 
and kneeling (dimension C), standing (dimension D) and walking, jumping and running (dimension E). 
Each item is scored on a four-point scale. Inter-and intra-reliability measures were high, even amongst 
un-experienced observers. 
81-83
 In addition, it has been validated by demonstrating its capability to 
detect change in gross motor function over time.
84
  
The Pediatric Inventory of Disability Inventory (PEDI) is a standardized assessment instrument for 
chronically ill and disabled children from six months to 7,5 years. It consists of a questionnaire, 
designed to evaluate the child’s functional ability along three scales: typical functional skill level, 
physical assistance and modifications or adaptive equipment used. Each scale is divided into three 
domains: self-care, mobility and social function. The PEDI has been developed for both discriminative 
as well as evaluative purposes. A number of studies report the PEDI as reliable and valid. 
80,85
 
Responsiveness of the PEDI was confirmed over a six-month period.
86
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Rosenbaum et al. described the patterns of gross motor development of Canadian children with CP, 
using longitudinal observations.
77
 Based on 2632 GMFM measures, five distinct motor development 
curves were created (Figure 8), describing the important and significant differences in the rates and 
limits of motor development among children with CP by severity. There was substantial variation in 
gross motor development among the different functional levels. Logically, children functioning at 
GMFCS I and II reach a higher maximum GMFM-66 scores than children functioning at level III, IV 
and V. The motor development curves also suggest a trend for children severe of impairment reach 
their limit in gross motor function level at a younger age than more functional children. In addition, 
children functioning at levels III through IV progress significantly faster that children with level I, but 
children in level II do not progress faster than level I.
77
 In a similar Swedish study, Beckung et al. 
differentiated motor development amongst the different types of CP and found similar results for the 
subgroups of diplegia and hemiplegia.
87
 Recently, Smits et al. confirmed the development trends seen 
in the Canadian study in a Dutch population.
88
  
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Predicted average development by the Gross Motor Function Classification System Levels. 
The diamonds on the vertical axis identify 4 Gross Motor Function Measure-66 items that predict when 
children are expected to have 50% chance of completing that item successfully. (Source: Rosenbaum 
et al. 2002
77
) 
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Participation restrictions 
Children with disabilities are less involved in leisure activities than their peers, participate less in family 
activities outdoors and often experience social experience at school.
89
 Their recreational activities are 
therefore more passive, home-based and lack variety. Facilitators for participation include age, 
motivation, cognitive abilities, support, coping and environmental resources. Barriers are behavioural 
difficulties, activity limitations, parental stress and speech-and language impairments. 
89-93
 Other  
factors that influence the choice and intensity of participation are gender and family preferences. 
Children often report a significant higher presence of adults in their life and a reduced perception of 
independence and autonomy.
89
 The School Function Assessment
94
, the Children’s Assessment of 
Participation and Enjoyment (CAPE), the Preference Activities for Children (PAC)
95
 and the Life-H 
questionnaire
96
 seem to show the best clinimetric properties to evaluate participation limitations. 
However, limited data is available to suggest that these measures are adequately sensitive to detect 
minimal clinically significant change. 
97
 
Evidence is provided that the Goal Attainment Scale is a more responsive measure of motor change 
and participation limitations in infants with motor delays than standardized motor assessment like the 
Peabody Developmental Motor Scales (PDMS) or the GMFM.
62,97,98
 GAS has unique features that are 
advantageous for measurement of qualitative change and small but clinically important improvement 
in motor development and function. In addition, it can capture meaningful aspects of a person’s 
progress and in that way, improve motivation. By convention, scores of -2 and -1 represent the two 
less favourable outcomes, 0 represents the expected level of goal attainment and +1 and +2 represent 
the two levels of goal attainment that exceed expectations. 
98-100
 Additionally, a change score can be 
calculated for multiple goals. The composite T-score, with a mean equal to 50 and a standard 
deviation of 10, provides a method to quantify change over time and across individuals.
100
Studies 
evaluating the clinimetric properties of the GAS in pediatric rehabilitation support the content validity 
and responsiveness to change. 
98,101
 However, evaluation of its concurrent validity suggests that GAS 
should not replace standardized idiosyncratic measures like the GMFM, the Peabody Developmental 
Gross Motor Scale and the PEDI but preferably used complementary. 
98,99,101-104
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2.3.4 Interactive dynamics  
The interactive dynamics the ICF suggests underlying correlations between the measurements at the 
different levels of the model. Chiarello et al. defined a multivariate model of determinants of change in 
motor abilities and participation in daily activities for children with cerebral palsy (Fig 9).
105
 The model 
demonstrates the complexity of the pathology by scheduling the relationship between the different 
levels of the ICF. It demonstrates how aspects of the child, family, environment and community 
influence children’s activity and participation. 
 
Fig. 9 Multivariate model of determinants of motor change in motor abilities and participation in daily 
activities for children with Cerebral Palsy. (Source: Chiarello et al.
105
)   
Characteristics 
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Change in 
basic motor 
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Family ecology Rehabilitation and 
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The relationship between the different levels of the ICF however, remains a complex und unravelled 
entity of direct and indirect interactions. Several researchers have therefore expressed the relationship 
between the different impairments underlying functional and participation limitations quantitatively and 
have confirmed inverse relationships between the different models.
47,52,53,106-109
 Ostensjo et al. found 
moderate correlations between measurements of spasticity, strength and selective motor control and 
gross motor function, but weaker correlations of the impairments to mobility, self-care and social 
function of the PEDI evaluations.
52
 Thereby, the selective motor control score was the strongest 
predictor explaining 15-45% of the variance in gross motor function. The GMFM-66 score accounted 
for 88% of the variations in mobility. Wright et al found poor relationships (r<40) between the change 
scores of measures of body functions and structure (spasticity), activity (GMFM and PEDI) before and 
after injections with botulinum toxin A.
53
 In a more recent study including more functional children 
(GMFCS I and II), Bartlett et al. could only explain 58 % of the variance in gross motor function by the 
primary and secondary problems at impairment level.
47
 Gorter et al. found only a very low correlation 
(-0,28) between spasticity and gross motor function.
106
 Ross et al. found that, in children with spastic 
diplegia, strength explained more variation in gait and gross motor function than spasticity.
107
 This 
positive relationship between strength and gait was confirmed by Eek et al.
108
, who observed that in 
independently walking children showed more than 50% of the predicted strength values and by 
Damiano et al.
27
, who demonstrated a direct relation between strength of the knee extensors, GMFM 
and gait velocity.  
The relationship between gross motor function and participation restriction has been investigated by 
Kerr et al., indicating a moderate but negative relation between the GMFM-88 and the Lifestyle 
Assessment Questionnaire.
110
 Beckung et al. showed that restriction in participation was best 
predicted by the GMFCS.
13
 Jaspers et al. investigated the indirect relation between gait pathology and 
quality of life and observed an adverse impact of the severity of gait pathology on quality of life as 
reported by parents and children.
111
 Both parents and children identified gait speed as an important 
factor contributing to their quality of life.  
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3. Treatment context of children with bilateral Cerebral Palsy 
3.1 Multidisciplinary context 
The pathology of CP is complex. The variety of clinical problems associated with the brain lesion all 
requires sufficient attention. This is at best offered by a multidisciplinary team surrounding the child 
and its family. 
2,59
  
Figure 9 describes the usual treatment time strived for at the University of Pellenberg. From birth until 
early childhood, management optimally consists of intensive physiotherapy to support motor 
development, and to maintain range of motion.  Children with CP optimally receive conservative 
treatment until their motor patterns are matured, usually between 8 and 10 years. Delaying the often 
inevitable need of surgery is important because the results of early surgery are less predictable and 
have a higher risk of failure and relapse. 
59,112
 The consequences of persistent increased tone can be 
limited with the use of Botulinum Toxin A injections (BTX-A). BTX-A is a paralysing agent that inhibits 
the release of the neurotransmitter acetylcholine at the neuromuscular junction, resulting in a reduced 
muscle tone. Selective tone reduction by means of BTX-A, combined with different conservative 
treatment options, has the potential to achieve functional benefits. 
113-115
 An adequate follow-up 
treatment including orthotic management, serial casting and intensive physical therapy has been 
demonstrated of major importance for a maximal benefit of the injections. 
2,113,114,116
  
 
Fig 9. Usual treatment timeline at the Gilette Children’s Speciality Hospital, Minnesota, US (Source: 
Gage et al.
59
)  
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4. Physiotherapy in children with Cerebral Palsy 
The motor impairments typically associated with CP are such that physiotherapy is often one of the 
first interventions recommended for a young child diagnosed with CP.  Physiotherapy treatment in 
early childhood therefore mostly focuses on stimulation of motor development and learning new 
functional activities.
117,118
 Thereby, stimulation by the parents and handling techniques are of major 
value to reassure treatment continuity. 
119,120
  
Although stimulation of motor development and functional activities remains a central aspect 
throughout the lifespan of children with CP, tone reduction becomes increasingly important, especially 
in the growing, school-aged child (Fig 9). Crucial in the success of BTX-A treatment is the adequate 
follow-up treatment with serial casting, appropriate orthotic management and intensive physical 
therapy. The selective tone reduction of overactive muscles provides a window of opportunity for 
therapeutic interventions by decreasing muscle tone, and thereby allowing increased range of motion, 
the potential to strengthen antagonist muscles and the opportunity to develop better motor control and 
balance. 
8,116
 Thereby, transferring the use of these improved joint-and muscle conditions into 
functional activities is an essential step.
121,122
   
Nevertheless, treatment of children with CP is probably complicated by the fact that clinical 
manifestations are widely believed to change through life-span. In particular, after developmental 
gains in childhood, children with CP may decline in gross motor function as they move into 
adolescence and adulthood.  Bottos et al. found that 13 of 29 children with CP who could walk 
independently before 18 years lost independent ambulation between the ages of 20 and 40 years.
123
 
In a survey of 766 Norwegian adults with CP, 88% of the participants were ambulant but 45% of this 
study group reported that their walking ability had deteriorated.
124
 A large longitudinal study by Day et 
al on 7550 children with CP showed that 34% of the children who walked unsteadily and sometimes 
used a wheelchair as a child, lost their ambulatory mobility as young adults.
125
  
During the last decades, the ICF has played a major role as an eye-opener for many physical 
therapists and researchers. 
5,126
 Using the ICF as a framework has confronted the therapist with the 
complexity of the pathology and the extensiveness of the problems, at all levels of the model. This 
concept has forced the therapist to consider the functional perspective of the pathology and to enable 
children to master important tasks and to participate in day-to-day activities.
1,127,128
 Nevertheless, the 
core problem of CP implies the progressive nature of the pathology. Addressing primary impairments 
and prevention of secondary impairments therefore remains a difficult but inevitable task for the 
physiotherapist treating children with CP. 
2,3,59
 Therefore, treatment of children with CP is a balanced 
but challenging exercise between optimizing motor development, promoting independent functionality 
and participation but with sufficient attention to prevention of secondary problems that limit activities 
and participation.   
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In the last decades, research in physiotherapy treatment of children with CP has increased 
remarkably. Many intervention studies so far have evaluated the effectiveness of individual techniques 
and have shown promising results. 
7,129
 A variety of ‘impairment-based’ studies demonstrated positive 
effects of for example strength training on muscle strength, gait and gross motor in children with 
bilateral CP. 
130-132
 At the other side of the spectrum, there are ‘participation-based’ studies, 
demonstrating positive effects at children’s participation and enjoyment.
6,133
 Functional, task-oriented 
training programs demonstrate promising results on gross motor function and participation of children, 
but unfortunately, are not able to meet the problems regarding deteriorating muscle lengths and joint 
deformities.
134
 The effectiveness of the individual techniques and specific approaches used in 
treatment of children with bilateral spastic CP are summarized in chapter 1 and 2. 
Although the view of the ICF has brought a very positive change, it opened many discussions 
regarding the entry point in treatment. As a physiotherapist, it needs to be a well-balanced decision to 
aim for a focused treatment of an impairment, to modify the environment or maybe both.
5
 In addition, 
children with CP and especially the weaker ones, are usually in need of assistive devices and 
consequently, adapting environmental aspects is an important task for the physiotherapist treating 
children with CP.
135,136
 Adaptive orthopaedic materials and devices children are mainly used to 
improve the child’s daily functioning, but can also be applied in positioning to prevent contractures and 
deformities.
137
 In addition, the role of parents in the clinical decision process of the physical therapist is 
a factor that has been neglected in the past. It is however clearly demonstrated that enabling parents 
to participate more fully in their child’s treatment regime, protects mothers from distress, increases 
self-efficacy and motivation and thereby therapy outcome.
138-140
  
Addressing all these issues in a well-balanced therapy plan is a challenging task for the therapists. 
Therefore, several research studies have successfully introduced the principle of goal-setting in 
physiotherapy of children with CP. Goal-oriented treatment has the potential benefit from targeted 
interventions to enhance training specificity. Goal planning, in that context, can be used to identify the 
tasks and contexts of particular interest.
141
 Several clinical reasoning strategies are available to guide 
the physical therapist in goal selection. Unfortunately, these clinical reasoning strategies are usually 
complex, extensive and are not developed specifically to guide the physiotherapist in priority 
setting.
142-144
 Additionally, to our knowledge, none of these strategies has been validated. Chapter 3 
therefore introduces and validates a clinical decision framework, based on existing structures, to guide 
physiotherapists in defining the main problems for an ambulant child with bilateral spastic cerebral 
palsy. It thereby supports the selection of appropriate individual goals for the child.    
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There is lacking insight in the effectiveness of multifaceted physiotherapy approaches, tailored to the 
needs of the child and thereby, addressing more adequately the heterogeneity of the pathology and 
integrating all these aspects. Based on the goals selected in chapter 3, the evidence tables from 
chapter 1 and 2 can be used to select to the appropriate technique to reach the specific treatment 
goal. In this way, an individually defined, tailored treatment program can be defined.  
As a next step, the effectiveness of the individually defined programs on gait and gross motor function 
will be evaluated in an intervention study. To be able to set-up a blinded and randomized controlled 
study, objective and blinded evaluation is required. Objective evaluation of gait can be performed 
independently at the University Hospital Pellenberg, by means of three-dimensional gait analysis. 
Evaluation of gross motor function can at best be performed using the Gross Motor Function Measure 
-88. However, an obstacle for blinded evaluation of the test is the need for the child to feel 
comfortable. An assessor unknown to the child might make the child insecure, frightened and less 
compliant. Therefore, a reliability study will be performed to evaluate the agreement between live 
scores of the GMFM-88, performed by a person familiar to the child, and the blinded scores of the 
video-registrations by independent assessors (Chapter 4). 
Consequently, in chapters 5 and 6, the effectiveness of an individually defined treatment approach 
are compared to the effectiveness of a general program that is not based on individual problems of the 
child. 
Even though only weak evidence is available for the majority of the physiotherapy interventions in 
lower limb treatment, physiotherapy still remains a key treatment for children with CP.  This can mostly 
be supported by the fact that intervention studies in CP are limited by several factors and thereby face 
inevitable methodological difficulties. Although some researchers state that it is still very early for 
straightforward clinical guidelines, some key features need to be translated into practice. Chapter 7 
therefore evaluates evidence-based practice behaviour in usual care of ambulant children with 
bilateral CP. 
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5. Aims and outline of the project 
 
5.1 Aims and objectives 
 
The overall aim of the project is to validate and evaluate an individually defined targeted 
physiotherapy treatment approach for children with bilateral spastic cerebral palsy. 
 
The specific objectives of the of doctoral project are 
1. To define the effectiveness of the most commonly used techniques used in physiotherapy of 
children with CP, based on literature; 
2. To develop a clinical decision framework for the identification of main problems and treatment 
goals for ambulant children with bilateral spastic CP; 
3. To evaluate the validity and reliability of the Gross Motor Function Measure -88 by means of 
video-scoring; 
4. To evaluate the effectiveness of an individually defined targeted physiotherapy program on gait 
and gross motor function of ambulant children with bilateral CP.  
5. To evaluate evidence-based practice behaviour in usual care physical therapy in Flanders. 
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5.2 Outline 
 
Part 1 (chapter 1 and 2) describe a systematic literature search evaluating the effectiveness of the 
most commonly used techniques and approaches in lower limb physiotherapy treatment of children 
with spastic CP. The results of the reviews are used to develop evidence tables summarizing the 
effectiveness of the different techniques on the most main outcome parameters in treatment of these 
children. 
In part 2 (chapter 3), a clinical decision framework is developed to identify the main problems and 
treatment goals for ambulant children with bilateral spastic CP. This model is based on the 
International Classification of Functioning, Disability and Health and the Hypothesis Oriented 
Algorithm for Clinicians II. 
In part 3 (chapter 4), the agreement of the Gross Motor Function Measure-88 by means of blinded 
scoring of video-registrations is evaluated; 
In part 4 (chapter 5, 6 and 7) the effectiveness of the individually defined physiotherapy treatment 
approach based on the evidence tables developed in chapter 1 and the clinical decision framework in 
chapter 3 and 4, are evaluated for children with bilateral spastic CP.  
 Chapter 5 reports the results of a pilot study using a repeated measures design, comparing 
the effectiveness of the individually defined targeted treatment approach to the results of a 
general program and a period of usual care in ten children.  
 Chapter 6 describes a randomized controlled trial comparing the effectiveness of the 
individually defined treatment approach to the effectiveness of the general approach using 60 
interventions.  
 Chapter 7 evaluates evidence-based practice behaviour in usual care physiotherapy in 
Flanders. This study compares the effectiveness of a predefined therapy program based on 
evidence-based guidelines to the effects of a period of usual care. It is hypothesized that 
supporting therapists by providing a predefined evidence-based intervention program, results 
in an improved treatment outcome compared to the usual care physiotherapy.   
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Fig 1. Outline of the project. 
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Abstract 
 
Objective 
This systematic review provides an overview of the effectiveness of basic techniques used in lower 
limb physical therapy of children with cerebral palsy. It aims to support the development of clinical 
guidelines for evidence-based physical therapy planning for these children. 
 
Data sources and study selection  
A literature search in 5 electronic databases extracted literature published between January 
1995 and December 2009. Studies were evaluated using the framework recommended by the 
American Academy for Cerebral Palsy and Developmental Medicine (AACPDM), which classifies 
outcomes according to the International Classification of Functioning, Disability and Health. 
 
Data extraction  
Three independent evaluators rated the strength of evidence of the effects according to the AACPDM 
levels of evidence classification, and the quality of the studies according to the AACPDM conduct 
score system. 
 
Data synthesis  
A total of 83 studies was selected and divided into categories (stretching, massage, strengthening, 
electrical stimulation, weight-bearing, balance-, treadmill- and endurance training). Interventions 
targeting problems at body function and structure level generally influenced this level 
without significant overflow to activity level and vice versa. 
 
Conclusion  
The more recent studies evaluating strength training mainly demonstrated level II evidence for 
improved gait and gross motor function. There was limited evidence for specific information on 
intensity, duration and frequency of training. 
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Introduction 
 
Cerebral palsy (CP) describes a group of disorders of movement and posture that cause activity 
limitations. CP is attributed to non-progressive disturbances occurring in the developing foetal or infant 
brain
,1,2
 Physical therapy (PT) plays a major role in the treatment of children with CP. High intensities 
and frequencies of therapy are reported and varying approaches and techniques are used.
3
 In lower 
limb treatment, basic techniques, such as passive stretching, massage, muscle strengthening and 
many others, are frequently used. These basic techniques usually target specific problems at the level 
of body structure and function, such as range of motion (ROM), strength and muscle tone. More 
complex treatment approaches, such as neurodevelopmental treatment (NDT), Vojta therapy and Petö 
therapy are generally based on different principles of motor learning and require specific, specialized 
training. 
A structural basis for PT planning is provided by the International Classification of Functioning, 
Disability and Health for Children and Youth (ICF-CY).
4-7
  The ICF-CY describes a conceptual 
framework to report the variety of health information (diagnosis and functioning) and thereby delivers a 
common language and terminology to describe the child’s problems in relation to functions and 
anatomical properties, activity limitations and participation problems. Physical therapists can use the 
model to guide the selection of measurement tools, both in goal-setting and decision-making 
processes and to determine meaningful outcomes. 
Limited evidence is available on the effectiveness of different PT interventions in CP. A high-quality 
review by Anttila et al. included both upper- and lower-limb treatment and included randomized 
controlled trials (RCTs) only.
8
 This review found only limited evidence supporting strength training, 
constraint-induced movement therapy and hippo-therapy. 
In general, little consistency is provided on the use of different techniques in clinical practice of lower 
limb treatment in CP. While interventions at any of the elements of the ICF model may be important, 
each using different PT strategies and techniques
9
, only limited emphasis is put on differentiation of 
the outcome effects on the different levels of the ICF.  
 
This systematic review aims to summarize the effectiveness of different basic PT techniques used in 
children with CP and to differentiate the outcome effects on the different levels of the ICF. It thereby 
aims to identify interaction effects between the different outcome levels of the ICF and to explore the 
possibilities to develop clinical guidelines in PT treatment of children with CP. 
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Method 
 
Search strategy  
A systematic, stepwise search of the literature on PT in CP was performed using the following 
electronic databases: Web of Science, PubMed, Cochrane Library, Physiotherapy Evidence Database 
(PEDro) and CINAHL. The general search terms used were: “cerebral palsy” and “physiotherapy”, 
“physical therapy”, “exercise” and “training”. More specific search terms 
were: “stretching”, “electrical stimulation”, “electrostimulation”, “massage”, “strength”, “treadmill”, 
“balance” and “weight bearing”. Inclusion criteria were: original articles published in peer-reviewed 
journals between January 1995 and December 2009, focusing on PT interventions targeting lower 
limb treatment in children and adolescents (< 18 years) with CP. Only articles written in English were 
included. Articles including children with different pathologies or targeting upper limb or trunk only 
were excluded from the study. In addition, interventions using mixed approaches or techniques and 
post-surgical interventions were not included in the study. 
Based on the title and abstracts of the resulting articles, a first selection resulted in 159 articles. In a 
subsequent step, all articles were then screened by the first author. Articles not fulfilling the inclusion 
criteria were withdrawn. If the title and abstract did not provide sufficient information to fulfill the 
inclusion criteria, the full article was checked. In addition, all case-studies, expert opinions and non-
systematic reviews were excluded. As a final step, reference lists of all systematic reviews included in 
the study were searched and missing articles fitting the inclusion criteria were added. The inclusion of 
more doubtful articles was discussed with a second and third assessor. 
A resulting total of 83 studies was included in the study. A flow diagram of the selection process is 
shown in Fig 1. 
 
Data collection 
The full texts of all selected articles were read. The following data were extracted: type of PT 
intervention, numbers of patients included, topographic distribution of cerebral palsy, age of patients, 
type, frequency and duration of intervention, duration of follow-up, evaluation method and timing, 
summary of the results and conclusion.  
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Grouping data 
The selected articles were grouped according to the type of intervention used. Interventions at the 
level of body function and structure were stretching (n = 5), massage (n = 4), electrical stimulation (n = 
13), strength training (n = 25), endurance and physical fitness training (n = 10) and weight-bearing (n 
= 7). Interventions at both body structure and function and activity level were balance training (n = 6) 
and treadmill training (n = 13). Interventions using treadmill training were considered as a separate 
group, since mixed training goals, such as gait function, endurance or strength, made these articles 
difficult to categorize in one of the previous groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1. Flow-diagram describing the selection process  
First selection based on title and abstract (n=159) 
Exclusion  
 Non-systematic/general reviews (n=23) 
 Case-studies (n=14) 
 Expert opinions, editorials (n=4) 
 Mixed approaches (n=4) 
 Postsurgical interventions (n=7) 
Included from reference lists from 
systematic reviews (n=4) 
Excluded after reading full text (n=28) 
Included in systematic review: 
N= 83 
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Classification and rating of the different outcome measures 
Classification of outcome measures, rating of level of evidence and scoring of conduct scores was 
carried out by 3 independent evaluators: 1 PhD physical therapist (CVdB), 1 research physical 
therapist (IF) and 1 physical therapist MSc student (LVL). 
 
Classification of the outcome measure 
All 3 evaluators rated the outcome of the intervention on the level of the ICF: Body structure and 
function, Activities and Participation, Personal factors, and Environmental factors. Body structures are 
defined as the anatomical parts of the body, such as organs, limbs and their components. Body 
functions are the physiological functions of body systems (including psychological functions). Activity 
is the execution of a task or action by an individual. Participation is involvement in a life situation. 
Environmental factors make up the physical, social and attitudinal environment in which people live 
and conduct their lives. They can be viewed as facilitators (positive influence) or barriers (negative 
influence). Personal factors are the particular background of an individual’s life and living, and 
compromise features of the individual that are not part of a health condition. These factors may 
include gender, race, age and other health conditions.
7
  
 
Level of evidence 
The same independent evaluators rated the studies according to their level of evidence using the 
rating system proposed by the American Academy of Cerebral Palsy and Developmental Medicine 
(AACPDM) (Table 1).
10
  Level of evidence describes the potential in a research study design to control 
for factors, other than the intervention, that may affect the observed outcome. In descending order, the 
designs decreasingly demonstrate that the intervention, and not something else, is responsible for the 
observed outcome. Level I evidence is the most definitive for establishing causality, with greatest 
reduction in bias. Level IV evidence can only hint at causality; level V evidence only suggests the 
possibility.
10 
Reliability between the grading of the levels of evidence assigned by the different evaluators was 
tested in pairs, using an un-weighted Kappa coefficient. The Kappa coefficient varied between 0.608 
and 0.919. In a second step, all discrepancies were discussed. The raters argued the reasons for the 
score given. In case an agreement could not be found in this way, the score with the highest 
frequency was chosen (2 out of 3 raters scoring the same level of evidence). This final consensus 
score was used in the summary tables. 
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Table 1.  Hierarchy of levels of evidence based on research design types (Amercan Academy of 
Cerebral Palsy and Developmental Medicine) 
 
Level Intervention (group) studies Single Subject Research Design (SSRD) 
I Systematic review of randomized controlled trials 
(RCT’s) 
Large RCT’s with narrow confidence intervals 
(n>100) 
Randomized controlled n-of-1 (RCT) 
Alternating treatment design 
Concurrent or non-concurrent multiple baseline  
Generalizability if the ATD is replicated across three or 
more subjects and the MBD consists of minimum of three 
subjects, behavior setting. These designs can provide 
causal interferences 
II Smaller RCT’s with wider confidence intervals 
(n<100) 
Systematic reviews of cohort studies 
Outcomes research (large ecologic studies) 
Non-randomized controlled concurrent MBD 
Generalizability if design consists of minimum three 
subjects, behaviours or settings 
Limited causal interferences 
III Cohort studies with concurrent control group 
Systematic reviews of case control studies  
Non-randomized, non-concurrent, controlled MBD 
Generalizability if design consists of minimum of three 
subjects, behaviours or settings. 
Limited causal interferences. 
IV Case series 
Cohort studies without concurrent control group 
(eg historical control group) 
Case-control study 
Non-randomized controlled SSRD with at least three 
phases (ABA, ABAB, BAB etc) 
Generalizability if replicated across three or more 
different subjects. Only hints at causal interferences. 
V Expert opinion 
Case study or report 
Bench research 
Expert opinion based on theory or physiologic 
research 
Common sense - anecdotes 
Non-randomized controlled AB SSRD, generalizabiilty if 
replicated across three or more different subjects. 
Suggests causal interferences allowing testing of ideas. 
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Quality of the studies 
The conduct of the study rating indicates the extent to which a study applied the controls possible 
within the research design. Quality assessment was again performed by the same 3 independent 
evaluators, using the conduct score system proposed by the AACPDM (Table 2). For group designs, 
the conduct of an individual study is judged as “Strong” (yes on 6–7 questions), “moderate” (score 4–
5) or weak (≤ 3). For single subject designs, the conduct of an individual study is judged as strong (yes 
on 11–14 questions), moderate (scores 7–10) or weak (score < 7). Systematic reviews are also 
evaluated using this score system, reaching a maximum of 10 points. Inter-rater reliability of the 
conduct score system was tested resulting in an ICC score of 0.640 for group designs, 0.352 for single 
subject designs and 0.888 for systematic reviews. 
Larger discrepancies were discussed in a similar way to the quality rating score. The answers of the 
different assessors to the questions were compared and the questions causing the disagreement were 
traced. Again, the reasons for the scores given were discussed until agreement was found and if no 
consensus could be found, the score with the highest frequency was chosen. After this discussion, the 
conduct score was recalculated. These consensus scores were used in the summary tables. 
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Table 2. Assessment of study conduct as proposed by the AACPDM 
Conduct of group design studies 
1. Were inclusion and exclusion criteria of the study population well described and followed? 
2. Was the intervention well described and was there adherence to the intervention assignment? For 2-group designs, was the control exposure also well described?  
3. Were the measures used clearly described, valid and reliable for measuring the outcomes of interest? 
4. Was the outcome assessor unaware of the intervention status of the participants (i.e., were the assessors masked)? 
5. Did the authors conduct and report appropriate statistical evaluation including power calculations? Both parts of the question need to be met to score ‘yes’. 
6. Were dropout/loss to follow-up reported and less than 20%? For 2-group designs, was dropout balanced? 
7. Considering the potential within the study design, were appropriate methods for controlling confounding variables and limiting potential biases used? 
Conduct questions for single subject designs 
1. Was/were the participant(s) sufficiently well described to allow comparison with other studies or with the reader’s own patient population? 
2. Were the independent variables operationally defined to allow replication? 
3. Were intervention conditions operationally defined to allow replication? 
4. Were the dependent variables operationally defined as dependent measures? 
5. Was inter-rater or intra-rater reliability of the dependent measures assessed before and during each phase of the study? 
6. Was the outcome assessor unaware of the phase of the study (intervention vs. control) in which the participant was involved? 
7. Was stability of the data demonstrated in baseline, namely lack of variability or a trend opposite to the direction one would expect after application of the intervention? 
8. Was the type of SSRD clearly and correctly stated, for example, A-B, multiple baseline across subjects? 
9. Were there an adequate number of data points in each phase (minimum of five) for each participant? 
10. Were the effects of the intervention replicated across three or more subjects? 
11. Did the authors conduct and report appropriate visual analysis, for example, level, trend and variability? 
12. Did the graphs used for visual analysis follow standard conventions, for example x- and y- axes labeled clearly and logically, phases clearly labeled (A,B, etc.) and delineated with vertical lines, 
data paths separated between phases, consistency of scales? 
13. Did the authors report tests of statistical analysis, for example celeration line approach, two-standard deviation band method, C- statistic, or other? 
14. Were all criteria met for the statistical analyses used? 
Conduct scores for systematic reviews 
1. Were the search methods reported? 
2. Was the search comprehensive? 
3. Were the inclusion criteria reported? 
4. Was selection bias avoided? 
5. Were the validity criteria reported? 
6. Was validity assessed properly? 
7. Were the methods used to combine studies reported? 
8. Were the findings combined appropriately? 
9. Were the conclusions supported by the reported data? 
10. What was the overall scientific quality of the overview? 
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Results 
 
Stretching techniques 
Two systematic reviews and 3 interventions studies were found that used stretching techniques 
(Appendices, Table A). The intervention studies included one RCT
12
 and two single subject 
designs
11,13
 ,all with moderate conduct scores. A total of 47 children with CP were included in these 
studies. Effectiveness was evaluated on the level of Body structure only and demonstrated level II 
evidence for the positive effect of passive stretching on ROM and spasticity.
12,13
 Fragala et al. reported 
a significant deterioration in passive range of motion (pROM) after non-intervention periods longer 
than 5 weeks, but no significant change during the intervention periods.
11
 A limited positive additional 
effect was found when stretching was combined with electrical stimulation
12
 and heat application
13
. In 
addition, Lee & Ng indicated that sustained stretching of longer duration (minimum 30 s) was 
preferable to improve ROM and to reduce spasticity of the muscles around the targeted joints.
13 
The mean duration of treatment in the studies was 8.2 weeks (standard deviation (SD) 10.4), using a 
mean frequency of stretching of 4.5 times per week (SD 2.8). The 2 systematic reviews each included 
7 studies and confirmed the weak evidence on the effectiveness of passive stretching.
14,15 
 
Massage 
Four studies used different massage techniques in treatment of 125 children with CP (Appendices, 
Table B).  
On body structure and function, one level II study found a significant positive effect on spasticity, 
ROM, fine-and gross motor function and cognitive behaviour.
16
 However, similar effects were reported 
in the control group and the difference in progress between both groups was not evaluated. One level 
IV study found no significant effects on pROM and stretch reflexes
17
, another study demonstrated 
significant improvements on Psychological well-being and Satisfaction with Life scales.
18 
A similar 
study showed that children enjoyed the relaxing aspects of massage and reported a number of other 
improvements in their health, such as muscle relaxation, mobility and bowel movements and reduced 
pain.
19
  On activity and participation level, Hernandez-Reiz
16
 found significant positive effects on the 
Development Programming and Videotaped interactions, but Macgregor et al.
17
 could not find 
significant improvements in gross motor function measurement (by the Gross Motor Function 
Measure; GMFM). On environmental factors, one level IV study demonstrated improved parent 
anxious behaviour and depressed mood, stress, self-efficacy and satisfaction with life, together with 
subjective feelings of their child’s well-being and functioning after a 4-month training and support 
programme involving basic massage.
18 
The mean duration of the massage programme was 8.3 weeks (SD 2.9 weeks). Two studies reported 
a mean training frequency of twice per week, while in the two other studies the frequency was not 
specified.   
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Electrical stimulation 
Of the 13 articles using electrical stimulation, 3 interventions used threshold electrical stimulation 
(TES, lower level electrical stimulation causing no visual contraction, < 10 mA)
22-22
 and 8 intervention 
studies used neuromuscular electrical stimulation (NMES, higher level electrical stimulation causing 
visual contraction, > 10 mA)
23-32
. An overview of the studies using TES and NMES is given in 
Appendices, Tables C & D. 
The studies using TES included a total of 59 children. The conduct of these studies varied from 
moderate
18
 to weak
20-22
. On body structure and function, two level II studies based on a randomized 
controlled design found no significant long-term effect of TES on strength, ROM, deep tendon reflexes 
or muscle cross-sectional area of the m. quadriceps femoris and m. tibialis anterior
20,21
. Level IV 
evidence was found for the positive effect of 1 month of TES on ROM and selectivity.
22
 On Activity 
level, only level IV evidence was found for standing/hopping on 1 foot.
22
 Nevertheless, parents and 
children rated an important subjective feeling of improvement along with a high feeling of 
satisfaction.
20,21 
Seventy-eight children with CP were included in the 10 studies evaluating the effectiveness of NMES. 
On body structure and function, level II effectiveness was mainly demonstrated on strength
27
, muscle 
cross-sectional area
27
, ROM at the extremities
26,12,28
 and the trunk
23
 and on spasticity.
28,12,29
  On 
activity level, two level II studies showed significant better effects of NMES on the quality of gait and 
walking velocity compared with the control group.
24,28
 In a RCT design, Park et al. found significantly 
greater improvement on the sitting dimension of the GMFM in a group of children receiving electric 
stimulation of the abdomen and the back extensors compared with a control group.
23
 This positive 
effect on gross motor function could not be demonstrated by van der Linden
25
 and Kerr et al.
30
 On 
participation level, Kerr et al.
30
 measured statistically significant improvements on the Lifestyle 
Assessment Questionnaire and this provided level II evidence. The studies using TES were rather 
long-term and had a mean duration of 40.1 weeks (SD 23.9). The duration of the studies using NMES 
varied from 3 days to 12 weeks only, with a mean of 6.1 weeks (SD 4.7 weeks). The mean frequency 
of treatment was 4.95 and 9.37 times per week for TES and NMES, respectively.  
One RCT compared TES with NMES, but showed no significant difference on body function and 
structure or on activity level.
30
 One study compared the effectiveness of NMES with 15 s isometric 
voluntary contractions and reported improvements in strength and muscle morphology of the m. 
quadriceps femoris, but not in the triceps surae.
27
 In contrast to NMES, volitional isometric strength 
training did not significantly influence walking speed. 
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Strength training 
Twenty intervention studies and 6 systematic reviews evaluated the effect of strength training in 
children with CP. The studies were subdivided according to the specific modality of strength training 
used: isotonic strength training, functional strengthening exercises, isokinetic strength training, 
isometric strength training and mixed forms of strength training.  
Appendices, Table E summarizes the 11 studies evaluating the effectiveness of isotonic strength 
training. A total of 128 children with CP was included.  On the level of body function and structure, 7 
out of 8 studies evaluating the effect of isotonic strength training on strength registered significant 
improvements
32,33,35,38,40-42
,  including one study demonstrating level II evidence. Other level II 
evidence was demonstrated on economy of movement.
39  
Hints of causality or level IV evidence were 
found on muscle volume
42
 , energy expenditure
36
  and ROM
40
. A RCT by Dodd et al. demonstrated a 
significantly lower self-concept of scholastic competence and social acceptance in a group of 10 
children with CP participating in a home based strength training programme compared with a control 
group.
37
 However, another RCT by Unger et al. reported a significant improvement in the perception of 
body image of a group of children using circuit training.
39 
On activity level, level II evidence was found 
for the effectiveness on gait
39,41
 and gross motor function.
41 
No studies evaluated the effect of isotonic 
strength training on participation level.  
The studies using isotonic strength training reported only limited description of the resistance used 
during training. Three studies used a resistance of 65% of the one repetition maximum (RM) and one 
study used 80% of RM. The mean training frequency was 3.8 times per week, with a duration of 12.4 
weeks. All studies using isotonic strength training scored moderate to weak based on conduct scores.  
An overview of the different studies using functional, isokinetic, isometric and mixed strength training 
is provided in Appendices, Table F&G. 
Four studies evaluated the effects of functional strength training and included a total of 40 children 
with CP. Functional strength training often consisted of a home-based training programme, including 
task-oriented strength training during functional activities. Effects of functional strength training were 
demonstrated on Activity level: gross motor function significantly improved in one level II study (46). A 
high-quality RCT by Dodd et al. demonstrated significant effects on muscle strength, but only a trend 
towards improved gross motor function.
44
 Level IV evidence was also recognized for participation in 
school and leisure activities and self-perception.
45
 The studies frequently used 8–10 repetitions and 
had a mean duration of 5.4 weeks at a frequency of 2.4 times per week.  
Level II evidence was also found for isokinetic strength training and this on all levels of the ICF.
47,48
  
None of the studies using any form of strength training demonstrated an increase in spasticity. Only 9 
studies used a follow-up period, with an average duration of follow-up of 32 weeks. All these studies 
recognized a decrease in training results at all levels after a non-training follow-up period. 
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The studies demonstrate strong evidence of all forms of strength training on body structure and 
function, but to a lesser extent on activity and participation. Appendices, Table H provides an 
overview of the systematic review evaluating the effectiveness of strength training.
50-55
 The results are 
confirmed by all except one meta-analytic review on strength training by Scianni et al. stating that 
muscle strengthening is not effective in children with CP.
55
 However, since Scianni also included 
biofeedback and electrical stimulation under interventions of muscle strengthening the results cannot 
be compared with the results of this systematic review. 
 
Endurance training 
Eight intervention studies and two systematic reviews evaluated the effect of endurance training for 
children with CP, with a main focus on aerobic capacity (Appendices, Table I).
56-65
 A total of 108 
children were included in the intervention studies. Modalities used varied from walking and running to 
circuit training, cycling and mixed gymnastic exercises. 
On body function and structure, significant level II effects were mainly found for aerobic capacity
56,60
 , 
anaerobic capacity
60
, muscle strength
60
 , agility
60
 and oxygen uptake
62
. On Activity level, level II 
significance was reported for improvements in gross motor function.
60,62
 Improved Participation 
measured by use of the Children’s Assessment of Participation and Enjoyment (CAPE) was reported 
by Verschuren et al.
60
 Endurance training positively influenced quality of life (QoL) measured by the 
Health-Related Quality of Life (HRQoL) (level II evidence)
63
 and self-perception of physical 
appearance (level IV evidence)
57
. 
The mean duration of the training programmes was 13.3 weeks (SD 13.1). Four studies used a follow-
up period with a mean of 9.3 weeks.
57,59,60,63 
Weak to moderate conduct scores were found for all 
interventions. 
All studies reported little to no deterioration when comparing the measurements after follow-up with 
the immediate post-training results. The two systematic reviews on aerobic training both confirm the 
overall positive effects of endurance training in children with CP.
64,65
 Nevertheless, both reviews report 
low methodological qualities of the studies and lack of information on the effectiveness on daily activity 
and participation level. 
 
Weight-bearing 
Of the selected studies, 6 intervention studies and 1 systematic review investigated the effectiveness 
of weight-bearing activities in children with CP (Appendices, Table J).
66-72
 A total of 89 children was 
included in the studies. Included modalities were standing programmes in different types of walking 
frames and PT programmes focusing on weight-bearing exercises. The studies were of very low to 
moderate quality. 
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On body structure and function, two level II studies demonstrated a positive effect of increased weight-
bearing on bone mineral density.
66,69
 However, level IV evidence was demonstrated for a positive 
effect on bone mineral density
68
, ROM
67,70
 and bowel activity
71
. A positive effect on the behavioural 
characteristics and personal feeling of improved daily functioning was demonstrated with level IV 
evidence.
68
  
On activity and participation level, two level II studies evaluated the effectiveness of weight-bearing 
programmes on activities of daily living (ADL), functional performance and walking speed, but this did 
not yield statistical significance.
70,71 
The duration of the standing programmes was very variable and ranged from 2 weeks to 9 months, 
with a frequency ranging from 2 to 5 times per week. 
 
Balance training 
Five intervention studies and one systematic review evaluated the effectiveness of different forms of 
balance training for a total of 43 children with CP, each using different modalities (Appendices, Table 
K.
73-78
 Three studies used a moveable platform to train balance, with one study using additional visual 
feedback.
74-76 
On body structure and function, one study targeting specific sitting balance found significant positive 
effects on trunk control, as well as in the extremities.
73
 The studies mainly evaluated on Activity level 
and registered task-specific improvement meaning a reduced centre of pressure (CoP) area and a 
reduced stabilization time. One level II study also reported a more symmetrical walking pattern after a 
6-week training programme and one level III study reported visible improvements in GMFM-D (no 
statistics) after a 5-day training programme. One study using multidimensional random perturbation 
also evaluated on activity level only and found level II evidence for significant improvement on gross 
motor function together with an improved mechanical efficiency.
77 
The systematic review including 12 studies, reported low quality experiments providing low levels of 
evidence on the effectiveness of studies targeting postural control and balance.
78 
 
Treadmill training 
In the last years, treadmill training has become a very popular therapy method in CP. Three 
systematic reviews and 10 interventions studies (including 61 children) evaluated the effect of 
treadmill training in children with CP, with different objectives, such as gait rehabilitation, functional 
improvement and improvement of aerobic capacity (Appendices, Table L).
79-91
 Training modalities 
varied strongly among the different modalities, such as body weight support, treadmill speed (range 
0.25 km/h up to 5 km/h or as fast as possible) and duration (10–30 min). 
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On the level of body structure and function, weak level IV evidence was reported for positive effects on 
energy expenditure
85
 and H-reflex
87
. Effects of treadmill training in children with CP were mainly 
limited to activity level. Two level II
81,83
  and 5 level IV studies
82,84,85,87,88 
found significant effects on 
different gait parameters. One level II
84
  and one level IV
88
 reported a significant positive effect on 
gross motor function. The mean duration of the training periods was 6.4 weeks (SD 5.7 weeks) at a 
mean frequency of 6.7 times per week (SD 5.21). Three studies used a follow-up period, with a mean 
of 10.08 weeks. Results at follow-up are concurrent with the results of endurance training and also 
show very limited deterioration during the follow-up period. 
 
Summary of the results 
Table 3 provides an overview of the evidence of the different interventions. For this summary table, 
the most commonly used outcome parameters on the different levels of the ICF were selected.  
It compares the number of studies finding statistical significant effects on this parameter to the total 
number of specific interventions evaluating this parameter. Some level II RCTs did not statistically 
compare between-group differences in progress. Therefore, in Table 3, these studies are assigned to 
the level IV studies. Although the design of these studies could be rated as level II, statistically 
significant differences within in the experimental or control group only can be compared with the 
analysis of a level IV case series. 
On the level of body structure and function, the parameters spasticity, ROM, bone mineral density, 
energy expenditure, strength and muscle morphology were the most commonly used. As 
demonstrated in Table 3, level II evidence was most frequently demonstrated for the effectiveness of 
all forms of strength training on muscle strength. More conflicting evidence was found for the influence 
of NMES and endurance training on muscle strength. Weight-bearing positively influenced bone 
mineral density.  On the level of activity and participation, level II evidence for positive effects on 
different gait parameters were also demonstrated by different forms of strength training. In addition, 
treadmill training, NMES and balance were methods that significantly improve gait. The same is valid 
for effectiveness on gross motor function. Limited evidence was available on the most useful methods 
to improve participation, but this is mainly because studies rarely used participation as an outcome 
measure. 
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Table 3a. Overview of the number of studies demonstrating level II evidence 
Level II evidence 
 Muscle tone Bone mineral density Energy expenditure/movement efficiency 
Body 
structure 
and 
function 
stretching (1/1)
12 
weight bearing (2/2)
69,72 
isotonic strength training (1/1)
39 
NMES (1/2) 
24,28 
 functional strength training (1/1)
46 
TES (0/2) 
20,21 
 balance training (1/1)
77 
ROM Strength Muscle morphology/cross sect area 
stretching (1/1)
12 
NMES (1/3) 
25,27,30 
isometric strength training (1/1)
27 
NMES (1/4)
12,23,24,25 
TES (0/1)
20 
NMES (1/1)
27 
TES (0/2)
20,21 
isotonic strength training (1/1)
41 
TES (0/1)
21 
 functional strength training (1/2)
44,46 
 
 isometric strength training (1/1)
27 
 
 endurance training (1/2)
56,60 
 
 Gait Gross motor function Participation 
Activity 
and 
participat
ion 
NMES (1/3)
24,25,27 
NMES (1/3)
23,25,30 
endurance training (1/1)
60 
TES (0/1)
20 
TES (0/2)
20,21 
NMES (1/1)
30 
isotonic strength training 
(2/2)
39,41 
isotonic strength training (2/2)
39,41 
 
isometric strength training 
(1/1)
27 
functional strength training (1/2)
44,46 
treadmill training (1/1)
83 
endurance training (2/2)
60,62 
 
balance training (1/1)
75 
balance training (0/1)
77 
 
 
Abbreviations: 
…/… indicates the number of studies reaching significant treatment effects versus the total number of studies 
evaluating the effect of the interventions on that specific parameter 
In case of conflicting evidence, the reference demonstrating significant effects are in bold 
ROM: Range Of Motion; NMES: Neuromuscular Electrical Stimulation; TES: Threshold Electrical Stimulation 
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Table 3b. Overview of the number of studies demonstrating level III and IV evidence 
 
Level III and IV evidence 
Body 
structure 
and 
function 
Muscle tone Bone mineral density Energy expenditure/movement efficiency 
stretching (1/1)
13 
weight bearing (1/1)
74 
isotonic strength training (1/2)
34,39 
NMES (2/2)
28,29 
 treadmill training (1/1)
85 
treadmill training (0/1)
81 
 isokinetic strength training (0/1)
47 
massage (1/2)
16,17 
  
ROM Strength Muscle morphology/cross sect area 
stretching (2/2)
11,13 
isotonic strength training 
(6/7)
32,33,34,35,38,40,42 
isotonic strenght training (1/1)
13 
TES (1/1)
23 
functional strength training (1/1)
43 
 
NMES (2/2)
28,29 
isokinetic strength training (2/2)
47,48 
isotonic strength training 
(1/3
)35,40,42 
endurance training (1/1)
57 
 
massage (1/2)
16,17 
  
weight bearing (1/3)
70,71,73 
  
 Gait Gross motor function Participation 
Activity 
and 
participati
on 
NMES (1/1)
28 
TES (0/2)
20,21 
massage (3/3)
16,18,19 
isotonic  strength training 
(5/7)
32,34,35,36,38,40,42 
isotonic strength training (3/4)
34,38,40,42 
treadmill training (1/2)
84,88 
functional strength training (1/1) functional strength training (1/1)
43 
Environmental factors 
endurance training (1/1)
63 
isokinetic strength training (2/2)
47,48 
massage (1/1)
18 
treadmill training 
(6/7)
79,81,82,84,85,87,88 
endurance training (2/2)
61,63 
isokinetic strength training (1/1)
48 
isokinetic strength training 
(1/1)
48 
treadmill training (2/5)
79,81,84,85,88 
weight bearing (1/1)
74 
 massage (1/2)
16,17 
Quality of Life 
 balance training (1/2)
73,74 
treadmill training (1/1)
86 
   isokinetic strength training (1/1)
48 
 
Abbreviations: 
…/… indicates the number of studies reaching significant treatment effects versus the total number of studies 
evaluating the effect of the interventions on that specific parameter 
In case of conflicting evidence, the reference demonstrating significant effects are in bold 
ROM: Range Of Motion; NMES: Neuromuscular Electrical Stimulation; TES: Threshold Electrical Stimulation 
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Discussion 
 
This systematic review evaluated the effectiveness of different basic PT techniques used in the 
treatment of children with CP. Eighty-three articles were included, comprising 27 RCTs, 16 systematic 
reviews, 11 single-subject designs and 29 prospective, non-randomized trials. One study 
demonstrated level I evidence, 44 studies level II, 2 studies level III and 34 studies level IV. Since 
case-studies and non-systematic reviews were excluded, only 2 studies were included with level V 
evidence. These numbers demonstrate that, high-quality research is possible and being done. It 
should be noted that studies demonstrating high levels of evidence did not necessarily reach high 
conduct scores. even well-designed RCTs often showed methodological difficulties, such as a small 
number of participants, a lack of control over different confounding variables and an inappropriate 
description of the exercises used in the control group. Statistically, RCT designs often missed an 
appropriate comparison of between-group differences in treatment effects. on the other hand, some 
single-subject research designs (SSRDs) and prospective interventions used a relatively high number 
of participants and reached high conduct scores with an adequate control over confounding variables. 
For this reason, lower level of evidence designs were also included in this systematic review. 
Nevertheless, the authors support the AACPDM statement that level IV and V studies only hint at 
causality and the results of these studies should be interpreted very cautiously. Low to moderate 
agreement was found for the rating system on the conduct score system and this was specifically a 
problem for the SSRDs. The evaluators encountered difficulties when scoring the last questions 
regarding visual and statistical analysis. These questions were obviously more open for interpretation 
and therefore more subject to individual opinion. 
Other weaknesses of the conduct score system was the fact that it did not consider the number of 
subjects in the studies and also did not take into account that some questions may be more critical 
than others. The conduct scoring system therefore was found to be valuable in giving a general score 
for the quality of the interventions, but should also be interpreted cautiously. Only one study reported 
adverse effects. Dodd et al.’s results suggested that participation in a relatively short home- based 
strength training programme may have an inhibitory effect on the self-concept of children with CP.
37
 
despite the inhibitory effect, self-concept in the experimental group remained positive after strength 
training, suggesting that clinicians should not be overly concerned about the psychological effects of 
the intervention. However, this study does demonstrate that we have to appreciate the fact that 
children with CP may show different values from their therapists. 
A wide variety of frequencies and intensities were used in the intervention studies, and thus the 
optimal training modalities remain open for discussion. For strength training, many different types of 
resistive exercises were used and in physical fitness or endurance training, different training heart 
rates and durations of trainings were used. This indicates a need for structured research comparing 
different training intensities, which is necessary to develop more specific clinical guidelines. 
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Strength interventions often do not respect adequate training principles according to the training 
recommendations by the National Strength and Conditioning Association
92
: the age of the children is 
often not appropriate, the training intensity is often insufficient or the duration of training is too short. 
This might be another reason why Scianni et al.
55
 and Verschuren et al.
93
 did not find significant 
results regarding the effectiveness of strength training. 
Another important issue is the fact that a lack of evidence does not always reflect a lack of 
effectiveness. In particular, the lack of control over confounding variables was often a major problem 
limiting the studies to demonstrate evidence. Careful interpretation is advised, considering the large 
numbers of studies evaluating, for example, strength training in comparison with a much lower number 
of studies evaluating the effectiveness of massage or stretching. In addition, a higher number of 
studies evaluated the effectiveness of the level of body structure and function in comparison with the 
number of studies using outcome parameters on activity and participation level. Older studies in 
particular often restricted their outcome parameters to the level of body structure and function. 
None of the studies differentiated outcome effects according to the age or functional level of the 
participants. However, many studies use a wide age range and a large variety in functional level in 
their inclusion criteria. Nevertheless, a young child with mild unilateral CP might benefit from a 
completely different treatment approach with different techniques from a teenager with severe bilateral 
CP. Concerning effects on gross motor function, in particular, it is important to consider the expected 
outcome related to age and GMFCS level. A younger child with a GMFCS level I or II usually develops 
more in the natural course of development than an older child with a GMFCS level IV or V.
94-96 
A restriction of the ICF model was found in the scoring of the parameter QoL, a problem that was 
previously reported in the literature.
97
 The World Health Organization (WHO) defines QoL as “an 
individual’s perception of their position in life in the context of the culture and value system in which 
they live and in relation to their goals, standards and concerns”.
98
 WHO suggests that QoL can be 
broken down into different domains: physical, psychological, social relationships and environmental. 
Given the inclusion of personal and environmental factors in its model of functioning and disability, the 
ICF encompasses all domains that comprise human life and thus impact QoL. The components of 
functioning and contextual factors can be seen as the various manifestations of a person’s QoL. In this 
systematic review, not many interventions used QoL measures in their outcome parameters. However, 
to be able to give this discussion a place, the authors have scored these parameters under a separate 
category of QoL. 
This systematic review did not include mixed or eclectic approaches. This decision was based mainly 
on the methodological limitations of mixed interventions to distinguish the causes of the different 
reported effects. Nevertheless, the results of this review indicate that, in clinical practice, one might 
have to combine different techniques and methods in order to have a meaningful outcome. 
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Summarizing the effectiveness of all these interventions demonstrates that the ICF model provides a 
good model to evaluate the effectiveness of different physiotherapy interventions for CP. The results 
reveal very limited interactions between the different levels of the ICF. In general, interventions 
targeting problems at body function and structure, mainly influence body structure and function with 
only limited overflow to activity level. Stretching only significantly improved ROM and spasticity, 
without evidence of improved ROM during walking or other functional activities. only for the different 
forms of strength training and for NMES, effectiveness was also demonstrated on activity level. 
Likewise, interventions at activity level directly influenced motor functions, but limited evidence was 
available for direct influence on impairment problems such as strength, ROM or spasticity. It was even 
more challenging to look for interaction effects of participation and other ICF levels. 
This leads to the conclusion that a targeted treatment approach based on a complete and extensive 
evaluation on all levels of the ICF is necessary to create an appropriate treatment plan. In true efforts 
to increase independence and to prevent secondary disabilities, the child should be considered as a 
whole. The PT treatment plan should therefore comprise specific goals and exercises targeting the 
individual problems specified on each level of the ICF. Specific motor learning strategies might be 
necessary to integrate the different components of impairment level during functional activities. The 
effectiveness of different general conceptual approaches will therefore be investigated in a 
subsequent paper.
100
 The aim of developing further specific clinical guidelines cannot yet be fulfilled 
with the present paper. Only a limited number of clinical messages could be deduced. Developing 
clinical guidelines should, however, be an important extra step, to be performed in a systematic way 
and based on both literature and expert opinion. 
Conclusion 
 Interventions targeting problems at body function and structure generally influenced this level  
without significant overflow to activity level and vice versa.  
 Stretching can be useful to improve ROM in children with CP. The stretch should preferably be 
maintained for a minimum of 30 s.  
 Conflicting evidence is available on the effectiveness of electrical stimulation strength. NMES 
(visual contraction, > 10mA) is preferable.  
 Strength training is very effective in improving muscle strength and into a lesser extends to 
improve gait and motor function. Resistance of 65–80% of one RM seems to be well tolerated 
by the children. Effects seem to be lost relatively quickly after stopping the programme.  
 Treadmill training is beneficial in improving gait and endurance in children with CP. With partial 
body weight support, treadmill training can be effective in very young children with CP.  
 Endurance training is useful to improve aerobic endurance. effects seem to last minimally as 
long as the training programme itself. A training heart rate of 75% of the maximum heart rate 
seems to be well tolerated.  
 Massage improves the feeling of well-being in children with CP and their parents.  
 Balance training is optimally trained in a task-specific context.  
 Weight-bearing is useful to improve bone mineral density in children with CP.   
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Abstract 
 
Objective 
This systematic review provides an overview of the effectiveness of conceptual approaches and 
additional therapies used in lower limb physical therapy of children with cerebral palsy and supports 
the development of clinical guidelines. 
Data sources and study selection 
A literature search in 5 electronic databases was performed, extracting literature published between 
1995 and 2009. Studies were evaluated using the framework recommended by the American 
Academy for cerebral Palsy and Developmental Medicine (AACPDM), which classifies outcomes 
according to the International Classification of Functioning, Disability and Health (ICF). Data 
extraction: three evaluators rated the strength of evidence of the effects according to the AACPDM 
levels of evidence classification, and the quality of the studies according to the AACPDM conduct 
score system. 
Data synthesis 
A total of 37 studies used conceptual approaches (neurodevelopmental treatment (NDT), conductive 
education, Vojta therapy, sensory integration, functional training and goal-oriented therapy) and 21 
studies focused on additional therapies (aquatic therapy and therapeutic horse-riding). 
Conclusion 
Level ii evidence was found for the effective- ness of therapeutic horse-riding on posture and for NDT 
and functional training on gross motor function. Goal-oriented therapy and functional training were 
effective on the attainment of functional goals and participation. With level IV evidence, NDT was 
effective on all levels of the ICF. 
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Introduction 
 
Cerebral palsy (CP) describes a group of disorders of movement and posture that cause activity 
limitations. CP is attributed to non-progressive disturbances occuring in the developing foetal or infant 
brain.
1,2 
The effectiveness of different basic physical therapy (PT) techniques in the treatment of 
children with CP has been described in a previous article.
3
 The results of that analysis revealed limited 
interaction effects between the different levels of the International Classification of Function, Disability 
and Health (ICF) of the World Health Organization (WHO), thereby suggesting that specific 
neurological approaches and motor learning strategies might be necessary to facilitate these 
interaction effects. 
Different principles of motor learning can be recognized. Neurophysiological and neuromaturational 
approaches are based largely on assumptions drawn from the neuromaturational theories of 
development. The main assumption of these theories is that the development of movements and 
motor skills result solely from the neurological maturation of the central nervous system (CNS): higher 
centres inhibit and control lower centres, thereby allowing voluntary movement.
4 
That initial theory of 
motor development has evolved, with more recent theories of motor learning emphasizing that motor 
behaviour or developing behaviours should not be viewed as the unfolding of predetermined patterns 
represented in the CNS. These approaches favour a more heterarchical view, in which motor 
development and coordination are assumed to emerge from the dynamic interaction of many 
subsystems in a task-specific context. These approaches, therefore, are based on an active rather 
than a passive view of motor learning. People learn by actively attempting to solve the problems 
inherent to a functional task.
5,6 
In treatment of CP, various approaches are based on differ- ent theories of motor learning. Commonly 
used approaches in treatment of children with CP are neurodevelopmental treat- ment (NDT) or 
Bobath therapy, conductive education (CE) by Pet , reflex locomotion therapy by  ojta, and functional 
task-oriented training. Other methods used are the patterning method by Doman & Delacato, and 
sensory integration by Ayres. 
NDT or Bobath therapy (Karl & Bertha Bobath, 1943) is an interdisciplinary problem-solving approach 
to the assessment, treatment and management of individuals with changes in sensorimotor, 
perceptual and cognitive function, tone and patterns of movement resulting from a CNS lesion.
7,8
 In 
the last decade, especially, the use of NDT in treatment of children with CP has been controversial, 
with the most common concern that NDT insufficiently targets functional activities and participation by 
using only neuromaturational strategies in learning.
9 
CE (Andreas Pet , 1 4 ) is based on an educational rather than on a medical model of intervention. 
CE integrates edu- cational and rehabilitation goals into a single programme to assist children with 
motor dysfunction to attain orthofunction, enabling them to attend school with maximum independence 
.
10
 Repetitive learning is a central aspect within CE. In the same way as for NDT, several objections 
have been raised against CE, and cost-effectiveness, especially, is seen as a major concern.
11  
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In the Vojta method (Vaclav Vojta, 1968) normal patterns of movement sequences, for example, 
reaching and grasping, standing up and walking, are not taught or trained as such. Vojta therapy 
rather stimulates the brain, activating “innate, stored movement patterns”, which are then “exported” 
as co- ordinated movements involving the musculature of the trunk and extremities.
12 
Functional and task-oriented training are based on learning motor abilities that are meaningful in the 
child’s environment and perceived as problematic by either the child or the parents.
5,6
 The child has an 
active role in finding solutions to motor problems rather than the physical therapist providing a solution 
using handling. Functional goals are established with parents and children based on their priorities 
and functional activities are assumed to be learned by repetitive practice of goal-related tasks in 
functional situations.
5,6 
A closely related approach is the method of individual goal setting, as proposed by Bower et al..
13
 Like 
functional and task-oriented training, this strategy uses the identification of individually defined tailor-
made goals to structure the therapy process.
13
 However, the approach is not necessarily based on 
repetitive learning, but sometimes uses an eclectic approach or a mixture of different techniques.  
The patterning method (Doman & Delacato, 1955) derives from a phylogenetic interpretation of 
development. The therapeutic programme aims to recapitulate the physiological stages of motor 
development through exercises, by the involuntary imposition of patterns of activation or by having the 
child voluntarily practice, presumably missed, earlier stages of mastery.
14 
Sensory integration (Jean Ayres, 1960) refers to a theory and a neurological process that enables the 
individual to take in, interpret, integrate and use the spatiotemporal aspects of sensory integration 
from the body and the environment to plan and produce organized behaviour. It postulates that 
learning is dependent on the ability of normal children to take in sensory information derived from the 
environment and from movement of their bodies, to process and integrate these sensory inputs within 
the CNS and to use this sensory information to plan and produce organized behaviour.
15 
Besides these conceptual approaches, therapeutic horse- riding or hippotherapy and aquatic therapy 
or hydrotherapy are frequently used additional therapies for children with CP, with many different 
opinions regarding their effectiveness.
16,18 
Despite the frequent use of these treatment strategies, the effectiveness of these interventions is not 
clear and, especially, effectiveness on the different levels of the ICF has not been elucidated. Little 
consistency is provided on the use of these different approaches in clinical practice of lower limb 
treatment in CP. However, a differentiation of the effects supports a targeted treatment approach 
based on an adequate selection of intervention type adjusted to the specific therapy goal. 
This systematic review aims to summarize the effectiveness of different conceptual approaches and 
additional therapies used in children with CP and to differentiate the outcome effects on the different 
levels of the ICF. It thereby aims to identify interaction effects between the different outcome levels of 
the ICF and to explore the possibilities of developing clinical guidelines in PT treatment of children with 
CP. 
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Method 
 
Search strategy 
A systematic, stepwise search of the literature on PT in CP was performed using the following 
electronic databases: Web of Science, PubMed, Cochrane Library, Physiotherapy Evidence Database 
(PEDro) and CINAHL. General search terms used were: “cerebral palsy” and “physiotherapy”, 
“physical therapy”, “exercise”, and “training”. More specific search terms were: “functional training”, 
“functional therapy”, “neurodevelopmental treatment”, “ obath”, “Pet ”, “conductive therapy”, 
“conductive education”, “ ojta”, “reflex locomotion”, “patterning”, “doman delacato”, “sensory 
integration”, “hydrotherapy”, “aquatic therapy”, “hippotherapy”, “horse-riding” and “goal-setting”. 
Inclusion criteria were: original articles published in peer-reviewed journals between January 1995 and 
December 2009, focusing on PT interventions targeting lower limb and trunk treatment in children and 
adolescents (< 18 years) with CP. Only articles written in English were included. Articles including 
children with different pathologies or only targeting the upper limb were excluded from the study, as 
were interventions using mixed approaches or techniques. 
Based on the title and abstracts of the articles, a first selection resulted in 127 articles. All articles were 
subsequently screened by the first author. Articles not meeting the inclusion criteria were withheld. If 
the title and abstract did not provide sufficient information to fulfil the inclusion criteria, the full article 
was checked. In addition, all case studies, expert opinions and non-systematic reviews were excluded. 
As a final step, the reference lists of all systematic reviews included in the study were searched, and 
missing articles meeting the inclusion criteria were added. The inclusion of doubtful articles was 
discussed with a second and third assessor. 
A resulting total of 58 studies was included in the study. A flow diagram of the selection process is 
shown in Fig 1. 
 
Data collection 
The full text of all selected articles was read. The following data were extracted: type of intervention, 
numbers of patients included, topographic distribution of cerebral palsy, age of patients, type, 
frequency and duration of intervention, duration of follow-up, evaluation method and timing, summary 
of the results, and conclusion. 
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Fig 1. Flow chart describing the selection process  
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General and specific search terms 
Web of Science, PubMed, Cochrane Library, 
Physiotherapy Evidence Database (PEDro) and 
CINAHL 
Peer reviewed journal jan 1995 - dec 2009 
 
First selection based on title and abstract (n=127) 
Exclusion  
 Non-systematic and general reviews (n=29) 
 Case-studies (n=6) 
 Expert opinions, editorials (n=6) 
 Postsurgical interventions (n=4) 
 Mixed interventions (n=1) 
Included from reference lists from 
systematic reviews (n=3) 
Excluded after reading full text (n=26) 
Included in systematic review: 
N= 58 
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Grouping data 
The selected articles were subdivided into two categories: a first group of articles covering the 
conceptual PT approaches (n = 37), and a second group of articles focusing on additional therapies (n 
= 21). 
Classification and rating of the different outcome measures 
Classification of outcome measures, rating of the level of evidence and scoring of conduct scores was 
carried out by 3 independent evaluators: 1 PhD physical therapist (CVdB), 1 research physical 
therapist (IF) and 1 physical therapist MSc student (CD). 
Classification of the outcome 
The evaluators classified the outcome of the intervention on the level of the ICF model: body structure 
and function, activities and participation, personal factors and environmental factors. 
Body structures are defined as the anatomical parts of the body, such as organs, limbs and their 
components. Body functions are the physiological functions of body systems (including psychological 
functions). Activity is the execution of a task or action by an individual. Participation is involvement in a 
life situation. Environmental factors make up the physical, social and attitudinal environment in which 
people live and conduct their lives. They can be viewed as facilitators (positive influence) or barriers 
(negative influence). Personal factors are the particular background of an individual’s life and living 
and comprise features of the individual that are not part of a health condition. These factors may 
include gender, race, age and other health conditions.
19 
Level of evidence 
The same 3 independent evaluators rated the studies according to their level of evidence using the 
rating system proposed by the American Academy of Cerebral Palsy and Developmental Medicine 
(AACPDM).
20
 Level of evidence describes the potential in a research study design to control for 
factors, other than the intervention, that may affect the observed outcome. In descending order, the 
levels of evidence decreasingly demonstrate that the intervention, and not something else, is 
responsible for the observed outcome. Level I evidence is the most definitive for establishing causality, 
with greatest reduction in bias. Level IV evidence can only hint at causality; level V evidence only 
suggests the possibility.
20
 Any discrepancies were discussed and a final agreement score was used. 
In a first step, agreement between the grading of the levels of evidence assigned by the different 
evaluators was tested in pairs, using a Kappa coefficient. The resulting agreement scores varied 
between 0.604 and 0.780. 
As a second step, all discrepancies were discussed. The raters argued the reasons for the score 
given. If an agreement could not be found in this way, the score with the highest frequency was 
chosen (2 out of 3 raters scoring the same level of evidence). This final consensus score was used in 
the summary tables. 
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Quality of the studies 
The conduct of the study rating indicates the extent to which a study applied the control possible within 
the research design. Quality assessment was performed using the conduct score system proposed by 
the AACPDM.
20
 For group designs, the conduct of an individual study is judged as “strong” (yes on 6–
7 questions), “moderate” (score 4– ) or weak (≤ 3). For single subject designs, the conduct of an 
individual study is judged as “strong” (yes on 11–14 questions), moderate (score 7–10) or weak (score 
< 7). Systematic reviews are also evaluated using a score system, reaching a maximum of 10 points. 
Validity assessment of the studies was performed by 3 independent evaluators. Similarly to the quality 
rating score, larger discrepancies were discussed and an agreement score was used. Inter-rater 
reliability of the validity assessment system was tested, resulting in an Intraclass Correlation 
Coefficient (ICC) score of 0.927 for group designs, 0.947 for single subject designs, and 0.906 for 
systematic reviews. 
Similarly to the quality rating score, larger discrepancies were discussed. The answers of the different 
assessors to the questions were compared and the questions causing the disagreement were traced. 
Again, the reasons for the scores given was discussed until an agreement was found and if no 
consensus could be found, the score with the highest frequency was chosen. After this discussion, the 
conduct score was recalculated. These consensus scores were used in the results tables. 
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Results 
 
Within the category of conceptual approaches, the included articles were grouped according to their 
named approach: Bobath or NDT (n = 13), Vojta or reflex locomotion therapy (n = 1), Pet  or CE (n   
13), Doman Delacato or patterning (n = 0), a goal-oriented approach (n = 3), functional training (n = 6) 
and sensory integration according to Ayres theory (n = 1). 
 
Neurodevelopmental treatment or Bobath therapy 
Eleven intervention studies, which included a total of 181 children with CP, evaluated the effect of 
NDT (Appendices, Table M).
21,23 
Five studies used a single-subject research design (SSRD), 3 
studies were case series and 3 studies used a randomized control trial (RCT) design. The conduct 
scores thereby varied between weak (n = 2), moderate (n = 7) and strong (n = 2). The mean duration 
of the NDT treatment was 18.0 weeks (standard deviation (SD) 16.5 weeks) with a mean frequency of 
4 times per week. 
No level II evidence was found for the effectiveness of NDT on the level of body structure and 
function. Level IV evidence was found on posture
22
, spasticity
25
, range of motion (ROM)
25
 and 
mechanical efficiency
29
. On activity level, level II and III evidence was found for the effectiveness of 
NDT on gross motor function.
26,28
 Two other level II studies could not find significant effects on gross 
motor function: one study focused on treatment contexts
21
 and one study on the frequency of 
intervention.
28
 In these studies, however, significant improvements in gross motor function were 
registered in the intervention group (within- group differences), but no significant between-group 
differences were found when compared with the control group. One level III study found significant 
effects on participation and this on self-care and caregiver assistance.
26 
It should be noted that many of the studies were RCTs comparing different interventions, using NDT 
as a control intervention. Therefore, the results of these studies could not be scored as level II 
evidence and had to be scored as level IV evidence. Kerem compared a group of children receiving 
frequent NDT combined with Johnstone pressure splints (JPS) with a group of children receiving only 
NDT, and found a significantly higher improvement in ROM and spasticity in the combination group.
25
 
A high-quality RCT by Bar-Haim compared a group of children receiving Adeli Suit with a group of 
children receiving NDT.
29
 The results demonstrated a superior effect of Adeli Suit treatment on 
mechanical efficiency during activities, while no differences were found when evaluated on activity 
level using the Gross Motor Function Measure (GMFM). In a complex SSRD comparing an AAB with 
an ABA design, Cherng compared the effectiveness of a NDT programme with a combined 
programme of NDT and body weight supported treadmill training.
30
 The results of this study 
demonstrated no significant effects on gait parameters or gross motor function after the periods of only 
NDT. 
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Trahan & Malouin
27
, Tsorlakis
28
 and Christiansen
31
 all focused on frequency of intervention. Where 
Tsorlakis underlined the importance of an intensive treatment regime of 5 times per week
28
 Trahan & 
Malouin and Christiansen supported the feasible option of using intermittent periods with lower 
treatment frequencies. Both researchers demonstrated only a limited deterioration in gross motor 
function during these periods.
27,31 
There have been two previous systematic reviews evaluating the effectiveness of NDT in children with 
CP, which concluded that there was insufficient evidence to support NDT at the time of their review. 
Both reported the problems of evaluating and interpreting research results due to marked 
standardization problems in therapy, clinical and environment aspects.
32,33
 The interventions evaluated 
by Butler & Darrah
32
 and Brown & Burns
33
 were much older and therefore there was only a limited 
overlap of 1 and 3 studies, respectively, with our review. 
 
                                       
Ten intervention studies evaluated the effectiveness of CE, including two RCTs and 8 case series and 
non-randomized controlled trials (Appendices, Table N).
10,34-45
 A total of 185 children with CP were 
included in the intervention studies. The duration of the interventions was relatively long, with a mean 
of 30.1 weeks (SD 46.9) and high frequency of intervention of 4.6 times per week (SD 0.42). It was 
remarkable that 8 of the 10 interventions demonstrated weak conduct scores. 
No level II evidence was found for the effectiveness of CE. 
On body function and structure, the effectiveness of CE was only demonstrated with level IV evidence 
on language skills.
37 
On activity level, the effectiveness of CE was demonstrated with level IV evidence 
on gross motor skills and individual motor goals.
36,40,44
 Conflicting level IV evidence was available on 
participation
36,38,40,42 
as well as on environmental factors parental coping and stress 
34, 35, 38, 40
. The 
systematic reviews evaluating CE concluded positive effects of CE on motor function of children with 
CP, with effects comparable to the effects of different treatment approaches.
10,44,45
 Training in a group 
probably had a significant social impact. 
 
Sensory integration according to Ayers 
One study was found evaluating the effectiveness of sensory integration (SI) in children with CP.
15
 
(Appendices, Table O) This study, based on a RCT, compared the effectiveness of sensory training, 
vestibular training, balance and postural reactions, bimanual activities and motor planning with the 
effectiveness of a home-based training programme. Effects were evaluated on Impairment and Activity 
level using the Ayers Southern Californian Sensory Integration test and on activity level using the 
Physical Ability Test. The results revealed significantly positive effects in favour of the children 
receiving sensory integration programme on both levels. Although this study had a level II design 
(RCT), the conduct score of this study was rated as “weak”. In addition, the study statistics were 
limited to within-group effect sizes. 
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Reflex locomotion therapy or Vojta therapy 
One level II study evaluated the effectiveness of reflex locomotion according to Vojta.
46
 (Appendices, 
Table O) and this only on activity level. Kanda evaluated a group of 5 children with CP receiving 
intensive Vojta therapy for 52 months. Comparing this group of children with 2 children re- ceiving no 
therapy and 3 children receiving insufficient therapy, revealed a significantly higher motor 
development level in the children following Vojta therapy. Taking into account the low quality (conduct 
score of 2/7) and the small number of participants in this study, no conclusions can be drawn on the 
effectiveness of Vojta therapy. 
 
Patterning according to Doman Delacato 
No study was found evaluating the effectiveness of patterning according to Delacato in children with 
CP. 
 
Functional and task-oriented training 
Six studies, including a total of 85 children, evaluated the effect of functional and task-oriented 
training, which mostly consisted of group training targeting specific activities of daily life.
4, 5, 47–50
 
(Appendices, Table P) These programmes were task-specific, with more attention on successful 
accomplishment of the specific tasks rather than quality of movement. Most of the studies used a 
variety of functional exercises and 1 study used a coordination dynamics board.
47 
On body structure and function, only weak evidence (level IV) was found for ROM, spasticity, and 
selective muscle activation.
50
 No significant level II effects were found on strength. Effects of the 
functional training programmes were mainly found on activity level, with level II evidence on gross 
motor function and on different functional ambulation tests.
5,48,49
 One level IV and 1 level II study 
reported improved Participation measured by Pediatric Evaluation of Disability Inventory (PEDI) self-
care and mobility scores.
5,6 
The mean duration of training was 21.8 weeks (SD 23 weeks). Three studies included a follow-up, 
with a mean follow-up period of 10.3 weeks. The intensity of treatment ranged from very intense (2 
times per day) to 3 times per month. 
 
Goal-oriented approach 
Three studies evaluated the effect of a goal-oriented approach in in total of 72 children with CP 
Appendices, Table Q).
13, 51, 52
 Setting goals involves identify- ing and formulating standards of motor 
activity that are in advance of the child’s current capacity or which slow down deterioration. Therefore, 
goals need to be formulated in such a way that there is no doubt about the extent to which they have 
been achieved when performance is reviewed.
13
 In two RCTs (level II), Bower et al. compared the 
effect of therapy based on specific and SMART (Specific, Measurable, Attain- able, Realistic and   
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Timely) formulated goals with therapy based on general aims.
13,51
 Significant effects were thereby 
highlighted on Activity level, with a positive effect on motor development evaluated by GMFM, but only 
in the short term. A more recent study by L wing compared goal-directed functional therapy with 
activity-focused therapy.
52
 This study demonstrated significantly clearer gains both on activity (gross 
motor function) and participation (measured with the PEDI) in the group of children receiving goal-
directed functional therapy. 
 
Within the category of additional therapies, a subdivision was made in a group of therapies using 
exercises in water (hydrotherapy, aquatic exercise) (n = 4) and horseback riding (therapeutic 
horseback riding, hippotherapy) (n = 14). 
Aquatic therapy or hydrotherapy 
Four studies evaluated the effect of different aquatic therapy interventions in 66 children with CP, 
varying from swimming training sessions to individual aquatic exercises (Appendices, Table R). 
53–56
 
The mean duration of the aquatic training programmes was 17.5 weeks (SD 1.91), with a mean 
frequency of 2.75 times per week. Three studies used a RCT design; however, they were rated with 
very weak conduct scores.
53,54,56
 on the other hand, the single subject design was rated with a 
moderate conduct score.
55 
On body structure and function, level II effectiveness was demonstrated on vital capacity after 26 
weeks of swimming sessions.
53
 Nevertheless, this study was rated as weak, based on the conduct 
score. Furthermore, positive effects of aquatic therapy were demonstrated on self-perception, body 
awareness and child behaviour.
54,56
 on Activity level, level IV evidence was demonstrated as 
significantly improved water-orientation skills, improved functional mobility and gross motor function 
.
53,56 
 
Therapeutic horse-riding or hippotherapy 
Fourteen intervention studies including 217 children evaluated the effectiveness of hippotherapy in 
children with CP (Appendices, Table S).
57–73
 The mean duration of therapy was 12.8 weeks (SD 5.7 
weeks) with 4 studies, including a follow-up period of a mean duration of 11 weeks. Four RCTs, 5 
case series and non-randomized controlled trials and 5 single-subject designs were selected. The 
majority of the studies had moderate conduct scores. 
On body structure and function, level II evidence was demonstrated on trunk and pelvic posture and 
stability
58, 63
 and child behaviour.
57
 Level IV evidence confirmed improved posture
60,61,67
 and 
controversial effects on spasticity.
64, 66 
On activities, level II evidence was only demonstrated on upper 
limb function.
57
 In addition, 4 level IV studies demonstrated significant improvements on gross motor 
function.
59,62,64,65  
One level II study could not find a statistically significant increase in participation.
69
 
Controversial findings were found in the 2 III–IV studies.
61,65 
One level II study showed improvement in 
Quality of Life (QoL), but the results were not statistically significant.
69  
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The results did not concur with the findings of the 3 systematic reviews on horse-riding therapy, which 
concluded that evidence is available for the effectiveness of horse-riding therapy on muscle tone of 
children with CP. Our review found that therapeutic horse-riding was more effective to increase trunk 
and pelvic control and, to a lesser extent, to improve gross motor function.
71-73 
 
Summary 
Table 1 provides an overview of the evidence of the different interventions. For this summary table, 
the most commonly used outcome parameters on the different levels of the ICF were selected. Similar 
as in the review describing basic techniques, Table 1 considers the results of level II studies not 
statistically analysing between-group differences as level IV evidence.  
On the level of body function and structure, Table 1 demonstrates that level II evidence was only 
obvious for the effective- ness of horse-riding therapy on different measures of posture and postural 
control and for aquatic therapy on lung function. 
No effectiveness could be demonstrated on muscle strength or muscle cross-sectional area for the 
different interventions. An indication of the effectiveness was demonstrated by the level IV studies 
highlighting significant effects of therapeutic horse-riding on spasticity and energy expenditure. 
On activity level, NDT, functional training, goal-oriented approach, sensory integration as well as Vojta 
therapy significantly influenced gross motor function and this was graded as level II evidence. 
However, the effectiveness of sensory integration and Vojta therapy was only evaluated in one study, 
both with a low conduct score, indicating careful consideration of these results. The effectiveness of 
CE, therapeutic horse-riding and aquatic therapy on gross motor function was only supported by level 
IV evidence. NDT was the only intervention that significantly improved different gait measures; 
however, these only reached level IV evidence. 
Of all the studies, 16 used different participation outcome measures. Only two level II studies found 
significant effects on participation, including one level II study indicating significant effects of goal-
directed therapy on social function measured using the PEDI.
62
 The effectiveness of NDT on self-care 
skills, caregiver assistance and subjective findings by the parents was demonstrated with level IV 
evidence.
21 
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Table 1a. Overview of the number of studies demonstrating level II evidence 
 
 Level II evidence 
Body 
structure and 
function 
Spasticity Posture Energy expenditure/movement efficiency 
  Therapeutic horse-riding (2/3)57,58,63   
      
      
ROM Strength Muscle morphology/cross sect area 
  Functional training (0/1)48   
      
      
Activity and 
participation 
Gait Gross motor function Participation 
Functional training (1/2)
48,49
 NDT (2/4)
27,28,29,31
 Goal oriented approach (1/1)
52
 
  Goal oriented approach (3/3)
13,61,62
 Functional training (1/1)
5
 
  Functional training (2/3)
5,48,49
 Conductive education (0/1)
39
 
  Conductive education (0/2)
37,39
 Environmental factors 
  Therapeutic horseriding (0/2)
57,69
 Conductive education (0/1)
37
 
  Vojta therapy (1/1)
46
 Quality of Life 
    Therapeutic horse-riding (0/1)
69
 
 
Abbreviations: 
…/… indicates the number of studies reaching significant treatment effects versus the total number of studies 
evaluating the effect of the interventions on that specific parameter 
In case of conflicting evidence, the reference demonstrating significant effects are in bold 
ROM: Range Of Motion; NDT: Neurodevelopmental Treatment 
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Table 1b. Overview of the number of studies demonstrating level III and IV evidence 
 
Level III and IV evidence 
Body 
structure 
and 
function 
Spasticity Posture Energy expenditure/movement efficiency 
Therapeutic horse-riding (1/2)
64,68
 NDT (1/1)
22
 Therapeutic horse-riding (1/1)
59
 
NDT (1/2)
25,30
 Therapeutic horse-riding (3/3)
60,61,67
 NDT (1/1)
29
 
Functional training (1/1)
49
   Aquatic therapy (0/1)
55
 
ROM Strength Muscle morphology/cross sect area 
NDT (1/1)
20
 Aquatic therapy (0/1)
55
   
Functional training (1/1)
50
 
 
  
  
 
  
Activity and 
participation 
  
  
Gait Gross motor function Participation 
NDT (2/2)
24,30
 NDT (4/4)
24,26,29,30
 NDT (1/1)
26
 
Functional training (2/2)
48,49
 Conductive education (3/4)
36,40,41,42
 Functional training (1/1)
6
 
Aquatic therapy (0/1)
55
 Functional training (3/4)
6,48,49,50
 Conductive education ( 2/4 )
36,38,40,42
 
  Aquatic therapy (1/1)
55
 Therapeutic horse-riding (1/2)
61,65
 
  
Therapeutic horse-riding (5/6)
59,61,62,64,65,68
 Environmental factors 
Sensory integration (1/1)
15
 Conductive education(1/4) 
34,35,38,40
 
    
   
Abbreviations: 
…/… indicates the number of studies reaching significant treatment effects versus the total number of studies 
evaluating the effect of the interventions on that specific parameter 
In case of conflicting evidence, the reference demonstrating significant effects are in bold 
ROM: Range Of Motion; NDT: Neurodevelopmental Treatment 
 
  
  
89 
Discussion 
 
This systematic review overviews the effectiveness of different conceptual approaches and additional 
therapies used in PT of children with CP. A total of 52 articles were included in this analysis. Thirty-
four included articles were graded as level II, 3 as level III, and 21 as level IV. As for the basic 
techniques, these numbers demonstrate that high-quality research in PT is possible and is being 
done. However, the validity assessment demonstrates an overweight of moderate and weak conduct 
scores, highlighting limitations in methodological conduct, such as appropriate statistical or visual 
analysis and description of the control groups. In addition, the number of individuals overall who have 
been studies is small. 
Kappa coefficients for the level of evidence scores were similar to the agreement scores reported in 
the previous article summarizing basic techniques and were acceptable.
3 
The ICC scores calculated 
for the conduct scores system, however, were much higher in this part of the systematic review (0.927 
for group designs, 0.947 for SSRDs and 0.906 for systematic reviews) as in the part evaluating basic 
techniques (0.640 for group designs, 0.352 for single subject designs and 0.888 for systematic 
reviews).
3
 This may be explained by the experience of the raters, who scored and discussed the 
articles described in the previous article first. To increase inter-rater reliability of the scores, 
appropriate training and experience in training might therefore be recommendable. 
No adverse effects were demonstrated in any of the studies. 
As for the individual techniques, summarizing the effectiveness of all interventions demonstrates that 
the ICF provides a good model to evaluate the effectiveness of different physiotherapy interventions 
for CP. As recognized in the systematic review describing basic techniques, only specific 
measurements of QoL could not be scored by the ICF.
3
 In clinical research trials, however, limited 
interventions measure outcome effects on all levels of the ICF and again, especially older studies only 
evaluated effectiveness on the level of body structure and function. 
Only the studies using NDT appear to demonstrate a tendency of effectiveness on all levels of the 
ICF: impairment, activity and, to a lesser extent, participation measures, although the results were 
inconsistent. Surprisingly, in contrast to the recent critiques of NDT being too passive and not 
sufficiently targeting activity and participation level, 2 level II
27, 28
, 1 level III
26
 and 3 level IV 
studies
23,24,30
 highlight a significant effect on gross motor function. These studies demonstrate the 
recent developments within the neurodevelopmental treatment concept, with an obvious and important 
component of integration of improved muscle tone and length into function. The results refute the 
arguments that NDT only targets problems at impairment level without sufficient attention to activity 
level and functionality of the child. From a motor learning point of view, PT in an NDT context is 
considered not to be a repetition of the functional task, but is carefully considered by task-analysis. In 
other words, the child is not taught to do these skills as best he or she can despite the presence of 
spasticity or fluctuating tone. Rather, there is specific preparation for specific functional skills to enable 
the child to function in the most efficient way possible. The aim is to perform postural and voluntary   
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tasks with the least possible interference from abnormal postural tone. 
The results of this review are not confirmed by the conclusions of the two high-quality systematic 
reviews by Butler & Darrah
32
 and Brown & Burns
33
, evaluating the effectiveness of NDT. Butler and 
Brown did not include the same studies in their analysis.
27,28
 The studies in their reviews were much 
older (pre-2001) and therefore, there was a limited overlap of 1 and 3 studies, respectively, with this 
review. In addition, the interventions available for their reviews were of lower quality. 
CE claims to increase orthofunction, which means that, in spite of fundamental motor problems, an 
individual acquires strategies to be as independent as possible in activities of daily living and lives as 
normally as possible. Thus, CE is expected to be an intervention at the activity and participation 
dimensions of the ICF. Indeed, regarding CE, level IV evidence was demonstrated only on gross 
motor function, No studies evaluated the effectiveness of CE on body structure and function 
parameters, such as strength, ROM and spasticity, but only on cognition and language development. 
From a motor learning perspective, the repetitive learning principles from CE lean to a certain extent 
towards the functional and task-oriented approach. It is possible that the additional impact of the goal-
setting procedures and the active learning component in the functional and task-oriented approach, 
have a clearer and more obvious impact on gross motor function and participation. 
The results of the goal-oriented approach by Bower et al.
13,51
 and the functional and task-oriented 
approaches
5, 6, 50
 demonstrate that individual goal-setting procedures can be very effective on the 
attainment of individual functional goals and gross motor function. Most of the individual goals are only 
defined on activity level. In the short term especially, the definition of measurable, specific treatment 
goals can be very motivating for therapist, parents and children. on participation level, only Ahl et al.
6
 , 
Ketelaar et al.
5
  and L wing et al.
52
 found significant effect of task-oriented training on the PEDI, but 
no other measures of participation, such as Children  s Assessment of Participitation and Enjoyment or 
Assessment of Life Habits for Children were used. However, in the Measures of Process Care 
Questionnaire, parents reported positive feelings about their involvement in the therapy and the goal-
setting process, suggesting a positive impact on the child’s environment.
6,51 
These approaches use a more neuromaturational learning component, and, therefore, Vojta therapy 
especially would be expected to work in the body structure and function dimension of the ICF. 
Nevertheless, there were no measures in this dimension. The 1 outcome of statistically significant 
gross motor function score in the activity dimension may represent greater coordination of purposeful 
movement. 
It would be interesting and useful to compare the effectiveness of these more “passive forms” of 
learning with the more recent “action” approaches. Ketelaar et al.
5
 compared a functional task-oriented 
approach with an approach that was based more on normalization of quality of movement, like that of 
NDT. The major difference between both approaches was defined as the active learning component. 
Normalization of quality of movement, however, might not necessarily mean a passive learning 
component, but may also be learned in an active way and in a functional, task-oriented context. 
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In this regard, another important aspect that needs more detailed investigation is age and severity of 
involvement. Children who are more mildly involved might benefit from a different approach from those 
children with severe involvement and, maybe, young children would also benefit from another 
approach than older children. 
Home-based training was not included, since these programmes often include a mixture of 
approaches and techniques, and a mixture of occupational therapy and physical therapy. However, 
the authors would like to state that this does not mean that they underestimate the value of home-
based therapy. As demonstrated by Karnish et al., children with disabilities have been found to 
demonstrate superior performance of skills in natural educational settings compared with in an 
isolated therapy room.
21 
A recent approach that could unfortunately not be included this review, is context therapy, as 
proposed by Darrah et al.
74
 and Law et al. 
75
. This approach is also built on the theoretical construct of 
dynamical systems theory, which posits that motor behaviours are organized around functional tasks 
or goals and that the specific motor solution is influenced by the spontaneous interaction between 
variables from the child, the task and the environmental influences. Context therapy emphasizes 
changing the parameters of the task or environment rather than focusing on remediation of a child’s 
abilities. The assumption of this approach is that changes in the task and/or environment will enable 
the child to perform an activity that they were unable to do previously. 
This is a review of the research evidence for the effectiveness of the most commonly used therapy 
approaches as a first step in supporting the therapist to build an evidence-based targeted therapy 
programme based on the main problems of the child. It is based on the AACPDM review process, 
which uses the ICF as a two-part conceptual framework: the ICF to identify the types of evidence 
currently available, and a level of evidence classification to rate the strength of that evidence. The 
types of outcomes that have been studied so far are very few; outcomes for which we have positive 
evidence have not yet been adequately replicated. The robustness of the evidence is still too weak 
and the number of peadiatric studies is still too few to provide conclusive evidence. Therefore, it is still 
very early to define specific clinical guidelines. However, a targeted treatment approach based on 
appropriate evaluation of all levels of the ICF is advised to create an appropriate, individually-defined 
treatment plan. Integrating improvements at body function and structure during functional activities 
and vice versa appears to be very challenging for children with CP. Therefore, continuing high-quality 
research focusing on the motor-learning aspect of integrating these components remains necessary 
for future research. 
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Conclusion 
 The effects of NDT are demonstrated at all levels of the ICF.  
 The use of CE has significant effects on gross motor function. 
 Setting individual, measurable goals supports the achievement of functional PT goals. 
 Functional training can be beneficial in learning new motor activities, but no studies demonstrate 
benefit on the level of body function and structure. 
 Hippotherapy can be considered as an effective additional therapy method to improve posture and 
postural control. 
 Except for a beneficial impact on lung function, hydrotherapy is not yet proven to be effective in 
children with CP. 
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Abstract 
 
The primary aim of the study was to investigate how a clinical decision process based on the 
International Classification of Function, Disability and Health (ICF) and the Hypothesis-Oriented 
Algorithm for Clinicians (HOAC-II) can contribute to a reliable identification of main problems in 
ambulant children with cerebral palsy (CP). As a secondary aim, to evaluate how the additional 
information from three-dimensional gait analysis (3DGA) can influence the reliability. 
Twenty-two physical therapists individually defined the main problems and specific goals of eight 
children with bilateral spastic CP. In four children, the results of 3DGA were provided additionally to 
the results of the clinical examination and the GMFM-88 (gross motor function measure-88). 
Frequency analysis was used to evaluate the selected main problems and goals. For the main 
problems, pair-wise agreement was calculated by the number of corresponding problems between the 
different therapists and using positive and negative agreement per problem. Cluster analysis using 
Ward’s method was used to evaluate correspondence between the main problems and specific goals. 
The pair-wise agreement revealed frequencies of 47%, 32% and 3% for the identification of one, two 
or three corresponding main problems. The number of corresponding main problems was higher when 
additional information of 3DGA was provided. Most of the specific goals were targeting strength (34%), 
followed by range of motion (15.2%) and GMFM-D (11.8%). In 29.7% of the cases, therapists could 
not prioritize and exceeded the number of eight specific goals. Cluster analysis revealed a logic 
connection between the selection of strength as a main problem and as specific goal parameters. 
Alignment as a main problem was very often associated with specific parameters like ROM and 
muscle length and with hypertonia as a main problem.  
The results show a moderate agreement for the selection of main problems. Therapists are able to 
use the proposed model for a logic and structured clinical reasoning. Setting priorities in the definition 
of specific goals is revealed as a remaining difficulty. Further research is required to investigate the 
additional value of 3DGA and to improve priority setting. 
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Introduction 
 
Cerebral palsy (CP) describes a group of disorders of movement and posture, causing activity 
limitations. CP is attributed to non-progressive disturbances occurring in the developing foetal or infant 
brain
1,2
 Several research studies have demonstrated the positive effects of goal-setting in physical 
therapy (PT) of children with CP. It is accepted that involving both parents and children in the definition 
of realistic and acceptable goals improves motivation and thereby therapy outcome. 
3-6
  
Another aspect in goal-oriented PT is the potential benefit from targeted interventions to enhance 
training specificity. Goal planning, in that context, is being used to identify the tasks and contexts of 
particular interest.
7
 In children with CP however, this can be very challenging. Children with CP usually 
face a heterogeneous variety of problems. Primary problems like muscle tone, muscle weakness and 
many others usually have inevitable effects on activity and participation. Many research studies 
therefore praise the International Classification of Functioning, Disability and Health for Children and 
Youth (ICF-CY) as a clinical framework and an important rehabilitation tool. 
8,9
 Physical therapists can 
use the model to organi e the characteristics of children’s functioning, to guide the selection of 
measurement tools and to determine meaningful outcomes.
10,11
 
Still, recent research investigating the relationship between the different levels of the ICF do not 
demonstrate a clear and causal relationship between measures of impairments and functional 
outcome.
10,12,13
 Several studies identify spasticity and weakness as causal factors in gross motor 
function. Still, the amount of explained variance suggests that other variables should be included to 
explain functional outcome more fully.
14
 As a physical therapist, it might therefore be very challenging 
to determine factors that influence outcome of the PT program.
15
 Setting priorities is an essential but 
complicated part of a targeted approach, requiring an adequate strategy for clinical reasoning. The 
hypothesis-oriented algorithm for Clinicians II (HOAC-II) provides a structured approach for science-
based clinical practice. It is focused on functional deficits and how impairments relate to these 
deficits.
16
 Unlike the ICF, the HOAC-II is directly strategy-oriented and is designed to guide the clinical 
reasoning process for the physical therapist. By generating a hypothesis as to why a problem exists, 
the HOAC-II supports the reduction of an often long problem list to a refined list of key problems.
16
 The 
ICF and the HOAC-II can therefore be considered as complimentary to each other. 
Three-dimensional gait analysis (3DGA) is a commonly used measurement tool that supports the 
identification of main problems in ambulant children with CP. Still, the use of the results of 3DGA is 
mostly limited to the identification of key problems for orthopaedic surgery and botulinum toxin 
treatment. It is considered as an important additional measure that supports the selection of target 
muscles.
17,18
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To the best of our knowledge, no studies have investigated the role of a combined strategic approach 
and the use of 3DGA in the identification of specific PT goals. However, it is hypothesized that the 
results of the 3DGA can provide additional information to support the paediatric physical therapist to 
identify the main and key problems of the child. In that way, combined with a complete evaluation at all 
levels of the ICF and the clinical reasoning of the HOAC-II, it could provide a better understanding in 
the relationship between the impairments and functional outcome of an ambulant child with CP. 
This study aims to investigate how a clinical decision process based on the HOAC-II and the ICF can 
contribute to a reliable identification of main problems and specific PT goals in ambulant children with 
CP. Additionally, it aims to evaluate how the additional information of three-dimensional gait analysis 
can influence the reliability of this information. 
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Methodology 
 
The study was organized in different phases, starting from development of the clinical reasoning tool 
and validation by expert consensus to reliability testing by means of a larger scale agreement study 
(Fig. 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1. The different steps of validation and reliability testing 
Abbreviations:  
ICF: International Classification of Functioning, Disability and Health; HOAC-II: Hypothesis Oriented 
Algorithm for Clinicians II; 3DGA: Three Dimensional Gait Analysis 
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Phase 1 – Development of the clinical reasoning tool 
The clinical reasoning tool was developed by the first authors of this manuscript (IF and JD) and was 
based both on clinical experience as on the existing validated structures of the ICF and the HOAC-II 
(Fig. 2) 
As a first step, the results of the most routine practice assessments in ambulant children with CP were 
organized within the framework of the ICF. 
At the level of body structure and function, clinical examination is commonly performed according to 
the standardized protocol used at the Laboratory of Clinical Motion Analysis and includes 
measurements of range of motion (goniometrical measurements), spasticity (Modified Ashworth Scale 
and Tardieu), selectivity (selective motor scale) and muscle strength (manual muscle testing). 
19-21
 
At activity level, the Gross Motor Function Measurement (GMFM-88) and three-dimensional gait 
analysis (3DGA) are used most frequently. The GMFM-88 is a standardized clinical instrument to 
evaluate gross motor function that fulfills the criteria of reliability and validity with respect to 
responsiveness to change.
22,23
 It provides an overview of the gross motor capacities at different 
functional levels and organized within five dimensions. 3DGA is also performed according to the 
standardized protocol of the Laboratory of Clinical Motion Analysis of the University Hospital 
Pellenberg (Leuven). Results of 3DGA include measurement of joint movement during gait 
(kinematics), moment and power (kinetics) and muscle activity registered by EMG. 
On participation level, structured interviews with the parents and children are often supplemented 
using the standardi ed questionnaire of the Children’s Assessment of Participation and Enjoyment 
(CAPE).
24,25
 
Organizing these results within the ICF provided a profound and complete overview of the child and 
resulted in an objective problem list of the child. In children with CP however, this problem list could be 
very extensive. Most children had problems at all levels of the ICF and as a therapist, one had to 
prioritize and select possible and realistic targets in treatment. 
Therefore, as a next step, the HOAC-II was used to reduce this list to a selection of main problems: 
the key problems for the child. In this step, the therapist generated a hypothesis as to why a problem 
existed and the rationale behind this problem. The main problem was defined as the main underlying 
problem that can mostly explain the problems at all levels of the ICF. Consequently, when the main 
problems for the child were defined, the individual goals for the child could be deducted logically. 
Although not specified in this figure, during the treatment process, regular re-assessments and 
redefinitions are obviously necessary to test these hypotheses.  In order to facilitate the next phase of 
the study, the authors prepared a list of main problems and a list of specific goals. The list of main 
problems was based on clinical experience and the most commonly reported main problems during 
the consultations at the CP reference centre of the U.Z. Pellenberg. The list of specific goals consisted 
of specific parameters from clinical examination, GMFM and 3DGA. 
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Fig 2. Structured approach of the ICF and the HOAC-II as a clinical reasoning tool in treatment of 
ambulant children with CP 
Abbreviations: 
GMFM-88: Gross Motor Function Measure; 3DGA: Three-dimensional Gait Analysis; CAPE: 
Children’s Assessment of Participation and Enjoyment, ROM: Range of Motion  
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Phase 2 – Validation of the clinical reasoning framework 
For this part of the study, a small group of four expert paediatric physical therapists was recruited. The 
experts all had a minimum experience of 10 years in treatment of children with CP. A structured 
meeting was organized under the supervision and guidance of the first authors. During this structured 
meeting, the existing clinical reasoning process was presented and a case study was demonstrated 
and discussed as an example. Subsequently, the assessment results of another child were presented. 
The therapists were asked to individually use the presented approach to identify the main problems 
and goals for this child. When all four therapists had accomplished this task, the predefined list of main 
problems and the lists of treatment goals were introduced. The answers of the physical therapist were 
compared to the lists and it was checked if all answers were part of this predefined list. In case a main 
problem or a goal identified by one of the four therapists was not part this lists, this was discussed 
within the group and an agreement was searched whether or not this should be added to one of the 
lists. As a last part of the meeting, a group discussion was held to identify problems and goals that 
were not defined in these lists. 
Phase 3 – Reliability testing by means of an agreement study 
During the second phase of the study, 185 therapists were invited to a two-day seminar. All physical 
therapists had to be specialized in paediatric PT by means of an advanced paediatric neurology 
(masters) program or a Bobath certificate. A minimum of three years of experience in treatment of 
children with CP was required. Additionally, the therapists had to be familiar with 3DGA by following a 
specialized course in gait analysis. To insure an independent opinion, the selected therapists had no 
direct involvement with the University Hospital of Pellenberg. Twenty-five therapists agreed to 
participate.  
Similar to the structured expert meeting, the seminar started with an information session on the clinical 
reasoning process. When all participants were familiar with the process, the assessment results of 
eight children were presented in the same structured way. All children presented during the study 
were children with bilateral spastic CP, aged between 4 and 9 years old. All children were ambulant 
and had a GMFCS level between I and III. Classification of the children’s pathology according to the 
SCPE guidelines
1
 as well as classification of the children’s gait pattern according to Rodda (2004)
26
 
are listed in Table 1.  
 
Background information regarding the child’s environment and school was provided. A video selection 
of the GMFM and a short video of the child walking were showed and the results of the clinical 
examination were provided. In four of the eight cases, the results of the 3DGA were provided as 
supplementary information. The physical therapists worked individually. The cases were presented 
one by one. For every child, the therapists were asked to follow the structured approach. After the 
definition of a problem list, they were asked to select maximally three main problems from the list. 
Subsequently, they could select maximally eight goals for the different lists of treatment goals. In this 
way, three children were presented on the first day of the seminar and five children on the second day.   
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Table 1. Description of the children presented for the reliability study 
 
Age GMFCS Classification Gait Pattern 
3DGA 
provided 
Child 1 4y3mo I Spastic Bilateral Asymmetric gait no 
Child 2 6y9mo III Spastic Bilateral Apparent equinus yes 
Child 3 4y11mo II Spastic Bilateral Asymmetric gait no 
Child 4 5y7mo II Spastic Bilateral True equinus yes 
Child 5 3y11mo III Spastic Bilateral Jump gait yes 
Child 6 4y5mo II Spastic Bilateral Jump gait no 
Child 7 6y1mo III Spastic Bilateral Asymmetric gait yes 
Child 8 6y6mo I Spastic Bilateral Jump gait no 
Abbreviations: 
GMFCS: Gross Motor Function Classification System; 3DGA: three-dimensional gait analysis; Y: years; Mo: 
months 
 
The study was approved by the ethics committee of the University Hospital Leuven. The parents of the 
children agreed with the demonstration of their child’s results and signed an informed consent 
accordingly. 
Phase 4 – Feedback 
Since no discussion amongst the therapists was allowed during the two-days seminar, a feedback-day 
was planned after completion of the seminar. During this day, the children were discussed one by one 
and feedback was provided on the results of the study. Results of these discussions are not part of 
this study. 
Data analysis 
For the main problems, initial data analysis consisted of a profound frequency analysis. Positive 
agreement was calculated as the percentage of therapists that selected the specific main problem, 
negative agreement was considered as the percentage of therapists that did not select this problem. 
Additionally, the frequencies of the three most frequently selected main problems were summed and 
then proportionally compared to the total number of possible selections (66). This percentage also 
provided a measure of agreement regarding the three most frequently selected main problems. 
Another way to consider agreement was calculating the pair-wise agreement between the different 
therapists (231 combinations). An agreement score between 0 and 3 was noted when no 
corresponding goals were registered up to 3 when all main problems were selected accordingly. The 
frequencies of total agreement (score 3), 2 corresponding goals (score 2), 1 corresponding goals 
(score 1) and no agreement (score 0) were calculated per child. Subsequently, these frequencies 
were summed separately for the group of children with or without the results of the analysis. 
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Data analysis of the specific goals consisted mainly of an explorative frequency analysis. Goals were 
grouped into 14 categories. In case the therapist exceeded the number of eight goals, data was 
excluded. 
To evaluate the additional value of 3DGA, these analyses were also performed separately for the with- 
and without gait analysis group. 
To provide an impression of the clinical decision process of the therapists, the selection of main 
problems was compared to the selection of main goals. This linkage was further explored using 
hierarchical cluster analysis based on Ward’s method using Euclidian distance as a dissimilarity index. 
This analysis was performed after rescaling the frequencies of the selected main problems and the 
specific goals: the frequency of the selected main problem or goal was divided by the total number of 
main problems or goals respectively for that child. 
All statistics were performed in SPSS 21 IBM SPSS Statistics for Windows, Version 21.0. (Armonk, 
NY: IBM Corp). 
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Results 
 
Phase 2: validation of the clinical reasoning framework 
During the first session with the expert group, the proposed clinical reasoning process was introduced 
and feedback was asked. All four therapists agreed with the decision tree. 
Regarding the list of main problems, two main problems were mentioned by the therapists but not 
separately in the list: muscle length and postural control. It was decided to add muscle length to the 
list and to use postural control as a subheading for static and dynamic alignment. The experts also 
proposed to keep the subdivisions in categories, to provide an easy structure. The list was finished 
with a total of 14 main problems. It was agreed that the number of main problems identified per child 
should have a maximum of three. The completed list is given in Appendix T. 
The list of treatment goals was immediately accepted. This list consisted of 29 items from clinical 
examination, 43 goals derived from the 3DGA and 88 items from the GMFM-88. The complete list is 
provided in Appendices V-W. For the individual goals, it was agreed that a maximum number of eight 
goals could be selected. 
For the reliability study, the experts proposed a more extensive explanation of the process and more 
time to introduce the goal of the study at the start of the two-days seminar. Additionally, the expert 
group proposed a more extensive introduction of the example case and a full-written copy of the 
example case. 
Phase 3: reliability testing by means of an agreement study 
Participants 
Twenty-five therapists agreed to participate to the two-days seminar. However, at the first day, two 
therapists cancelled because of personal reasons. One therapist could not come back on the second 
day of the study and results of this therapist from the first day were excluded. 
The results of 22 therapists were included. The average experience of the therapists was 16.1 years 
(range between 3 and 40 years). Seventeen therapists were certified Bobath therapists. Thirteen 
therapists had a physiotherapy degree at university level, comparable or equal to a Master’s degree. 
Nine therapists had a professional physiotherapy degree, comparable or equal to a professional 
 achelor’s degree. Most therapists were full-time employed in paediatric rehabilitation (average 
percentage 94%) in a paediatric rehabilitation centre, special-needs school or private sector. 
Main problems 
The frequencies of the main problems identified by the therapists are provided in Table 2. For the total 
group, muscle strength (98 times or 18.56%), hypertonia (100 times or 18.94%) and static alignment 
(73 times or 13.83%) were most frequently identified as one of the main problems. Thirteen main 
problems (2.5% of all main problems) were registered that were not part of the list and nine times 
(1.7%) no problem was selected.  
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Table 2. Frequencies of the selected main problems 
 
Total 
Total 
 (with GA) 
Total  
(without 3DGA) 
 
n % n % n % 
Hypertonia 100 18,94 67 25,4 33 12,50 
Hypotonia 20 3,79 6 2,27 14 5,30 
Fluctuating muscle tone 1 0,19 1 0,38 0 0,00 
Static alignment 73 13,83 31 11,7 42 15,91 
Dynamic alignment 50 9,47 25 9,47 25 9,47 
Lack of cocontration 34 6,44 18 6,82 16 6,06 
Laxity 4 0,76 2 0,76 2 0,76 
Extension pattern 7 1,33 3 1,14 4 1,52 
Flexion pattern 23 4,36 17 6,44 6 2,27 
ATNR 0 0,00 0 0 0 0,00 
Other patroon 3 0,57 3 1,14 0 0,00 
Muscle strength 98 18,56 47 17,8 51 19,32 
Muscle length 52 9,85 25 9,47 27 10,23 
Bony deformities 41 7,77 10 3,79 31 11,74 
Others 13 2,46 7 2,65 6 2,27 
No problem selected 9 1,70 2 0,76 7 2,65 
 
528 100 264 100 264 100 
Abbreviations: 
Total (without): total frequencies of child 1,3,6 and 8, (were the gait analysis information was not provided) 
Total (with): total frequencies child 2,4,5 and 7 (were the results of the gait analysis was provided) 
N: number 
%: percentage of the frequency of the selected main problem to the total number of selected problems for the 
total group, the total group (without) and the total group with gait analysis information 
ATNR: Aysmmetric Tonic Neck Reflex 
 
 
Table 3 provides the frequencies of the selected main problems per child, together with the positive 
and the negative agreements. Child 2 and child 5 were children with the highest positive agreement 
values, with 95.9 and 90.5% respectively for the selection of hypertonia. Asymmetric Tonic Neck 
Reflex (ATNR) was never selected as a main problem. 
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Table 3. Positive and negative agreement values of the main problems per child 
 
Child 1 Child  2  Child 3 Child 4  Child 5  Child 6 Child 7 Child 8 
  
N 
 
pos 
agr 
neg 
agr 
n 
pos 
agr 
neg 
agr 
n 
pos 
agr 
neg 
agr 
n 
pos 
agr 
neg 
agr 
n 
pos 
agr 
neg 
agr 
n 
pos 
agr 
neg 
agr 
n 
pos 
agr 
neg 
agr 
n 
pos 
agr 
neg 
agr 
Hypertonia 2 9,1 90,9 21 95,5 4,5 9 40,9 59,1 13 59,1 40,9 20 90,9 9,1 8 36,4 63,6 13 59,1 40,9 14 63,6 36,4 
Hypotonia 2 9,1 90,9 2 9,1 90,9 5 22,7 77,3 3 13,6 86,4 0 0 100 5 22,7 77,3 1 4,5 95,5 2 9,1 90,9 
Fluctuating muscle tone 0 0,0 100 0 0,0 100 0 0,0 100 1 4,5 95,5 0 0 100 0 0 100 0 0 100 0 0 100 
Static alignment 10 45,5 54,5 5 22,7 77,3 15 68,2 31,8 7 31,8 68,2 5 22,7 77,3 12 54,5 45,5 14 63,6 36,4 5 22,7 77,3 
Dynamic alignment 2 9,1 90,9 0 0,0 100,0 5 22,7 77,3 12 54,5 45,5 8 36,4 63,6 7 31,8 68,2 5 22,7 77,3 11 50,0 50,0 
Lack of cocontraction 4 18,2 81,8 4 18,2 81,8 1 4,5 95,5 7 31,8 68,2 5 22,7 77,3 6 27,3 72,7 2 9,1 90,9 5 22,7 77,3 
Laxity 0 0,0 100 0 0,0 100,0 0 0,0 100 2 9,1 90,9 0 0 100 2 9,1 90,9 0 0 100 0 0 100 
Extension pattern 3 13,6 86,4 1 4,5 95,5 1 4,5 95,5 0 0 100 1 4,5 95,5 0 0 100 1 4,5 95,5 0 0 100 
Flexion pattern 3 13,6 86,4 4 18,2 81,8 3 13,6 86,4 0 0 100 8 36,4 63,6 0 0 100 5 22,7 77,3 0 0 100 
ATNR 0 0 100 0 0,0 100 0 0 100 0 0 100 0 0 100 0 0 100 0 0 100 0 0 100 
Other pattern 0 0 100 0 0,0 100 0 0 100 0 0 100 0 0 100 0 0 100 3 13,6 86,4 0 0 100 
Muscle strength 16 72,7 27,3 15 68,2 31,8 9 40,9 59,1 12 54,5 45,5 7 31,8 68,2 12 54,5 45,5 13 59,1 40,9 14 63,6 36,4 
Muscle length 9 40,9 59,1 8 36,4 63,6 8 36,4 63,6 4 18,2 81,8 9 40,9 59,1 3 13,6 86,4 4 18,2 81,8 7 31,8 68,2 
Bony deformities 11 50,0 50,0 3 13,6 86,4 5 22,7 77,3 2 9,1 90,9 2 9,1 90,9 9 40,9 59,1 3 13,6 86,4 6 27,3 72,7 
Others 3 13,6 86,4 2 9,1 90,9 0 0 100 3 13,6 86,4 1 4,5 95,5 1 4,5 95,5 1 4,5 95,5 2 9,1 90,9 
No problem selected 1 4,5 95,5 1 4,5 95,5 5 22,7 77,3 0 0 100 0 0 100 1 4,5 95,5 1 4,5 95,5 0 0 100 
Sum 3 most frequently selected 37 
  
44 
  
33 
  
37 
  
37 
  
33 
  
40 
  
39 
  (sum/66)*100 56,1 
  
66,7 
  
50,0 
  
56,1 
  
56,1 
  
50,0 
  
60,6 
  
59,1 
   
Abbreviations: 
Pos agr: Positive Agreement or the percentage of therapists that selected the specific problem; Neg agr: Negative Agreement or the percentage of therapists that did not select the specific problem 
N: number; ATNR: Asymmetric Tonic Neck Reflex 
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In this sample, the median percentage of the three most frequently selected main problems was 
higher when 3DGA was provided: 58.3 in comparison to 53.03% (Fig. 3). 
As a next step in the agreement analysis, the pair-wise agreement between the different therapists 
was checked (231 combinations of therapists). The frequencies of the agreement scores were 
calculated per child (Fig. 4). Also here, a higher agreement was found for child 2 and 5. 
The frequencies of the pair-wise agreements were summed. This analysis revealed that in 47% of the 
cases, therapists agreed on one of the main problems and in 32% of the cases, two main problems 
were selected similarly. Total agreement was only found in 3% of the cases and no agreement was 
found in 18% of the cases. In our sample, the proportion of no agreement (score 0) was higher when 
3DGA was not provided (22% versus 14%). The proportion of moderate agreement (score 2) was 
higher when the results of the 3DGA were provided (37% versus 26%). The proportion of total 
agreement was equal between both groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3. Distribution of the positive agreement values for the different main problems per child  
Abbreviations: 
° and * indicate the outliers with the corresponding number of main problem: 1 (hypertonia), 4 (static 
alignment) and 12 (strength) 
3DGA: Three Dimensional Gait Analysis; Positive agreement:  the percentage of therapists that 
selected the specific main problem 
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Fig 4. Proportional distribution of the number of corresponding main problems for the different children 
0 no corresponding main problems 
1 1 corresponding main problems 
2 2 corresponding main problems 
3 3 corresponding main problems 
with GA children from whom the results of the three-dimensional gait analysis were provided 
without GA children from whom the results of the three-dimensional gait analysis were not 
provided  
 
Fig 5. Proportion of selected goals based on clinical examination (CE), gait analysis (3DGA) or gross 
motor function (GMFM) for the total group (total), the group of children where 3DGA information was 
provided (with 3DGA) and not provided (without 3DGA) 
  
0
10
20
30
40
50
60
Child 2 Child 4 Child 5 Child 7 Child 1 Child 3 Child 6 Child 8
With GA without GA
%
  0
1
2
3
0,0
10,0
20,0
30,0
40,0
50,0
60,0
70,0
CE 3DGA GMFM
%
 o
f 
go
al
s 
total
with 3DGA
without 3DGA
  
117 
Specific goals 
A total number of 991 goals were selected. Since the total possible selection of goals was 1408 (22 
therapists, eight children and eight goals), this means that 417 times or in 29.3% of the cases, the 
therapists could not limit the selection to eight goals. 
Of all these goals, 556 (56.2%) were based on problems identified from clinical examination and 
targeted impairment level. 130 (13.1%) and 304 (30.7%) of the goals targeted gait and gross motor 
function parameters respectively (Fig. 5). When evaluating per child, this trend was similar. In all 
children, most of the goals were based on the results of the clinical evaluation. 
Table 4 provides a more detailed overview of the selected goals. This demonstrates that most of the 
goals were targeting strength (34%), followed by range of motion (15.2%) and GMFM D (11.8%). For 
all children, different strength parameters were most frequently selected as treatment goals. 
When the additional information of gait analysis was provided, the proportion of gait parameters 
selected as a specific goal was lower: 11.8 versus 14.2% (Fig. 5). 
 
Overall clinical reasoning 
To explore the clinical reasoning process of the therapists, the three most frequently selected main 
problems were compared to the three most frequently selected group of goals (Table 5). Logically, the 
selected goals were directly derived from the definition of main problems. In all children, a direct 
relation could be noticed between the main problems and the most frequently selected goals. Only for 
femoral anteversion and hypertonia, no specific goal could be derived. In all children except child 1, 
hypertonia was selected as one of the main problems. However, only in child 2, specific goals were 
based on spasticity parameters. In child 5, strength was not identified as a main problem. However, 
the most frequently selected goals for this child were based on strength parameters. 
Fig. 6 demonstrates the proportion of goals from clinical examination and gait analysis in the different 
regions. For the goals based on clinical examination, in all children, the hip was obviously the most 
selected region. The comparison of the goals based on 3DGA with the goals based on clinical 
examination demonstrated a shift to goals based on ankle parameters. 
Fig. 7 shows the dendrogram based on the rescaled frequencies of the selected main problems and 
goals. Three main clusters can be deducted. A first cluster combines the main problems and specific 
goals that were the least frequently selected: at the top of the dendrogram, from the specific goal bony 
deformities to the main problem of hypotonia. A second cluster can be divided into two subgroups. A 
first subgroup shows that muscle length and bony deformities as main problems are very often 
selected in combination with GMFM-D and E and dynamic alignment. The second subgroup shows 
association between flexion pattern, spasticity and GMFM-C. In the last cluster, strength as a specific 
goal, associates with the main problems of hypertonia, static alignment and strength. ROM and static 
alignment can be found together in a subgroup, also confirming obvious clinical reasoning. 
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Table 4. Frequencies of selected specific goals  
 
Abbreviations: 
Total (with): total frequencies of child 1,3,6 and 8, (were the gait analysis information was provided); %: proportion of the frequency of the goal to the total number of goals in 
the with or without group; Total (without): total frequencies child 2,4,5 and 7 (were the results of the gait analysis was not provided); ROM: Range of Motion; 
TD parameters: time and distance parameters derived from the 3DGA; GMFM-A: Gross Motor Function Measure dimension A; GMFM-B: Gross Motor Function Measure 
dimension B; GMFM-C: Gross Motor Function Measure dimension C; GMFM-D: Gross Motor Function Measure dimension D; GMFM-E: Gross Motor Function Measure 
dimension E 
 
 
  
Child 1 Child 2 Child 3 Child 4 Child 5 Child 6 Child 7 Child 8 Total Total (%) 
Total 
(With) 
% 
Total 
(without) 
% 
ROM 14 12 27 16 26 8 26 22 151 15,21 80 17,7 71 13,1 
Spasticity 0 10 5 3 11 1 10 10 50 5,04 34 7,5 16 3,0 
Strength 52 27 37 38 41 58 46 45 344 34,64 152 33,6 192 35,5 
Bony deformities 1 0 1 0 1 1 1 0 5 0,50 2 0,4 3 0,6 
Pelvis 7 2 5 5 4 6 3 2 34 3,42 14 3,1 20 3,7 
Hip 8 2 7 2 9 2 4 0 34 3,42 17 3,8 17 3,1 
Knee 7 1 5 4 2 3 4 5 31 3,12 11 2,4 20 3,7 
Ankle 4 2 1 4 1 1 3 5 21 2,11 10 2,2 11 2,0 
TD parameters 1 0 1 1 0 1 2 1 7 0,70 3 0,7 4 0,7 
GMFM-A 1 2 0 2 5 0 0 0 10 1,01 9 2,0 1 0,2 
GMFM-B 0 4 2 0 4 2 0 0 12 1,21 8 1,8 4 0,7 
GMFM-C 1 5 18 11 13 7 1 6 62 6,24 30 6,6 32 5,9 
GMFM-D 20 7 15 5 13 17 20 20 117 11,78 45 10,0 72 13,3 
GMFM-E 21 4 12 24 3 19 6 26 115 11,58 37 8,2 78 14,4 
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Table 5. Comparison of the most frequently selected main problems to the most frequently selected 
specific goals per child. In child 2,4,5 and 7 the results of the 3DGA were provided, in child 1,3,6 and 8 
this information was not provided. 
 
Main problems Selected goals 
Child 1 
strength strength 
femoral anteversion GMFM E 
static alignment ROM 
Child 2 
hypertonia strength 
strength ROM 
muscle length spasticity 
Child 3 
static alignment strength 
strength ROM 
hypertonia GMFM C 
Child 4 
hypertonia strength 
strength GMFM E 
dynamic alignment ROM 
Child 5 
hypertonia strength 
muscle length ROM 
dynamic alignment GMFM C /D 
Child 6 
strength strength 
static alignment GMFM E 
hypertonia GMFM D 
Child 7 
static alignment strength 
strength ROM 
hypertonia GMFM D 
Child 8 
strength strength 
hypertonia GMFM E 
dynamic alignment ROM 
 
Abbreviations: 
ROM: Range of Motion; GMFM-C: Gross Motor Function Measure – dimension C;  GMFM-D: Gross 
Motor Function Measure – dimension D;  GMFM-E: Gross Motor Function Measure Dimension E 
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Fig 6. Proportion of the goals based on clinical examination (CE) and three-dimensional gait analysis (3DGA) per target region and per child 
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Fig 7. Dendrogram using Ward Linkage evaluating the Euclidian distance between the 14 main 
problems (MP) and the 16 categories of specific goals (SG)  
Abbreviations 
MP: Main Problem 
SG: Specific goal 
3DGA: three-dimensional gait analysis 
  
Cluster 1 
Cluster 2 
Cluster 3 
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Discussion 
 
The primary aim of this study was to demonstrate how a clinical decision process based on the 
HOAC-II and the ICF can contribute to a reliable identification of main problems and specific goals for 
ambulant children with CP. 
As a first step in this process, validity of the clinical decision framework was evaluated. All experts 
agreed on the contents of the predefined lists and the structure of the clinical reasoning process. In 
addition, the results of the reliability study demonstrated that only 2.5% of the main problems identified 
by the therapists were not part of the list, which confirms good validity. However, one had to mention 
that the list of main problems was limitative and the authors decided not to include ‘other problems’. 
The therapists were specifically asked to select items from the predefined list. Only in case they 
identified a main problem that was not part of the list, they were asked to note this down separately. 
The main problem that was not part of the list but was mentioned five times was endurance. 
Considering the second step of the study, reliability was tested by means of the different agreement 
measures. The pair- wise agreement scores provided the main measure of agreement. This analysis 
revealed a low to moderate agreement, with 3% of agreement upon all three main problems. Still, in 
32% of the pairs, an agreement of two out of three main problems was registered. A very logic 
association was demonstrated between the different main problems and specific goals. The therapists 
seemed to use the clinical reasoning in a way that the specific goals logically followed out of the 
selection of main problems. 
However, for the specific goals, one has to mention that many therapists were not able to limit the 
number of goals to eight. Even though the therapists were instructed to select only eight goals, many 
therapists still reported more than the proposed number. In this case, the authors decided not to 
include the specific answer. This obviously influenced the results of our study.Nonetheless, the results 
of the study highlight that, even though the therapists were able to use the clinical reasoning structure 
in an adequate way, setting priorities was still a clear difficulty. 
A possible explanation for the moderate agreement could be that the therapists were not sufficiently 
trained in using the structured clinical reasoning tool and the stepwise approach was fairly new. This 
can be confirmed by the feedback at the end of the study. All except one therapist reported that he or 
she had learned throughout participation of the study. The feedback from the therapists was very 
positive and the structure was appreciated as clear and user-friendly. Still, more time was required to 
complete the first case-study in comparison to the last one. Most likely, the therapists were much more 
familiar to the predefined lists by the end of the study. Nevertheless, a learning effect was not 
immediately visible throughout our results and the agreement was not higher in child 8 compared to 
child 1. More training time for the therapists might however, be advisable for future studies. 
Another possible explanation could be the classification and pathology of the children. Although the 
selection of children was limited to ambulant children with bilateral spastic CP, all children had 
different functional abilities. The GMFCS levels of the children might have influenced the results of the   
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study. However, also this effect was not clearly visible throughout our results. Nevertheless, it is 
animportant future direction to test the agreement analysis on children with unilateral CP and/or 
fluctuating muscle tone. 
Several studies have demonstrated significant differences in clinical reasoning between expert and 
novice physical therapists. 
27,28
 This aspect was not specifically reported in this study. However, it was 
explored in a frequency analysis. We could not find obvious differences between the expert and 
novice physical therapists. It is possible that younger physical therapists are more familiar with 3DGA, 
as in the last 10 years, gait analysis is part of the master’s program in paediatric rehabilitation. Older 
therapists had to take additional courses in gait analysis, which might have been less extensive. 
Previous studies demonstrated that more experienced physical therapists rely more on observations 
and interactions with patients rather than medical records.
28
 Additionally, due to our inclusion criteria, 
the youngest participating therapists in our study already had three years of experience, so no real 
non-experienced or novice therapists participated in our study. 
The secondary aim of study was to demonstrate how the additional information of 3DGA can influence 
the reliability of this information. Different pair-wise agreement scores were found in both groups, in 
the advantage of the group where additional information of 3DGA was provided. This higher 
agreement might indicate a more profound insight into the child’s main problems. However, the 
additional 3DGA information was only provided in four children. Since both groups consisted of 
different children, it was difficult to compare the choices of main problems and goals. The order in 
which the children were presented was decided randomly. There were a higher number of children 
with GMFCS level III in the group of children from whom the results of the 3DGA was provided. 
Hence, the results of this analysis should be interpreted carefully and more research is necessary to 
support or refute this statement. 
 
 
Conclusion 
This study confirms the proposed framework as a valid structure that supports logic clinical reasoning. 
The results show a moderate agreement for the selection of main problems but results highlight the 
difficulty of priority setting in the selection of specific goals. Further research is necessary to support 
the therapist in setting priorities and to investigate the additional value of 3DGA in this process. 
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Abstract 
 
Objective 
To investigate the agreement between live- and video- scores of the Gross Motor Function Measure–
88. 
 
Design 
Reliability study  
 
Subjects 
Forty children with bilateral spastic cerebral palsy 
 
Interventions 
Fifty evaluations were administered according to the test guidelines. The evaluation moments were 
videotaped. After a minimum interval of one month, the same assessor rated these video-recordings. 
Additionally, two physical therapy students scored the recordings twice, using a minimal interval of one 
month.  
 
Main measures 
Agreement between live- and video-scores as well as inter- and intra-rater agreement of the video- 
scores were assessed using intra-class correlation coefficients (ICC), standard error of measurements 
(SEM) and smallest detectable changes (SDC). Weighted kappa coefficients were used for individual 
item-analysis. 
  
Results 
Comparing the live- and video-scores from the same assessor, showed good to very good agreement 
for the total score (ICC 0,973; SEM 2,28; SDC 6,32), dimension B (ICC 0,938), D (ICC 0,965) and E 
(ICC 0.992) but lower for A (ICC 0,720) and C (ICC 0,667). Agreement for the total score was higher 
for live-versus-video compared to the inter-rater agreement by video (ICC 0,949; SEM 3,15; SDC 
8,73) but lower than the intra-rater agreement by video (ICC 0,989; SEM 1,42; SDC 3,96).  
 
Conclusion 
Scoring the Gross Motor Function Measure-88 using video-recordings can be done reliably. 
Nevertheless, agreement between live- and video- scores is lower in comparison to the intra-rater 
reliability using video recordings only. In the future, the appropriate SEM and SDC values should be 
used to interpret the results of clinical trials.  
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Introduction 
 
The Gross Motor Function Measure is a criterion-referenced and observational measure to evaluate 
gross motor function, validated for children with Cerebral Palsy, Down syndrome and traumatic brain 
injury.
1-3
 The original Gross Motor Function Measure-88 (GMFM-88) consists of 88 items, divided into 
five dimensions.
4
 Although, the Gross Motor Function Measure- 66 (GMFM-66) represents the more 
recent, shorter and more reliable version, it still has several disadvantages. It may be less descriptive 
for children functioning at lower ability levels and specific software is required to calculate the child’s 
total score.
5
 Therefore, the Gross Motor Function Measure-88 is still very commonly used.  
A well-known challenge in pediatric research is the requirement of blinded assessment.  Blinded 
evaluation has the possibility to reduce tester bias and thereby, to increase study quality. The difficulty 
in gross motor function evaluation however, is the need for a child to feel comfortable. Especially in 
young children, an assessor unknown to the child might make the child insecure, frightened and 
thereby, less compliant. This might reduce performance. Video-recordings can therefore be a useful 
tool to allow a qualitative and optimal testing situation. It does not only allow blinded evaluation by 
means of video scoring, but might also increase reliability since it allows the person scoring the test to 
pause scoring or to review items in case of doubt.  
Several researchers have used video-recordings and have investigated inter-rater reliability of the 
Gross Motor Function Measure-88 by means of video-scoring.
1,6-8
 However, to our knowledge, none of 
these studies evaluated agreement between the live- and video-scores. Nevertheless, scoring video-
recordings as such might cause limitations. This is especially true for the Gross Motor Function 
Measure-88, as the test is known to be very vulnerable for missing items.
1, 4 
It is important to verify 
whether scoring video-recordings increases the chance for missing items and whether this creates a 
systematic error.  
 
The aim of the study was to examine the agreement in test results when comparing the scores of the 
Gross Motor Function Measure-88 live and by video. Therefore, the agreement between the live- and 
video-scores was compared to the inter-and intra-rater agreement of the raters.   
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Methodology 
 
Children were recruited at the Cerebral Palsy Reference Centre of the University Hospital Pellenberg. 
Data from the participants of an ongoing intervention study was used. This study included ambulant 
children with bilateral spastic cerebral palsy, aged between four and nine years and gross motor 
function classification system level I to III. Children were excluded when they showed severe 
associated problems that could influence test results (blindness, deafness, severe cognitive 
limitations). All caretakers of the children signed an informed consent form. 
 
All children were tested by the first author of the study, a pediatric physical therapist, acquainted with 
the test items and manual. The English version of the test manual was used and all evaluations were 
administered accordingly. The test was administered in the pediatric physical therapy room of the 
child’s usual therapist so that the room was comfortable and familiar. During the tests, children were 
barefoot. No assistive devices were used. Each session took 40–60 minutes. The assessor tested all 
88 items for each assessment. All assessments were videotaped for subsequent extra scoring. To 
register the child’s performance without distraction, the camera was well positioned on a tripod and no 
additional person was used for filming. Video-recordings were not edited.  
After a minimal interval of one month, the same physical therapist scored the video-recordings of the 
test.  Additionally, the recordings were copied and distributed to two physical therapy students (MSc), 
specializing in pediatric physical therapy.  Both students scored the video-recordings of the tests 
twice, again with a minimal interval of one month between both scoring moments.  The students were 
also familiar to the test and the guidance manual and were trained by scoring five video recordings 
with the possibility to ask questions. It was allowed to pause the video-recordings and to review items 
as often as necessary.   
According to the test guidelines, all items were tested and scored on an ordinal scale of zero (does not 
initiate) to three (completed item).  Subsequently, the total dimension scores were calculated and 
expressed as percentage scores. Total scores were calculated as the average of all dimensions. 
 
 
As a first step in the data-analysis, the agreement in test results between the live- and video- scores of 
the first evaluator was evaluated.  
Secondly, intra-rater agreement of the video-scores was calculated using the first and second scores 
of both independent raters. Inter-rater agreement of the video-scores was calculated between the 
second scores of all three raters. 
Association between the total and dimension percentage scores was evaluated using intra-class-
correlation coefficients (ICC 3,1) for absolute agreement with 95% confidence intervals.
9
 Although the 
ICC can be defined as a measure of association, it assesses the consistency or reproducibility of 
quantitative measurements made by different observers measuring the same quantity. Therefore, the 
ICC will further be described as an agreement measure.  
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To investigate systematic differences between the measurements and to identify possible outliers, 
Bland-Altman plots were used. The limits of agreement with 95% confidence interval (1,96 SD) were 
reported.
10
  
In addition, the Standard Error of Measurement (SEM) and the smallest detectable change (SDC) 
were calculated based on the variance components.
11
 The SEM provides an absolute index of 
reliability. It indicates the variability of the scores around the subject’s true score and thereby provides 
a value for the measurement error in the same unit as the measurement itself. The SDC represents 
the amount by which a patient’s score needs to change to ensure that the change is greater than the 
measurement error.   
Agreement between the live-and video ratings was also assessed at item level. As items scores use 
an ordinal scale, Weighted Kappa coefficients (ƙ) are applied. However, when there is a limited range 
of scores, Weighted Kappa coefficients cannot be calculated. Therefore, the proportion of positive 
agreement was used as an additional measure for item-analysis.
12
 Proportions of positive agreement 
are calculated as the proportion of scores with positive agreement divided by the total number of 
scores. 
Finally, the number of items that could not be scored based on the video-recordings because of 
practical reasons (e.g. when the child was out of the video-range) was registered.  
Statistical analysis was performed using the IBM SPSS 22 Statistics for Windows version 22.0 
(Armonk, NY: IBM Corp). Weighted-kappa coefficients were obtained using MedCalc for Windows, 
version 12.5 (MedCalc Software, Ostend, Belgium).  
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Results 
 
Forty children were included in the study. Mean (SD) age of the children at the time of testing was 5,8  
(1,3) years. All children were diagnosed with bilateral spastic cerebral palsy. Twelve children were 
classified at gross motor function classification system level I, 18 at level II and 10 at level III. For ten 
children, two different measurements were used.  When different measurements of the same child 
were used, a minimal interval of 10 weeks was applied. This resulted in a total number of 50 test 
results. Before the study, none of the children had previously been tested with the gross motor 
function measure-88.   
 
Table 1 provides an overview of the results of the agreement measures between the live- and video- 
scores of the first evaluator. The results showed good to very good agreement for the total score (ICC 
0,973), dimension B (ICC 0,938), D (ICC 0,965) and E (ICC 0,992) and good agreement for dimension 
A (ICC 0,720) and C (ICC 0,667). 
The SEM for the total score when comparing the live and video-scores was 2,28% with an SDC of 
6,32%. The limits of agreement at 95% CI as demonstrated in the Bland-Altman-plot (Fig 1 and table 
1) for the total scores range from -5,28 to 7%. The mean value of the difference was 0,81%.  
Weighted Kappa coefficients (see appendix) revealed a moderate to high agreement for all except 
four items: item 32 (attaining 4 point over left side) (ƙ=-0.101, positive agreement 0,96), item 38 
(prone, forward creeping) (ƙ=-0.101, positive agreement 0,96), item 40 (4 point, attains sitting arms 
free) (ƙ=-0.204, positive agreement 0,92) and item 45 (crawling reciprocally (ƙ=0.310, positive 
agreement 0,96).  
 
Table 2 provides the results of the intra-rater reliability for scores of video-recordings by the two 
independent evaluators.  The ICC could be interpreted as very good for both the total score (ICC 
0,989) and all dimension scores (ICC ranges from 0,894-0,993).  The SEM for the total score was only 
1,43% with an SDC of 3,96%. Overall, both independent assessors reported an average of 4,14 items 
per registration that could not be scored based on the video-recordings.   
 
 
Table 3 represents the inter-rater agreement values for the second scores of all three raters. These 
results revealed a weak agreement for dimension A (ICC 0,374), a good agreement for dimension B 
(0,603) but a very good agreement for all other dimensions and the total score (ICC ranges from 
0,836-0,996).  The overall SEM was 3,15%, with an SDC of 8,73 %. 
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Fig 1. Bland-Altman plot representing the difference between the live- and the video-scoring of the 
total score of the gross motor function measure-88. The average difference and the 95% confidence 
interval (±1,96 SD) of the difference are indicated. 
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Table 1. Live-and video-scores of the GMFM-88 with corresponding agreement values (first rater).. 
GMFM-88 parameter Total score  Dimension A Dimension B Dimension C Dimension D Dimension E 
Live scoring: Mean (SD) (%) 83,03 (14,01) 99,25 (2,13) 96,8 (6,26) 90,71 (12,46) 70,87 (25,97) 57,53 (28,12) 
Video scoring: Mean (SD) (%) 82,22 (13,74) 99,25 (1,63) 97,3 (5,15) 88,00 (15,04) 69,28 (25,51) 57,28 (27,78) 
Mean Diff (live-video) (SD diff) 0,81 (3,15) 0 (1,43) -0,5 (1,97) 2,71 (11,11) 1,59 (6,65) 0,25 (3,61) 
Limits of agreement  
(Bland Altman) 
-5,28 - 7,00 -2,80 - 2,80 -4,36 - 3,36 -19,08 - 24,50 -11,44 - 14,63 -6,83 - 7,33 
ICC agreement  
(95%CI)  
0,973 
(0,952 - 0,985) 
0,72 
(0,553-0,831) 
0,938 
(0,893-0,965) 
0,667 
(0,481-0,796) 
0,965 
(0,939-0,980) 
0,992 
(0,986-0,995) 
SEM (%) 2,28 1,00 1,42 8,01 4,79 2,53 
SDC (%) 6,32 2,77 3,94 22,02 13,27 7,01 
  
Abbreviations:  
GMFM-88: Gross Motor Function Measure-88; SD: Standard Deviation; Diff: Difference as measured by Live-Video; ICC Intraclass correlation coefficient 
(ICC between 0,00-0,19 is considered as very weak, 0,20-0,39 as weak, 0,40-0,59 as moderate, 0,60-0,79 as strong and 0,80-1,00 as very strong 
agreement); 95%CI : 95%confidence interval; SEM: t Standard Error of Measurement (SEM) calculated as SEM = (
2
PT+
2
residual) ; SDC: Smallest detectable 
change calculated as 1,96*2*SEM  
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Table 2. First and second rating of the two independent video-raters with corresponding agreement values. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations:  
GMFM-88: Gross Motor Function Measure-88; SD: Standard Deviation; Diff: Difference as measured by score1-score2; ICC Intraclass correlation coefficient 
(ICC between 0,00-0,19 is considered as very weak, 0,20-0,39 as weak, 0,40-0,59 as moderate, 0,60-0,79 as strong and 0,80-1,00 as very strong 
agreement); 95%CI : 95% confidence interval; SEM: Standard Error of Measurement (SEM) calculated as SEM = (
2
PT+
2
residual) ; SDC: Smallest detectable 
change calculated as 1,96*2*SEM  
 Total score Dimension A  Dimension B 
Rater PT 2 PT 3 PT 2 PT 3 PT 2 PT 3 
Score 1: Mean (SD) (%) 78,75 (13,78) 77,89 (13,80) 97,53 (6,51) 95,41 (6,38) 94,17 (8,70) 93,17 (9,64) 
Score 2: Mean (SD) (%) 77,82 (13,55) 78,78 (14,78) 96,55 (6,78) 96,51 (5,55) 92,57 (9,29) 93,57 (9,24) 
Mean Difference (%) 0,93 -0,89 0,98 -1,10 1,60 -0,40 
       
Limits of agreement 
 (Bland Altman) 
-2,63 - 4,50 -4,44 - 2,66 -4,01 - 5,97 -6,14 - 3,94 -7,96 - 11,16 -6,02 - 5,22 
ICC agreement  
(95%CI)  
0,989  
(0,974-0,995) 
0,989 
(0,976-0,995) 
0,918  
(0,847-0,995) 
0,894  
(0,797-0,943) 
0,842  
(0,729-0,909) 
0,954 
 (0,920-0,974) 
SEM (%) 1,43 1,42 1,91 1,96 3,6 2,03 
SDC (%) 3,96 3,93 5,29 5,43 9,97 5,62 
 Dimension C Dimension D Dimension E 
Rater PT 2 PT3 PT 2 PT 3 PT 2 PT 3 
Score 1: Mean (SD) (%) 82,19 (16,68) 83,48 (15,71) 67,59 (25,91) 65,64 (24,87) 51,64 (26,47) 51,75 (26,58) 
Score 2: Mean (SD) (%) 82,19 (16,41) 85,57 (14,79) 66,36 (25,22) 66,77 (24,81) 51,42 (26,23) 51,47 (26,80) 
Mean Difference (%) 0,62 -2,10 1,23 -1,13 0,22 0,28 
       
Limits of agreement 
(Bland Altman) 
-11,95 - 13,19 -13,55 - 9,36 -6.91 - 9,36] -9.81 - 7,56] -6,03 - 6,48 -7,24 - 7,80 
ICC agreement  
(95%CI)  
0,926  
(0,873-0,957) 
0,919 
 (0,853-0,955) 
0,986 
 (0,975-0,992) 
0,983 
 (0,971-0,991) 
0,993  
(0,987-0,996) 
0,990 
 (0,982-0,994) 
SEM (%) 4,51 4,35 3,03 3,2 2,24 2,69 
SDC (%) 12,49 12,05 8,39 8,86 6,2 7,45 
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Table 3. Overall inter-rater agreement values for the second ratings of all 3 raters. 
 
Abbreviations:  
GMFM-88: Gross Motor Function Measure-88; SD: Standard Deviation; ICC Intraclass correlation 
coefficient (ICC between 0,00-0,19 is considered as very weak, 0,20-0,39 as weak, 0,40-0,59 as 
moderate, 0,60-0,79 as strong and 0,80-1,00 as very strong agreement); 95%CI : 95% confidence 
interval; SEM: Standard Error of Measurement (SEM) calculated as (
2
PT+
2
residual) ; SDC: Smallest 
detectable change, calculated as 1,96*2*SEM  
  
GMFM-88  Total score  Dimension A Dimension B Dimension C Dimension D Dimension E 
ICC agreement 
(95%CI)  
0,949 0,374 0,603 0,836 0,962 0,966 
(0,808-0,979) (0,200-0,548) (0,417-0,746) (0,723-0,905) (0,938-0,977) (0,894-0,985) 
SEM (%) 3,15 4,23 5,34 6,35 4,93 4,99 
SDC (%) 8,73 11,72 14,8 17,6 13,67 13,83 
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Discussion 
 
This paper aimed to investigate the agreement between the live- and video-scores of the Gross Motor 
Function Measure-88.  
The results showed a very good agreement between the live-and video-ratings for the total scores. 
The ICC of 0,973 demonstrated very good agreement. Additionally, the mean value of the difference 
(0,81%, demonstrated on the Bland Altman plots) did not significantly differ from 0, demonstrating no 
fixed or consistent bias.   
Nevertheless, the ICC values comparing the association between the video-versus live scores were 
lower in comparison to the intra-rater assessment values (ICC 0,989 and 0,989) but higher in 
comparison to the inter-rater agreement as evaluated by video-ratings (ICC 0,949).  Similarly, the 
SEM was lower for video versus live agreement (SEM 2,28) compared to the intra-rater values (SEM 
3,32), but higher in the comparison to the inter-rater values (SEM 3,15).  
In general, the lowest ICC scores were found for dimension A and C. The lower agreement of 
dimension A is consistent with previous results of other authors, as these items are more difficult to 
score and more prone to subjectivity.
4,6
 The lower agreement in dimension C was probably caused by 
missing items, as most of the items that could not be scored based on the video-recordings, were 
items from dimension C. Items from dimension C usually require more active involvement and 
demonstration by the tester, who thereby often hinders the camera. These results suggest that it might 
be recommendable to use an additional person for filming. However, this might distract the child and 
therefore influence the test results negatively. 
In general, our results showed lower inter-and intra-rater agreement values in comparison to previous 
studies using experienced raters.
5,6,13
 Still, higher agreement values were observed compared to 
Nordmark et al., who investigated the agreement between un-experienced raters.
8
 As the test manual 
can be used during the video-ratings, experience of the rater might of less importance regarding 
reliability.  In our study, the master students were trained in the observation of children’s motor 
functioning and familiar with the test but were not as experienced in rating the gross motor function 
measure as the first assessor.  
Since only ambulant children with bilateral spastic cerebral palsy were included, our study population 
was relatively homogeneous. This limitation specifically concerns dimension A and B of the study, as 
very high scores were registered in these dimensions.  
The SEM and SDC values were very variable for the different types of scoring. This requires 
carefulness when interpreting the results of clinical trials. For the total test score, the SEM of 2,28% 
should be considered as the measurement error when comparing live-to video-scores. When using 
video-scores, 1,43 and 3,15 % should be considered for intra-and- inter-rater reliability respectively. 
When interpreting changes in scores of the Gross Motor Function Measure-88 in future intervention 
studies, the appropriate SEM and SDC should be considered and this should depend on the type of 
scoring used. 
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Clinical messages 
 There was a high agreement between the live- and video-scores of the gross motor function 
measure-88;  
 Agreement between live- and video-scores was lower compared to the intra-rater reliability of 
video-scores; 
 When using video-scores in a clinical trial, the appropriate reliability measures should be 
considered.  
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Abstract   
Objective 
A pilot study to compare the effectiveness of an individual therapy program with the effects of a 
general physical therapy program. 
 
Design  
A randomized, single-blind cross-over design.   
 
Participants 
Ten ambulant children with bilateral spastic cerebral palsy, age four to nine years.  
 
Intervention  
Participants were randomly assigned into a ten-week individually defined, targeted or a general 
program, followed by a cross-over.   
 
Main outcome measures  
Evaluation was performed using the Gross Motor Function Measure-88 and three-dimensional gait 
analysis. General outcome parameters were Gross Motor Function Measure-88 scores, time and 
distance parameters, gait profile score and movement analysis profiles. Individual goal achievement 
was evaluated using z-scores for gait parameters and Goal Attainment Scale for gross motor function.  
 
Results  
No significant changes were observed regarding gross motor function. Only after individualized 
therapy, step- and stride-length increased significantly (p = 0.022; p = 0.017). Change in step-length 
was higher after the individualized program (p = 0.045). Within-group effects were found for the pelvis 
in transversal plane after the individualized program (p = 0.047) and in coronal plane after the general 
program (p = 0.047). Between-program differences were found for changes in the knee in sagittal 
plane, in the advantage of the individual program (p = 0.047). A median difference in z-score of 0.279 
and 0.419 was measured after the general and individualized program, respectively. Functional goal 
attainment was higher after the individual therapy program compared with the general program (48 to 
43.5).  
 
Conclusion  
The results indicate slightly favorable effects towards the individualized program. To detect clinically 
significant changes, future studies require a minimal sample size of 72 to 90 participants.  
  
148 
Introduction 
 
Many different techniques and approaches are available for physical therapy treatment of children with 
cerebral palsy.
1
 Although promising results are available for isolated physical therapy techniques, 
evidence about the outcome of complete programs using a combination of different techniques is 
more limited.
2,3
 
Several research studies have evaluated the effects of goal-setting in physical therapy of chil- dren 
with cerebral palsy.
4–9
 The results of a recent systematic review, however, could not provide support 
for the effectiveness of goal-setting within an activity-focused approach on treatment outcome.
10
 The 
authors of this review found that none of the included studies were designed specifically to determine 
the effect of goal-setting per se, as goal- setting was additional to guiding the interventions. 
An important advantage of goal-oriented physical therapy however, is the potential benefit to enhance 
training specificity. Goal planning, in that context, can be used to identify the tasks and contexts of 
particular interest and thereby, to use a more targeted and focused approach.
11 
In a previous study, we developed and validated a clinical decision framework based on the 
hypothesis- oriented algorithm for clinicians
12
 and the International Classification of Functioning, 
Disability and Health (ICF) for Children and Youth,
13,14
 Organizing assessment results within the 
framework of the International Classification of Functioning provides a profound and complete 
overview of the child and results in an objective problem list for the child. In children with cerebral 
palsy, however, this list is generally very extensive. Therefore, as a therapist, one has to prioritize and 
select possible and realistic targets in treatment. The hypothesis-oriented algorithm for clinicians 
provided this strategy-oriented structure for clinical reasoning and was used to reduce the long 
problem list to a selection of main problems. The combined approach of both frameworks was 
demonstrated as a positive structure that supported clinical reasoning in pediatric physical 
therapists.
14
 
As a next step, a pilot study was set up to use this clinical reasoning structure in a controlled 
intervention. This study, therefore, aims to investigate the effectiveness of an individually defined and 
targeted physical therapy approach using structured clinical reasoning on gait and gross motor 
function of ambulant children with bilateral spastic cerebral palsy. Using a randomized, repeated- 
measures, cross-over design, the outcome of this approach is compared with the outcome of a gen- 
eral program. 
It is hypothesized that an individually defined targeted approach, based on structured clinical 
reasoning and including the results of three- dimensional gait analysis, provides better results than a 
general program. 
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Method 
 
Participants were selected through the cerebral palsy reference center of the University Hospital of 
Leuven. Inclusion criteria were diagnosis of bilat- eral spastic cerebral palsy, Gross Motor Function 
Classification System Level I, II or III, age between four and nine years and sufficient cooperation to 
understand and execute simple verbal instructions. Patients were excluded when they showed severe 
muscle contractures or bony deformities, a history of multilevel orthopedic surgery or additional dis- 
orders that would make participation to the physi- cal therapy programs not feasible (e.g. severe 
cognitive disorders, deafness, blindness, etc.). The programs were planned at a time when children 
had not received botulinum-toxin A injections within the previous six months. A convenience sample of 
10 children represented a manageable number to reassure an adequate follow-up for this pilot study. 
Children were recruited between January 2010 and January 2012. 
The programs were executed by the child’s personal physical therapist, who agreed to precisely follow 
the prescribed program. A physical therapy degree was required, no further specialization was 
mandatory. The therapist and parent or caretaker of the child signed an informed consent. The study 
was approved by the ethical committee of the University Hospital of Leuven. 
At the start of the study, the selected group of 10 children was followed for a period of 10 weeks of 
usual care. During this period, usual physical therapy of the child was continued without a specific 
intervention. A diary was provided to document the content of the therapy sessions. The therapists 
were asked to fill in the diary after each session, to register how much of the therapy time targeted the 
impairment, activity and participation level. 
Subsequently, the children were enrolled in the actual intervention study. For this part of the study, an 
alternating treatment design with rand- omization and cross-over was set up. A first treatment 
program, general or individualized, was presented to the participants based on an independent 
randomization procedure. Randomization was performed by a person blinded and independent to the 
study, and was based on the principles of minimization, as described by Altman and Bland.
15 After 
completing one program, a wash-out period of minimally 10 weeks usual care was continued. 
Consequently, each child participated in the remaining program. The children that originally received 
the individualized program, now received the general program and vice versa (Figure 1). 
The general treatment program was based on the most common aims in children with bilateral spastic 
cerebral palsy of the involved age-range
16 and was the same for all children. The main aims were in 
accordance with the clinical management recommendations for children with spastic diplegia as stated 
by the task force of the American Physical Therapy Association.
16 The general considerations reported 
in this statement, are musculoskeletal and neuromuscular systems including strength, range of 
motion, posture, balance, motor function, muscle tone and movement patterns. The program, 
therefore, contained exercises to improve strength, selectivity and mobility and included a set of func- 
tional exercises to encourage mobility and play. 
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Fig 1: Study design  
 
Abbreviations:  
N:Number; GMFM-88: Gross Motor Function Measure 88; 3DGA: Three-dimensional Gait Analysis 
  
Randomization 
Pilot sample  
N=10  
Usual Care ( 10 weeks) 
N= 10 
Intervention 1: 
General therapy program  
(10 weeks) 
N=5 
Intervention 1: 
Individualized therapy program 
(10 weeks) 
N=5 
Intervention 2: 
General therapy program  
(10 weeks) 
N=5 
Intervention 2: 
Individualized therapy program 
(10 weeks) 
N=5 
Evaluation 1:  
GMFM-88 
3DGA 
Evaluation 2:  
GMFM-88 
3DGA 
Evaluation 3:  
GMFM-88 
3DGA 
Evaluation 4:  
GMFM-88 
3DGA 
Evaluation 5:  
GMFM-88 
3DGA 
Wash-out (minimally 10 weeks) + 
cross-over 
Wash-out (minimally 10 weeks) + 
cross-over 
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The individually defined, targeted programs (further referred to as “individuali ed programs”) were 
designed to target the specific main problems of the child, tailored to the needs of the child and 
specific problems at the different levels of the ICF at that particular moment. Definition of the indi- 
vidual problems was based on the results of all assessments. At the level of body structure and 
function, results of the clinical examination were considered. At activity level, three-dimensional gait 
analysis and gross motor function evaluation was used, complemented with a structured inter- view 
with the parents and child. The results of the gait analysis thereby played a major role in unrave- ling 
the motor problems of the child and the identification of the main problems. The programs were based 
on the clinical decision framework as described by Franki et al.,
14 which use the ICF and the 
Hypothesis-Oriented Algorithm for Clinicians (HOAC-II)
12 to identify a selection of main problems. This 
allowed goal-setting at all levels of the ICF, according to the needs of the child. The goals were 
discussed with the child’s parents or caretakers, as well as the child’s physical therapist. The designs 
of the programs thereby approached the reality of clinical practice, using a mixture of individual 
techniques, each targeting a specific problem of the child at that particular moment. The choice of the 
appropriate techniques to achieve a specific goal was performed according to the evidence-table 
designed by Franki et al. in previous systematic reviews.
2,3 Table 1 provides an overview of the 
similarities and differences between the programs. 
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Table 1: Differences and similarities between the general, aim-oriented program and the individually 
defined targeted programs  
 
  
 
General program Individually defined, targeted program 
D
if
fe
re
n
c
e
s
 
 The same program for all children; 
 Based on the most common problems of ambulant 
children with bilateral spastic CP; 
 Aspecific, based on general aims; 
 A predefined set of exercises to improve strength, 
selectivity and mobility and gross motor function; 
 The results of the three-dimensional gait analysis 
were not used to define of the program; 
 The program was not discussed with the therapist and 
parents. 
 Different for all children; 
 Based on the results of the individual assessments; 
 Specific, tailored to the individual problems; 
 Goal-oriented; 
 Depending on the needs of the child, the exercises 
targeted the different levels of the ICF; 
 Based on structured clinical reasoning using the 
HOAC-II and the ICF; 
 The results of the three-dimensional gait analysis 
were included to define the program; 
 The program was discussed with the parents and the 
therapist. 
S
im
ila
ri
ti
e
s
 
 Respected the basic principles for evidence-based PT 
regarding intensity and repetitions were respected.  
- Stretching: 3 repetitions of 30 seconds;  
       - Strength: 3 series of 12 to 15 repetitions; 
       - Functional exercises: not restricted. 
 Executed by the child’s private physical therapist, 
familiar to the child; 
 At the child’s usual frequency and duration of therapy. 
 Respected the basic principles for evidence-based PT 
regarding intensity and repetitions were respected.  
- Stretching: 3 repetitions of 30 seconds;  
       - Strength: 3 series of 12 to 15 repetitions; 
       - Functional exercises: not restricted. 
 Executed by the child’s private physical therapist, 
familiar to the child; 
 At the child’s usual frequency and duration of therapy 
  
153 
Participants were evaluated before and after the period of usual care, as well as after each treatment 
program using the gross motor function measure,
17 standardized clinical examination and three- 
dimensional gait analysis. 
The Gross Motor Function Measurement-88 is a standardized clinical instrument to evaluate 
change in gross motor function in children with cerebral palsy. It fulfills the criteria of reliability and 
validity with respect to responsiveness to change.
18–20
 The gross motor function evaluations were 
performed by the first author of this study, but video-taped. Two independent assessors, blinded to the 
set-up of the study, scored the video. The average of both video-scores was used. 
Clinical examination and three-dimensional gait analysis were performed according to the 
standardized protocol used at the Laboratory of Clinical Motion Analysis of the hospital. An inde- 
pendent assessor, blinded to the study, performed both assessments. Clinical examination included 
measurements of range of motion (goniometrical measurements), spasticity (Modified Ashworth Scale 
and Tardieu), selectivity (selective motor scale) and muscle strength (manual muscle testing).
21–23
 For 
gait analysis, information on kinematics, kinetics and spatial-temporal data was collected by a 16-
camera VICON system (Nexus PluginGait marker set, Oxford Metrics, Oxford, UK), two ATMI 
forceplates (Advanced Medical Technology, Inc, Watertown, MA, USA) and a 16-channel EMG device 
(Zero-Wire, Cometa, Milano, Italy). Three representative trials were selected. Specific gait parameters 
were automatically extracted using a custom-made Matlab graphical user interface (Mathworks®, 
Natick, MA, USA). The results of the children were compared with the means and standard deviations 
of a reference group. Our reference data was based on the data obtained from a control group of 55 
typi- cally developing children, with a mean age of 10.94 years, range between the ages of four years 
and 18 years. Outcome parameters were derived at two different levels (Figure 2). 
At a first, general level, overall therapy success was evaluated using outcome parameters that pro- 
vide a general outcome description. From the Gross Motor Function Measure, the total and 
dimensional percentage scores were extracted. Regarding gait analysis, time and distance param- 
eters, the Movement Analysis Profiles and the Gait Profile Score were calculated.
24
 The average 
scores from the left and right sides were used. The Movement Analysis Profiles were calculated as the 
root mean square error between the point-by-point comparison of the lower limb joint angle and the 
averaged joint angle of the reference group. Calculation of the average of all lower limb joint angles 
results in the Gait Profile Score, which summarizes the overall severity of gait pathology.
24 
Second, individual goal achievement was evaluated before and after the programs. 
For the individual, functional goals extracted from the Gross Motor Function Measure-88, the 
original version of the Goal Attainment Scale (GAS) was used, as developed by Kirusek et al.
25
 and 
used in several pediatric rehabilitation studies.
26,27
 Before the start of the programs, individual goals 
based on specific goal items of the Gross Motor Function Measure-88, were formulated according to 
the SMART-principle.
28
 A score between –2 and 2 was given depending on the goal achievement. 
Subsequently, a converted T-score and the percentage of achieved goals (⩾0) were calculated. 
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Fig 2.  Outcome measurements and parameters 
Abbreviations: 
GMFM-88: Gross Motor Function Measure-88; 3DGA: three-dimensional gait analysis; GAS: Goal 
Attainment Scale; GPS: Gait Profile Score; MAPS: Movement Assessment Profiles  
GMFM - 88 3DGA 
GMFM – 88 
Total scores 
Dimension scores 
GAS (original version) 
GPS and MAPS 
Time – and distance 
parameters 
z-scores  
Individual level 
General level 
Outcome 
measurements 
Outcome 
parameters 
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Individual goal achievement of the specific goals derived from gait analysis was evaluated using 
z-scores and proportional changes. As a first step, two to eight specific deviated gait parameters were 
identified as specific goals for each child. Each goal was represented by a relevant data point that was 
expected to improve, such as maxima, minima, range of motion and angles at specific events in the 
gait cycle. These data points were defined based on literature and by clinical experts in gait analysis of 
children with cerebral palsy.
29,30
 The parameters were converted into z-scores. A z-score represents 
the deviation from a reference group (z = (mean child – mean typical child)/standard deviation (SD) 
typical child). To evaluate the z-scores, the absolute difference to zero, in either direction, was 
considered as an equal deviation from typical gait. Following standard clinical practice, we assumed 
that a deviation greater than 1 could be considered as pathological. Therefore, all z-scores smaller 
than 1 were eliminated.
29
 Consequently, the median z-scores of the specific goals were calcu- lated. 
Z-scores are non-dimensional and, therefore, allow the comparison of different parameters. Finally, 
the proportional change was calculated (proportional change = (|pre median z-score| – |postmedian z-
score| / |premedian z-score|)). This percentage score allowed a description of therapy success. A 
positive proportional change described a successful therapy and a negative proportional change 
indicated an unsuccessful therapy. For the individually defined programs, these individual goals were 
taken into account to design the programs. For the general programs, the individual goals were only 
considered as outcome parameters, but not specifically taken into account to during the programs. 
 
Statistical analyses were performed in different steps. First, other treatment modalities, including the 
use of orthosis, aquatic and horse-riding therapy, during the different intervention periods were 
compared using a McNemar test. Similarly, differences in the frequency and duration of the physical 
therapy sessions were tested using the related- samples Wilcoxon Signed-Rank test. Secondly, the 
median and interquartile range (IQR) of all parameters before and after the programs were calculated 
as appropriate. A related-samples Wilcoxon signed rank analysis was applied to calculate within-group 
differences of pre- and postvalues. In order to evaluate the effect between the different interventions, a 
related-samples Friedman’s two-way analysis of variance by rank analysis with post-hoc related- 
samples Wilcoxon signed rank analysis was applied. This analysis compared the difference scores of 
the outcome parameters (difference score = Pre – Post), further described as between-program 
differences. 
All statistics were performed in SPSS 21 IBM SPSS Statistics for Windows, Version 21.0. (IBM Corp, 
Armonk, NY, USA). 
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Results 
 
Patient characteristics, as well as duration, frequency of therapy and the use of orthosis are reported 
in Table 2 and were not significantly different between the different periods. The results of the diaries 
provided during the period of usual care show that 55.8% of therapy time was dedicated at impairment 
level. Thereby, 22.5% (interquartile range (IQR) 16.7–28.6) targeted joint mobility and muscle length 
and 33.3% (IQR 23.9–35.9) strength. A median of 48.1% (IQR 35.6–54.8%) of therapy time was used 
to train activities. Only 1.55% (IQR 0–6.5%) of therapy time addressed specific participation 
restrictions. 
 
Table 2: Patient Characteristics 
 
Patient characteristics  
Age (median + IQR)  6,2y (4,6 – 7,0 y) 
Gender (n) (male/female) 6/4 
GMFCS (n) (I/II) 5/5 
History of BTX-A injections (n) 4 
 UC GT IT 
Use of day orthosis (n) 
>50%/day 
<50%/day 
no  
 
8 
0 
2 
 
7 
2 
1 
 
7 
2 
1 
Use of night orthosis (n) 
>50%/night 
<50%/night 
   no 
 
1 
0 
9 
 
2 
2 
6 
 
0 
4 
6 
Frequency of PT (times/week) Med (IQR) 2 (2-3) 3 (2-3) 3 (2-4)  
Duration of PT (minutes /session) Med (IQR) 40 (30-60) 40 (30-60) 40 (30-60) 
Total PT (minutes/week) 105 (80-120) 120 (90-128) 120 (90-123) 
Abbreviations: 
UC: period of Usual Care; GT: period of general treatment; IT: period of Individualized, targeted 
treatment 
GMFCS: Gross Motor Function Classification System; PT: Physical Therapy; N: number; Y: year 
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The median total percentage scores of the Gross Motor Function Measure-88 showed only very 
limited and no significant changes, but a slight increase after the individualized program, from 93.5 to 
95.5% (Table 3). 
Dimension D and E showed a slight decrease during the period of usual care, but an increase after the 
period of individualized therapy. Evaluating the between-program differences revealed no significance. 
Considering time and distance parameters showed significant improvements on step and stride length 
(p = 0.022 and 0.017, respectively) after the period of individualized therapy. Between- program 
effects were, therefore, also significant for step length in the advantage of the individualized therapy 
program (p = 0.045). Changes in Gait Profile Score and Movement Assessment Profile Scores are 
provided in Table 4. Significant changes were found after the individualized program, for the pelvis at 
the transversal plane (p = 0.047), while for the general program differences were found for the pelvis 
in the coronal plane (p = 0.047). Between- program changes were only found for the knee in the 
sagittal plane and this in the advantage of the individualized therapy program (p = 0.047). The results 
of the Gait Profile Score showed slight progress after the individualized program, whereas 
deterioration was registered after the general program. No changes were measured after the period of 
usual care.  
Functional goal attainment was higher after the individualized than after the general therapy pro- 
gram: 48.0 (IQR 43.3–59.3) compared with 43.5 (IQR 30.3–43.5) (p = 0.285). Additionally, the 
averaged percentage of achieved goals was 50.0 (IQR 25.0–100) after the individualized program, 
compared with 41.7 (IQR 0–75) for the general program (p = 0.589). Nevertheless, none of the 
programs caused treatment success (GAS ⩾50) and the differences were not statistically significant. 
Table 5 provides an overview of the changes in z-scores for the goals derived from the gait analysis 
after both training periods. This analysis revealed a median difference in z-score (pre– post) of 0.279 
and 0.419 after the period of general and individualized therapy program, respectively. This was 
translated in a proportional change of 12% and 19%, respectively. These changes, how- ever, were 
not significantly different. 
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Table 3. Changes in GMFM-88 total and dimensional scores before and after the period of usual care, the general therapy program and the individualized 
therapy program. 
 
 
Usual Care General Therapy Individualized Therapy p between 
 
Pre Post p 
(within) 
Pre Post p 
(within) 
Pre Post p 
(within) 
UC vs 
GT 
UC 
vs IT 
GT 
vs IT 
 
Median (IQR) Median (IQR) Median (IQR) Median (IQR) Median (IQR) Median (IQR) 
Total GMFM 94,5 (88,2-98,3) 94,5 (90,1-98,5) 0,173 92,2 (87,0-99,3) 92,5 (88,5-97,7) 0,333 93,2 (87,6-97,9) 95,5 (89,4-98,7) 0,065 0,173 0,917 0,441 
GMFM-A% 100 (100-100) 100 (100-100) 1 100 (100-100) 100 (100-100) 1 100 (100-100) 100 (100-100) 1 1 1 1 
GMFM-B% 100 (100-100) 100 (100-100) 1 100 (100-100) 100 (100-100) 1 100 (100-100) 100 (100-100) 1 1 1 1 
GMFM-C% 100 (96,4-100) 100 (96,4-100) 1 100 (82,1-100) 100 (85,7-100) 0,068 100 (84,2-100) 100 (89,3-100) 0,18 0,317 1 1 
GMFM-D% 89,1 (70,8-100) 87,8 (73,1-100) 0,581 90,4 (83,0-100) 90,4 (82,1-100) 0,917 89,1 (84,0-98,1) 94,9 (82,1-100) 0,667 0,581 0,465 0,735 
GMFM-E% 86,5 (72,7-98,6) 83,7 (75,9-97,6) 0,893 77,1 (65,8-96,0) 80,9 (67,5-92,0) 0,572 78,8 (65,8-89,9) 82,6 (68,8-93,4) 0,675 0,344 0,752 0,932 
 
Abbreviations: 
GMFM: Gross Motor Function Measure-88; GMFM-A: Gross Motor Function Measure dimension A; GMFM-B: Gross Motor Function Measure Dimension B; 
GMFM-C: Gross Motor Function Measure Dimension C GMFM-D: Gross Motor Function Measure Dimension D GMFM-E: Gross Motor Function Measure 
Dimension E IQR: Interquartile Range; Diff: difference (pre-post); p (within): p value for the within-group effects provided by the Wilxocon Signed Ranks 
Test; p value (between): p value for the between-group effects provided by the Wilcoxon Signed Ranks Test 
 
  
159 
Table 4. The Movement Assessment Profiles (MAPS) and Gait Profile Score (GPS) before and after the period of usual care (UC), the GT program (general 
therapy) and the individually defined targeted therapy program (IT).  
 
 
 
Usual Care General Therapy Individualized therapy p between 
 
Pre Post p 
(within) 
Pre Post 
p (within) 
Pre Post p 
(within) 
UC vs 
GT 
UC 
vs IT 
GT 
vs IT Median (IQR) Median (IQR) Median (IQR) Median (IQR) Median (IQR) Median (IQR) 
MAPS Sag P 8,8 (3,4-12,2) 9,3 (4,3-12,9) 0,575 8,4 (4,0-15,1) 9,0 (5,6-14,0) 0,386 9,3 (6,1-12,9) 8,5 (4,7-14,7) 0,878 0,575 0,721 0,799 
MAPS Sag H 9,9 (5,4-13,2) 9,8 (5,4-13,5) 0,508 8,6 (6,0-15,9) 10,2 (6,8-14,3) 0,575 10,8 (8,1-13,5) 10,2 (5,7-15,6) 0,799 0,386 0,878 0,575 
MAPS Sag K 13,5 (7,6-19,3) 13,4 (10,2-16,7) 0,959 13,6 (8,3-16,1) 13,6 (8,7-19,8) 0,333 14,2 (9,2-20,9) 12,9 (7,3-18,9) 0,203 0,646 0,203 0,047 
MAP Sag A 7,0 (5,5-12,3) 7,0 (4,9-13,1) 0,799 6,5 (4,5-11,1) 7,3 (5,5-10,4) 0,878 7,0 (4,9-14,7) 7,8 (5,6-12,5) 0,959 0,445 0,959 0,508 
MAPS Cor P 2,9 (2,1-4,0) 2,8 (2,2-4,4) 0,721 3,4 (2,2-4,1) 3,3 (1,9-3,6) 0,047 3,4 (2,3-4,8) 3,3 (2,1-3,6) 0,241 0,721 0,878 0,799 
MAPS Cor H 4,0 (3,6-5,3) 4,2 (3,4-5,1) 0,878 4,0 (3,7-5,9) 4,9 (3,6-6,4) 0,386 4,7 (4,0-5,3) 4,3 (4,0-5,9) 0,799 0,508 0,878 0,445 
MAPS Trans P 8,4 (5,3-11,4) 7,3 (5,5-8,4) 0,241 6,5 (4,9-8,2) 5,1 (4,0-7,7) 0,508 6,9 (5,5-9,3) 5,7 (3,6-8,4) 0,047 0,333 0,241 0,139 
MAPS Trans H 7,0 (6,4-12,4) 7,6 (6,1-11,5) 0,333 7,8 (6,3-12,2) 6,9 (5,2-9,3) 0,285 7,4 (5,9-10,0) 8,7 (6,1-10,47) 0,445 0,203 0,508 0,386 
MAPS Trans F 10,4 (5,2-17,5) 9,0 (6,5-16,2) 0,445 10,9 (5,4-13,9) 9,1 (5,5-20,9) 0,508 9,1 (6,7-17,3) 10,0 (6,5-14,4) 0,878 0,139 0,799 0,799 
GPS 10,0 (7,0-12,5) 9,7 (6,6-12,9) 0,445 9,9 (5,9-11,9) 9,4 (6,7-15,2) 0,386 10,5 (6,8-13,0) 10,9 (6,5-13,4) 0,721 0,139 0,646 0,333 
 
Abbreviations 
IQR: Interquartile Range; p(within): p value for the within-group effects of the z-scores as provided by the Wilcoxon Signed-Ranks test; p (between): p value 
for the evaluation of the between-program effects of the z-scores as provided by the Wilcoxon Signed-Ranks test; Diff: difference between the pre-and post 
value; PC: Proportional Change, calculated by (z pre- z post)/z pre; UC: Usual Care; IT: Individualized Therapy Program; GT: General Therapy Program; 
MAPS: Movement Assessment Profile; Sag: Sagittal plane; Cor: Coronal plane; Trans: Transversal plane; P: Pelvis; H: Hip; K: knee; A: Ankle 
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Table 5. Overview of the changes in z-scores and the converted proportional changes as derived from the 
individual goals based on the results of the three-dimension gait analysis 
 
Child 
General Program Individualized program p 
(between) Pre Post Diff PC p (within) Pre Post Diff PC p (within) 
1 2,967 3,142 -0,175 -6% 
0,368 
2,718 2,656 0,062 2% 
0,169 0,333 
2 1,646 1,184 0,462 28% 1,669 0,738 0,931 56% 
3 2,334 1,576 0,759 33% 2,271 1,629 0,641 28% 
4 3,093 2,475 0,618 20% 2,410 1,672 0,738 31% 
5 1,592 2,026 -0,434 -27% 2,449 2,536 -0,088 -4% 
6 1,439 0,747 0,693 48% 3,349 3,003 0,347 10% 
7 1,485 0,741 0,744 50% 1,867 1,179 0,688 37% 
8 1,472 1,886 -0,414 -28% 1,453 0,961 0,492 34% 
9 2,134 2,038 0,096 4% 2,703 2,804 -0,101 -4% 
10 3,263 4,127 -0,864 -26% 2,788 3,681 -0,893 -32% 
50th (Median) 1,889 1,817 0,278 12%   2,429 2,104 0,419 19%     
25th 1,481 1,070 -0,419 -27% 
 
1,817 1,124 -0,090 -4% 
 
 
75th 2,990 2,641 0,705 36%  2,735 2,853 0,700 35%    
 
Abbreviations 
p(within): p value for the within-group effects of the z-scores as provided by the Wilcoxon Signed-Ranks 
test; p (between): p value for the evaluation of the between-program effects of the z-scores as provided 
by the Wilcoxon Signed-Ranks test; Diff: difference between the pre-and post value; PC: Proportional 
Change, calculated by (z pre- z post)/z pre 
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Discussion 
 
The effects of the present study demonstrated a tendency in favor of the individually defined, targeted 
program on gait and gross motor function. On a general level, significant advantageous results were found 
for the individualized program on step length and for the movement assessment profiles of the knee in the 
sagittal plane. At an individual level, goal achievement was non-significantly higher after the individualized 
program compared with the general program, and this for both the functional goals as the goals based on 
gait analysis. 
The applied approach was representative for the reality of clinical practice, which usually makes use of a 
mixture of individual techniques, each targeting a specific problem. It differed from more recent goal-
oriented, activity-focused interventions that usually apply a ‘top-down’ approach within the IFC.
31
 The 
clinical reasoning strategy used to define the individually tailored programs was based on a horizontal 
approach and, therefore, considered all dimensions of the model of equal impor- tance. It aimed to 
specifically address the thoughts behind the dynamic and interactive concept of the ICF and, thereby, also 
the multidimensional diffi- culties following cerebral palsy. Gait rehabilitation was an essential part of our 
programs and a large part of our outcome parameters consisted of gait measures. This was motivated by 
previous research that highlighted that both gait speed and the amount of gait pathology adversely 
affected quality of life, as reported by the child and their proxy.
32
 This unique but realistic concept can be 
considered as a major strength of our study. 
Another strength of the study was the randomized cross-over design, allowing comparison of individual 
changes. The length of the wash-out period, thereby, was the same as the duration of the program. Wash-
out periods are required assuming that therapy effects are still present for a certain period after the 
intervention. In our recent systematic literature review, none of the studies using follow-up periods 
detected treatment effects lasting longer than the duration of the intervention itself.
2
 Additionally, in the 
current study, only the contents of the programs were adjusted and the researchers did not interfere with 
the frequency and duration of the programs. These considerations allowed us to be confident that a 10 
weeks wash- out period is sufficient to avoid overflow effects. 
Nevertheless, only a limited number of parameters showed statistical significant changes. A first and 
major reason might be the small sample size. Although the set-up of the study was controlled and 
randomized, the sample size of 10 children provided low power. Post-hoc power calculation using SAS 
Power and Sample Size 3.1 (SAS insti- tute Inc, Cary, NC, USA) revealed the gait profile score as being 
most vulnerable for the limited power. Considering a change score of 3° on the gait profile score as 
clinically relevant, provided 8% power. To be able to detect this change, future studies should use 
between 72 (80% power) to 91 participants (90%). The Gross Motor Function Measure-88 was identified 
as least vulnerable for limited power. When using the Gross Motor Function Measure-88 as an outcome 
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measure, future studies should use between 12 (80% power) to 15 participants (90%) to detect a change 
of 3%. 
A second restriction might be related to the fact that both programs were executed by the child’s personal 
physical therapist. Besides the strict follow-up, influencing factors as cooperation of the therapist and 
correct execution of the programs still existed and were probably important confounding variables. The 
adequate follow-up could probably not completely control the correct appliance and execution of the 
prescribed programs. During the period of usual care, regular physical therapy sessions were continued. 
Therefore, the contents of the programs were dependent of the physical therapist responsible for the child 
and a large variation in therapy contents was possible. A diary was used to be able to monitor therapy 
contents without interfering with the quality and contents of therapy. Follow-up visits might have influenced 
therapy behavior and, therefore, diaries were preferred. Although the diary was a useful and objective 
tool, the physical therapists reported that filling the diary was time-consuming and caused a relatively 
large administrative burden. Therefore, diaries were avoided during the periods of interventions. The need 
for a diary during the periods of intervention was not strong as the programs were prede- fined using 
specific exercises. Therefore, follow-up during the interventions was performed using regular visits and 
phone-calls. Nevertheless, although the therapy programs were developed with more than 50% of the 
exercises targeting activity level, this did not necessary mean that therapy time was divided accordingly. 
Providing a diary during the periods of interventions might have provided more precise insight into the 
follow-up of the programs. 
A third limitation was the duration of the applied interventions. Ten weeks was a relatively short period to 
reach significant improvements. Guidelines by the National Strength and Conditioning Association stated 
that strength training should be applied 2–4 times a week on non-consecutive days for at least 8–20 
weeks in order to find an increase in muscle strength.
33
 Therefore, a study of longer duration could have 
resulted in greater benefits. Additionally, longer-term studies allow an evaluation at participation level.
34
 As 
the study period of 10 weeks was too short to expect significant changes at participation level, outcome 
evaluation did not include participation measures.
34
 Nonetheless, the design of the individualized 
integrated discussions with parents, children and therapists. In that way, individual participation limitations 
were considered during the development of the programs and were considered of equal value among the 
assessment measures when designing the programs. 
Additionally, while the inclusion criteria allowed inclusion of children with Gross Motor Function 
Classification Level III, no children func- tioning at this level could be included for this inter- vention study. 
Children with Gross Motor Functional Classification Level III are more fre- quently in need of tone-
reduction by means of bot- ulinum toxin and, therefore, we were not able to include these children during 
the predefined win- dow of six months post-botulinum toxin. 
The results demonstrated very limited difference but advantageous results of the interventions compared 
with the period of usual care. This might be explained by the variation in therapy as reported by the 
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different therapists. Remarkably however, as all children were ambulant and thus very func- tional, the 
percentage of time spent on impairment level (range between 40.3% and 70.3% of therapy time) was 
relatively high during the period of usual care. During the periods of intervention, the number of exercises 
targeting activity level was usually higher than 50%. Although this implies that during the interventions the 
average therapy time spent at activity level was probably higher than 50%, it might be a future 
recommendation to monitor therapy time more accurately during the periods of intervention as well. 
The proportional change scores allowed us to describe therapy success by explaining the gain or loss in 
performance. However, one needs to be careful with the interpretation of a proportional change score 
because it is easily influenced by extraneous factors (such as the standard deviation of the control group), 
and it may therefore overes timate outcome results. 
The study results of the present study are concur rent with the previous experience of our research group, 
in which we evaluated the effectiveness of an individually defined approach.
9
 This study showed 
fundamental differences with the present study: the order of the programs was not randomized and they 
were of shorter duration (6 weeks). Additionally, the present structured clinical reasoning was not yet the 
basis for the individual programs.  
The recent review by Brogren et al. concluded that the scientific evidence regarding goal-setting is 
inconclusive.
10
 Also, Law et al. could not find significant differences between a context-focused therapy 
containing goal-setting, and child and activity focused therapy without goal-setting.
35
 However, these 
studies used goal-setting within an activity-focused approach only. This again supports our hypothesis 
that a successful treatment approach is probably multifactorial and depends on several aspects like 
correct appliance of techniques, adequate goal and priority setting, frequency and duration of therapy, 
timely tone-reduction, attention for posture and positioning and maybe many others. Future research stud- 
ies should probably continue to look for the effectiveness of individually tailored approaches addressing 
the heterogeneous nature of cerebral palsy, not only in individual goal-setting, but also in the choice of 
techniques and approaches. 
 
In conclusion, the results can only provide an indication of the additional value of goal-setting within an 
integrative approach. To confirm our hypothesis however, future studies should include sample sizes of 
minimally 72 participants, evaluate long-term effects and use individual goal-achievement measures. 
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Abstract 
 
The first aim of this study was to compare the effectiveness of an individually-defined therapy program (IT) 
and a general therapy program (GT) on gait and gross motor function in children with bilateral Cerebral 
Palsy (CP).  The second aim was to evaluate interaction effects, time-effects, treatment with Botulinum 
Toxin A, age, gross motor function classification scale (GMFCS), therapy frequency, and treatment quality 
as factors influencing outcome.  
Forty children with spastic bilateral CP (mean age 6 years 1month, GMFCS I-III) were included in an 
evaluator-blinded, randomized controlled-trial to receive either IT or GT over a 10 week period. Nineteen 
of these children were enrolled into a second and/or third program, resulting in 60 interventions. Outcome 
was evaluated using the Gross Motor Function Measure–88 (GMFM-88), three-dimensional gait analysis, 
the Five-Times-Sit-To-Stand-Test (FTSTS) and the Timed-Up-and-Go (TUG). Primary outcome evaluated 
individual goal achievement using the Goal Attainment Scale (GAS) for gross motor function goals and z-
scores for goals based on specific gait parameters. Secondary outcome included total- and dimensional 
scores of the GMFM-88, time- and distance gait parameters, Gait Profile Score, Movement Analysis 
Profiles and time needed to complete the TUG and FTSTS.  
There was a clear tendency for a higher individual goal achievement after the IT program compared to the 
GT program. There were higher, but non-significant GAS and z-score changes following the IT program 
compared to the GT program (GAS: 46.2 for the IT versus 42.2 for the GT group, p=0.332, ES 0.15; z-
score: 0.135 for the IT compared to 0.072 for the GT group, p=0.669, ES 0.05).  
Significant time-effects could be found on GAS-T score (p<0.001) and the GMFM-88 total score 
(p<0.001). Age was identified as a predictor for GAS and GMFM-88 improvement (p=0.023 and p=0.044). 
In conclusion, no significant differences could be registered between the effects of an IT and a GT 
approach. Future research should use longer intervention periods, and improved evaluation of treatment 
quality. Comparison with a non-intervention group is necessary to re-evaluate the benefits of an IT 
approach. 
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Introduction 
 
Cerebral palsy (CP) describes a group of disorders of movement and posture, causing activity limitations, 
attributed to non-progressive disturbances occurring in the developing fetal or infant brain.
1,2
 Thereby, 
45% of the children with CP show bilateral involvement with increased muscle tone or spasticity.
1
 Ninety 
percent of the children with bilateral spastic CP show abnormal MRI findings, with periventricular 
leucomalacia or white matter disease associated with prematurity observed most frequently.
3
 Although the 
brain lesion in CP is known to be non-progressive, the consequences of the injury are not. These often 
lead to secondary problems such as muscle contractures, bone deformities and thereby, loss of gross 
motor function and mobility.
2
 CP is seen as a chronic disability, with physical therapy (PT) as a major life-
long intervention. Over the past 10 years, research into PT interventions for children with CP has grown 
exponentially. However, literature describes a large variety of frequencies and intensities of PT.
4,5 
Also 
regarding the applied techniques and therapy approaches, different outcome studies report diverse and 
contradicting results. 
6-8
 
A first and major methodological problem in the evaluation of the outcome of PT programs is the 
heterogeneous nature of CP.
2 
Children with CP usually present with a variety of problems, distributed 
among all levels of the International Classification of Functioning (ICF).
9
 Interventions at any of the 
elements of the ICF may be important and appropriate.
7,9
 Many interventions studies so far have 
evaluated the effectiveness of individual techniques and have shown promising results.
7,8,10
 However, the 
use of isolated techniques might not be satisfactory to reach clinically significant treatment effects for this 
group of children. Also the reality of clinical practice usually requires a mixture of individual techniques, 
each targeting a specific problem.  In a previous study, we therefore developed and validated a clinical 
framework to identify the main problems and specific goals for ambulant children with CP.
11
 We thereby 
hypothesized that individually tailored PT treatments more specifically meet the needs of the individual 
child and therefore also provide better treatment results. This hypothesis was tested in a smaller pilot 
study that indicated non-significant but advantageous results in favor of an individually defined, targeted 
approach.
12 
To the best of our knowledge, no other studies have evaluated the effects of an individually 
defined PT approach for children with CP.   
A second methodological hindrance to outcome evaluation is the variety of factors influencing 
interventions. Many other confounding factors hamper even the most optimally designed interventions: the 
difficulty to control the frequency of therapy
5
, treatment quality and fidelity
13
 and the fact children from 
different age groups
14  
and children with different functional mobility levels
15
 might require different therapy 
approaches. Additionally, children with spasticity are in regular need of Botulinum-Toxin A (BTX-A). 
Selective tone reduction by means of BTX-A treatments in children with CP is usually recommended 
because of a lack of progression in motor development, development of muscle contractures, intolerance 
of splinting and / or decrease in functionality. There is now evidence that the consequences of persistent   
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increased muscle tone can be limited when conservative therapies such as PT and orthotics are 
complemented by a selective treatment for spasticity by BTX-A.
16-18
 This selective tone reduction thereby 
provides a window of opportunity for therapeutic interventions as the decreased muscle tone allows 
increased range of motion, the potential to strengthen the antagonist muscle and the opportunity to 
develop better motor control and balance. 
19,20
  
Several studies reported these variables as confounding factors or attempted to control for these variables 
by optimizing the quality of their study designs. However, to the best of our knowledge, no intervention 
studies have controlled for the combination of these variables either design-wise or statistically.  
The aim of this paper is twofold. The first aim is to compare the effectiveness of an individually defined 
therapy approach to the results of a general therapy program. We thereby hypothesize that an individually 
defined treatment aim provides better treatment results than a general treatment approach. 
As a second aim, we evaluate the extent to which time-effects, Botulinum Toxin A (BTX-A), age, gross 
motor function classification (GMFCS), frequency of therapy and quality of the programs influence 
treatment outcome. It is hypothesized that these factors can be identified as predictors in treatment 
outcome.  
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Methodology 
 
Participants 
Participants were selected through the Cerebral Palsy Reference Centre of the University Hospital 
Pellenberg, between January 2010 and September 2013. Inclusion criteria were diagnosis of bilateral 
spastic CP, age between 4 and 9 years and sufficient cooperation to understand and execute simple 
verbal instructions and Gross Motor Function Classification System (GMFCS) level I, II or III. The GMFCS 
classifies children into five levels based on functional mobility.
21
 Children functioning at GMFCS I to III are 
ambulant, with GMFCS level I referring to children able to walk indoors without restrictions, children 
functioning at level II have difficulties walking outdoors and children with GMFCS III use assisting devices 
for functional mobility. Children were excluded when they showed severe muscle contractures or bony 
deformities, a history of multilevel orthopedic surgery or additional disorders which would influence the 
execution of the PT programs (e.g. severe cognitive disorders, deafness, blindness etc.).  The parents or 
caretakers as well as the physical therapist of all children that were eligible for inclusion, were contacted. 
When the parent or caretaker as well as the physical therapist agreed to participate, both signed an 
informed consent form. Fifty-seven children and their physical therapists were invited to participate. 
Although all physical therapists agreed to participate, seventeen parents declined because of personal 
and practical reasons. (Fig.1) The study was approved by the ethical committee of the University Hospital 
Leuven. 
 
Study Design 
To fulfill the first aim, the study was designed as a randomized, controlled and evaluator-blinded trial. A 
flow-cart of the study design is provided in Fig.1. Randomization was performed by an independent 
person who was not involved in the selection procedure and did not have access to clinical information 
about the children. Children were randomly assigned into a 10 weeks individually defined (IT) or a general 
(GT) PT program. However, as timing of BTX-A was decided by the multidisciplinary team and not 
influenced by the study, some children were in need for BTX-A at the time of inclusion in the study and 
others were in a BTX-A free period. Therefore, to obtain comparable groups, stratification was performed 
according to the BTX situation. This resulted in two strata: BTX-A immediately prior to the intervention or 
no BTX-A prior to the intervention. Additionally, within each BTX-stratum, a minimization procedure was 
applied for GMFCS and age according to the procedure described by Altman & Bland.
22
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Invited to participate n= 57 
Declined to participate 
 n= 17 
Individually defined Targeted 
treatment program (IT) 
 
BTX-A 
N=15 
No 
BTX-A 
N=15 
 
BTX-A 
N=15 
No 
BTX-A 
N=15 
Subsequently, after a wash-out period of minimally 10 weeks, children, parents and physical therapists 
willing and able to continue, were enrolled into a second and/or third program. The children were newly 
randomized into an IT or GT program, according to the same procedure. Of the 40 children eligible for 
inclusion, 19 children were enrolled into a second program and 1 child continued a second and a third 
program. However, within the different BTX-A strata, participation to the same type of program was 
avoided. For example, if a child started with an IT program in a post-BTX-A situation, the child would 
receive a GT program as a second post-BTX program.  If the second program for this child was planned in 
BTX-free situation, the child was newly randomized into a GT or IT program.  Although participation to 
multiple programs was possible, the wash-out period allowed us to consider each participation to a 
program as a new observation. From that perspective, all analyses were performed on the total number of 
60 interventions. However, the presence of correlation induced by multiple participation was taken into 
account in the statistical approach (see section 2.7 statistical analysis). 
To fulfill the second aim of the study, patient characteristics as well as therapy frequency and quality 
were registered accurately (see section treatment quality). 
 
 
   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1. Study flowchart 
Abbreviations:N: number of programs; n: number of children; BTX-A: botulinum toxin A  
60 interventions 
Completed one program: n=40 children 
Completed two programs: n=19 children 
Completed three programs: n=1 child 
 
 
General Therapy Program 
(GT) 
Inclusion: n=40 children 
Concealed random allocation 
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Interventions 
The individually defined targeted programs (IT) were designed to target the specific main problems of 
the child. These were, tailored to the needs of the child and specific problems at the different levels of the 
ICF at that particular moment. Definition of the individual problems was based on the results of all 
assessments. At the level of body structure and function, results of a clinical examination were 
considered. At activity level, three-dimensional gait analysis (3DGA) and gross motor function evaluation 
was used, complemented with a structured interview with the parents and child. The results of the 3DGA 
thereby played a major role in unraveling the motor problems of the child and the identification of the main 
problems. The programs were based on the clinical decision framework as described by Franki et al 
(2014), which use the ICF and the Hypothesis-Oriented Algorithm for Clinicians (HOAC-II) to identify a 
selection of main problems.
 11,23
 This allowed goal setting at all levels of the ICF, according to the needs of 
the child. The goals were discussed with the child’s parents or caretakers as well as the child’s physical 
therapist. The designs of the programs thereby approached the reality of clinical practice, using a mixture 
of individual techniques, each targeting a specific problem of the child at that particular moment. The 
choice of the appropriate techniques to achieve a specific goal was performed according to the evidence-
table designed by Franki et al in previous systematic reviews. 
7,8
  
The general treatment program (GT) was not based on the individual assessment results of the child. 
Instead, it targeted the most common aims in children with bilateral spastic CP of the involved age-range 
and was the same for all children. The program consisted of a predefined set of exercises to improve 
strength, selectivity and mobility and included a set of functional exercises. 
 
 oth the IT and GT programs were executed by the child’s personal physical therapist, who agreed to 
precisely follow the prescribed program. A PT degree was required but no further specialization was 
mandatory.  As only the content of the programs were influenced by the researchers, the frequency and 
duration of the therapy remained unchanged during the study and followed the usual intensity as 
recommended by the multidisciplinary team. Following the basic principles for evidence-based PT, 
stretching was performed in 3 repetitions of 30 seconds, strength was trained in series of 3 times 12 to 15 
repetitions and functional exercises were not restricted to a specific repetition number.
7
 
Table 1 of chapter 5 provides an overview of the similarities and differences between the IT and GT 
programs. The general program is provided in Appendix Y, an example of an individually defined 
provided in Appendix Z. 
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Compliance, Follow-up and Evaluation of Treatment Quality 
The participating therapists were contacted prior to the start of the study. During this conversation, the 
physical therapist received an extensive explanation of the study and the importance of the programs.  
The physical therapist had the opportunity to refuse or agree upon participation. However, all physical 
therapists agreed and were very motivated to participate. For the individual programs, the first author of 
the study discussed the main problems of the child with the physical therapist before the start of the study. 
Based on this commonly defined main problems, the first and third author of the study (IF and JD) 
proposed a first draft of the program. This draft was again discussed with the therapists and if necessary, 
changes were made. Actively involving the therapists in designing the program, increased awareness and 
thereby motivation of the participating therapists. When the child was enrolled into the general program, 
the program was proposed to the therapist but when necessary, minor changes were allowed. During the 
second week of the program, the therapist was contacted by phone or e-mail to discuss the progress of 
the program and again, the possible needs to change and adjust exercises. Minor adjustments to specific 
exercises were allowed, major changes in treatment goals were avoided.  
A follow-up visit was organized around five weeks after the start of the program. During that visit, a 
discussion was held with the therapist to evaluate the progress of the program. Additionally, in teh 
presence of teh researcher, the therapist performed a regular therapy session using the specified 
program. The quality of execution of this therapy session was scored using a custum-made quality 
assessment form (appendix AA). To the best of our knowledge, no specific and validated evaluation 
forms are available to score the quality of exercises. Therefore,, the authors based their quality 
assessment form on the main parameters used in physical therapy education.
24-26
 The form evaluated the 
position of the child, number of repetitions, intensity, feedback and attention for compensation (50% of the 
score). The other 50% of the quality score was used to evaluate the distribution of the session time in 
more analytical (impairment level) and more functional exercises (activity and participation level), resulting 
in a possible maximum quality score of 100%. 
 
Assessment 
Participants were evaluated before and after each treatment program. To evaluate the child at the level of 
body structure and function, clinical examination was used. At activity level, three-dimensional gait 
analysis (3DGA), gross motor function measure (GMFM-88), the timed-up-and-go (TUG) and five-times-
sit-to-stand-test (FTSTT) were used. 
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Clinical examination included measurements of range of motion (goniometrical measurements)
27
, 
spasticity (Modified Ashworth Scale and Tardieu) 
28-30
, selectivity (selective motor scale) 
31
 and muscle 
strength (manual muscle testing).
24,27
  
For 3DGA, information on kinematics, kinetics and spatial-temporal data was collected by a 15-camera 
VICON system (Nexus PluginGait marker set, Oxford Metrics, Oxford, UK), two ATMI force plates 
(Advanced Medical Technology, Inc, Watertown, Massachussets) and a 16 channel electromyography 
device (Zero-Wire, Cometa, Milano, Italy). Three representative walking trials were selected. Specific gait 
parameters were automatically extracted using custom-made software designed in Matlab (Mathworks®, 
Natick, MA, USA).  Clinical examination and 3DGA were performed according to the standardized protocol 
used at the Laboratory of Clinical Motion Analysis of the hospital. An independent assessor, blinded to the 
study, performed both assessments.  
The GMFM-88 is a standardized clinical instrument
 
to evaluate change in gross motor function in children 
with CP. It fulfills the criteria of reliability and validity with respect to responsiveness to change. 
32,33
 
GMFM-88 measurements were collected by the 1
st
 author of this study and video-taped. An independent 
assessor, blinded to the set-up of the study, scored the video-registrations.  
The timed up and go (TUG) test and the five-times-sit-to-stand test (FTSTS) are measures to assess 
functional mobility. The TUG test is a test used for assessing functional ambulatory mobility and dynamic 
balance and has a high intra-rater reliability.
34
 The FTSST is a reliable assessment tool that is 
representative for functional performance.
35
  
 
Outcome Parameters 
Outcome parameters were derived at two different levels (Fig 2).  
Primary outcome parameters were based on achievement of the individual goals defined using the 
results of the GMFM-88 and 3DGA.  
For the individual, functional goals extracted from the GMFM-88, the original version of the Goal 
Attainment Scale (GAS) was applied, as developed by Kirusek et al.
36
 and used in several pediatric 
rehabilitation studies.
37,38
 Before the start of the programs, individual goals based on specific goal items of 
the GMFM-88, were formulated according to the SMART-principle meaning that goals are Specific, 
Measurable, Assignable, Realistic & Time-related.
39
 A score between -2 and 2 was given depending on 
the goal achievement. Subsequently, a converted T-score was calculated. Converted GAS scores under 
50 are usually considered non-successful treatments. Scores of 50.or more represent successful 
treatments. 
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GMFM – 88 
Total scores 
Dimension scores 
 
GAS (original version) 
GPS and MAPS 
Time – and distance 
parameters 
z-scores  
Time required for 
FTSTS 
Time required for TUG 
Primary outcome 
parameters 
Individual level 
Secondary 
outcome 
parameters 
General level 
Outcome 
measurements 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2. Outcome measurements and parameters 
Abbreviations: GMFM-88: Gross Motor Function Measurement; 3DGA: Three-Dimensional Gait 
Analysis; GAS: Goal Attainment Scale; GPS: Gait Profile Score; MAPS: Movement Assessment Profiles; 
FTSTS: Five-Times-Sit-To-Stand; TUG: Timed-Up-and Go 
 
 
Individual goal-achievement of the specific goals derived from 3DGA, was evaluated using z-scores. 
As a first step, 2 to 8 specific deviated gait parameters were identified as specific goals for each child. 
Each goal was represented by a relevant discrete value that was expected to improve, such as maxima, 
minima, range of motion and angles at specific events in the gait cycle. These discrete values were 
defined based on literature and by clinical experts in 3DGA of children with CP.
40
 The values were 
converted into z-scores. This z-score represented standardized deviation from a reference group and was 
calculated by the following formula: (mean child-mean typical children)/ SD typical children.  Our reference 
data was based on the data obtained from a control group of 55 typically developing children, with a mean 
age of 10.94 years, range between the ages of 4 years and 18 years.  Z-scores are non-dimensional and 
therefore allow the comparison of different parameters. To evaluate the z-scores, the absolute difference 
to zero, in either direction, was considered as an equal deviation from typical gait. Consequently, 
individual changes were calculated as the difference between the pre and post value of the z-scores. The 
median value of the z- change scores represented the individual progress on gait analysis goals.   
GMFM - 88 3DGA Functional tests 
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Secondary outcome parameters were defined at a general level, using outcome parameters that 
provide a general outcome description and thereby represent a more overall therapy success. 
For the GMFM-88, the total and dimensional scores were extracted and expressed as percentages. For 
the functional tests, the average of three trials was calculated.  
From the 3DGA data, Movement Analysis Profiles (MAPS), the Gait Profile Score (GPS) and time-
and distance parameters were calculated.
40
 The MAPS were calculated as the root mean square error 
(RMSE) between the point-by-point comparison of the lower limb joint angle and the averaged joint angle 
of the reference group. Calculation of the average of all lower limb joint angles results in the GPS, which 
summarizes the overall severity of gait pathology.
40
 The average scores from three left and three right 
trials were used. Time-and distance parameters were corrected for normal age development, by 
normalizing the data for step length.
41
 Subsequently, the normalized time-and distance parameters were 
also transferred into z-scores. To allow comparison of individual progress, pre-post values were calculated 
using the absolute values. 
Statistical Analysis 
As a preparatory step, observations were summarized using means and SDs as appropriate. Baseline 
characteristics were compared using Pearson Chi-square tests for the use of orthotics and independent t-
tests for age, therapy hours per week and treatment quality. 
To evaluate the first goal of the study, the changes in outcome after both programs were compared, 
using a linear model with ‘program’ (IT or GT) as factor of interest and ‘ TX’, ‘GMFCS’ and ‘age’ as 
additional predictors. To take into account the correlation between the changes from the same child, a 
random child effect was added yielding a so-called linear mixed model. The Estimated Marginal Means 
(EMMeans) of the change scores were calculated, providing the mean response for that factor, adjusted 
for the variables in the model. Additionally, effect si es (ES) were calculated using the Cohen’s d formula.  
According to Cohen, effect sizes of 0,2 to 0,5 are considered as small, 0,5 to 0,8 are medium and >0,8 are 
large.
42
  
To evaluate the second goal of the study, a specific set of analysis aimed to identify which children 
benefited most from the interventions. First, interaction effects between the ‘type of program’ and  TX, 
GMFCS and age were evaluated to verify if the effect of the specific program depends on these 
characteristics. Second, this analysis was also performed regardless of the type of program they were 
enrolled. Therefore, a linear mixed model analysis with random effect child was used for each potential 
predictor separately (BTX, GMFCS, age, time or within-group effects, therapy hours per week and 
treatment quality).  For all analysis, the changes calculated as pre-post value were used. P-values smaller 
than 0,05 were considered significant. A Bonferroni Holms procedure was applied to correct for multiple 
testing for the two primary outcome parameters. All statistics were performed in SPSS 22 IBM SPSS 
Statistics for Windows, Version 22.0. (Armonk, NY: IBM Corp).  
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Results 
Patient and therapist characteristics 
Forty children participated in the study, resulting in a total of 60 interventions. Thirty interventions were 
performed in a post-BTX-A situation, 30 interventions in a BTX-A-free situation. (Fig 1) 
Table 2 provides a detailed description of the patient characteristics.  Both groups were comparable 
regarding age, GMFCS and prior BTX-A injection. The total therapy time per week was higher in the GT 
group compared to the IT group, with 184,2 (SD 82,3) and 158,8 (SD 79,03) minutes per week 
respectively. This difference was not statistically significant. Also regarding treatment quality, no relevant 
differences were observed between both programs: 61,19 % (SD 13,86) for the GT and 64,91 %  (SD 
16,78) for the IT group. 
Thirty-two different therapists participated in the study. On average, the therapists had 13,8 years of 
experience (SD 9,5). Twenty-seven therapists had a PT degree at university level, 17 were specialized in 
pediatric rehabilitation and 21 were certified Bobath therapists. 
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Table 2. Patient Characteristics 
 GT IT 
Gender (n)  
   Male 
   Female 
 
19 
11 
 
18 
12 
Age (mean + SD, in months) 77,16 (15,23) 68,35 (16,72) 
GMFCS (n) 
  Level I 
  Level II 
  Level III 
 
 
9 
13 
8 
 
10 
11 
9 
Use of day orthosis (n) 
>50%/day 
<50%/day 
no  
 
24 
3 
3 
 
25 
3 
2 
Use of night orthosis (n) 
>50%/night 
<50%/night 
   no 
 
11 
12 
7 
 
12 
12 
6 
Total PT (minutes/week) 
Sessions/week 
Minutes/session 
184,2 (82,3) 
3,9 (1,5) 
48,5 (13,3) 
158,8 (79,03) 
3,7 (1,5) 
43,3 (14,6) 
Program in a post-BTX situation 30 30 
Prior BTX (before study) 
  No prior BTX 
  1 time 
  2 times 
  3 times 
  more than 3 times 
 
 
8 
2 
5 
3 
12 
 
9 
7 
6 
4 
8 
Abbreviations 
UC: period of Usual Care; GT: period of general treatment; IT: period of Individualized, targeted treatment 
GMFCS: Gross Motor Function Classification System; PT: Physical Therapy; N: number 
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First analysis: General versus individually defined therapy 
Primary outcome parameters – individual goal achievement 
Fig. 3 demonstrates the EMMeans after correction for BTX-A, GMFCS and age for the changes in z-
scores and the GAS. This figures demonstrates that both the change in z-scores and the GAS-T score 
were non-significantly higher after the IT compared to the GT program (p=0,669; ES=0,05 and p=0,322; 
ES=0,15).   
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Fig 3. Estimated marginal means (after correction for GMFCS, BTX-A and age) for the changes in z-
scores (change score = pre-post value) and the Goal Attainment Scale (GAS-T score) for the Individually 
Defined Therapy Program (IT) and the General Therapy program (GT). 
  
EMMean Std. Error 
95% Confidence Interval 
EMMean Std. Error 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound Lower Bound Upper Bound 
0,135 0,103 -0,071 0,341 46,208 2,91 40,354 52,063 
0,072 0,105 -0,138 0,282 42,166 2,799 36,542 47,79 
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Secondary outcome parameters – general parameters 
Fig.4 provides the distribution of the observed GMFM-88 total scores before and after the programs for 
the different treatment groups. No significantly different changes in outcome could be registered between 
both groups. The estimated mean change score was -1,65% (95% CI -2,37 to -0,917%) for the IT group 
and -1,27% (95%CI -1,98 to -0,565) for GT group (p=0,463; ES =0,29). 
Regarding the GMFM dimensions, no significant differences between both intervention groups could be 
registered.  For dimension D, the EMMean change (pre-post) was -5,28% (95% CI -7,81 to 2,75) for the IT 
group and only -1,8 % (95% CI -4,27 to 0,674) for the GT group, (p=0,056, ES=0,64). For dimension E, 
the EMMean change showed no change after the IT program, but a slight improvement after the GT 
program: 0,83% (95%CI -2,70 to 1,04) versus -2,74 (95% CI  -4,52 to -0,96) (p=0,086; ES=-0,25).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4.  Scores of the Gross Motor Function Measurement (GMFM-88) before and after the programs.  
  
General Therapy 
Program 
Individually Defined 
Therapy Program 
Pre Post Post Pre 
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The EMMean change score for the GPS showed limited changes for both groups: -0,66° (95%CI -3,2 to 
1,86) in the IT group and 0,28° (95%CI -2,29 to 2,84) in the GT group (p=0,607; ES=-0,13). Fig.5 provides 
an overview of the changes in MAPS in the different planes for both treatment groups. Although generally 
more deterioration was found for the GT group, especially in the sagittal plane, no significant differences 
were found in response to the programs. (Fig 5). 
The means and standard deviations of the normalized time-and distance parameters are reported in 
table 3. This shows improved cadence in the IT group but slight deterioration in the GT group (p=0,053, 
ES=0,57). The increased single support phase in the IT group shows improved stability in the IT group but 
not in the GT group (p=0,034; ES=0,6). 
No significant different effects were obtained for the time needed for the FTSTS and the TUG test: 
p=0,478; ES=-0,10 and p=0,887; ES=0,23 respectively. 
 
 
 
 
Fig 5.  Changes in the movement assessment profile scores (MAPS) for the Individually Defined (IT) and 
the General (GT) therapy group. Change scores are calculated as the pre-post values (positive value = 
improvement, negative value=worsening)  
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Table 3. Means and standard deviations for the normalized time-and distance parameters 
 
 
IT GT       
 
Pre Post Diff Pre Post Diff F p value ES 
Cadence -4,04 (5,04) -3,99 (4,20) 0,67 (2,14) 3,20 (3,93) -3,55 (3,92) 0,64 (2,46) 3,914 0,053 0,57 
Step Length -0,15 (0,23) -0,76 (0,07) -0,56 (0,18) -0,14 (0,19) -0,75 (0,07) -0,52 (0,25) 0,101 0,755 -0,15 
Step Time 1,26 (1,81) 1,10 (1,51) 0,21 (0,72) 0,87 (1,57) 0,99 (1,44) -0,13 (1,16) 1,357 0,249 0,36 
Walking velocity -0,65 (0,76) -0,61 (0,65) 0,07 (0,31) -0,48 (0,75) -0,50 (0,75) -0,02 (0,36) 0,451 0,507 0,26 
Stride Length -0,16 (0,24) -0,13 (0,22) 0,02 (0,11) -0,15 (0,20) -0,14 (0,18) 0,01 (0,14) 0,016 0,9 0,09 
Stride Time 1,35 (1,96) 1,17 (1,59) 0,27 (0,72) 0,98 (1,70) 0,98 (1,49) -0,02 (1,29) 0,788 0,379 0,28 
Single Support 0,62 (1,02) 0,48 (0,66) 0,19 (0,53) 0,37 (0,54) 0,42 (0,61) -0,10 (0,42) 4,729 0,034 0,6 
Double Support 1,75 (2,82) 1,51 (2,29) 0,32 (1,33) 1,31 (2,96) 1,26 (2,08) 0,21 (2,49) 0,002 0,963 0,06 
Foot Off 2,60 (1,63) 2,44 (1,44) 0,20 (0,83) 2,17 (1,40) 2,15 (1,12) 0,08 (0,70) 0,007 0,931 0,15 
 
Abbreviations: 
IT: Individually defined targeted treatment group; GT: General Therapy group; Diff: difference as defined 
by pre-post value; ES: effect size 
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Second Analysis: Prognostic Factors  
Interaction effects 
For neither for the primary, nor for the secondary outcome parameters, significant interaction were 
registered between the type of program and BTX, age or GMFCS. 
 
Time or within-group effects 
For individual goal achievement, significant time-effects could be found on GAS-T score (p<0,001) but not 
on z-scores (p=0,142). Almost all children showed improved GMFM-88 scores, with an EMMean change 
of -1,46% (95% CI -1,96 to 0,96; p=0,000). For dimension D and E, mean changes of -3,42 % (95% CI -
5,25 to -1,60; p=0,000) and -2,07% (95% CI -3,30 to -0,85; p=0,006) were registered.  With a mean 
change of -0,36°(95% CI -2,10 to 1,38), the GPS showed no time-effects (p=0,683). Furthermore, 
significant time-effects were found for stride length (p<0,001). 
 
BTX-A 
The GAS was lower for children in the BTX-A situation: 40,5 (95%CI 34,63 to 46,44) versus 47,8 (95%CI 
41,7 to 53,92) for the children not receiving BTX-A. This difference however, was not significant (p=0,087). 
In contrast, for the individual goals based on the 3DGA, children who received BTX showed a mean 
positive change of 0,215 (95% CI 0,017 to 0,413) on z-scores. Children who did not receive BTX-A, 
showed a limited change of -0,006 (95% CI -0,208-0,195).  Again, this difference was not significant 
(p=0,122). For none of the other outcome parameters however, the influence of BTX-A however, was 
observed. 
Age 
Significant and relevant relations between age and changes were found on the attainment of functional 
goals (p= 0,023), the GMFM D (p=0,047) and walking velocity (p=0,044), timing of foot off (p=0,030) and 
the STS test (p=0,041). Older children showed a higher achievement of functional goals and change in 
GMFM-D score, but younger children showed a larger change in walking velocity, timing of foot-off and 
time needed for FTSTS.  
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GMFCS 
No significant effects could be found for GMFCS in relation to gait – or gross motor changes.  
Remarkably, functional goal achievement seemed to decrease with a decreased level of functionality. 
GAS was 48,8 (95% CI 41,2 to 56,37) for the children with GMFCS I, 43,6 (95% CI 36,5 to 50,6) for 
children with GMFCS II and 38,8 (95% CI 30,7 to 48,9) for children with GMFCS III. However, due to the 
wide variability seen in the large CI, these differences were not significant (p=0,203) and should be 
interpreted carefully. 
An opposite trend was visible for the goals derived from 3DGA: children with GMFCS III seemed to have a 
non-significantly higher improvement on their z-scores (change 0,144 95% CI -0,13-0,419) than children 
with GMFCS II (change 0,121, 95% CI -0,116-0,358) and GMFCS I (change 0,059, 95%CI -0,203-0,321). 
Again, the wide variability in resulted in a non-significant p-value (p=0,893). 
 
Treatment quality 
No significant relations were found between treatment quality and changes in outcomes. 
 
Treatment intensity per week 
The number of minutes of therapy per week showed a significant influence on the MAPS of the foot in 
transversal plane (p=0,003). 
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Discussion 
 
The first goal of this study was to evaluate differences between the effects of an individually defined 
therapy and a general training program on gait and gross motor function. The results of our study could 
not confirm the first hypothesis that an individually defined approach provides better treatment results. No 
significant differences could be registered between the intervention groups. Nevertheless, the GAS-T 
scores suggest a higher degree of individual goal achievement after the IT program compared to the GT 
program. This could be seen in the achievement of higher GAS scores (46,2 versus 42,2) as well as 
slightly greater changes in the z-scores based on 3DGA (0,135 vs. 0,072) in the advantage of the IT 
group. A similar trend was visible on GMFM dimension D, the Movement Assessment Profiles, cadence 
and the duration of single support phase. 
A major reason for the lack of significant differences could be the content of the GT program. The GT 
program was designed to control for the individual differences of therapists during their usual care. It 
thereby primarily aimed to bring all therapy interventions during the control phase to the same level.  As a 
result, the GT program was not only a standardized, but also still a highly qualitative program with a wide 
set of exercises targeting the major problems in children with bilateral CP from this age-range. Therefore, 
the difference between the IT and the GT program may not have been sufficient to reach significant 
differences in outcome. Additionally, even the GT program was often very different compared to the usual 
exercises the child received prior to the intervention study. In a subsequent research project, we 
compared the effectiveness of a period of usual care to the effects of a predefined intervention program. 
(Franki et al., 2014c). No changes to a slight deterioration in gross motor function and a similar trend on 
gait analysis parameters was found after the period of usual care. These results are in contrast with the 
results of both intervention programs, as a trend of non-significant improvements is observed. Registering 
the contents of usual care physical therapy (no intervention) using a diary, demonstrated a very large 
focus of usual physical therapy on problems at impairment level (stretching & analytical strength training). 
Only 41,7% of therapy time was spent on functional, activity-related exercises. Our intervention programs 
always contained more than 50% of exercises targeting the activity level. This might suggest that simply a 
change in therapy from usual care to GT or IT might be an important factor influencing the outcome. 
As such, it is hopeful to see that all children responded well to the therapy programs in terms of their gross 
motor function. Although sometimes with small changes, almost all children showed improved GMFM-88 
scores, resulting in significant time-effects for the GMFM-88. Only three children showed a decrease in 
GMFM-88 scores. This was also reflected in individual functional goal achievement based on the GMFM, 
as significant time-effects were also found for the GAS. The mean GAS for the total group was 44,26 with 
an average percentage of achieved goals of 48,2%. Results were less pronounced for gait analysis 
parameters. As for the GPS, only 50% of the children showed an improved gait pattern after the 
programs. On gait analysis goals, only 33% of the program responses were positive.  
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The lack of significant effects of the training programs may also be related to the duration of the applied 
interventions. Ten weeks was a relatively short training time. Guidelines by the National Strength and 
Conditioning Association (NSCA), stated that strength training should be applied 2 to 4 times a week, on 
non-consecutive days and for at least 8 to 20 weeks in order to affect muscle strength.
44
 Since strength 
training was an essential part of both programs, a study of longer duration could have resulted in greater 
benefits. Also for functional changes, a period of 10 weeks might have been too short. In a recent review 
evaluating the effectiveness of upper limb training, Sakzweski et al. concluded that 40 hours of therapy 
was adequate to yield meaningful clinical changes on the upper limb and individualized outcome.
45
 In 
another review evaluating dosing parameters, Gannotti et al. concluded that thresholds for time to 
produce changes in performance warrant further investigation.
4
 Studies evaluating the effectiveness 
regarding BTX-A however, demonstrated positive effects up to one year after injection.
46
  
Additionally, as some children participated in multiple programs, a learning effect might have been created 
for the therapists. Therapists receiving the IT program first, were more aware of and therefore probably 
more attentive to the individual problems of the child. Subconsciously and instinctively, they might have 
incorporated these aspects during the general program. Twenty-three children received the IT program as 
a first program and 17 children received the GT program first.  However, separate analysis of the results 
of the 40 first interventions (excluding the repeated interventions in the same child) showed no major 
differences to the results of all 60 interventions. This allows us to reject our hypothesis of indirect carry-
over effects. 
The second analysis attempted to evaluate the influence of the factors BTX-A regime, age, GMFCS, 
treatment quality and therapy time per week on the outcome of the intervention. This analysis revealed a 
non-significantly but relevant lower GAS for the children receiving BTX-A prior to their program 
(GAS=40,5) compared to children not receiving BTX (GAS=47,8). The children receiving BTX-A however, 
were mostly children with a lower functional level.  This might therefore coincide with the trend that was 
visible on GMFCS levels, where children with lower functional levels also seemed to achieve less 
functional goals.  In contrast, when the focus was on goals based on gait analysis, children with lower 
functional levels and children receiving BTX-A seemed to reach their goals more easily.   
The results revealed age as a relevant predictor for GAS-T scores and change in GMFM-88 total 
dimension D scores. When considering individual functional goals, older children seemed to benefit more 
from the period of intervention. Therefore, it is useful to involve older children more actively in the process 
of goal-setting, as this might cause greater therapy-effects.  
Our study evaluated the effectiveness of a general program that was the same for all children. 
Nevertheless, supervision and guidance of a physical therapist reassured correct execution of the 
exercises. Especially, for the younger children, this was still crucial.  As group training is known to have 
positive effects on participation, it might however be a recommendation for future studies to compare the 
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influence a predefined program using group sessions to the effects of individual training using the same 
program. 
Yi et al evaluated contributing factors for the change of gross motor function in children with spastic CP 
after physical therapy.
47
 Initial GMFM score and degree of spasticity were identified as major predictors in 
the responsiveness to therapy: children with mid-range of initial GMFM-88 scores showed more 
improvements on the GMFM-88 score compared to lower-and higher range of initial GMFM-88 scores. 
The degree of spasticity was identified as a negative predictor for functional changes. A similar trend is 
visible in the results of our study, as children with GMFCS III show lower GMFM-88 scores and generally 
show a higher degree of spasticity. 
No relationship was found between the effects of the program and treatment quality. Treatment quality 
was evaluated using a self-developed quality assessment form. The assessment form evaluated the basic 
factors of position, repetition, intensity and feedback and thereby focused on the correct technical and 
practical execution of the exercises.  Other factors like context, used materials and play are not included 
in the assessment form and might have influenced our results. Although the specific exercises were 
prescribed, the time to invest in certain exercises was not prescribed. Our assessment form did not 
capture adequately the amount of time that was spent for the more analytical exercises versus the time 
that was spent on more functional exercises, a factor that also may have influenced the outcome. The 
Paediatric Rehabilitation Observational measure of Fidelity (PROF) is a new generic measure evaluating 
treatment fidelity and quality, developed and published by Di Rezze et al. in 2012.
48
 At the start of our 
study in 2011, unfortunately, this measure was not yet available. However, the PROF focuses on the 
comparison of child and context therapy and may therefore not fully capture the quality of performance of 
the exercises as such. A combination of our quality assessment form with the PROF may address this 
issue in future studies.  
In a systematic review examining dosing parameters for children with CP, Gannotti et al.
 
registered a large 
variability in frequency, intensity and time of training.
4 
Our study also could not find a relationship between 
the amount of therapy per week with the progress on gait and gross motor function.  This confirms the 
conclusion of Gannotti et al. that identified multiple gaps in knowledge and the need for conceptualizing 
dosing thresholds for individual children. In our study, total therapy time was not influenced by the 
researcher and children remained at their usual therapy frequency. Therefore, total therapy time per week 
was higher in the GT group compared to the IT group, with 184,2 (SD 82,3) and 158,8 (SD 79,03) minutes 
per week respectively. Nevertheless, testing the difference in therapy per week using an independent t-
test revealed no statistical difference. In addition, therapy hours per was evaluated as a prognostic factor 
in the second part of the study and revealed no statistically significant influence. Therefore, the authors 
hypothesize that the differences in the amount of therapy per week in this study, can be excluded as a 
causal factor for the observed differences between both groups.  
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In conclusion, no significant differences could be registered between an individually defined and a 
general physical therapy treatment approach for children with bilateral spastic CP. Only slight, non-
significant trends in the advantage of the IT program were visible. Age was identified as a predictor for the 
attainment of functional goals. Future research using longer intervention periods, improved evaluation of 
treatment quality and comparison with a non-intervention group is necessary to confirm trends of the 
current study. 
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Abstract 
 
Aim 
This study aims to identify the contents of usual care physical therapy and to compare the 
effectiveness of 10 weeks usual care (UC) to the effects of a 10 weeks intervention of a predefined 
evidence-based physical therapy program (IP). 
 
Method 
Sixteen ambulant children with bilateral spastic CP (age 5y11m, GMFCS I-III) started with UC, in 
which the content of their therapy sessions was registered using a diary. Subsequently, all children 
enrolled into the IP, applying a predefined evidence-based program with feedback and support to the 
therapists. Outcome was evaluated using the Gross Motor Function Measurement (GMFM-88) and the 
Gait Profile Score (GPS), Movement Assessment Profiles (MAPS) and time-and distance parameters, 
extracted from three-dimensional gait analysis.  
 
Results 
During UC, 22,5% (IQR 16,7-32,5%) of therapy time addressed muscle length and 33,3% (IQR 30,2-
33,3%) strength. 41,7% (IQR 33,3-56,2%) of therapy time was used for functional exercises and 0,1% 
(IQR 0-6%) addressed participation limitations. The applied resistance in strength training was not 
quantified or graded. In 67,5% of the sessions, therapists performed gait training.  
We found a significant increase in GMFM-88 score after the IP (p=0,002), but not after UC (p=0,56). 
Improved sagittal MAPS were only observed after the IP. 
 
Conclusion 
UC physiotherapy in CP is predominantly dedicated to problems at impairment level and characterized 
by insufficient dosing. An evidence-based predefined intervention provides more advantageous effects 
on gross motor function compared to UC. 
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Introduction 
 
The use of the International Classification of Functioning, Health and Disability (ICF) has provided an 
opportunity to integrate several perspectives in children with Cerebral Palsy (CP).
1
 Nevertheless, the 
use of the ICF in rehabilitation has confronted many physical therapists with the complexity of the 
pathology of CP and the variety of problems at all levels of the model.
2
 Additionally, as several 
researchers have demonstrated the relationships in between the different ICF levels 
3,4
, the ICF has 
opened different points of entry in treatment, causing several different opinions regarding physical 
therapy treatment for these children.
5
 As up today, systematic reviews evaluating different physical 
therapy programs in children with CP, have demonstrated promising results regarding the 
effectiveness of individual techniques.
5-7
 However, these studies also identify the need to evaluate the 
effectiveness of well-balanced therapies, using a mixture of techniques, addressing all levels of the 
ICF. To be able to address the individual problems of a child, the physical therapist therefore, 
nowadays, faces the difficult and challenging task of knowledge translation.
8
  
In two recent intervention studies, the effectiveness of an individually defined, targeted physical 
therapy approach was compared to the effects of a general physical therapy program.
9,10
 Overall, the 
effects of both programs were not found to be significantly different and the authors could not provide 
evidence for the individually defined, targeted approach. Nevertheless, the individually defined as well 
as the general program demonstrated effectiveness. In both studies, almost all participating children 
demonstrated improved Gross Motor Function Measure (GMFM-88) scores and improved gait 
characteristics evaluated using three-dimensional gait analysis. Although the limited power of both 
studies also limited the possibility to draw clear and definite conclusions, we identified therapy support 
based on guidelines from literature as a potential factor influencing our treatment results. This raised 
the question to define the influence of the evidence-based intervention program as such. It may be 
possible that guiding and supporting the participating therapists by providing guidelines built on 
evidence based treatment algorithms, might already have caused a significant impact on treatment 
quality and outcome. 
In a large randomized controlled trial, Campbell et al. evaluated the effectiveness of an evidence alert 
system on evidence-practice behavior of 135 allied health professionals.
8
 The results demonstrated 
that the group of therapists receiving a three days skills training workshop and multiple faceted 
workplace support significantly improved their evidence based knowledge. However, this knowledge 
was not translated into significant evidence-based practice behavior in treatment. Campbell et al. 
therefore identified the need for tailored knowledge translation strategies. Unfortunately, so far, no 
other studies focused on the impact of stimulation of evidence-practice behavior and workplace 
support on the treatment outcome. 
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Therefore, this study aims to evaluate evidence-based practice behavior in usual care physical 
therapy in Flanders. Secondly, it aims to compare the effectiveness of a predefined physical therapy 
program based on evidence-based guidelines to the effects of a period of usual care. It is 
hypothesized that supporting therapists by providing a predefined evidence-based intervention 
program, will result in an improved treatment outcome compared to the usual care physical therapy.   
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Methodology 
 
Participants 
A convenience sample of 16 children was recruited at the Cerebral Reference Centre of the University 
Hospital Pellenberg. Children were included when they were diagnosed with bilateral spastic CP, aged 
between 4 and 9 years and a GMFCS level between I and III. Children were excluded when they 
received Botulinum Toxin A injections within the past six months, orthopedic surgery in the past or had 
severe associated problems that limited participation to therapy (blindness, deafness, severe cognitive 
limitations or autism). 
 
Study design 
All children started the study with a registration period. During this period, the children’s usual physical 
therapy (UC) was registered using a diary. Immediately following the UC period, children were 
enrolled into a predefined intervention program (IP).  
Both the period of UC and IP had a duration of 10 weeks. Before and after both periods, children were 
evaluated using the Gross Motor Function Measurement (GMFM-88) and three-dimensional gait 
analysis (3DGA). 
 
Usual Care 
During the period of UC, no specific intervention was provided. Children received the frequency, 
intensity and contents of therapy as they usually received by their own private physical therapist. A 
diary was provided to the child’s physical therapist. The diary contained session forms, designed for 
the therapist to carefully register the contents of therapy after each session. A template session form 
is provided in Appendix AB.  
In the session forms, the therapist noted down how much time of the therapy session targeted 
problems at the different levels of the ICF. At the level of body structure and function, the time 
spent on muscle length and muscle strength was registered. For muscle length, the therapists were 
asked to report the targeted muscles, the number of repetitions, the duration of stretch and treatment 
modality (activo, activopassivo or passivo).
11
 About muscle strength, therapists noted the specific 
muscle that was trained, the intensity (number of repetitions and resistance) and whether the exercise 
was performed as analytical (single-joint) or functional (multiple-joint) muscle work. Concerning 
activity level, the specific functional activity that was practiced and the averaged position in which this 
was performed, was registered. Finally, the therapist reported whether any problems at participation 
level were specifically addressed.  
During the period of UC, the therapist was not contacted and no instructions or advice was provided 
regarding physical therapy treatment of the child.  
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Intervention period 
Immediately following the UC period, children were enrolled into a predefined intervention program 
(IP), designed by the first and third author of the study (IF and JD). The programs were executed by 
the child’s personal physical therapist, who agreed to precisely follow the prescribed program. Similar 
as for the UC program, the children received the frequency of therapy as they usually received by their 
own private physical therapist. 
Two different types of programs were designed. Ten children received an individually defined, targeted 
program tailored to the individual needs of the child and six children received a general program 
based on general age-appropriate treatment aims for children with bilateral spastic CP.
12
 For an 
extensive description of the differences and similarities between both types of intervention programs, 
the authors refer to our previous intervention studies.
9,10
 All intervention programs had two major 
common features.  
The first central and common aspect in the intervention programs was that basic principles regarding 
evidence-based training were respected. All programs consisted of a predefined set of exercises to 
improve strength, selectivity and mobility and a set of functional exercises. Thereby, stretching was 
prescribed as three repetitions of 30 seconds and strength training was prescribed in series of three 
times 12 to 15 repetitions. Functional exercises were not restricted to a specific repetition number. As 
appropriate, all intervention programs contained more than 50% of exercises at activity and 
participation level.
13-15
   
The second major common feature in the intervention programs was the support and follow-up to the 
therapist. At the start of the intervention study, therapists were visited and the prescribed program was 
thoroughly explained. All exercises were provided in a clear and structured way, with specific 
instructions regarding anatomical position, sets and repetitions.  The specific exercises were 
discussed and demonstrated if necessary. During the second or third week, the therapist was 
contacted by phone or email to discuss the progress of the program and the possible needs to change 
and adjust exercises. Additionally, a follow-up visit was organized around halfway through the 
program.  During this visit, the program was again discussed and the therapist performed a regular 
therapy session using the program, in attendance of the first author of the study. Difficulties in 
performance were discussed and if necessary, some exercises were demonstrated. The opportunity 
for feedback on handling or position was thereby provided.  
Due to these common aspects in our programs, and because previous data analysis revealed that the 
overall effects of both programs were not found to be significantly different, we could test our 
hypothesis regarding the influence of evidence-based support on the pooled data-set. 
 
An overview of the differences and similarities between the intervention programs and the period of 
usual care is provided in Table 1. 
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Table 1. Differences and similarities between the period of usual care and the interventions 
 
 
  
 Intervention programs Usual care 
D
if
fe
re
n
c
e
s
 
 The program was predefined and designed by the 
first and third author of the study; 
 The predefined program was thourougly explained 
and discussed with the therapist at the start of the 
10 weeks; 
 One follow-up phone-call and one follow-up visit 
was made during the program; 
 The therapist had the opportunity to ask questions 
and to discuss problems regarding the child with the 
first and third author of the study; 
 If necessary, exercises were explained and 
demonstrated; 
 Based on the most common problems or specific 
goals for ambulant children with bilateral spastic 
CP; 
 A predefined set of exercises to improve strength, 
selectivity, range of motion, gait and gross motor 
function and if necessary addressing participation 
limitations; 
 The exercises targeted the different levels of the 
ICF;  
 Minimally 50% of the exercises were functional 
activities;  
 Basic principles for evidence-based PT regarding 
intensity and repetitions were provided to the 
therapist  
o Stretching: 3 repetitions of 30 seconds;  
o Strength was trained in series of 3 times 
12 to 15 repetitions; 
o Functional exercises were not restricted in 
repetition number.  
 The physical therapist was free in decision making 
about the goals and specific exercises for the child;  
 No intervention, a continuation of therapy as usual; 
 No follow-up phone-calls or therapy visits; 
 No guidance or advice regarding the goals and 
specific exercises in therapy; 
 Therapist were not given the opportunity to ask 
questions or to discuss problems; 
 No specific evidence-based guidelines were 
provided; 
 The contents of the therapy and the use of therapy 
time registered using a diary; 
 The therapist decided how much therapy time and 
how many exercises targeted the different levels of 
the ICF. 
S
im
il
a
ri
ti
e
s
  Executed by the child’s private physical therapist, 
familiar to the child; 
 At the child’s usual frequency and duration of 
therapy. 
 A duration of 10 weeks. 
 Executed by the child’s private physical therapist, 
familiar to the child; 
 At the child’s usual frequency and duration of 
therapy. 
 A duration of 10 weeks. 
 203 
Evaluations 
Before and after the period of usual care and the interventions, all children were evaluated using the 
gross motor function measure (GMFM-88) and three-dimensional gait-analysis (3DGA).  
The GMFM-88 is a standardized clinical instrument
 
to evaluate change in gross motor function in 
children with CP.
16
 It fulfills the criteria of reliability and validity with respect to responsiveness to 
change.
17,18
 GMFM-88 measurements were collected by the 1
st
 author of this study and video-taped. 
Two independent assessors, blinded to the set-up of the study and without access to information 
about the children, scored the video-registrations. The independent assessors were pediatric physical 
therapy students (MSc). The average of both scores was used.  The total and dimensional scores 
were extracted and expressed as percentages.  
For 3DGA, information on kinematics, kinetics and spatial-temporal data was collected by a 15-
camera VICON system (Nexus PluginGait marker set, Oxford Metrics, Oxford, UK), two ATMI force 
plates (Advanced Medical Technology, Inc, Watertown, Massachussets) and a 16 channel EMG 
device (Zero-Wire, Cometa, Milano, Italy). Three representative trials were selected. Specific gait 
parameters were automatically extracted using a custom-made Matlab graphical user interface. 
(Mathworks®, Natick, MA, (USA). Specific parameters extracted from the 3DGA data were the 
Movement Analysis Profiles (MAPS), the Gait Profile Score (GPS) and time-and distance parameters. 
The MAPS were calculated as the root mean square error (RMSE) between the point-by-point 
comparison of the lower limb joint angle and the averaged joint angle of the reference group. 
Calculation of the average of all lower limb joint angles results in the GPS, which summarizes the 
overall severity of gait pathology.
5
 The average scores from three left and three right trials were used 
as outcome parameters. Time-and distance parameters were transformed into non-dimensional 
parameters as reported by At Hof (1996).
5
  
 
Statistical Analysis 
As a preparatory test, the frequency of therapy as well as the use of orthosis during the period of UC 
and IP were compared using the Wilcoxon Signed Ranks test and the Mc Nemar test respectively.  
To evaluate the first goal of the study, data from the diaries were extracted and summarized using 
Medians (Me), interquartile ranges (IQR) and frequencies as appropriate. 
The median duration and frequency of therapy as well as the total therapy time per week was 
calculated.  The registered time spent on impairment level (muscle length and muscle strength), 
activity and participation was analyzed and expressed as percentage of total therapy time.  
For stretching, the median parameters of intensity (number of sets and repetitions and the duration of 
stretch) were calculated for each target muscle. The applied resistance was registered and grouped 
as no resistance or manual/external resistance. In addition, the frequency of functional strength 
training was compared to the total frequency of muscle training.  
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Regarding the specific exercises at activity level, frequencies were registered for the position (lying, 
sitting, kneeling/high-kneeling or standing) and type of activity (walking, jumping, stairs or more 
complex activities as climbing, hopping or jumping). Subsequently, the frequency of the applied 
position or activity was expressed as a percentage or relative frequency by dividing it by the total 
number of therapy sessions. The median percentage for all children was calculated. 
For participation training, frequencies were calculated for sport, home-based or school-based specific 
activities. The relative frequency was calculated similarly to the activities.  
To evaluate the second goal of the study, the median change scores (pre-post) of the GMFM-88, 
MAPS, GPS and time- and distance parameters were compared between the UC and IP using the 
Wilcoxon-Signed Ranks Test. Changes within the period of UC and IP were evaluated based on the 
pre-and post values, using the Wilcoxon-Signed Ranks test as well. 
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Results 
 
Participants 
Sixteen children were included in the study.  The median age of the children was 5y11months (IQR 
5y1m – 6y10m).  Five children were classified as GMFCS I, four children GMFCS II and two children 
GMFCS III. Details of the therapy frequency and the use of orthosis are provided in table 2. There 
were no significant differences between both periods regarding therapy frequency (p=0,888) and the 
use of orthosis (p=0,135).  All children except one were included in mainstream education. All children 
received physical therapy by a private physical therapist. One child was included in a special 
education program and received physical therapy by the physical therapist at school and two extra 
sessions per week by a private therapist. 
 
Fourteen different physical therapists participated in the study. The median number of experience was 
8 years (IQR 5-11 years).  Eleven therapists were specialized in pediatric rehabilitation and 12 
therapists had a basic or advanced Bobath certificate.  
As three therapists reported not having enough time to complete the diaries, three diaries were not 
returned and usual care data was not available for these children. Nevertheless, as the therapist still 
fully participated in the use of the programs and the children underwent all analysis, they were not 
excluded from the study.   
 
Evidence-based practice behavior in usual care physical therapy 
Fig 1 provides the distribution of therapy time over the different problems on the ICF. Based on the 
diaries, therapists reported that more than 50% of therapy time targeted impairment level, with 22,5% 
(IQR 16,7- 32,5%) of therapy time spent on stretching and 33,3% (IQR 30,2-33,3%) of therapy time 
targeting muscle strength.  
Regarding activities and participation level, 41,7% (IQR 33,3-56,2%) of therapy time was spent on 
specific functional exercises and only 0,1% (IQR 0-6%) was used to address specific participation 
issues.  
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22,5 
33,3 
41,7 
0,1 
Muscle length and joint
mobility
Muscle Strength
Functional activities
Participation problems
Table 2. Treatment characteristics during the period of usual care and interventions 
  Usual Care Intervention 
   Frequency (times/week)  2 (1 - 5) 2,5 (1-4) 
Duration (minutes of session time) 45 (30-60) 35 (30-60) 
Therapy per week (minutes/week) 105 (30-300) 120 (30-240) 
   
   Use of day orthosis 
   Not used 3 3 
Not Frequently (<50%/day) 2 2 
Frequently used (>50%/day) 6 6 
   Use of night orthosis 
   Not used  8 6 
Not Frequently (<50%/night) 1 4 
Frequently used(>50%/night) 2 1 
Note:  
 Frequency, duration and therapy per week are provided using medians (IQR), for the use of orthosis, 
the number of patients is provided 
 
 
 
 
 
   
 
 
 
 
           
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
Figure 1. Proportion of therapy time spent on the different problems of the ICF based on registration 
in the diaries during the period of usual care.  
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Table 3 summarizes the characteristics and the treatment modalities applied for muscle length and 
muscle strength. Regarding muscle length, M.Triceps Surae, hamstrings and M.Psoas were most 
frequently stretched. All therapists applying stretching techniques, targeted these muscles. An active 
or dynamic component of stretch was most frequently used, except for hamstrings, where only 44,4% 
of the stretching time applied an active component. The number of repetitions varied between 2 to 6 
times and the stretch was mostly maintained for 10-15 sec.  
Strength training was most commonly performed for the hip extensors, hip abductors and ankle 
dorsiflexors (90,8; 90,8 and 80% respectively). For the hip extensors and ankle dorsiflexors, exercises 
were mostly performed as analytical exercises, while no functional strength exercises were used.  
Three sets of 10 repetitions were used most commonly. In the majority of the exercises, therapists 
reported that they applied external or manual resistance. However, none of the therapists quantified 
the applied resistance and none of the therapist registered or mentioned an increase in intensity or 
resistance. 
 
 
Table 3. Characteristics and use of the treatment modalities used for muscle length and muscle 
strength as registered in the diaries during the period of usual care. 
 
 
 
Muscle length 
 
Frequency  
(%)  
Active  
(%) 
Duration of stretch 
(sec) 
Repetitions 
(N)   
M.Triceps Surae 100 (86,7-100) 61,1 (0-90) 10 (10-17) 3 (2-5) 
 Hamstrings 100 (84,2-100) 42,4 (0-91) 10 (10-16) 5 (3-6) 
 M.Psoas 100  (66,2-100) 89,7 (17,9-100) 10 (10-15) 3 (2-5) 
 Adductors 65 (30-100) 100 (87,5-100) 15 (8-19) 4 (2-6) 
 m.Rectus Femoris 57,5 (20-95) 100 (100-100) 12 (10-15) 2 (2-3)   
Muscle strength  
  
Frequency 
(%) 
Functional  
(%) 
Sets  
(N) 
Repetitions 
(N) 
Resistance  
(%) 
Hip extensors 90,8 (67,5-100) 0 (0-19,4) 3 (2-3) 10 (10-12) 100 (81,9-100) 
Hip abductors 90,8 (62,1-100) 10,8 (0,5-8,3) 3 (2-3) 10 (10-13,8) 100 (84,0-100) 
Ankle dorsiflexors 80,0 (30-100) 0 (0-3) 3 (2-3) 10 (10-10) 100 (45,8-100) 
Abdominal muscles 70 (52,5-100) 1,7 (0-77,8) 3 (2-3) 10 (10-14) 100 (52,4-100) 
Knee extensors 67,5 (38-98) 18,1 (0-48,2) 3 (2-3) 10 (10-10) 100 (94,6-100) 
Ankle Plantar Flexors 10,9 (6,2-25,4) 50 (12,5-87,5) 2 (1-3) 10 (10-11) 75 (12,5-100) 
Notes: 
Medians and interquartile ranges are provided 
Active: proportion of total time targeting muscle length using an active/dynamic stretch 
Functional:  percentage of total time targeting muscle strength using functional strength training 
Resistance: percentage of total time targeting muscle strength applying external or manual resistance 
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Functional exercises were mainly performed in standing (63,3 %), followed by kneeling or high-
kneeling (28,3 %) and sitting (10,0%). In 67,5 % of the sessions, therapists performed gait training and 
transfers were practiced in 39,2 % of the sessions. (table 4). Regarding participation, therapists most 
frequently reported that they address limitations at school, followed by sports and problems at home. 
As participation issues were not often addressed, the median frequencies were 0 (range 0-29%), 0 
(range 0-62%) and 0 (range 0-12%) respectively.   
 
Effects of evidence-based practice behavior on outcome 
Comparing the GMFM-88 changes during the period of UC to the changes during the IT, showed no 
significant differences (p=0,595).  Table 5 provides the GMFM-88 scores before and after the 
programs. However, a significant improvement on the GMFM-88 total score was observed after the IT 
(p=0,002) but not after the period of UC (p=0,508).  Similar results were found for GMFM dimension E 
that showed significant improvement after the IT (p=0,042) but not after the period of UC (p=0,139). 
On gait analysis measures, no significant between-group differences were observed for the GPS 
and MAPS.  Nevertheless, the median change score for the GPS showed a slight improvement after 
the period of IT (change 0,26°; p=0,33) and deterioration after the period of UC (change -0,48°, 
p=0,50). These changes were not significant. Overall, slight improvements were registered after the IP 
for all MAPS except the MAPS for the ankle in sagittal plane and the hip in coronal plane.  After the 
UC, slight improvements were only registered for the MAPS in the coronal and transversal plane (Fig 
2). Table 6 represents the normalized time-and distance parameters. Significant deterioration was 
observed for step length during the period of IP. However, as these values ranged within normal 
values, these differences may clinically be interpreted with limited relevance. Otherwise, no significant 
changes could be observed.  
 
Table 4. Frequencies of the positions and specific activities targeted in the functional exercises as 
registered in the diaries during the period of usual care.  
Position 
Frequency  
Med(IQR) 
Lying  7,5 (0-43,7) 
Sitting 10,0 (0-52,1) 
Kneeling or high-kneeling 28,3 (1,3-64,3) 
Standing 63,3 (41,3-100) 
Target function 
Frequency  
Med(IQR) 
Trunk control  7,5 (0 - 19,2) 
Transfers 39,2 (5,0 - 53,8) 
Gait 67,5 (50 - 100) 
Arm & hand function 12,1 (1,3 - 48,5) 
Jumping, hopping or climbing 9,6 (0 - 20,0) 
Stair climbing 0 (0 - 15,0) 
Note Median frequencies represent the number of times using the specific position or targeting the 
specific function to the total number of therapy sessions.  
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Table 5.  Results for the Gross Motor Function Measure before and after the period of usual care and the period of intervention 
 
 
  Usual Care     Interventions     
 
Pre Post 
  
Pre Post 
   
  Median IQR Median IQR p (within)   Median IQR Median IQR p (within) 
 
p (between) 
GMFM total  92,09 87,91; 98,20 93,21 86,22; 98,01 0,508   88,67 85,69; 97,34 91,35 85,46; 98,30 0,002   0,594 
GMFM-A 100,00 100; 100 100,00 100; 100 0,317 
 
100,00 100; 100 100,00 100; 100 1,000 
 
0,317 
GMFM-B 100,00 100; 100 100,00 100; 100 0,317 
 
100,00 100; 100 100,00 100; 100 1,000 
 
0,317 
GMFM-C 100,00 85,71; 100  100,00 89,29; 100 0,655 
 
100,00 84,82; 100 100,00 85,12; 100 0,686 
 
0,180 
GMFM-D 87,15 70,84; 98,08 86,54 75,00; 99,04 0,779 
 
84,62 77,24; 98,08 89,10 81,73; 100 0,214 
 
0,237 
GMFM-E 74,30 60,26; 90,28 80,91 61,28; 96,88 0,139   71,88 58,68; 87,33 75,69 60,41; 91,49 0,042   0,515 
 
Abbreviations: GMFM-88: Gross Motor Function Measure–88; IQR Interquartile range 
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Figure 2. Median, interquartile ranges, minimal and maximal values of the changes in the Movement 
Assessment Profiles (MAPS) and the Gait Profile Score (GPS) after the period of Usual Care and the 
Intervention Period. (change score = pre-post) 
Abbreviations:  
Sag: Sagittal; Cor: Coronal; Trans: Transversal; P: Pelvis; H: Hip; K: Knee; A: Ankle; * and ° 
represent the outliers 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Usual Care 
Intervention 
period 
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Table 6 Normalized time-and distance parameters before-and after the period of Usual Care and Intervention  
 
  Usual Care     Interventions     
 
Pre Post 
  
Pre Post 
   
  Median IQR Median IQR p (within)   Median IQR Median IQR p (within)   p (between) 
Cadence 0,55 0,45;0,61 0,54 0,46;0,61 0,955 
 
0,54 0,46;0,60 0,53 0,50;0,60 0,550 
 
0,438 
Step Lenght 0,80 0,60;0,87 0,7565 0,65;0,83 0,187 
 
0,76 0,66;0,83 0,17 0,15;0,23 <0,001 
 
<0,001 
Step Time 1,82 1,62;2,12 1,86 1,63;2,19 0,816 
 
1,86 1,65;2,18 1,88 1,66;2,06 0,796 
 
0,438 
Stride Lenght 1,59 1,20;1,78 1,52 1,34;1,68 0,179 
 
1,52 1,37;1,69 1,63 1,28;1,67 0,293 
 
0,121 
Stride Time 3,64 3,29;4,52 3,76 3,28;4,39 0,918 
 
3,76 3,33;4,40 3,78 3,35;4,0 0,501 
 
0,393 
Walking 
Velocity 
0,42 0,29;0,53 0,40 0,36;0,49 0,379 
 
0,41 0,34;0,49 0,43 0,36;0,45 0,421 
 
0,326 
Single Support 0,34 0,32;0,36 0,33 0,32;0,38 0,737 
 
0,34 0,32;0,38 0,34 0,31;0,38 0,456 
 
0,756 
Double Support 0,17 0,14;0,28 0,18 0,14;0,24 0,605 
 
0,18 0,13;0,25 0,20 0,16;0,28 0,798 
 
0,609 
Foot Off 0,60 0,59;0,64 0,60 0,58;0,63 0,569 
 
0,60 0,58-0,63 60,84 0,59;0,63 0,91   0,91 
 
 
Note 
Time and distance parameters are presented as non-dimensionless parameters, according to Hof 
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Discussion 
 
The first aim of the study was to evaluate the contents and effects of usual care physical therapy for 
children with bilateral spastic CP in Flanders.   
The results revealed a dominant focus on impairment level, with 22,5% of therapy time spent on 
muscle length and 33,3% of therapy time targeting muscle strength.  Although the time per session 
spent on functional activities was very limited, the contents of the functional exercises seemed more 
appropriate. In 67,5% of the sessions, gait training was part of therapy and in 63,3% of the therapy 
sessions, functional exercises were performed in and from a standing position. This can be considered 
as clinically relevant and appropriate in relation to the classification and pathology of the participating 
children.
12
    
Exercises on muscle length followed the evidence-based recommendations using three repetitions. 
However, the applied stretches were of relative short duration (10 sec) in comparison to the findings of 
Lee et al, demonstrating more advantageous results for a 30 seconds stretch.
19
 
Regarding muscle strength, the number of three sets of 10 repetitions that was most commonly 
reported, was very close to the recommendations by the NSCA guidelines, that recommended three 
sets of 12 to 15 repetitions.
5
 Although the physical therapists registered a very high frequency of using 
external of manual resistance, dosing of the applied resistance was not registered. In 95% of the 
exercises, therapists reported the use of manual resistance and only in 5% of the cases, therapists 
applied an external resistance.  The sessions forms in the diaries, specifically asked to specify the 
applied resistance. However, none of the therapists quantified the applied resistance nor mentioned 
an increase in intensity or resistance throughout the ten weeks training period. Therefore, the median 
applied resistance could not be objectified nor quantified. These results correspond to the findings of 
Verschuren et al., who identified the common problem of insufficient dosing as a major limitation to 
achieve treatment effects.
20
   
In a large cohort study, Palisano et al. reported parent ratings on the focus and process for 
occupational and physical therapy.
21
 The authors thereby highlighted that a great extent of therapy 
was addressed to primary impairments. However, it is difficult to compare the present results 
adequately to the results of Palisano et al., as our study questioned therapist instead of parents about 
the therapy focus and content. The use of diaries in our study aimed to find more objective figures to 
evaluate therapy contents. To our knowledge, no other studies have monitored therapy contents. Still, 
monitoring therapy using a diary as such might be a more specific and precise tool to evaluate therapy 
contents. However, it is also possible that it gives therapists the feeling of being evaluated. In general, 
therapists also experienced the diary as time-consuming and therefore, causing a large additional 
administrative burden. Additionally, although one must thrust the therapists in their honesty, there may 
also be a discrepancy between what was registered in the diary and what was actually performed.  
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The second goal of this research paper was to compare the effectiveness of the period of UC to the 
effects of an evidence-based physical therapy program used as an intervention. It was hypothesized 
that supporting therapists and providing an evidence-based predefined intervention program, would 
cause better treatment results than usual care physical therapy.   
Effects the interventions were mainly visible on gross motor function. Children showed a significant 
change in GMFM-88 total and dimension E score after the period of intervention but not after the 
period of usual care. On gait measures, a non-significant tendency was visible showing improved 
MAPS in sagittal plane after the period of intervention but not after the period of UC. However, the 
reason behind these differences remains unclear. The diaries demonstrated a rather low ratio of 
therapy time addressing functional activities during the period of UC (41,7%). The predefined 
intervention programs consisted of more than 50% functional exercises. This might, besides the 
support to the therapists, be an important factor influencing our results. A limitation of our study was 
that we did not monitor the execution of the IP using a diary. This could have provided us more 
precise information on the specific time spent on the different exercises of the program. The 
differences in effects may also be related to the impact of the intervention as such. Providing therapist 
a framework of support might break routine therapy behavior and might as such make therapists more 
aware of the contents and impact of their treatment. Finally, a fundamental change in the content of 
the routine therapy might have an effect on the motivation of the children, who might have been 
triggered by new tasks and exercises. 
It is therefore promising to see the positive effects of the evidence-based predefined intervention. This 
suggests the need for future studies to understand the mechanisms behind the effects of an 
therapeutic intervention and further investigate knowledge translation strategies to improve evidence-
base practice behavior. 
 
Conclusion 
 
In physical therapy of ambulant children with bilateral CP, regular therapy sessions during a period of 
usual care are dedicated into a large extent to problems of muscle length and muscle strength. 
Thereby, especially muscle strength exercises seemed to have insufficient dosing compared to 
evidence-based guidelines. Functional exercises mainly involved exercises in standing and specifically 
gait training. A period of evidence-based intervention providing support to the therapists, 
demonstrated more advantageous effects on gross motor function compared to a period of usual care. 
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General discussion 
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The scope of this doctoral project was to develop and evaluate an evidence-based, individually 
defined and targeted physiotherapy approach for ambulant children with bilateral spastic CP.  
Children with bilateral CP face a variety of problems at all levels of the ICF. Therefore, the 
physiotherapist treating these children stands for the challenging task of priority setting and selecting 
appropriate treatment goals. A variety of physiotherapy treatment tools are available to reach those 
treatment goals, ranging from basic techniques (stretching, strengthening etc.) to more complex 
treatment concepts like neurodevelopmental treatment, functional training and conductive education, 
possibly complemented with additional therapies like aquatic therapy and horse-riding therapy.  
The first part of this project (chapter 1 & 2) provided an overview of the available evidence for these 
techniques. An extensive literature review was performed and evidence tables were developed to 
overview the possible use of these different techniques and approaches that can be applied to reach 
the most frequently selected treatment goals for ambulant children with bilateral CP. In the second 
part (chapter 3), a framework was developed and validated to support the physiotherapist in clinical 
decision making. This framework facilitates the selection of individual treatment goals based on an 
appropriate definition of the main problems of the child. In part 3, the reliability of the GMFM-88 by 
means of video-scoring was assessed. The last part (chapter 5, 6 & 7) evaluated the effectiveness of 
an evidence-based, individually defined targeted treatment approach by comparing it to the 
effectiveness of a general program and a period of usual care. 
Fig 1 summarizes the different chapters and highlights the main conclusions of each study. 
This general discussion will summarize the main findings of the doctoral thesis and will provide critical 
considerations and recommendations for future research.  
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Chapter 2: The evidence-base for conceptual 
approaches and additional therapies 
Chapter 3: Development of a clinical decision framework 
Chapter 5: Pilot study: repeated-measures design 
comparing the effects of an individually defined targeted 
treatment program or a general program 
Chapter 6: Randomized controlled trial comparing the 
effects of an individually defined, targeted treatment 
program to the effects of a general program 
Chapter 4: Reliability of the gross motor function 
measure based on video-registration scores 
Chapter 7: Evidence-based principles in usual care  
 The ICF provided a good model to evaluate the effectiveness of different physiotherapy 
interventions for CP on the different outcome parameters; 
 
 The effectiveness of the different techniques and conceptual approaches could be summarized 
in evidence tables; 
 
 The results showed limited interactions between the different levels of the ICF.  P
a
rt
 1
: 
S
y
s
te
m
a
ti
c
 
re
v
ie
w
s
 
Chapters Conclusions 
 A clinical decision framework based on the ICF and the hypothesis oriented algorithm for 
clinicians II was confirmed as a valid structure to support clinical reasoning; 
 
 There was a moderate agreement for the selection of main problems;  
 
 Therapists have difficulties in priority setting in the selection of specific goals. 
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 The GMFM can be scored reliably by means of video-scoring; 
 
 Agreement between live- and video-scoring is lower compared to usual intra-rater agreement. 
 An individually defined targeted physiotherapy program is effective on gait and gross motor 
function in children with CP but the effects were not significantly different than the effects a 
general approach; 
 
 Usual care physiotherapy in children with CP in Flanders is mainly focused on treatment of 
impairments and makes limited use of evidence-based guidelines;   
 
 Supporting therapists by providing follow-up and evidence-based guidelines has positive effects 
on treatment outcome. 
 
 
 
 
 
   
 
 
 
 
 
 
 
    
 
  
 
 
Fig 1. Outline and conclusions of the different studies.
Chapter 1: The evidence-base for basic physical therapy 
techniques targeting lower limb function  
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1. Summary of the results 
 
As a first step in this doctoral study, a systematic literature review was performed to describe and 
discuss the effectiveness of the different physiotherapy techniques and approaches targeting the 
lower limbs in children with CP.  Between 1995 and 2010, 87 studies could be selected evaluating the 
effectiveness of basic techniques (study 1).
1
 Evidence-tables were developed to facilitate the 
selection of the appropriate techniques to reach specific treatment goals. The most frequently selected 
outcome parameters in the interventions were situated at impairment level. To improve range of 
motion, the use of stretching could be supported with level II evidence.  Strong evidence was found for 
the effects of isometric and isotonic strength training on muscle strength. On the other hand, 
conflicting evidence was found for the use of electrical stimulation and endurance training on different 
strength measurements. Energy expenditure and movement efficiency were positively influenced 
following functional and isotonic strength training and treadmill training. On activity measures, level II 
evidence supported the use of treadmill training, isotonic or isometric strength training and balance 
training to improve different gait measures. Gross motor function was found to be effectively 
influenced by endurance training and strength training. Regarding participation and quality of life, level 
IV evidence was established for the effectiveness of massage on self-efficacy and on reduced 
parental anxious behaviour and depression.  
Furthermore, 37 studies evaluated the effectiveness of conceptual approaches (study 2).
2
 At 
impairment level, only level IV evidence was found for the effects of NDT on posture. At activity level, 
level II evidence was found for the effect of functional training, NDT and goal-oriented approaches on 
gait and gross motor function. To improve children’s participation, functional training using a goal-
oriented approach was confirmed as being effective. 
Overall we could conclude that limited interactions were found between the different levels of the ICF. 
Interventions targeting problems at body structure and function mainly influenced this level without 
significant overflow to activity level and vice-versa. An important clinical message following this 
conclusion was that a targeted treatment approach based on a complete and extensive evaluation at 
all levels of the ICF is necessary to create an appropriate treatment plan.  
Therefore, part two aimed to develop a clinical reasoning strategy to support the paediatric 
physiotherapist in selecting the appropriate treatment goals (study 3).
3
 The clinical reasoning 
framework integrated two existing but complementing frameworks: the ICF and the Hypothesis 
Oriented Algorithm for Clinicians – II (HOAC-II). The ICF provided the perfect structure to organise 
assessment results.  The HOAC-II was used as a structured strategy-oriented approach for evidence-
based clinical reasoning and to reduce the problem list to a refined shortlist of main problems. Within 
this structure, three-dimensional gait analysis was used as a supportive tool to unravel the complex 
interaction between the different components and problems. The framework was validated using a 
group of 22 physiotherapists, who identified the main problems and specific treatment goals for eight 
ambulant children with bilateral CP.  Cluster analysis revealed a logic connection between the   
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selection of main problems and specific goals, confirming the algorithm as being a valid structure that 
supports logic clinical reasoning. Additionally, the results of this study revealed a very high agreement 
between the therapists concerning the identification of main problems. Agreement regarding the 
selection of specific treatment goals was lower and in 29% of the cases, therapists could not reduce 
their selection of goals to a number lower than eight. Most of the goals however, targeted muscle 
strength, range of motion and items from the GMFM-88 dimension D.  
As a next step, in part 3 of the project, the evidence-based knowledge and the clinical reasoning 
strategy were used to develop an individually defined, targeted treatment approach. The clinical 
reasoning strategy was applied to identify the main problems of the child. The corresponding specific 
treatment goals were selected based on the discussion with the child, the child’s therapist and 
parents. The evidence tables from the systematic literature review were used to select the appropriate 
treatment technique to reach the goals. To be able to evaluate the effectiveness of the individually 
defined targeted treatment approach, an objective, blinded assessment of the children was necessary. 
Thereby, both clinical gait analysis and the GMFM-88 were identified as valid and reliable measures to 
evaluate gait and gross motor function in children with cerebral palsy. As the Clinical Motion Analysis 
Laboratory at the University Hospital Pellenberg has built up extensive experience in clinical gait 
analysis with several efforts to achieve high-standard quality measurements, these evaluations could 
be considered as being reliable. Additionally, the measurements could be performed by the 
experienced but independent staff of the laboratory, blinded to the set-up of the study.   
To be able to use the GMFM-88 in an evaluator- blinded trial, the GMFM-88 had to be tested in a new 
reliability study assessing the agreement between a live assessment and an evaluator-blinded 
assessment by video-scoring (study 4).
4
 The results revealed a high agreement between the live-and 
video scores but lower agreement compared to regular intra-rater reliability. Blinded video-scorings of 
the GMFM-88 were reliable, but when interpreting the results of clinical trials, we concluded that the 
changes should be interpreted using the adjusted responsiveness measures. 
Consequently, part 4 of this dissertation represented the intervention studies evaluating the 
effectiveness of the individually defined targeted treatment approach. Study 5 was designed as a 
randomized, single-blind repeated measures study.
5
 After a period of 10 weeks usual care with no 
intervention, ten children with bilateral spastic CP were randomly assigned into an individually defined, 
targeted treatment program or a general program, followed by a cross-over.  Evaluation was made 
using the GMFM-88 and three-dimensional gait analysis with outcome measures evaluating both the 
general progress of the child as well as the attainment of the individual goals of the child. The results 
of this study only indicated slightly favourable effects towards the individually defined program but 
could not confirm statistically significant differences between the outcomes of both programs. Limited 
changes however, were observed after the period of usual care. Study 6 compared the effectiveness 
of the individually defined approach to the effectiveness of a general therapy program in a larger, 
randomized trial using the same outcome measures.
6
 Although this study included 60 interventions, 
the results did also not demonstrate statistically different results between an individually defined 
treatment approach and a general program on gait and gross motor function of these children.  
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However, analysis of the entire intervention group highlighted positive treatment effects for all children, 
regardless of the type of program they were enrolled.  
Hence, we hypothesized that supporting therapists by providing a predefined evidence-based 
intervention program, may have contributed to the improved treatment outcome compared to the usual 
care physiotherapy.  Consequently, study 7 aimed to evaluate evidence-based practice behaviour in 
usual care physiotherapy in Flanders and to compare the effectiveness of the predefined 
physiotherapy programs based on evidence-based guidelines to the effects of a period of usual care.
7
 
The results of this study indeed revealed that the predefined intervention programs provided better 
treatment results compared to the period of usual care, with significant differences in changes on 
gross motor function.  Looking into the contents of usual care physiotherapy in Flanders showed that 
physiotherapy still mainly focuses on problems at impairment level and that exercises were 
characterized by insufficient dosing. 
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2. Critical considerations 
 
2.1 Systematic reviews 
 
2.1.1 Basic techniques 
In 2008, Anttila et al. performed two high-quality systematic reviews evaluating the effectiveness of 
physiotherapy and conductive education.
8
 Although these reviews only included randomized trials and 
systematic reviews respectively, the authors still identified severe limitations in methodological quality 
because of the large variations in population, interventions and outcome parameters of the trials. In 
our systematic reviews, we also observed a large discrepancy between the study designs (providing 
the level of evidence, Sacket) and the study quality scores (conduct scores, AACPDM 
recommendations). Our findings confirm that the randomized controlled trials, valued as providing a 
high level of evidence, generally showed conspicuously low quality scores. This conclusion led to our 
main motivation to include all types of intervention studies regardless of their level of evidence.  
Comparing the specific conclusions, Anttila et al. only concluded moderate evidence of ineffectiveness 
of strength training on gross motor function. Our systematic reviews found level II evidence for the 
effectiveness of strength training on both strength measurement and gross motor function. These 
differences in results can probably be explained by the fact that Anttila et al. applied different study 
inclusion criteria. In addition, Anttila et al. could not yet include the trials published between 2007 and 
2010, a period during which several intervention studies on strength training were published.  
A more recent meta-analysis by Scianni et al. reported inconclusive results regarding the effectiveness 
of strength training in children with CP.
9
 These conflicting results may be explained by the fact that 
Scianni et al. considered neuromuscular electrical stimulation as a direct strength intervention and 
therefore, included different studies using strength training in the meta-analysis. Nevertheless, all 
reviews described the findings regarding the use of strength training as promising and identified the 
weak trial qualities as factors limiting the development of specific evidence-based guidelines. 
Verschuren et al. summarized the contents of the strength interventions and thereby identified 
insufficient dosing used in the majority of the studies as a major contributor for limited results.
10
 
For the remaining basic techniques, our conclusions regarding stretching, balance training, endurance 
training correspond with the results of Antilla et al. 
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2.1.2 Conceptual approaches 
Regarding the effectiveness of the different approaches, different systematic reviews report even more 
conflicting results. 
Regarding Neurodevelopment Treatment (NDT) or Bobath therapy, our review found level IV 
evidence for the effectiveness of NDT but identified the concept as the only treatment concept causing 
effects at all levels of the ICF.   In an AACPDM evidence report, Butler & Darrah found no advantage 
of NDT over the alternatives to which is was compared.
11
 With the exception of immediate 
improvement of dynamic range of motion, there was no consistent evidence that NDT demonstrated 
positive effects on the development of contractures, abnormal motor responses or motor development. 
Brown & Burns reported similar findings.
12
 The conclusions of Anttila et al. were more positive and 
reported high-level evidence of NDT on the developmental status of very young infants.
8,13
 A very 
recent systematic review by Novak et al. however, concluded that there was no superior value of 
Bobath therapy compared to the more cognitive motor learning strategies and therefore, graded the 
therapy approach as ‘red light’.
14
 Red light was defined as ineffective, indicating that it should not be 
used.  
Nevertheless, Bobath therapy is one of the oldest treatment approaches for children with CP and 
probably still one of the most frequently used principles worldwide. In order to make evidence based 
guidelines, it is important to evaluate the available evidence and the contents of the concept more 
critically. 
An important reason for the controversial conclusions might again be the different study inclusion 
criteria applied by different reviews. Our study included level IV studies, but all other studies only 
included RCT’s and/or high level of evidence studies (I and II only). Many of the studies evaluating the 
effectiveness of NDT were not randomized controlled trials or had lower levels of evidence. Therefore, 
these studies were not included in the systematic reviews by Antilla et al., Novak et al., Butler & 
Darrah and Brown & Burns.
8,11-13,15
 Additionally, the review by Butler & Darrah and Brown & Burns are 
much less recent and therefore, included older studies (until 2001). 
Limited and controversial evidence is available regarding the use of Bobath therapy. Still, 
acknowledging the limitations of clinical trials of the involved RCT studies, it might be a precipitated 
decision to refute the usefulness of the concept. Additionally, when an intervention does not provide 
different treatment results compared to an alternative, it might more reflect the equal value of both 
therapies instead of its ineffectiveness.  
Evaluating the content of the Bobath concept more critically is a very challenging experience. 
Worldwide, different interpretations are made regarding the concept and unfortunately, some of these 
have drifted away from the original concept as defined by Dr and Mrs Bobath. Additionally, Bobath is a 
concept that has evolved a lot.  
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Looking into literature regarding the content of Bobath therapy highlighted several reported concerns 
regarding the concept. It is worthwhile to critically consider these concerns in the view of the original 
ideas and more recent evolutions. 
A first major concern is the statement that Bobath therapy is rather passive, using only 
neuromaturational principles of motor learning.
15-17
  
Motor learning is described as a set of (internal) processes associated with practice or experience 
leading to relatively permanent changes in the capability for responding.
18
 Motor learning can 
therefore be seen as a very broad term. Over the years, different principles of motor learning have 
been developed, all based on both explicit and implicit assumptions, associated with an underlying 
theory of motor development or motor control.  Neurophysiological and neuromaturational approaches 
are largely based on assumptions that the development of movements and motor skills result solely 
from the neurological maturation of the central nervous system. This maturation involves that higher 
centres inhibit and control lower centres, thereby allowing voluntary movement. More recent theories 
of motor learning emphasize that motor or developing behaviour should not be viewed as the 
unfolding or predetermined or prescribed patterns represented in the central nervous system. These 
approaches favour a more heterarchical view in which motor development and coordination are 
assumed to emerge from the dynamical interaction of many subsystems in a task-specific context. 
This approach, therefore, is based on an active rather than a passive view of motor learning. People 
learn by actively attempting to solve the problems inherent to a functional task.
19,20
 Looking back into 
to the Bobath concept, brings us to the following original text by Dr and Mrs Bobath (Appendix AC). 
The basic idea is that the child is assisted in problem-solving and that therapist enables him or her to 
experience the patterns of movement and success in achieving the task. For example, through 
facilitation, the Bobath clinician intends to provide key components of the spatial and temporal aspects 
of a specific movement or task. The therapist thereby enables the child to have an experience of 
movement that is not passive but he or she cannot yet do alone. The Bobath concept tries to progress 
from a facilitated movement to a hands-off, active learning position for the child.  From that 
perspective, the active learning component applied within the Bobath concept probably reflects more 
its heterarchical and active view on motor learning.   
A second important concern is that the Bobath concept is considered to address impairments (muscle 
tone and range of motion) only and insufficiently targets activities and participation.
15,21
The Bobath 
approach aims to modify the patterns of abnormal postural tone and to facilitate more normal motor 
patterns as a preparation for a specific functional skill such as dressing, eating, drinking, writing, 
walking etc. Treatment is not considered as a repetition of the functional task but is carefully 
considered by task-analysis. There is stepwise preparation for a specific functional skill to enable the 
child to function in the most possible efficient way. The aim is to perform postural and voluntary tasks 
with the least possible interference from abnormal postural tone.  Secondly, parent-training and home-
based training are an inherent part of the Bobath concept. The Bobaths emphasized that learning 
requires meaningful goals, relevant to the child. (Appendix AB). While the Bobath concept maybe 
based on a different strategy compared to functional, task-oriented training, the integrative approach  
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of the Bobath concept attempts to target the multifaceted problems of the child, thereby approaching 
the recent developments and ideas regarding child-and family involvement and participation.  It does 
not only take into account the impairments of the child, but beyond that, prepares the child for specific 
activities and participation limitations. In that way, Bobath therapy integrates and even fully addresses 
the different components of the ICF.
22
 
The third important concern regarding the interpretation of the Bobath concept is that it fails to allow 
the incorporation of other treatments (e.g. strength training) that have been shown to be equally 
effective.
23
 The Bobaths viewed strength more as a secondary problem in children with CP and have 
thereby probably overemphasised the neural control of movement.
24
 This may have caused them to 
neglect the importance of muscle strength, force production and movement velocity.  This can 
probably be explained by the fact that the Bobaths pioneered their work over 60 years ago, long 
before the recent developments in imaging technologies. Recent publications regarding Bobath 
therapy have reported the need to integrate strength training.
22,24
 Nevertheless, integration of strength 
training is probably not yet fully dispersed amongst all Bobath-clinicians. 
In summary, due to the limited available evidence regarding the Bobath-concept, evidence-based 
decision making about the Bobath concept is difficult. A high degree of confusion and different 
opinions exist regarding the content of the concept. Nevertheless, the basis of the concept meets the 
current evidence-based needs formulated by the dynamic concept of the ICF. To be applied in an 
adequate way, the concept needs to be evolving, with a dynamic and opened view on new knowledge.  
 
Functional training is often considered as the opposite concept of Bobath therapy. Functional 
training is based on a task-specific repetition of activities. Movement exploration, a (cognitive) 
selection of solutions to new task demands and the adaptation to changes in the environmental 
context are assumed to be critical parts of motor learning.
20,25,26
 Functional training prefers hands-off 
treatment and focuses on learning the child to perform a task within naturally occurring restraints. 
Nevertheless, level II evidence for the effectiveness of functional training was only demonstrated on 
gait and gross motor function.  
To our knowledge, no systematic review specifically summarizes the intervention studies evaluating 
the effectiveness of functional training.  
A first major difference between functional training and Bobath therapy is the specific preparation for 
function. Bobath therapy uses a more stepwise approach, starting from a specific preparation for 
function with attention for compensations. Functional training immediately practices the repetition of 
the specific functional task. Secondly, the cognitive component that is more often applied within 
functional training is much less pronounced within the Bobath approach, which is more based on 
movement experience.  
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Despite these difference, as both approaches aim to improve the child’s daily functioning with attention 
to family involvement, supporting materials and environmental aspects, they probably lie closer to 
each other than they claim to.  
Nevertheless, the heterogeneity of the pathology of CP requires individually defined treatment goals. 
Choosing the appropriate technique to reach the treatment goals is challenging and requires a 
balanced but evidence-based decision by the physiotherapist treating the child. Based on the available 
evidence, functional training seems to be very useful for the child to reach short-term functional goals. 
20,25,27
 Including children in functional goal-setting thereby clearly had a major additional value.
28-30
 
The effectiveness of physiotherapy in children with CP probably lies more in an adequate combination 
of techniques than the selection of an individual technique or approach. Discussions regarding the so-
called named approaches are often biased, theoretical and transcend the contents of the approaches 
as such.  Much more important than the discussion in which technique is more valuable than another, 
is probably an adequate and evidence-based integration of different approaches. Evidence-based 
physiotherapy may therefore rather focus on the strengths of the different approaches and the 
effectiveness that already has been proven.  Such thinking strategy allows integration of different 
aspects from different approaches into a comprehensive, multi-layer treatment approach that can 
address the individual problems of a child.  
The developed evidence tables can support the physiotherapist in selecting an appropriate technique 
to reach a specific goal.  Nevertheless, this approach requires an appropriate selection of individual 
treatment goals, which can be very challenging for the physiotherapist, seen the heterogeneous, 
complex and evolving nature of the pathology of cerebral palsy. An adequate clinical reasoning 
structure is still necessary to support the therapist in its evidence-based decision-making and priority- 
setting. 
 
 
2.2 Clinical decision framework 
 
In part two of this dissertation, a clinical framework was developed to support the therapist in 
evidence-based decision making. The ICF was thereby used as a structure to organize the 
assessment results, complemented with the Hypothesis-Oriented Algorithm for Clinicians – II (HOAC-
II), to integrate a strategy-oriented component. This first goal of the study was to investigate how 
clinical framework could contribute to a reliable identification of main problems and specific PT goals 
in ambulant children with CP. There was moderate agreement in the selection of main problems. The 
agreement between the selection of specific goals was lower and the physiotherapists had difficulties 
in limiting their selection of specific goals to eight treatment goals.  It is possible that specific individual 
goal-setting is still relatively new or unknown to the therapists and therefore maybe an aspect that 
requires additional training. However, it is also possible that selecting specific individual goals, is more 
subject to individual physiotherapist differences. Still, a logic connection was observed between the   
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identification of main problems and the selection of specific treatment goals. The first goal of this study 
was thereby achieved.  
The second goal of this study was to evaluate how the additional information of three-dimensional gait 
analysis could influence the reliability of this information. Unfortunately, this second goal could not be 
achieved because of methodological restrictions in our study design.  The gross motor function levels 
of the participating children were not equally divided over the groups with and without gait-analysis 
information and the number of children in both groups was too small. Although the agreement in the 
selection of main problems was higher in the group of children where gait analysis information was 
provided, we have to be careful to link these observed differences to the additional value of gait 
analyses only. Nevertheless, as gait analysis is a frequently used tool to evaluate ambulant children 
with CP, the use of this information to improve the understanding of the child’s functional problems 
remains an important topic that requires further research. 
 
2.3 Agreement video-scoring GMFM-88 
 
The ICC values for the live-and video scores from the same assessor were good, but were lower 
compared to ICC values for the intra-rater agreement of the MSc students scoring the video-
registrations. One might conclude that video-scores provided very good inter-and intra-rater-reliability 
values, but that the video-registrations as such created a small, systematic error that lowers 
concurrent validity of the GMFM-88 measurements. To evaluate the reasons behind this lower ICC 
values, it is recommended to compare the repeated live-scorings as well as the repeated video-scores 
all of the same assessor. Nevertheless, the reliability results were acceptable and allowed us to 
evaluate the within-person change values for the GMFM-88. Fig 2 provides an overview of the 
different values of the within-person changes as reported in study 4.  
   
  
 
 
 
 
 
 
Fig 2. Within-person changes for the Gross Motor Function Measure-88  
* Results from the agreement study (study 2) **Results of minimal clinical important change from 
Russell et al.
34
  - not rated  
  
Change=0? 
 
Parents: 
Large negative:-9,9% 
Large positive: 11,4% 
Small negative: - 
Small positive: 2,7% 
 
Therapists: 
Large negative: -   
Large positive: 24,6% 
Small negative: -2% 
Small positive: 1,3% 
 
Live vs video 2,28% 
Intra-rater video 
1,43% 
Inter-rater video 
3,15% 
 
 
Live vs video 6,32% 
Intra-rater video 
3,96% 
Inter-rater video 
8,73% 
 
Minimal Clinically 
Important Change** 
Smallest Detectable 
Difference* 
Standard Error of 
Measurement* 
No change 
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Thereby, the Standard Error of Measurement (SEM) provides an absolute index of reliability. It 
indicates the variability of the scores around the subject’s true score and thereby provides a value for 
the measurement error in the same unit as the measurement itself. The SEM allows the calculation of 
the Smallest Detectable Difference (SDD) or the Minimal Detectable Change (MDC), which is 
usually calculated as (SEM*1,96*2). The SDD represents the amount by which a patient’s score 
needs to change to ensure that the change is greater than the measurement error.  The Minimal 
Clinical Important Change/Difference (MCID) is referred to as the smallest change in measurement 
that is considered to be meaningful based on clinicians ratings.
33
  
The SEM and SDD could be calculated based on our agreement study. The MCID represented in Fig 
2 is based on the results of the study of Russell et al, who compared the subjective ratings of progress 
by parents and therapists to the actual change in GMFM-88 scores after a period of 6 months of 
physiotherapy.
34
 When parents rated ‘a small improvement’ in gross motor functioning, an actual 
change of 2,7% was registered on the GMFM-88 score. Therapists seemed to capture these 
differences somehow easier, rating a ‘small positive’ progress already when an actual change of 1,3% 
change on the GMFM-88 was registered.  
As relevant conclusions from this study, one can state that the intra-rater reliability of the GMFM-88 
scores based on the video-scores provided a very good agreement and video-scores can be used 
reliably to evaluate the effects of an intervention. Provided that the same rater scores the video-
registrations, one can define 3,96% as a change that provides 95% certainty that the change is larger 
than a measurement error. (Fig 2.) When evaluating clinical relevance, on might use the 2,7% of 
GMFM-88 change, representing the small positive change in gross motor functioning noticed by the 
parents, as MCID. (Fig.2) 
 
2.4 Intervention studies 
 
The first interventions (study 5&6) compared the effectiveness of the individually defined approach to 
a general program. Outcome was evaluated using the GMFM-88 and three-dimensional gait analysis, 
using parameters measuring general progress as well as progress at individual goals. Study 7 
evaluated the effectiveness of a predefined, evidence-based treatment program to the effects of usual 
care physiotherapy. Table 1 summarizes the results for the main outcome measures in the different 
intervention studies.   
Regarding gross motor function, the results demonstrate overall positive effects for both intervention 
programs (Table 1). Still, the changes in GMFM were usually quite small. In study 6, the estimated 
change (pre-post) in GMFM-88 score was only -1,65% and -1,27% for the IT and the GT group 
respectively. These differences were not only smaller than the minimally clinically detectable 
difference reported by Russell et al. (2,7%)
34
, but even smaller compared to the smallest detectable 
differences for the intra-rater reliability (3,96%) as calculated in by the reliability study.
4
 This statistical 
significance can probably be explained by the observed trends in the groups, as almost all children   
231 
 
tended to improve their GMFM-88 scores. When all observed scores change in the same positive 
direction, smaller changes can already cause statistical significance effects. Comparable overall 
positive changes in GMFM-88 scores were found in study 5. However, due to the small number of 
participants in this study, no statistical significance could be observed in this study. 
Trends in the outcome parameters of the three-dimensional gait analysis were different (Table 1). 
In none of the studies, significant changes could be found for the GPS. Only in the intervention group 
of study 7, changes in GPS were larger than the reported minimal clinical important difference as 
reported by Baker et al.
35
 Positive changes in time-and distance parameters were only found for step-
and stride length and this after the IT program in study 5 and 6.   
Looking into the parameters at individual level, children also seem to reach their functional, activity-
based goals more easily compared to the individual gait-analysis goals (Table 1). The motivational 
aspect of individual functional goals might have a significant impact on these results. Several studies 
have demonstrated the positive impact of goal-setting
25,27,36
 and logically, children are probably more 
motivated for functional activities than specific corrections of their gait patterns. Nevertheless, the 
results in study 6 demonstrate non-significant but positive evolution of both interventions on gait 
analysis goals.  
 
Table 1. Within-group changes for the main outcome measures for the intervention studies 
    IT program General program Usual Care 
    
Study 
5 
Study 
6 
Study 
7* 
Study 
5 
Study 
6 
Study 
7* 
Study 
5 
Study 
6 
Study 
7 
Individual 
goals 
GAS ✓ ✓ N/A = ✓ * N/A N/A N/A 
z-scores = ✓ N/A = ✓ * N/A N/A N/A 
General 
parameters 
 
GMFM-88 ✓   =  * = N/A = 
GMFM-88 - D ✓  = =  * = N/A = 
GMFM-88 - E ✓   ✓ ✓ * = N/A = 
GPS = = ✓ = = * = N/A = 
Time & distance 
parameters 
 ✓ = = = * = N/A = 
 
Abbreviations:  
 significant improvement;  non-significant improvement (>smallest detectable difference);  
significant deterioration;  non-significant deterioration (>smallest detectable difference); = no change 
(<smallest detectable difference); * pooled results with general program; GAS Goal Attainment Scale; 
GMFM-88 Gross Motor Function Measure 88; GPS Gait Profile Score; IT Individually defined, 
targeted; N/A Not Applicable  
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Based on these overall results, one might conclude that problems in gross motor function are more 
responsive to change compared to gait patterns.  It may also be possible that the period of 10 weeks 
was too short to cause significant effects in gait. Additionally, although several exercises from the 
programs aimed at improving gait, it is very probable that the actual therapy time spent on gait 
problems was too short. The results of the analysis of usual care demonstrated that generally, 
therapists practice gait in 67% of their therapy sessions. Nevertheless, the time per session that was 
spent on functional activities was usually very short. It might be possible that although the prescribed 
programs contained more than 50% exercises at activity level (including gait), the therapy time spent 
on different gait problems was still too short.  A last reason might be the well-known problem of 
regression to the mean. The heterogeneous nature of the pathology causes children to have problems 
at different joints and levels, which makes it very difficult to detect individual changes using general 
outcome parameters.
37
  
 
Overall, although the within-group changes indicate advantageous results for the individually defined, 
targeted program, no statistical between-group differences could be found.  The hypothesis that an 
individually defined, targeted treatment approach provides better treatment results than a general, 
aim-oriented program could thereby not be confirmed.  In the discussions of the concerning papers, 
several causes could be identified to explain these results. A first and major reason was probably the 
relatively low number of participants, providing low statistical power. This was confirmed in the power-
analysis of study 5. Additionally, the time required for the different exercises was not indicated by the 
researchers. Therefore, therapists may still spent too much time on the preparatory exercises of tone 
reduction, range of motion and analytical muscle strength and time left for functional exercises may 
have been too limited. This was clearly reflected in the treatment quality scores.  A last important 
reason might be that differences between the general and the individually defined program might have 
been too limited to detect differences in treatment outcome. The general program was still a well-
balanced program addressing the variety of problems seen in children with bilateral spastic cerebral 
palsy of this age-range and thereby, often came too close to the individually programs.  Also, by 
making very small adjustments and by providing appropriate feedback, well-experienced therapists 
often still managed to approach the exercises from the general program in an ‘individual way’. 
Nonetheless, both intervention programs provided better treatment results than a period of usual care, 
which was confirmed in our last study. 
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3.   Recommendations for future research 
 
This doctoral project aimed to develop and evaluate an evidence-based, individually defined and 
targeted treatment approach for ambulant children with bilateral spastic CP. The majority of 
physiotherapy intervention studies evaluate the effectiveness of individual techniques. These studies 
thereby contrast with the reality of clinical practice. As the pathology of CP is characterized by a 
variety of problems at all levels of the ICF and the interaction effects between the different levels are 
limited, there is a need for individually tailored and multi-layer approaches. It might also be possible 
that individual techniques complement each other in combined approaches. For example, limited level 
II evidence is available for the effectiveness of stretching on muscle length and range of motion. In 
clinical practice however, stretching is usually combined with a dynamic component of activation or 
strengthening of the antagonist. It might be that the use of strengthening the antagonist reinforces the 
effectiveness of stretching. However, interventions evaluating these combined approaches are scarce. 
These interventions are probably more complex to organise and to evaluate. Still, they reflect the 
reality of clinical practice and can thereby provide more opening for evidence-based practical 
guidelines. In addition, a clear and expedient clinical framework is needed to structure such 
interventions. Our clinical reasoning was only developed and validated for ambulant children with 
bilateral spasticity, aged 4 to 9 years. Further research is necessary to evaluate its use in children 
from different age-categories, typologies and functional levels. 
Additionally, the use of gait analysis in identifying main problems and treatment goals needs to be 
further explored. Gait analysis has proved its effectiveness in the identification of goals for orthopaedic 
surgery and BTX-A.
38-40
 At the University Hospital of Pellenberg many children receive frequent gait 
analysis during the course of their treatment follow-up. Therefore, the information is usually available, 
allowing large retrospective cohort studies. Study 3 gave an indication that the results can support 
physiotherapists in identifying the main problems of the child, but the way this can be used in clinical 
practice, needs to be further investigated.  
A weakness in our study was that we did not include strength measurements in our outcome 
parameters. The use of our strength measurements was limited to the analysis of the manual muscle 
testing scores and the visual interpretation of kinematic and kinetic parameters in the gait analysis 
results that reflect strength issues. Several researchers have observed significant increases in 
strength measurements after progressive resistance training, but identified smaller and non-significant 
mean increases in kinematic and functional outcomes.
41-45
 Some researchers thereby refer to the 
need for analytical approaches to identify individuals who are most likely to benefit from strength 
training and to identify the specific muscles that require strengthening.
41
 In addition, insufficient 
loading was identified as a reason for strengthening interventions to be ineffective. This might as well 
be related to the limited possibility to evaluate muscle strength and thereby, to identify weaker 
muscles. Although the use of handheld-dynamometry is a great progress compared to manual muscle 
testing, it still shows limited reliability and does not reflect functional, multiple joint muscle work.
46-48
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Instrumented three-dimensional gait analysis may thereby be a promising tool to contribute to the 
identification of the impact of muscle weakness on ambulatory function.  
Regarding the use of the different therapy concepts, Bobath currently stands in the line of fire. 
Although some comments regarding the concept are correct, others are probably based on 
misinterpretations.  The reason behind these misinterpretations might well be caused by the limited 
available information about the concept. The writings from Dr and Mrs Bobath are scarcely published 
and seem to be very fragmented. The concept is used all over the world, but with different ideas and 
interpretations.  A clear and concise definition based on a common view is probably needed for the 
concept to survive. It might be important to emphasize the preparation for function more clearly as a 
core aspect of the concept together with the existing clear structured, clinical reasoning approach. 
Furthermore, as most of the available information regarding the effectiveness of Bobath therapy is 
available through level IV evidence, high-quality interventions are urgently necessary. Finally, the 
Bobaths have identified their concept as being dynamic and opened to new evidence-based 
knowledge and techniques. The progressive view of the concept has been confirmed in Flanders, 
where the paediatric Bobath therapy course was integrated into a fully academic paediatric 
postgraduate course. This was a big step forward for the program and might be an example for other 
countries applying the Bobath concept. 
The basis of the individually defined therapy approach applied in this PhD was constructed on a wide 
set of principles, selected from different concepts. The approach thereby addressed the horizontal and 
dynamic structure of the ICF. Evidence-based guidelines and structured clinical reasoning were 
applied and attempted to transcend the on-going discussions between the theoretical concepts.  
Physiotherapy of children with cerebral palsy requires a dynamic physiotherapy approach, based on 
the balanced decision between the need to control impairments with sufficient attention to activity and 
participation, both on short-and long term. Goal-setting was a central aspect of the individually 
defined, targeted approach. This was not only a means to motivate the children, but also a means to 
structure the programs, to prioritize treatment goals and to address the individuality of a child’s 
problems.  
Future interventions should have a longer duration. In that way, the use of participation goals can be 
integrated more optimally. As ten weeks was too short to expect significant improvement at 
participation level, participation problems were only taken into account to design the individually 
defined programs. Extending the duration of the program will thereby allow an evaluation of the 
effectiveness of the programs at participation level. In addition, it may be encouraged to organize 
future interventions as multicentre studies. This allows larger treatment groups. Additionally, using 
international multicentred studies may allow the comparison of the effects of the different treatment 
strategies used in the different centres without the need to change the usual therapy.  
The last study of this dissertation showed the positive impact of providing evidence-based guidelines 
and support to paediatric physiotherapists on treatment outcome. A fundamental change in the 
content of the routine therapy might have caused an effect on the motivation of the children, who 
might have been triggered by new tasks and exercises. It is therefore promising to see the positive 
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effects of the evidence-based predefined intervention. This suggests the need for future studies to 
understand the mechanisms behind the effects of a therapeutic intervention and further investigate 
knowledge translation strategies to improve evidence-base practice behaviour.   
 
 
4. Conclusion 
 
This doctoral project made a contribution to the development of an evidence-based individually 
defined, targeted treatment approach for ambulant children with bilateral cerebral palsy. A systematic 
review summarizing the effectiveness of the most commonly used physiotherapy techniques 
highlighted limited interaction effects between the different levels of the ICF. As the outcomes were 
differentiated at the different levels of the ICF, these results can support the physiotherapist in 
selecting the appropriate treatment technique. Secondly, an innovative and validated clinical decision 
framework allowed an adequate selection of the main problems and treatment goals. Comparing the 
individually defined treatment approach to a general physiotherapy approach demonstrated promising 
results that need to be confirmed on larger groups, using programs of longer duration. Supporting 
physiotherapist by providing evidence-based guidelines and follow-up has beneficial effects on 
treatment outcome. Future research should take a next step to promote evidence-based behaviour in 
clinical practice.  
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Cerebral Palsy (CP) is defined as a group of disorders of the development of movement and posture, 
causing activity limitations that are attributed to non-progressive disturbances occurring in the 
developing fetal or infant brain. With an incidence of 2 to 4 in 1000 children, CP is the most common 
physical disability in childhood. It is characterized by a neurodevelopmental condition that begins in 
early childhood and persists throughout lifespan. It is estimated that around 46% of the children with 
CP show bilateral spasticity. In these children generally the lower limb is more involved than the upper 
limb. 
Besides the increased muscle tone, impairments in the lower limb include muscle weakness, reduced 
selective muscle use, sensory deficits and secondary risk of muscle contractures and deformities.  
Gait and gross motor function are thereby often compromised, restricting the child’s possibilities to 
participate in educational or leisure activities.  In addition, the pathology of CP is often complicated by 
the fact that clinical manifestations are widely believed to change throughout lifespan. 
The complexity of the problems seen in children with CP requires a multidisciplinary treatment. 
Thereby, the physiotherapist plays a key role. Physiotherapy treatment of children with CP is a 
balanced but challenging exercise between optimizing motor development, promoting independent 
functionality and participation and prevention of secondary problems that limit this daily functioning.  
Nevertheless, although limited but promising results are available for the effectiveness of individual 
techniques, studies evaluating the effectiveness of integrative physiotherapy programs are scarce. 
However, a combination of different techniques may address he heterogeneity of the pathology in a 
more optimal way. This doctoral thesis therefore aimed to develop and evaluate the effectiveness of 
an evidence-based individually defined treatment approach for ambulant children with bilateral 
cerebral palsy.  
In part 1 of this doctoral study (chapter 1 & 2), a systematic literature review was performed to 
describe and discuss the effectiveness of the different physiotherapy techniques and approaches 
targeting the lower limbs in children with CP. The evidence of the most commonly used physiotherapy 
techniques was evaluated by differentiating the effects on the different levels of the ICF. Evidence-
tables were developed to facilitate the selection of the appropriate techniques to reach specific 
treatment goals. Overall, limited interactions were found between the different levels of the ICF. 
Interventions targeting problems at body structure and function mainly influenced this level without 
significant overflow to activity level and vice-versa. An important clinical message following this 
conclusion was that a complete and extensive evaluation at all levels of the ICF is necessary to create 
an appropriate treatment plan for an individual child.  
Part 2 (chapter 3) aimed to develop a clinical reasoning strategy to support the paediatric 
physiotherapist in selecting the appropriate treatment goals. The clinical reasoning framework 
integrated two existing but complementing frameworks: the ICF and the Hypothesis Oriented 
Algorithm for Clinicians – II (HOAC-II). The ICF provided the perfect structure to organise assessment 
results.  The HOAC-II was used as a structured strategy-oriented approach for evidence-based clinical 
reasoning and to reduce the problem list to a refined shortlist of main problems. Within this structure, 
three-dimensional gait analysis was used as a supportive tool to unravel the complex interaction  
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between the different components and problems. The framework was validated with the support of a 
group of 22 physiotherapists, who identified the main problems and specific treatment goals for eight 
ambulant children with bilateral CP.  Cluster analysis revealed a logic connection between the 
selection of main problems and specific goals, confirming the algorithm as a valid structure that 
supports logic clinical reasoning. Additionally, the results of this study revealed good agreement 
between the therapists concerning the identification of main problems. Agreement regarding the 
selection of specific treatment goals was lower and in 29% of the cases, therapists could not reduce 
their selection of goals to a number lower than eight. The majority of the goals however, targeted 
muscle strength, range of motion and items from the GMFM-88 dimension D.  
As a next step, the evidence-based knowledge and the clinical reasoning strategy were used to 
develop an individually defined, targeted treatment approach. The clinical reasoning strategy could be 
applied to identify the main problems of the child. The corresponding specific treatment goals were 
discussed with the child, the child’s therapist and parents. The evidence tables from the systematic 
literature review allowed us to select the appropriate treatment technique to reach these treatment 
goals.  
To be able to evaluate the effectiveness of the individually defined targeted treatment approach, an 
objective, blinded assessment of the children was necessary. Thereby, both clinical gait analysis and 
the GMFM-88 were identified as valid and reliable measures to evaluate gait and gross motor function 
in children with cerebral palsy. Three-dimensional gait analysis could be performed reliably and 
independently at the clinical motion analysis laboratory of the University Hospital Pellenberg. 
However, to be able to use the GMFM-88 in an evaluator- blinded trial, the reliability of GMFM-88 by 
means of video-scoring had to be tested. Therefore, part 3 (chapter 4) described a reliability study 
assessing the agreement between a live assessment and an evaluator-blinded assessment by video-
scoring. These results revealed a high agreement between the live-and video scores but lower 
agreement compared to regular intra-rater reliability. Blinded video-scorings of the GMFM-88 were 
reliable, but probably caused a systematic error compared to live-scoring. When evaluating the results 
of clinical trials, we concluded that the changes should be interpreted using the adjusted 
responsiveness measures. 
Consequently, part 4 (chapter 5, 6 & 7) of this dissertation represented the intervention studies 
evaluating the effectiveness of the individually defined targeted treatment approach. Study 5 was 
designed as a randomized, single blind repeated measures study. After a period of 10 weeks usual 
care with no intervention, ten children with bilateral spastic CP were randomly assigned into an 
individually defined, targeted treatment program or a general program, followed by a cross-over.  
Evaluation was made using the GMFM-88 and three-dimensional gait analysis with outcome 
measures evaluating both the general progress of the child as well as the attainment of the individual 
goals of the child. As both programs seemed to be equally effective, the results of this study only 
indicated slightly favourable effects towards the individually defined program. No statistically 
significant differences between the outcomes of both programs could be found. However, limited to no 
changes were observed after the period of usual care. Study 6 compared the effectiveness of the  
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 individually defined approach to the effectiveness of a general therapy program in a larger, 
randomized controlled trial using the same outcome measures. Although this study included 60 
interventions, the results did also not demonstrate statistically different effects on gait and gross motor 
function of these children between an individually defined treatment approach and a general program. 
However, again, analysis of the entire intervention group highlighted positive treatment effects for all 
children regardless of the type of program they were enrolled.  
Hence, we hypothesized that supporting therapists by providing a predefined evidence-based 
intervention program may have contributed to the improved treatment outcome compared to the usual 
care physiotherapy.  Consequently, study 7 aimed to evaluate evidence-based practice behaviour in 
usual care physiotherapy in Flanders and to compare the effectiveness of the predefined 
physiotherapy programs based on evidence-based guidelines to the effects of a period of usual care. 
The results of this study indeed revealed that the predefined intervention programs provided better 
treatment results compared to the period of usual care, with significant differences in changes of gross 
motor function.  Looking into the contents of usual care physiotherapy in Flanders showed that 
physiotherapy still mainly focuses on problems at impairment level and that exercises on strength and 
range of motion were generally characterized by insufficient dosing. 
 
In conclusion, this doctoral project made a contribution to evidence-based physiotherapy of ambulant 
children with bilateral spastic CP by developing an individually defined, targeted treatment approach. 
Promising results are demonstrated regarding the effectiveness of the approach. However, the results 
need to be confirmed on larger groups, using programs of longer duration. Supporting 
physiotherapists by providing evidence-based guidelines and follow-up has beneficial effects on 
treatment outcome. Therefore, future research should take a next step to promote evidence-based 
behaviour in clinical practice.  
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Cerebrale Parese (CP) is een overkoepelende term voor een groep blijvende stoornissen in de 
ontwikkeling van houding en beweging die kan worden toegeschreven aan niet-progressieve 
hersenafwijkingen in de vroege ontwikkeling van het kind. Deze kunnen leiden tot beperkingen in de 
activiteiten. Met een prevalentie van  2 à 4  per 1000, is het de meest voorkomende fysieke 
aandoening bij kinderen. CP manifesteert zich in een grote diversiteit aan neurologische stoornissen 
en klinische beelden. Ongeveer 46% van de kinderen met CP vertoont bilaterale spasticiteit,  waarbij 
het onderste lidmaat over het algemeen meer aangedaan is dan het bovenste.  Naast deze 
toegenomen spiertonus, vertonen deze kinderen ook vaak spierzwakte, beperkingen in selectiviteit, 
sensorische problemen en een verhoogd risico op spiercontracturen en botdeformiteiten. Deze 
problemen leiden dan vaak tot moeilijkheden bij het stappen en het uitvoeren van grofmotorische 
activiteiten, waardoor zij beperkt zijn in deelname aan sociale en schoolse activiteiten. Daarenboven 
wordt de problematiek van CP nog bemoeilijkt door het progressieve karakter van het klinisch beeld 
doorheen de jaren. 
De complexiteit van de problemen van kinderen met CP vereist een multidisciplinaire aanpak. Daarbij 
speelt de kinesitherapeut een belangrijke rol. De kinesitherapeutische behandeling van deze kinderen 
vraagt om een complexe balans tussen het optimaliseren van de motorische ontwikkeling, het 
stimuleren van functionaliteit en onafhankelijkheid en de preventie van secundaire problemen die 
deelname aan dagdagelijkse activiteiten kunnen beperken. 
De meeste kinesitherapeutische interventiestudies bij kinderen met CP evalueren de effectiviteit van 
individuele technieken. Hoewel de resultaten van deze studies veelbelovend zijn, is er nog steeds 
geen evidentie over de effectiviteit van integratieve programma’s die een combinatie maken van 
verschillende technieken. De heterogeniteit in de pathologie van CP doet echter vermoeden dat een 
totaalaanpak, bestaande uit verschillende technieken en gericht op de specifieke problemen van het 
kind, meer tegemoet zou komen aan de individuele problemen van dit kind.  
Dit doctoraatsonderzoek had als doel het ontwikkelen en evalueren van een evidence-based, 
individueel aangepaste behandelingsstrategie voor stappende kinderen met bilaterale spastische CP. 
In deel 1 van dit onderzoek (hoofdstuk 1 & 2), werd een systematisch literatuuronderzoek 
uitgevoerd, waarin de effecten van de individuele kinesitherapeutische technieken en concepten bij de 
behandeling van problemen in de onderste ledematen bij kinderen met CP werden nagegaan. De 
evidentie van deze technieken werd geëvalueerd en de effecten werden gedifferentieerd op de 
verschillende niveaus van het ICF. Er werden evidentietabellen gemaakt die de systematische keuze 
van bepaalde technieken om een specifieke doelstelling te kunnen bereiken kunnen 
vergemakkelijken. In het algemeen werden beperkte interactie-effecten gevonden tussen de 
verschillende niveaus van het ICF. Interventies die gericht zijn op het herstellen van problemen op het 
niveau van lichaamsstructuur- en functie hadden meestal alleen effect op dit niveau en vertoonden 
geen over-flow effecten naar het activiteitenniveau. Omgekeerd kon geen evidentie worden gevonden 
dat technieken die gericht zijn op het verbeteren van specifieke functionele activiteiten effectief zijn om 
problemen op lichaamsstructuur en functie te verbeteren.  Een belangrijke klinische boodschap die uit 
dit onderzoek kon afgeleid worden, hield in dat een adequaat kinesitherapeutisch behandelplan best   
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vertrekt vanuit een totaalevaluatie van het kind, waarbij, bij voorkeur,alle niveaus van het ICF 
geëvalueerd worden. 
Deel 2 (hoofdstuk 3) van deze studie had als doelstelling het ontwikkelen van een strategie die het 
klinisch redeneren van de pediatrische kinesitherapeut kan ondersteunen bij het selecteren van 
specifieke doelstellingen. Het framework dat daarbij ontwikkeld werd steunde op twee gekende, 
complementaire structuren, met name, het International Classification of Functioning, Disability and 
Health (ICF) en het Hypothesis-Oriented Algorythm for Clinicians (HOAC-II).  Het ICF kon daarbij 
gebruikt worden als een perfecte structuur om de onderzoeksresultaten logisch en overzichtelijk op te 
lijsten. Het HOAC-II gaf ons een gestructureerde, strategische aanpak om het klinisch redeneren te 
ondersteunen. Op deze manier kon het ontwikkelde klinisch redeneermodel de kinesitherapeut 
ondersteunen. Hierbij kon op een correcte manier de lange probleemlijst van een kind gereduceerd 
worden tot een verkorte lijst van hoofdproblemen. Binnen dit model werden de resultaten van de drie-
dimensionele ganganalyse gebruikt om een beter inzicht te krijgen in de complexe interacties tussen 
de verschillende problemen op de verschillende niveaus. Het klinisch redeneermodel kon gevalideerd 
worden bij een groep van 22 therapeuten, die ieder afzonderlijk de hoofdproblemen en 
behandeldoelen van 8 kinderen met bilaterale CP identificeerden. Clusteranalyse toonde een logische 
relatie tussen de selectie van hoofdproblemen en behandeldoelen. Dit bevestigde dat ons klinisch 
redeneermodel een valide structuur was dat logisch en gestructureerd klinisch redeneren kan 
faciliteren. Bovendien zagen we een hoge overeenkomst tussen de verschillende therapeuten bij het 
identificeren van hoofdproblemen. Bij het selecteren van specifieke doelstellingen was de 
overeenkomst tussen de therapeuten lager. Bovendien konden de therapeuten zich in 29% van de 
gevallen niet beperken tot een selectie van maximaal 8 behandeldoelen. De meerderheid van de 
geselecteerd behandeldoelen was gericht op spierkracht, spierlengte- en gewrichtsmobiliteit en items 
uit de Gross Motor Function Measure-88. 
In een volgende stap werd de kennis uit de evidentietabellen en het gevalideerde klinisch 
redeneermodel gebruikt om een individuele en doelgerichte therapie-aanpak te ontwikkelen. Het 
klinisch redeneermodel kon gebruikt worden om de individuele problemen van een kind te 
identificeren. Vervolgens werden de specifieke behandeldoelen geselecteerd en besproken met de 
therapeut, de ouders en het kind zelf.  De evidentietabellen uit het systematisch literatuuroverzicht 
konden worden aangewend om de correcte techniek te kiezen voor het bereiken van deze specifieke 
behandeldoelstellingen.  
Om de effectiviteit van deze individuele en doelgerichte therapie-aanpak te evalueren, was een 
objectieve en onafhankelijke evaluatie van het stappen en de grofmotorische functie van de kinderen 
noodzakelijk. Daarbij werden drie-dimensionele ganganalyse en de gross motor function measure-88 
(GMFM-88) geïdentificeerd als valide en betrouwbare metingen om de gang en grove motoriek van 
deze kinderen te evalueren. Drie-dimensionele ganganalyse kon betrouwbaar en onafhankelijk 
worden uitgevoerd in het laboratorium voor klinische bewegingsanalyse van het U.Z.Pellenberg.  Om 
de GMFM-88 te kunnen gebruiken in een geblindeerd onderzoek, moest de betrouwbaarheid en 
validiteit van de GMFM-88 scores via videoregistratie worden nagegaan. In deel 3 (hoofdstuk 4) van  
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deze doctoraatsstudie werd de overeenkomst nagegaan tussen de live- en de video-scores van de 
GMFM-88. Hoewel deze resultaten een hoge overeenkomst tussen beide scores toonden was de 
intra-rater betrouwbaarheid tussen de live en video-score lager dan wanneer ze herhaald op video 
werd gescoord.  De GMFM-88 kon dus betrouwbaar worden gescoord via videobeelden, maar men 
moet rekening houden met een systematische fout tussen de live- en videoscores.  Dit kan gedaan 
worden door de aangepaste betrouwbaarheidsmaten te gebruiken. 
Vervolgens werd in deel 4 (hoofdstuk 5, 6 en 7) van dit doctoraatsonderzoek de effectiviteit van een 
individuele en doelgerichte behandelstrategie geëvalueerd. Studie 5 was daarbij opgezet als een 
gerandomiseerd, blinde studie met herhaalde metingen.  Na een registratieperiode van 10 weken 
(zonder interventie), werden tien kinderen met bilaterale spastische CP via een gerandomiseerde 
procedure verdeeld over twee groepen: de helft van de kinderen kreeg een 10 weken durend 
individueel aangepast doelgericht programma, de andere helft kreeg een algemeen, aspecifiek 
oefenprogramma. Na dit programma werden een cross-over doorgevoerd: de kinderen die in een 
eerste fase een individueel programma hadden gevolgd kregen nu een algemeen programma en 
omgekeerd. 
 oor en na de programma’s werden de kinderen geëvalueerd door middel van een drie-dimensionele 
ganganalyse en de GMFM-88. De geselecteerde outcome parameters evalueerden daarbij zowel de 
algemene progressie van het kind als het al dan niet behalen van individuele doelstellingen. De 
resultaten van deze studie toonden slechts kleine, niet-significante verschillen aan tussen de effecten 
van beide programma’s. De verschillen waren wel in het voordeel van het individuele programma. 
Weinig therapie-effecten konden echter geregistreerd worden na de registratieperiode.  
Studie 6 vergeleek de effecten van een individueel aangepast doelgericht therapieprogramma met de 
effecten van een algemeen programma door middel van een groter, gerandomiseerd gecontroleerd 
onderzoek met dezelfde outcome parameters. Hoewel in deze studie 60 interventies werden gebruikt, 
toonden ook deze resultaten geen statistisch significante verschillen op de gang en de grove motoriek 
van de kinderen tussen de effecten van beide programma’s. Analyse van de resultaten van de totale 
interventiegroep toonde echter wel positieve behandeleffecten aan voor alle kinderen, onafhankelijk 
van het type programma.  
Bijgevolg stelden we de hypothese dat het ondersteunen van de therapeuten door een gestructureerd 
evidence-based programma aan te bieden kan bijgedragen tot de verschillen in outcome tussen de 
programma’s en de registratieperiode.  Studie 7 had daarom als doel om het evidence-based 
therapiegedrag in de reguliere kinderpraktijk in Vlaanderen te evalueren en de effectiviteit hiervan te 
vergelijken met de effecten van de gestructureerde programma’s.  De resultaten van de e studie 
bevestigden onze hypothese. Er werd een significant verbetering in de grove motoriek vastgesteld bij 
deze kinderen na de interventie, die niet vastgesteld werd na de registratieperiode. Inhoudelijk studie 
van de therapie tijdens de registratieperiode toonde aan dat de therapeuten zich spontaan meestal 
toelegden op problemen op stoornisniveau en dat er vaak onvoldoende gedoseerd en opgebouwd 
werd bij het uitvoeren van deze oefeningen.  
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Samenvattend kunnen we stellen dat dit doctoraatsonderzoek een bijdrage heeft geleverd tot een 
verbeterd inzicht in evidence-based kinesitherapie bij stappende kinderen met bilaterale spastische 
CP. De effecten van de individueel aangepaste en doelgerichte behandelstrategie, die ontwikkeld 
werd in dit onderzoek, lijken veelbelovend. De resultaten moeten echter bevestigd worden op grotere 
groepen en moeten gebruik maken van programma’s met een langere duur. Het ondersteunen van 
therapeuten in de klinische praktijk door hen intensief op te volgen en evidence-based richtlijnen mee 
te geven had positieve effecten op de outcome van de behandeling.  Toekomstig onderzoek richt zich 
nu best op een volgende stap, met name op het promoten van evidence-based therapiegedrag in de 
klinische praktijk. 
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Table A. Overview of the studies using stretching – subjects, interventions, evaluation, results, level of evidence and conduct scores. 
Author Design Subjects Method Results 
ICF 
LE 
(CS) 
  N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int 
(weeks) 
Duration  
follow-up 
(weeks) 
Freq 
(*/week) Evaluation Exp Contr 
Exp 
vs.contr   
2003, 
Fragala
11 
prospective 
cross over 
7 - 4y2mo-
18y2mo 
GMFCS V Phase B: intervention phase with PT+ passive  stretching  20 6 1,5 pROM hip 
(goniometer) 
= ↓  I IV 
(9/14)    Phase A: non-intervention phase         
 SSRD      A (4 weeks)- B (14 weeks) – A (2 weeks) -B (6 weeks)     pROM knee 
(goniometer) 
= ↓  I  
 ABAB     stretching 3*, 40-60sec,30min         
2008, 
Khalili 
12 
Within 
patient-
control 
11 11 X=13y Diplegia Exp (one leg): 30min ES Qcps (30 Hz; pulse width 
0,4msec,4s/on 4sec off, ramp 0,5sec) + stretching 
hamstrings 
4 - 5 MAS hamstrings   ↓ I II 
(5/7) (22 legs)  SD=1y Knee flexor 
spasticity 
   pROM knee ext 
(goniometer) 
  ↑ I 
           
 Smaller RCT    Non-ambulant Contr: contralateral leg from same child: stretching          
2008, 
Lee
13 
randomized 
29 - 4-13y 
dystonia 4 sessions, random order: A 5*10 sec stretching, B 5*30 
sec stretching, C hotpack+5*10sec stretching, D 
hotpack+5*30sec stretching 
0,5 - 7 act hamstrings 
stretch (EMG) 
  
↓ ( D vs AC) I III 
(9/14) 
             
 SSRD    hypertonia    extensibility 
hamstrings 
  ↑ (A  vs CD) I  
 Cross-over     24h interval         
2006, 
Pin
14 
syst review 
7 
studies 
- - - Medline, CINAHL, PsychINFO, Embase, Cochrane Library, PEDRO AACPDM guidelines    - II (7) 
    ...-April 2006 Pedro scale      
     
keywords: cerebral palsy, muscle spasticity,  stretching, physical therapy, range of 
movement 
      
2008, 
Wiart
 15 
syst  review 
7 studies 
- - - Cinahl, Embase,Medline, PsycINFO, Scopus level of evidence    - II (7) 
    keywords: cerebral palsy, range of motion, stretching, contracture, positioning AACPDM guidelines      
     …-2007       
 
Abbreviations: 
N: Number; Exp: Experimental group period; Contr: Control group or period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; LE Level of Evidence, CS Conduct Score; y: years; 
mo: months; GMFCS: Gross Motor Function Classification; PT: Physical Therapy; sec: seconds, min: minutes; pROM: passive range of motion;  X: Mean; SD: Standard Deviation; HZ: Hertz; ES: Electrical Stimulation; Qceps: 
m.Quadriceps Femoris;  MAS Modified Ashworth Scale; Ext: extension; h: hours; act: activity; syst review: systematic review; AACPDM: American Academy of Cerebral Palsy and Developmental Medicine; SSRD: Single 
Subject Research Design 
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Table B. Overview of the studies using massage – subjects, interventions, evaluation, results, level of evidence and conduct scores. 
 
Author Design Subjects Method Results 
ICF 
LE 
(CS)  
 
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int  
(weeks) 
Duration 
follow-up 
(weeks) 
Freq 
(*/week) Evaluation Exp Contr 
Exp 
vs.c
ontr 
2005, 
Hernandez-
Reif
16 
RCT 10 10 Exp: X=29mo 
SD=8mo 
ambulant Exp: massage, 30 minutes 12 - 2 muscle tone flexors and extensors (MAS,ALT) ↓,↓ =,↓  I 
II 
(3/10)    
nonambulan
t 
Contr: reading    pROM hip abductors and extensors 
(goniometer) 
↑ =  I 
   Contr:X=33mo 
SD=10mo 
spastic          
 smaller RCT   ataxia     Developmental Programming for Infants And 
Young Children 
↑ ↑  A  
     athetosis          
          Videotaped Interactions ↑ ↑  A/P  
2007, 
Macgregor
17 
prospective 
intervention 
5 - 12-15y spastic 
diplegia 
massage therapy calf muscles, 
14 min (stretching transversely) 
5 - 2 pROM ankle dorsiflexion (goniometer) =   I IV 
(3/10)       gross motor function (GMFM) =   A 
 Case series     +slow passive stretching     stretch reflexes (EMG) =   I  
2007, 
Barlow
18 
prospective 
intervention 
70 parents - not reported not reported Training and Support 
Programme for parents 
8 17,3 not 
specified 
psychological well-being ↑   I IV 
(5/10) 67 children      Satisfaction with Life Scale ↑   I 
      (providing parents the basic 
skills in massage, 8 sessions) 
   Perceived stress scales ↓   E  
 case series        Parents' and child selfefficacy scale ↑   E  
          parental health status ↑   E  
          Child functioning ↑   I/A/P  
2010, 
Powell
19 
prospective 
intervention 43 
- 8-15y not reported Training and Support 
Programme for parents 
8 17,3 not 
specified 
enjoyment (qualitative interviews) ↑   P IV 
(2/10)        
 Case series     (8 weekly sessions, 1h)          
 
Abbreviations: 
N: Number; Exp: Experimental group or period; Contr: Control group or period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; LE: Level of Evidence; CS Conduct score; y: 
years; mo: months; GMFCS: Gross Motor Function Classification; PT: Physical Therapy; sec: seconds, min: minutes; pROM: passive range of motion;  X: Mean; SD: Standard Deviation; GMFM: Gross Motor Function 
Measure; h: hours 
  
257 
 
Table C. Overview of the studies using Threshold Electrical Stimulation (TES) – subjects, interventions, evaluation, results, level of evidence and conduct scores. 
 
Abbreviations: 
N: Number; Exp: Experimental group or period; Contr: Control group or period; Freq: Frequency; Int: Intervention group or period; Vs: Versus; ICF: International Classification of Functioning;  LE Level of Evidence; CS 
Conduct Score; RCT: Randomized Controlled Design; X: mean; SD: Standard Deviation; y: years; mo: months; GMFCS: Gross Motor Function Classification; TES: Threshold Electrical Stimulation; HZ: Hertz; h: hours; MMT: 
Manual Muscle Testing; ROM: Range of Motion; PDMS: Peabody Developmental Motor Scales m: meters; Qcps: m.Quadriceps Femoris; Tib Ant: m.Tibialis Anterior; MAS:Modified Ashworth Scale; CT: Computerized Axial 
Tomography; flex: flexion; ext: extension; aROM: active Range of Motion; pROM: passive Range of Motion 
 
 
  
Author Design Subjects Method  Results 
ICF 
LE 
(CS) 
  N 
(exp) 
N 
(contr) 
Age Type Intervention Duration 
int 
(weeks) 
 Duration  
follow-up 
(weeks) 
Freq  
(* 
/week) 
Evaluation Exp 
Cont
r 
Exp vs 
contr 
2001, 
Sommerfelt
20 
RCT  
cross-over 
6 6 4-12y diplegia Exp: TES year 1 (40Hz, <10mA, 300µS, 
5h/night, 6 nights)+PT; usual PT year 2 
52 52 6 muscle strength (MMT)   = I II 
(5/7)   X=8y8mo GMFCS II-III    ankle ROM (goniometer)   = I 
     Contr: TES year 2 (40Hz, <10MA, 300µS, 
5h/night, 6 nights)+PT; usual PT year 1 
   deep tendon reflexes    = I  
 matched 
groups 
       speed of standardized  movements   = I  
         gross and fine motor function (PDMS)   = A  
 smaller 
RCT 
        walking speed (6 min & 6mwalk test)   = A  
         Parent subjective feeling (questionnaire)   ↑ I  
2002, Dali
21 
RCT 36 21 5-18y hemi (25) Exp: TES, 1-5µA, 35Hz, 0,46µA/mm², 
Qceps and Tib Ant, 6h/night 
52 - 6 Gross motor function (set tests)   = A II 
(5/7)  Multi-
centre 
  X=10y11mo diplegia (32)    ROM legs and arms (goniometer)   = I 
    walking Contr: placebo (inactive stimulators)    spasticity legs and arms (MAS)   = I  
 smaller 
RCT 
    
! All children continued usual PT program 
   cross sectional area Qceps/ Tib Ant (CT)   = I  
        parent questionnaire on motor skills   = A  
2004, 
Mäenpää 
22 
Pro-
spective  
17 - 3,8 - 8,9y hemiplegia 
(11) 
TES of Tib Ant,1,8 times/week; 20-60min; 
10-20Hz, 4-20mA, 300µsec, on/off 1/1 
4,3 39 1,8 active dorsiflexion, toe flex/ext, in/eversion ↑   I IV 
(3/7)   X=6,4y    aROM and pROM dorsiflexion ↑   I 
 case-
series 
   diplegia (6) During ordinary PT sessions    standing on one foot and hopping ↑   A  
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Table D. Overview of the studies using Neuromuscular Electrical Stimulation (NMES) – subjects, interventions, evaluation, results, level of evidence and conduct scores. 
 
 
Abbreviations: 
N: Number; Exp: Experimental group or period; Contr: Control group or period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; LE: Level of Evidence; CS: Conduct Score; RCT: 
Randomized Controlled Design; X: mean; SD: Standard Deviation; y: years; mo: months; GMFCS: Gross Motor Function Classification System; PT: physical therapy; NDT: neurodevelopmental treatment; NMES: 
Neuromuscular Electrical Stimulation; HZ: Hertz; GMFM: Gross Motor Function Measure; BTX-A: botulinum toxin type A; 3DGA: threedimensional gait analysis; EMG: electromyography; MAS: Modified Ashworth Scale; 
ROM: Range of Motion; Glut Max: m Gluteus Maximus; h: hours; a ROM: active Range of Motion; pROM: passive Range of Motion; MVC: maximum voluntary contraction; triceps s: mm.Triceps Surae; gastroc: 
m.Gastrocnemius; MRI: Magnetic Resonance Imaging; Unilat: unilateral; CMAP: Compound Muscle Action Potential; AACPDM: American Academy of Cerebral Palsy and Developmental Medicine; SSRD: Single Subject 
Research Design 
  
Author Design Subjects Method Results 
ICF 
LE 
(CS)   
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int 
(weeks) 
Duration 
follow-up 
(weeks) 
Freq 
(*/week) 
Evaluation Exp 
Con
tr 
Exp 
vs 
contr 
2001, Park
23 
RCT 14 12 8-16y spastic 
diplegia 
Exp: PT (NDT) + NMES abdomen 
+posterior back muscles; 30 min/day; 
25-30mA, 250µsec pulse width, 35Hz; 
10sec on/12 sec off 
6 - 6 Cobb (Xray spine) ↓ = = I II 
(3/7) smaller 
RCT 
  Exp: X=16,6y, SD=4.4y    kyphotic angle (Xray) ↓ ↓ ↓ I 
   Contr: X=12,5y, 
SD=3.7y 
    Gross  Motor Function (GMFM) ↑ ↑ ↑ A  
              
      Contr: PT (NDT) only          
2002; 
Detrembleur
24 
RCT 6 6 4,75y-6y diplegia (3) Exp: BTX-A + NMES calf muscles 
(20Hz, 0,2msec, 50-90mA, 30min, 
6*/day, 3days followed by PT) 
0,5 26 42 gait (3DGA +EMG, Physicians 
Rating Scale) 
  ↑ A II 
(6/7) smaller 
RCT 
  X=5y hemi (9)        
        spasticity triceps surae (MAS)    = I  
      Contr: BTX-A + no adjuvant NMES, PT 
2-3*/week 
   measurement of muscle stiffness   = I  
         ROM ankle (goniometer)   = I  
      post BTX-A PT:strength ankle 
dorsiflexors, stretch calf muscles and 
hamstrings, gait rehabilitation 
         
               
               
2003, van der 
Linden
25 
RCT 11 11 5-14y diplegia (14) Exp: NMES Glut Max, 1h/day, 10 Hz, 
75µs (week 1); 2*30 min (week 2); 1 h 
30Hz, 100 µsec (week 3-6) 
8 - 6 Passive hip rotation (goniometer)   = I II 
(4/7)) matched 
groups 
  X=8y6mo hemi (7)        
   SD=2y9mo quadri (1)    gait (3DGA)   = A  
 smaller 
RCT 
   independent 
walkers 
Contr: no electrical stimulation, usual PT    gross motor function (GMFM)   = A  
    ! All children continued usual PT 
program 
   strength Glut Max (myometer)   = I  
               
2004, 
Maenpaa
26 
Intervention 12 - 4,5-16y hemiplegia Phase 1: Baseline (no intervention) 4 - 5 a+pROM dorsiflexion (goniometer) ↑ =  I V 
(7/14) prospective    moderate 
myocontract
ure triceps 
Phase 2:NMES gastroc, 300 µA, 30 Hz, 
5*/week, 1h 
   ROM popliteal angle (goniometer) ↑ =  I 
 SSRD 
 AB 
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Table D (continued). Overview of the studies using Neuromuscular Electrical Stimulation– subjects, interventions, evaluation, results, level of evidence and conduct scores. 
 
Author Design Subjects Method Results 
ICF 
LE 
(CS)   
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duratio
n int 
(weeks) 
Duration 
follow-up 
(weeks) 
Freq 
(*/week) 
Evaluation 
Ex
p 
Con
tr 
Exp 
vs 
contr 
2007, 
Stackhouse
27 
RCT 6 5 8 - 12y spastic diplegia Exp: NMES percutaneous; pulse duration 5-
200 µs, amplitude 25 mA, pulse freq 50pps, 
15 min 
12 - 3 MVC Qceps (dynamometer) ↑ ↑ ↑ I II 
(4/7) smaller 
RCT 
  Exp:X=10y7mo GMFCS II-III    MVC Triceps S (dynamometer) = = ↑ I 
   Contr:X=10y5mo     walking speed (3DGA) ↑ = = A  
      Contr: 15 MVC    Qcps cross sectional area (MRI) = = ↑ I  
      Qcps and triceps s    Triceps S cross sectional area (MRI) = = = I  
2007, Kang
28 
RCT 7 11 16m-10y spastic diplegia Exp: BTX-A + ES gastroc (40 Hz, 0,3 msec, 
10-25mA, 30 min) 
13 - 2 gait (Physicians Rating Scale) ↑ =  A II 
(5/7)  smaller 
RCT 
  X=45mo GMFCS I-IV    Spasticity (MAS) ↓ ↓  I 
     Contr: BTX-A gastroc    pROM ankle and knee (goniometer) ↑ ↑  I  
     ! PT for all children, 2*/week          
2008, Khalili 
12 
RCT 11 11 X=13y diplegia Exp (one leg): 30min NMES Qcps (30 Hz; 
pulse width 0,4ms,4s/on 4soff, ramp 0,5s) +  
stretching hamstrings 
4 - 5 spasticity hamstrings (MAS)   ↓ I II 
(5/7) 
 smaller 
RCT 
(22 
legs) 
 SD=1y non-ambulant    pROM knee ext (goniometer)   ↑ I 
   knee-flexor 
spasticity 
         
     Contr (contralateral leg): 5*/week stretching          
2008, Rha
29 
RCT 11 12 X=46 mo diplegia (18) NMES post BTX-A injection 1 4,3 6 CMAP gastroc (EMG) ↓ ↓  I II 
(3/7)  smaller 
RCT 
  SD=18,1mo quadriplegia (5) Unilat: ES 25Hz(11 children) or 4Hz (12 
children) m.Gastrocnemius 
   spasticity m.Gastrocnemius (MAS) ↓ ↓  I 
    GMFCS I-IV          
      Unilat: Sham stimulation (7 days, 30 
min/day) 
         
               
      + 6*week usual PT          
2006, Kerr
30 
RCT 38 22 5-16y diplegia (55) Exp 1(n=18):NMES, 1h/day,  35Hz,300m - - 5 peak torque Qcps (isokinetic dynamometer) = = = I II 
(7/7)  placebo    X=11y quadriplegia (1) Exp 2 (n=20): TES, 8h/d, 5d/week, 35Hz, 
300 msec, <10mA 
   gross motor function (GMFM) = = = A 
     distonia (1)    Lifestyle assessment questionnaire ↑ = ↑ P  
 smaller 
RCT 
  SD=3y6mo not class (2) Contr (n=22): placebo          
    ambulant           
                
2004, Kerr
31 
Syst 
Review 
18 
studies 
- -  Pedro, Cinhal, Medline Amed using 
'electrical stimulation and CP' 
- - - AACPDM levels of evidence - - -  II 
(8)            
 RCT’s               
Abbreviations:  
N: Number; Exp: Experimental group or period; Contr: Control group or period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; LE: Level of Evidence; CS: Conduct Score; RCT: 
Randomized Controlled Design; X: mean; SD: Standard Deviation; y: years; mo: months; GMFCS: Gross Motor Function Classification System; PT: physical therapy; NDT: neurodevelopmental treatment; NMES: 
Neuromuscular Electrical Stimulation; HZ: Hertz; GMFM: Gross Motor Function Measure; BTX-A: botulinum toxin type A; 3DGA: threedimensional gait analysis; EMG: electromyography; MAS: Modified Ashworth Scale; 
ROM: Range of Motion; Glut Max: m Gluteus Maximus; h: hours; a ROM: active Range of Motion; pROM: passive Range of Motion; MVC: maximum voluntary contraction; triceps s: mm.Triceps Surae; gastroc: 
m.Gastrocnemius; MRI: Magnetic Resonance Imaging; Unilat: unilateral; CMAP: Compound Muscle Action Potential; AACPDM: American Academy of Cerebral Palsy and Developmental Medicine  
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Table E. Overview of the studies using isotonic strength training – subjects, interventions, evaluation, results, level of evidence and conduct scores. 
 
Author Design Subjects Method  Results 
ICF 
LE 
(CS) 
 
 
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int 
(weeks) 
Duration 
follow-up 
(weeks) 
Freq  
(*/week) 
Evaluation 
Exp Contr Exp 
vs 
contr 
1995a, 
Damiano
32 
pre-post 14 - 6-14y spastic diplegia training Qcps 6 - 3 MVC quadriceps (handheld dynamometer) ↑   I IV 
(5/7) case series   X=9,1y knee flexion 
contracture 
ankle load 65% f 1RM, 4*5 repetitions    crouch gait (3DGA) ↓   A 
   SD=2,5y ambulant isotonic, concentric and excentric    stride lenght (3DGA) ↑   A  
1995b, 
Damiano
33 
prospective 14 25 6-14y contr: non CP exp:  65%max Qcps 6 - 3 strength m.Qcps  (handheld dynamometer) ↑   I IV 
(5/7) 
non 
randomized 
CT 
 no CP X=9,1y exp: spastic 
diplegia 
contr (NL): 65% max Qcps         
   SD=2,5y           
               
1998, 
Damiano 
34 
pre-post 11 - 6-12y diplegia (6) weakest lower limb muscles 6 - 3 MVC (isometric, handheld dynamometer), 8 
muscles 
↑   I IV 
(5/7) 
prospective   X=8,,81y hemiplegia (5) velcro attached free-weights, 65% of 
max isometric strength value 
  gross motor function (GMFM) ↑   A 
case series   SD=2,32y limited community 
ambulators 
   gait (3DGA) ↑   A  
     4*5 repetitions    energy expenditure (heart telemetry) =   I  
2004, 
Johnson
35 
case-series 5 - 3y10mo-
9y11mo 
diplegia (1) 2*/day, concentric and eccentric 3 3 14 Gait (video and footprint analysis) =   A IV 
(2/7) AB-design   hemiplegia (3) trampoline jumping, slope walking, toe 
raises, sit-to-stand, stairclimbing 
  ROM ankle during midstance  (goniometer and 
markers) 
=   I 
    X=6,06y ataxia (2)        
          strength plantar flexors (sphygomometer) =   I  
2004, 
Eagleton
36 
pre-post 7 - 12-20y not reported training program (school gym or local 
fitness centre) 
6 - 3 gait velocity, cadence, step length (10m walk 
test) 
↑   A IV 
(2/7) 
prospective    independently 
ambulant 
       
 case series    free weights and theraband exercises 
for trunk, hip, knee and ankle flexors 
and extensors, hip abductors 
   3 minute walk test ↑   A 
   energy expenditure index (heart rate pre-and 
post walking test) 
↓ I 
     
      40-60 min, 8 to 10 repetitions at 80% 1 
RM 
         
              
 
Abbreviations: 
N: Number; Exp: Experimental group or period; Contr: Control group or period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; LE: Level of Evidence; CS: Conduct Score; 
RCT: Randomized Controlled Design; X: mean; SD: Standard Deviation; y: years; mo: months; GMFCS: Gross Motor Function Classification System; Qceps: M.Quadriceps Femoris; RM: Repetition Maximum; MVC: 
Maximum Voluntary Contraction; 3DGA: threedimensional gait analysis; GMFM: Gross Motor Function Measure; ROM: Range of Motion; min: minutes; MAS: Modified Ashworth Scale; MMT: manual muscle testing, GFAQ: 
Gilette Functional Assessment Questionnaire; FMS: Functional Mobility Scale; MMT: Manual Muscle Testing; TUG: Timed Up and Go; pROM: passive Range of Motion ; NDT: Neurodevelopmental Treatment  
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Table E. (continued) Overview of the studies using isotonic strength training – subjects, interventions, evaluation, results, level of evidence and conduct scores. 
Author Design Subjects   Method     Results 
ICF 
LE 
(CS)   
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int 
(weeks) 
Duration 
follow-
up 
(weeks) 
Freq 
(*/week) 
Evaluation Exp Contr 
Exp 
vs 
contr 
2004, 
Dodd
37 
RCT 10 7 8-16y spastic 
diplegia 
Exp: home based, hip extensor, ankle 
plantar flexor, knee extensor  (heel 
rises, half squats, step-ups) 
6 12 3 self-concept   = I II (5/7) 
smaller 
RCT 
  X=12,1y    perception of scholastic competence   ↓ I  
   SD=2,5y     perception of social acceptance   ↓ I  
      Contr: normal daily activities    perception of athletic competence   ↓ I  
2005, 
Morton
38 
repeated 
measures 
8 - 6y10mo-
11y2mo 
hypertone progressive strengthening programme, 
hamstrings and Qcps 
6 4 3 muscle strength Qceps and hamstrings (hand-
held dynamometer) 
↑   I IV 
(5/7) 
prospective   X=8y5m GMFCS III    resistance to passive stretch (myometer) ↓   I  
 SSRD 
 AB 
    free-weight(65% of max isometric 
strength)  
   motor development (GMFM) ↑   A  
        10m timed walking test and walking speed ↑   A  
2006, 
Unger
39 
RCT 21 10 13-18y hemi (16) Exp: circuit training, free weights, 1-
3*/week,40-60min; individually 
designed programmes, 8-12 exercises 
8 - 2 measure of crouch (3DGA)   ↑ I/A II (5/7) 
   X exp=15,9y diplegia (15)    economy of movement (3DGA)      
 smaller 
RCT 
  X 
contr=16,28y 
independently 
ambulant 
   perception of functional competence (Self 
Perception Questionnaire) 
  ↑ I  
   Contr:  no additional intervention      = I  
          perception of body image   ↑   
2008, 
Eek
40 
pre-
postdesign 
16 - X=12y6mo GMFCS I - II free weights, rubber bands, body 
weight, 3*10 repetitions (easy, 
medium and heavy) 
8 - 3 muscle strength hip, knee and ankle (handheld 
dynamometer) 
↑   I IV 
(4/7) 
  range 9y4mo-
15y4mo 
spastic 
diplegia 
       
       gross motor function (GMFM) ↑   A  
 Case 
series 
        ROM hip, knee, ankle (goniometer) ↑   I  
         gait kinematics and kinetics (3DGA) ↑   A  
          spasticity hip adductors, hamstrings, plantar fl 
and rectus femoris (MAS) 
=   I  
               
2008, 
Lee
41 
RCT 9 8 Exp: X=6,3y, 
SD=2,1y 
spastic 
diplegia (9) 
Exp:strengthening program, 60 min 
(warm up, functional strengthening 
exercises, isotonic exercises using 
weight cuffs, 2-10 repetitions) 
5 6 3 muscle tone hip and knee  (MAS)   = I II (4/7) 
smaller 
RCT 
  spastic 
hemiplegia (8) 
   gross motor function (GMFM)    ↑ A  
   Contr: X=6,3y, 
SD=2,9y 
   strength hip, knee, ankle (MMT)   ↑ I  
   GMFCS II-III Contr : usual care (NDT, ROM 
exercises, gait) 
   gait (3DGA)   ↑ I/A  
        Lateral step-up, squat to stand   ↑ A  
2009, 
McNee
42 
pre-
postdesign 
13 - 6y11mo-
16y11mo 
diplegia (8) plantar flexion strengthening  (thera 
band and heel rises) 
10 13 4 muscle volume m.Gastrocnemius (3D US) ↑   I IV 
(4/7)   hemiplegia (5)    gait (3DGA) =   I/A 
     GMFCS I - III     gross motor function (GFAQ, FMS, TUG) =   A  
 Case 
series 
  X=10y11mo      unilateral heel rises ↑   I  
   SD=3y      pROM ankle (goniometer) =   I  
Abbreviations:N: Number; Exp: Experimental group or period; Contr: Control group or period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; LE: Level of Evidence; CS: 
Conduct Score; RCT: Randomized Controlled Design; X: mean; SD: Standard Deviation; y: years; mo: months; GMFCS: Gross Motor Function Classification System; Qceps: M.Quadriceps Femoris; RM: Repetition 
Maximum; MVC: Maximum Voluntary Contraction; 3DGA: threedimensional gait analysis; GMFM: Gross Motor Function Measure; ROM: Range of Motion; min: minutes; MAS: Modified Ashworth Scale; MMT: manual muscle 
testing, GFAQ: Gilette Functional Assessment Questionnaire; FMS: Functional Mobility Scale; MMT: Manual Muscle Testing; TUG: Timed Up and Go; pROM: passive Range of Motion ; NDT: Neurodevelopmental Treatment  
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Table F. Overview of the studies using functional strength training – subjects, interventions, evaluation, results, level of evidence and conduct scores. 
 
Author Design Subjects Method Results 
ICF 
LE 
(CS) 
  
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duratio
n int 
(weeks) 
Duration  
follow-up 
(weeks) 
Freq 
(*/week) 
Evaluation Exp Contr 
Exp 
vs 
contr 
2003, 
Blundell
43 
 
prospective  8 - X = 6,3y diplegia (7) Phase 1: 2 weeks follow-up 4 8 2 strength hip, knee and ankle flexors and 
extensors (dynamometer) 
↑   I IV 
(9/14) repeated 
mesures 
  range 4-8y quadriplegia 
(1) 
Phase 2: one hour circuit training (functional 
strength : treadmill, steps, sit to stand,  leg pre 
Phase 3: 8 weeks follow-up ss) 
       
  SD=1,3y    Motor Assessment Scale:sit-to-stand, lateral 
step-up 
↑   A 
 SSRD 
 ABA 
   ambulatory         
         Minimum Chair Height Test ↑     
          walking speed (2 minutes walk test) =     
          walking speed (timed 10 m test) ↑     
2003, 
Dodd
44 
 
RCT 11 10 X=13y1mo spastic 
diplegia 
home based training 6 12 2 strength ankle plantar flexors, knee + hip 
extensors, (hand-held dynamometer) 
  ↑ I II 
(7/7)    SD=3y1mo Contr: usual care        
smaller 
RCT 
  range 8-18y GMFCS I -III Exp:  LL training : heel squats, heel raises and 
step-ups (3 sets of 8-12 repetitions, 20-30 
min) 
   gross motor function (GMFM)   = A 
        timed-stair test   =   
          self-selected walking speed (10 metres 
walking test) 
  =   
               
2003, 
McBurney
45 
prospective 11 - X=12y9mo spastic 
diplegia 
home based training, 8-10 repetitions each 6 - 3 perception of body image ↑   I IV 
(3/7) no control   SD 2y10mo heel squat, heel raise and step-up (plantar 
flexors, knee extensors, hip extensors) 
   perception of functional performance ↑    
case series   range 8-18y GMFCS I-III    perception of social participation ↑     
2007, 
Liao
46 
RCT 10 10 range 5-12y spastic 
diplegia 
Exp: regular PT + sit-to-stand exercises  6 - 3 gross motor function (GMFM)   ↑ I II 
(6/7) smaller 
RCT 
  Exp: 
X=85,6mo 
SD=20,8 
Contr: regular PT only    gait speed (timed 10 metres walking test)   = A 
   GMFCS  
I and II 
max 25 repetitions, 1 session    isometric strenght Qcps (Nicholas Manual 
Muscle tester) 
  =   
    Contr: 
X=91,3mo 
SD=17,5mo 
         
         sit to stand   ↑   
          Physiologic Cost Index (heart rate walking - 
rest/walking speed) 
  ↑   
               
 
Abbreviations 
N: Number; Exp: Experimental group or period; Contr: Control group or period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; LE Level of Evidence; CS: Conduct Score; RCT: 
Randomized Controlled Design; SSRD: Single Subject Research Design; X: mean; SD: Standard Deviation; y: years; mo: months;  LL: Lower Limb; PT: Physical Therapy; percut: percutaneous; MVC:  Maximum Voluntary 
Contraction; Qceps: m.Quadriceps Femoris; triceps s: m.Triceps Surae; MVIC: Maximum Voluntary Isometric Contraction, HR: Heart Rate; GMFM: Gross Motor Function Measure; GMAE: Gross Motor Activity Estimator; MRI: 
magnetic resonance imaging; HR: Heart Rate; QoL: Quality of Life;  3DGA: threedimensional gait analysis 
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Table G. Overview of the studies using isokinetic, isometric and mixed forms of strength training – subjects, interventions, evaluation, results, level of evidence and conduct scores 
 
Author Design Subjects Method  Results 
ICF 
LE 
(CS) 
  N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int 
(weeks) 
Duration 
follow-up 
(weeks) 
Freq 
(*/week) 
Evaluation Exp 
Con
tr 
Exp 
vs 
contr 
Isokinetic strength training 
1995, Mac 
Phail
47 
pre-post 17 - 12-20y quadriplegia (1) min 45 minutes 8 13 3 peak torque knee flexors and extensors 
(dynamometer) 
↑   I IV 
(2/7) Prospective    hemiplegia (9)         
    diplegia (7) 3 submaximal warm-up efforts, 15 concentric 
and 15 eccentric MVC of knee extensors and 
flexors 
   spasticity (MAS + ankle clonus) =   A 
 case series    ambulant , 
without aids 
   gross motor function (GMFM) ↑     
        walking efficiency (Energy Expenditure 
Index, HR) 
=     
               
2006, 
Engsberg48 
RCT 12 - X=9,7 spastic diplegia Exp 1(n=3): dorsiflexor group 12 13 3 gross motor function (GMAE-GMFM)  , ↑ =  I II 
(4/7) smaller 
RCT 
  SD=3,3y GMFCS I-III Exp 2 (n=3): plantar flexor group    pROM ankle (goniometer) = =  A 
     Exp 3 (n=3): dorsi+plantarflexor group    strength ankle plantar and dorsiflexors 
(KinCom dynamometer) 
↑ =  
P  
      Exp 4 (n=3): control group    gait kinematics and gait speed (3DGA) ↑,  =    
          spasticity (KinCom dynamometer) ↓ =    
          quality of life parents+children (Peds QOL) ↑,   ↓  E 
QoL 
 
               
Isometric strength training 
2007, 
Stackhouse
27 
RCT 6 5 8 - 12y spastic diplegia Contr: NMES percut, pulse duration 5-200 µs, 
amplitude 25 mA, pulse freq 50pps, 15 min 
12 - 3 MVIC Qcps (dynamometer) ↑ ↑ ↑ I II 
(4/7) smaller 
RCT 
  Exp:X=10y
7mo 
GMFCS II-III    MVIC M.Triceps Surae (dynamometer) = = ↑ A 
   Exp: volitional max effort contractions, 15 
MVC 
   walking speed (3DGA) = ↑ =   
    Contr:X=1
0y5mo 
 Qcps and triceps s    Qcps cross sectional area (MRI) = = ↑   
         Triceps S cross sectional area (MRI) = = =   
Mixed strength training               
2001, 
Fowler
49 
Prospective 24 12 7-17y Exp:spastic 
diplegia 
isometric Qcps (kinCOM) 0,1 - - stretch reflexes pendulum test (spasticity 
KinCom; EMG + goniometer) 
=   I IV 
(4/7)  no CP X=11,4 isotonic Qcps (cuff weights)        
 non 
randomized 
CT 
  SD =3y Contr: typically 
developing 
isokinetic Qcps (60°/sec)          
    max 25 repetitions, 1 session          
               
 
Abbreviations: 
N: Number; Exp: Experimental group or period; Contr: Control group or period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; LE: Level of Evidence; CS: Conduct Score; RCT: 
Randomized Controlled Design; X: mean; SD: Standard Deviation; y: years; mo: months;  LL: Lower Limb; PT: Physical Therapy; percut: percutaneous; MVC:  Maximum Voluntary Contraction; Qceps: m.Quadriceps Femoris; 
triceps s: m.Triceps Surae; MVIC: Maximum Voluntary Isometric Contraction, HR: Heart Rate; GMFM: Gross Motor Function Measure; GMAE: Gross Motor Activity Estimator; MRI: magnetic resonance imaging; HR: Heart 
Rate; QoL: Quality of Life;  3DGA: threedimensional gait analysis  
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Table H. Overview of systematic reviews evaluating strength training 
 
Author type N Intervention Evaluation LE (CS) 
1997, Darrah
50
 syst review 7 studies Medline, CINAHL, Eric, Psychinfo, Sport DISCUS  II (7) 
   keywords cerebral palsy, exercise, strength and physical training   
   1966-1997   
1998, Haney
51 
syst review  8 studies search strategy not reported - II (1) 
2002, Dodd
52 
syst review 23 studies Medline, PubMed, EMBASE, CINAHL, Sports Discus Pedro scale II (8) 
   DARE, Psychinfo, ERIC, AusportMed, AMI, Cochrane, Pedro; 1966-2000   
   keywords: exercise, strength and physical training   
2008, Verschuren
53 
syst review 20 studies Medline, PubMed, EMBASE, CINAHL, Sports Discus, Cochrane, PEDro, untill sept 2006 Pedro Scale II (8) 
   keywords:CP,exercise, strength, working capacity,(an)aerobic power, endurance, cardiorespiratory 
physical training 
Outcome on ICF  
     
2008, Mockford
54 
syst review 13 articles 
Medline, AMED, CINAHL, Cochrance Library, EMBASE, PEDro, PsychInfo, SPORTdiscus 
,,,-March 2007 
Amsterdam-maastricht List II (8) 
   
keywords: CP, strength exercise, weight training and lifting, resisted exercise, resistance exercise, 
resisted training, resistance training 
  
2009, Scianni
55 
syst review 6 RCT's CINAHL, MEDLINE, EMBASE and Pedro Pedro I (8) 
 
meta-analysis 
 no language restrictions, RCT's only Meta-analysis  
  children with spastic CP upto 20y ICF  
 
Abbreviations: 
N: Number of studies, LE: Level of Evidence; CS: Conduct Scores; syst revie: systematic review, RCT; Randomized Controlled Trial; ICF: International Classification of Functioning 
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Table I. Overview of the studies using endurance and physical fitness training – subjects, interventions, evaluation, results, level of evidence and conduct scores. 
Author Design Subjects Method  Results 
ICF 
LE 
(CS)   
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int 
(weeks) 
Duration 
follow-up 
(weeks) 
Freq 
(*/week) 
Evaluation Exp Contr 
Exp 
vs 
contr 
1998, van 
den Berg - 
Emons
56 
RCT  10 10 X=9,2 y spastic CP Group 1:2*/week gymnastics + 4*/week physical 
training + usual PT 
39 - 2 Physical Activity Ratio  (energy 
expenditure/sleeping meth rate) 
↑ = = A II 
(3/7) Smaller 
RCT 
  SD = 1,4y diplegia (16)        
   tetraplegic (4) Group 2: 2*/week gymnastics+usual PT    Fat mass (anthropometry) = ↑ = I  
     ambulant  sports programme=wheelchair driving, cycling, 
running, swimming, flying saucer exercises, mat 
exercises 
  Peak aerobic power (ergometer) ↑ = ↑ I  
     non-ambulant    Anaerobic power (ergometer) ↑ ↑ = I  
         Isokinetic muscle strength (Cybex II) ↑ = = I  
1999, 
Darrah
57 
Pro-
spective 
23 - X=14.2y hemiplegia (13) warm-up (10min), aerobic exercise (10-30min), 
strength training (30 min), stretching and 
cooling-down(20 min) 
10 10 3 Energy Expenditure Index (EEI) and 
heart rate  
=   I IV 
(3/7)    diplegia (5)        
 Case 
series 
   quadriplegia (2)    strength shoulders flexors, knee 
extensors, hip extensors and 
abductors (handheld dynamometer) 
↑   I 
    ataxia (2) group training         
     dystonia (1)         
     ambulant     flexibility(sit-and-reach+behind the 
back reach) 
↑   I  
    (without aids)          
          Self Perception Profile fo 
Adolescents and Children 
↑   I  
               
2002, 
Shinohara
58 
Pro-
spective  
6 5 Exp: X=14,6y 
SD=0,9y 
ambulant Exp: leg exercises, 20 minutes at AT point 13 - 1,8 Oxygen Uptake  
(respirometer/gasometer) 
↑ =  I IV 
(3/7)   non-ambulant 8-20,6 weeks, 1,1 to 2,3 */week)        
non-
randomi
zed CT 
  range 13,3-
15,8y 
 Contr: arm cranking ergometer, 20 min, AT point         
   Contr X =14,2y 
SD=10,7y 
 5-19,9 weeks at 1-2,3 times/week          
    work rate 7 or 10 W per minute          
    range 11,8-
16,3y 
           
2005, 
Schlough 
59 
ABAB 3 - 17-20y spastic CP A1:  no intervention 6 2 3 Energy Expenditure Index (EEI) not 
stats 
  I IV 
(9/14) SSRD    hemiplegia (1) B1:  initial intervention:  treadmill, stepper, 
elliptical machine 
B1 6 
weeks 
A1 2 
weeks 
 muscle strength Qcps, hamstrings, 
ankle plantar and dorsiflexors 
(handheld dynamometer) 
  I 
    diplegia (2)       
     GMFCS I and III A2:  no intervention       
      B2: additional 15 weeks, treadmill, stepper, 
elliptical machine 
B2 7 
weeks 
A2 2 
weeks 
 gross motor function (GMFM)    A  
       Self-Perception Profile for College 
Students (SPCS) 
   I  
               
          Rate of Perceived Exertion (RPE)    I  
Abbeviations: 
N: Number; Exp: Experimental group or period; Contr: Control group or period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; LE: Level of Evidence; CS: Conduct Score; 
RCT: Randomized Controlled Design; X: mean; SD: Standard Deviation; y: years; mo: months; PT: Physical Therapy; AT point: Anaerobic Thresshold Point; W: watt; Qceps: m.Quadriceps Femoris; RM: Repetition 
Maximum; GMFM: Gross Motor Function Measure; HRQoL: Health Related Quality of Life; CAPE: Children's Assessment of Participation and Enjoyment; MoVra:   Mobiliteitsvragenlijst/mobility questionnaire; AACPDM: 
American Academy of Cerebral Palsy and Developmental Medicine; SSRD: Single Subject Research Design  
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Table I (continued). Overview of the studies using endurance and physical fitness training – subjects, interventions, evaluation, results, level of evidence and conduct scores. 
 
Authors Design Subjects Method  Results 
ICF 
LE 
(CS)   
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int 
(weeks) 
Duration 
follow-up 
(weeks) 
Freq 
(*/week) 
Evaluation Exp Contr 
Exp 
vs 
cont
r 
2007, 
Verschuren 
60 
RCT 32 33 7-18y GMFCS I-II Exp: usual care + 45min circuit  35 17,3 2 anaerobic capacity (power sprint test)   ↑ I II 
(5/7) Multi-
center 
  Exp X =11,6y 
SD 2,5 
unilateral (45) Contr: usual care    aerobic capacity (10 min shuttle run test)   ↑ I 
Smaller 
RCT 
  bilateral (23) Circuit training: 5 min warm-up, 25-35 min 
functional aerobic exercises, anaerobic 
exercises and muscle strengthening in 
circuit, 5 minutes cool-down 
   strength lower extremities (30 sec RM)   ↑ I  
   Contr 2 
X=12,7y SD 
2,7 
    agility (10*5m sprint test)   ↑ I  
        gross motor function (GMFM)   ↑ A  
         participation (HRQoL, CAPE)   ↑,↑ A/P  
2007, 
Williams
61 
Pro-
spective  
11 - 11-15y GMFCS IV-V Phase A:  baseline, no intervention 6 6 3 gross motor function (GMFM) ↑ =  A IV (10 
/14)   X=12y 7mo  spastic (8) Phase B: training (75% of max endurance, 
100% for speed/power) 
   cycling ability ↑,↑ =  I/A 
 single 
subject 
  SD 1y 4mo dyskinetic (3)    (pedalling resistance, overload)      
    diplegia (1) Phase C:  follow-up, no intervention          
 ABA    quadriplegia 
(7) 
          
2007, 
Uninithan 
62 
RCT 7 6 X exp : 15,9y spastic 
diplegia 
Exp: 70min/session, aerobic interval training 
and strength (handweights, 20 repetitions 
UL and 4*10 LL+usual PT (2*/week NDT) 
12 - 3 gross motor function (GMFM) ↑ = ↑ A II (4/7) 
   range 14-18y    VO2 (open circuit spirometer) ↓ = ↓ I 
Smaller 
RCT 
  X contr=15,7y GMFCS II-III    %VO2max (open circuit spirometer) ↓ = ↑ I 
   range 14-17y  Contr:  usual PT NDT 2*/week, no additional 
training 
   VE peak  ↑ = ↑ I  
               
2009, 
Gorter
63 
repeated 
measures 
13 - 8-13y GMFCS I-II A circuit with 4 stations of functional 
exercises on aerobic endurance, walking 
distance, walking velocity and ambulation 
9 11 2 max aerobic capacity (Bruce Test) ↑   A IV 
(4/14)        walking distance and velocity (6 min run) ↑   A 
 SSRD        functional mobility (Timed Up&Down Stairs) ↑   A  
      30 minutes, 60-70%Hrmax    Ambulation Questionnaire (MoVra) ↑   A  
2008, 
Rogers
64 
Syst 
Review 
13 
studies 
- - - Medline, Embase, Cinahl, Pascal, Cochrane Library, CSA Neuroscience 
Abstracts, Pedro and Sports Discus 
AACPDM guidelines    - II (8) 
         
     1960-2006       
    
 
keywords: cerebral palsy, athetoid, ataxic, spastic diplegia, hemiplegia, 
quadriplegia, aerobic exercise, training, physical activity, aquatic/pool/water 
therapy, exercise training, continuous exercise 
 
     
2009, 
Verschuren 
65 
Syst 
Review 
20 
studies 
- - - Medline, PubMed, EMBASE, CINAHL, Sports Discus, Cochrane, PEDro 
until september 2006 
keywords cerebral palsy, exercise, strength, working capacity, 
aerobic/anaerobic power, endurance, cardiorespiratory physical training 
AACPDM guidelines    - II (8) 
  
 
 
     
Abbreviations:N: Number; Exp: Experimental group or period; Contr: Control group or l period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; LE:Level of Evidence:; CS: 
Conduct Score; RCT: Randomized Controlled Design; X: mean; SD: Standard Deviation; y: years; mo: months; PT: Physical Therapy; AT point: Anaerobic Thresshold Point; W: watt; Qceps: m.Quadriceps Femoris; RM: 
Repetition Maximum; GMFM: Gross Motor Function Measure; HRQoL: Health Related Quality of Life; CAPE: Children's Assessment of Participation and Enjoyment; MoVra:   Mobiliteitsvragenlijst/mobility questionnaire; 
AACPDM: American Academy of Cerebral Palsy and Developmental Medicine.  
267 
 
Table J. Overview of the studies using weight-bearing exercises – subjects, interventions, evaluation, results, level of evidence and conduct scores. 
 
Author Design Subjects Method     Results 
ICF 
LE 
(CS)   
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int 
(weeks) 
Duration 
follow-up 
(weeks) 
Freq 
(*/week) 
Evaluation Exp Contr 
Exp 
vs 
contr 
1999, 
Chad
66 
RCT 9 9 Exp:X=9y, 
SD=2,9y 
dependent 
and 
independent 
walkers 
Exp: weight bearing physical activity, 2*/week (2 
months) and 3*/week (6 weeks), 60 min (20 min 
UL, 20 min LL, 20 min trunk, facilitation of 
normal movement with weight bearing) 
14 - 2,5 Bone Mineral Content  proximal 
femur and femoral neck 
  ↑ I II 
(2/7) 
    Contr: X=9y, 
SD=2.7y 
   % Bone Mineral Content proximal 
femur and femoral neck 
  ↑ I  
     Contr: usual lifestyle habits    (dual energy Xray absorptiometry)      
2000, Katz
67 
prospective 
intervention 
36 - X=5y diplegia (14) Achilles tendon lengthening surgery + 2 weeks 
casting and early weight-bearing (after 2 days) 
and gait training 
2 260 not 
reported 
pROM ankle (goniometer) * no 
stats 
  I IV 
(1/7)    4-7y hemi (15)   visual gait analysis (heel/toe 
contact) 
  I/A 
 case series    ambulatory         
2002, 
Gudjonsdot
tir
68 
prospective 
intervention 
2 2 4y5mo-
5y11mo 
non-ambulant Phase 1(8 weeks): group 1 dynamic standing, 
group 2 static stander (5*/week, 30 min) 
8 - 5 ROM hip and knee ext, ankle 
dorsiflex (goniometer) 
* no 
stats 
  I II 
(3/7) 
      BMC femoral neck, great trochanter, 
intertrochanteric) (Dual energy x-ray 
absorptiometry 
  I  
smaller 
RCT 
    Phase 2 (3 sessions): all children standing in the 
different standing frames 
        
        behavioral characteristics (CRIB)    I  
2004, 
Caulton
69 
RCT 13 13 4,3y -10,8y non-ambulant Exp: 50% longer standing  39 - 7 vertebral tibial volumetric trabecular 
bone density (vTBMD) (quantitative 
computed tomography) 
  ↑ I II 
(5/7) 
 smaller 
RCT 
    Contr: normal duration of standing         
     varying from 14min to 365 min standing/week    proximal tibial volumetric trabecular 
bone density (vTBMD) (quantitative 
computed tomography) 
  = I  
2009, 
Gibson
70 
prospective 
intervention 
5 - 5-9y non-ambulant phase A: standing in a standing frame, 1h/day 6 - 5 Popliteal angle (goniometer and 
angle finder) 
↑ ↓ ↑ I IV 
(9/14)   X=7y2mo phase B: no intervention    = = = A 
 SSRD   SD=1y4mo  ABAB design    ADL (feedback form)      
2009, 
Eisenberg
71 
prospective 
intervention 
11 11 Exp:X=6,2y, 
SD=2,1 
spastic 
quadriplegia 
Exp: Heart Walker 26 - 7 bowel activity (diary) ↑ = ↑ I III 
(4/7)   Contr: passive standing programme    functional performance (PEDI) ↑ ↑ = A/P 
 Non-
randomized
CT 
  Contr:X=6,7
y, SD=1,6y 
GMFCS IV-V     bone mineral density (ultrasound) ↑ ↑ = I  
       walking speed (2 min walking test) ↑ = = A  
2007, Pin
72 
syst review  - - - Medline, CINAHL, psychINFO, Embase, full Cochrane library, PEDro - PEDro scale     II (7) 
    start - 2006          
    
  keywords: child, cerebral palsy, bone density, hip dysplasia, contracture, range of 
motion, stretching, muscle spasticity, bowel and urinary function, morale, 
communication, hand function, feeding 
      
 
Abbreviations: 
N: Number; Exp: Experimental group or period; Contr: Control group or period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; LE:Level of Evidence:; CS: Conduct Score; RCT: 
Randomized Controlled Design; SSRD: Signel Subject Research Design; X: mean; SD: Standard Deviation; y: years; mo: months; PT: Physical Therapy; pROM: passive Range of Motion; BMC: Bone Mineral Content; ADL: 
Activities of Daily Living; CRIB: Carolina Record of Individual Behavior;  PEDI: Pediatric Evaluation of Disability Inventory  
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Table K. Overview of the studies using balance training – subjects, interventions, evaluation, results, level of evidence and conduct scores. 
 
Author Design Subjects Method Results 
ICF 
LE 
(CS)   
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int 
(weeks) 
Duration 
follow-up 
(weeks) 
Freq 
(*/week) 
Evaluation Exp Contr 
Exp 
vs 
contr 
1995, 
Myhr
73 
retrospective 
cohort 
10 - 2,1y-5,8y mild/moderate/ 5 y functional sitting position (pelvis forward, upper 
body anterior to the fulcrum, hip belt and 
abduction orthosis) 
260  no 
specified 
sitting position (Sitting 
Assessment Scale) 
↑   I/A IV 
(3/7) 
   X=3,6y severe       
 case series    spastic diplegia    head/trunk control ↑   I/A  
2003, 
Shumway-
Cook
74 
prospective 
intervention 
6 - 9y2mo-
12y11mo 
hemiplegia (2) phase A: usual therapy only 0,8 1 7 area and time to stabilization from 
CoP (moving forceplate) 
  ↓ I III 
(9/14)   diplegia (4) phase B: balance training on moving platform (100 
perturb/day for 5 days) + usual PT 30min-1h/week 
     ↓ A 
SSRD   X=9y2mo GMFCS I and II    gross motor function (GMFM)   = A  
 ABA    SD=2y  ABA design          
2005, 
Ledebt
75 
RCT 5 5 5-11y hemiplegia  Group 1: balance training with visual feedback 6 4 3 CoP displacement standing ↓ = = I/A II 
(4/7) smaller 
RCT 
    Group 2: control group    CoP displacement during dynamic 
standing  
↓ = ↓ I/A 
              
          average step length asymmetry ↓ = ↓ A  
2005, 
Woollacott
76 
prospective 
intervention 
6 - X=9y4mo hemiplegia (2) 5 days of intensive reactive balance training 0,8 4,3 7 muscle cocontractions (EMG):     IV 
(4/7)    diplegia (4) (100 perturbations/day on a moveable platform)    timing of muscle contraction ↓   I 
 case series    GMFCS I and II     distal-proximal muscle sequence ↑   I/A  
         agonist ↑   I  
          antagonist ↓   I  
2008, Bar-
Haim
77 
RCT 10 10 8,9-12,9y GMFCS II-IV Contr: structured intensive treatment 4,3  7 gross motor function (GMFM) ↑ = = A II 
(4/7)    X=9,2  Exp: structured intensive treatment + random perturbation   Mechanical Efficiency during stair 
climbing (rate oxygen 
consumption) 
= ↑ ↑ I 
 smaller 
RCT 
    1 month, daily treatment of 1,5h, 20 sessions         
     physio: stretching, functional weight-bearing, 
walking activities 
        
               
      random perturbation: engine induced passive 
cycling, 10 min 
         
               
2005, 
Harris
78 
syst review 12 
studie
s 
- - - search on Medline, CINAHL, EMBASE, PsychINFOR, SportDiscus, 
Cochrane Database of Syst Review, Cochrane Controlled Trial Register, 
PEDro, DARE, Dissertation Abstracts 1990-2004 
- AACPDM guidelines     II (8) 
 syst review     Cerebral palsy, Balance, Posture, Postural Control          
 
Abbreviations: 
 
N: Number; Exp: Experimental group or period; Contr: Control group or  period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; LE: Level of Evidence; CS: Conduct score; RCT: 
Randomized Controlled Design; SSRD: Single Subject Research Design; X: mean; SD: Standard Deviation; y: years; mo: months; PT: Physical Therapy; pROM: passive Range of Motion; CoP: Centre of Pressure; GMFM: 
Gross Motor Function Measure; EMG: Electroymyography; syst review: systematic review; AACPDM: American Academy of Cerebral Palsy and Developmental Medicine 
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Table L. Overview of the studies using treadmill training – subjects, interventions, evaluation, results, level of evidence and conduct scores. 
Author Design Subjects Method  Results 
ICF 
LE 
(CS)   
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int 
(weeks) 
Duration 
follow-up 
(weeks) 
Freq  
(*/ 
week) 
Evaluation Exp Contr 
Exp 
vs 
contr 
1997, 
Richards
79
  
prospective 
intervention 
4 - 1.7-2.3y nonambulant treadmill training+ NDT based  PT 17,3 - 4 gross motor function (GMFM) =   A IV 
(3/7)     treadmill on low speed (7cm/sec), progressive 
weight-bearing 
   gait (videographic test +3DGA) =   I/A 
 case series        Supported Walker Ambulation 
Performance Scale 
=   A  
               
2000, 
Schindl
80 
prospective 
intervention 
10 - 6-18y 6 nonambulatory  Phase B :  BWSTT , 25 min/session 13 - 3 gross motor function (GMFM) ↑ =  A V 
(8/14) 
  X=11,5y 4 req cont phys 
assistance 
Body weight support at start: X=14% (0-40%) + 
usual PT 
   Functional ambulation category ↑ =  A 
              
 SSRD 
AB 
    Mean treadmill speed 0,23 m/s (start of the 
study) to 0,40 (end of the study ) 
         
              
     Phase A: usual PT only (30 min, 2-3 sessions 
per week) 
         
               
2007, 
Cherng
81 
ABA or AAB 4 4 3,5-6,3y GMFCS I-III Exp:ABA 12 6 2,5 gross motor function (GMFM) ↑ =  A II 
(9/14) 
SSRD   X=4y spastic diplegia Contr:AAB    time-and distance parameters 
(GaitRite) 
↑ =  I/A 
      A=regular physio,NDT, 30 min/session         
     B=BWSTT, 20min/session+regular physio    muscle tone (MAS) = =  I  
          selective motor control (SMC) = =    
2007, 
Philips
82 
prospective 
intervention 
6 - 6-14y hemiplegia (4) 2*/day BWSTT 2 - 14 fMRI (3 tasks): (1) active ankle 
dorsiflexion  (2) finger tapping of the 
uninvolved hand; and (3) active ankle 
dorsiflexion of the involved ankle 
=   I IV 
(3/7) 
  X=10y5mo diplegia (2) Body support decreased from 30% initially to 0%        
     GMFCS I Treadmill speeds ranged from 2.4 to 3.1kmph 
initially and increased to 3.7 to 5.0kmph with 
training. 
       
           
 case-series        walking speed ↑   A  
          distance walked for 6 minutes =   A  
2007, 
Dodd
83 
prospective 7 7 5-14y GMFCS III-IV Exp: BWSTT (0.40 km/h upto 0,60km/h) 6 - 2 10 min walk test   = A II 
(4/7) 
matched    X=8y10m athetoid quadri (6) Untill child stopped or was tired (med 
12min(start) to 21 min (end)  
   self-selected walking speed in 10 min   ↑ A 
 non 
randomized 
CT 
  SD=2y6m spastic quadri (6)          
    spastic diplegia (2) Contr: usual PT (content not reported)          
               
2007, 
Begnoche
84 
prospective 
intervention 
5 - 2,3-9,7y quadriplegia (1) 2h/session treadmill+NDT 4 - 3,5 gross motor function (GMFM) =   A IV 
(3/7) 
   diplegia (4) 15-35 min/session partial body weight treadmill 
training  
   functional performance (PEDI-FS) =   A/P 
 case series    GMFCS I-IV    gait (pedography) ↑   I/A  
          walking speed (timed 10m walk test) =   A  
Abbreviations: N: Number; Exp: Experimental group or period; Contr: Control group or period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; LE: Level of Evidence; CS: 
Conduct score;RCT: Randomized Controlled Design; SSRD: Single Subject Research Design; X: mean; SD: Standard Deviation; y: years; mo: months; PT: Physical Therapy; NDT: neurodevelopmental treatment; 3DGA: 
threedimensional gait analysis; GMFM: Gross Motor Function Measure; BWSTT: Body Weight Supported Treadmill Training; QoL: Quality of Life; PEDI: Pediatric Evaluation of Disability Inventory; syst review: systematic 
review; AACPDM: American Academy of Cerebral Palsy and Developmental Medicine  
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Table L. (continued) Overview of the studies using treadmill training – subjects, interventions, evaluation, results, level of evidence and conduct scores. 
Author Design Subjects Method  Results 
ICF 
LE 
(CS)   
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int 
(weeks) 
Duration 
follow-up 
(weeks) 
Freq 
(*/week) 
Evaluation Exp Contr 
Exp 
vs 
contr 
2007, 
Provost
85 
prospective 
intervention 
6 - 6-14y diplegia (4) body weight supported treadmill training 2 - 14 gross motor function (GMFM) =   A IV 
(4/7) 
   hemiplegia (4) 2*/day 30 min    Energy Expenditure ↓   I 
 case series    ambulatory     6min walking test ↑   A  
     GMFCS I     Ten-Meter Walking Velocity ↑   A  
          Single Leg Balance Test =   A  
2009, 
Dieruf
86 
prospective 
intervention 
6 - 6-14y GMFCS I 2*30min/day BWSTT 2 - 14 Quality of life (Ped QOL Inventory ) =   QoL IV 
(3/7) 
   diplegia (2) (30 min: 10 min walking, with 5 min rest)    fatigue (PedsQL multidisciplinary 
Fatique Scale) 
=   QoL 
 Case-series    hemiplegia (4)          
2009, 
Hodapp
87 
prospective 
intervention 
7 - 5-15y GMFCS I-III treadmill training, without body weight support; 
1,90km/h to 3,10km/h 
1,5  7 soleus H reflex ↓   I IV 
(4/7) 
  X=9,7y     walking speed (ground and treadmill)  ↑   A 
 case series               
2009, 
Mattern-
Baxter
88 
prospective 
intervention 
6 - 2,5-3.9y GMFCS I - IV 2 individualized treadmill walks 4 4,3 3 gross motor function (GMFM)  ↑   A IV 
(5/7) 
   spastic diplegia (3) 1h, gait speed as fast as possible    functional performance (PEDI) ↑   A/P 
    spastic quadri (1)     walking speed (6 minute walk test)  ↑   A  
 case series    hypotonia (1)     walking speed (10m walk test) ↑   A  
     dystonia (1)           
2009, 
Willoughy 
89 
syst review 5 
studies 
- - - Cinahl, Cochrane, Pedro, ERIC, PsychINFO, AMED, PubMed, Ausport Medical 
and Sports Discus 
effect sizes     II (9) 
         
     until july 2008          
      keywords: cerebral palsy, child, treadmill training       
2009, 
Mattern-
Baxter
90 
syst review  10 
studies 
- - - Academic Search Complete, Blackwell Synergy, Cochrane Library,Google 
Scholar, Health Source, Nursing Academic, PubMed,Science Direct,SCOPUS 
and SPORTDiscus 
Sackett's levels of evidence     II (6) 
          
           
    
  
keywords: adolescent, child, gait, physical endurance,  fitness, spastic CP, 
treadmill training and walking; 1997 - 2008 
 
    
 
2009, 
Mutlu
91 
syst review - - - - Medline, PubMed, Google, Embase, Ovid Medline, Galter Health Sciences 
Library, Pedro Cochrane, Cinahl, APTA 
AACPDM guidelines     II (8) 
           
      1950-2007       
      keywords: CP, treadmill training, PBWSTT, locomotor therapy, gait, walking, 
physial therapy methods 
      
            
Abbreviations: 
N: Number; Exp: Experimental group or period; Contr: Control group or period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; LE: Level of Evidence; CS: Conduct score; RCT: 
Randomized Controlled Design; X: mean; SD: Standard Deviation; y: years; mo: months; PT: Physical Therapy; NDT: neurodevelopmental treatment; 3DGA: threedimensional gait analysis; GMFM: Gross Motor Function 
Measure; BWSTT: Body Weight Supported Treadmill Training; QoL: Quality of Life; PEDI: Pediatric Evaluation of Disability Inventory; syst review: systematic review; AACPDM: American Academy of Cerebral Palsy and 
Developmental Medicine  
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Table M. Overview of the studies using Neurodevelopmental Treatment of Bobath therapy – subjects, interventions, evaluation, results, level of evidence and conduct scores 
 Author Design Subjects Method Results 
ICF 
LE 
(CS) 
  
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int 
(weeks) 
Duration 
follow-
up 
(weeks) 
Freq 
(*/week) 
Evaluation 
 
 
Exp 
 
Contr 
Exp 
vs 
cont 
1995, 
Karnish
21
 
prospective 
intervention  
3 - 4,14 and 6y 
  
spastic quadri Training 1: PT in an isolated therapy room 1,5 - 14 motor skill tasking (video):     II 
(7/14
) 
  Training 2: PT in a natural education 
setting 
   quality of performance  = = = A 
  ABABAB       2 sessions/day, each of the two settings 
each day, 10 sessions 
   speed of completion = = = A 
               
  SSRD       inhibition/facilitation, transfer, standing 
balance, motor skill training 
     * no stats   
             
1997, 
Jonsdottir 
22
 
Prosp 
intervention 
8 - 10-15y spastic quadri Phase A: 1 week no treatment (control 
phase 
1 - 7 postural assessment scale 
(Bertoti): 
    III 
(6/14
) 
           
Alternationg 
treatments 
    Phase B: 1 week NDT (daily, 35 min; focus 
on reaching) (exp) 
   postural control (Seated 
Postural Control Measure) 
↑ =  I/A 
             
  SSRD ABAC      Phase C:1 week practice (repetition, no 
focus on quality) (control) 
   Total Displacement of the 
Head and Shoulder 
↑ =  I  
              
1999, 
Trahan
23
 
prospective 
intervention 
50 - 12-79mo 
  
quadri (24) PT as NDT, 45min/session 35 - 2 gross motor function (GMFM) ↑   A IV 
(4/7)   hemi (16)            
  Cases 
series 
    diplegia (10)             
2000, 
Adams
24
 
  
prospective 
intervention 
40 - X=6y hemi (11) 6 weeks intensive NDT 6 - 2 Stride and step length, foot 
angle, base of support, 
cadence, velocity (pedograph) 
↑   I/A IV 
(3/7)   2,6y-10,2y diplegia (18) 1h individually defined training 
  
      
Cases 
series 
  triplegia (3)         
     ataxia (5)             
       athetoid (3)             
2001, 
Kerem
25
 
prospective 
intervention 
17 17 X group 1 
=48,82mo 
spastic 
diplegia 
Exp: NDT +Johnstone Pressure Splints 13 - 5 spasticity (MAS) ↓ ↓ ↓ I III 
(3/7) Control: NDT    Somatosensory Evoked 
Potentials 
↓ ↓ ↓ I 
  Non-
randomized 
  X group 2= 
47,52mo 
moderate           
  
   
     ROM (goniometer) ↑ ↑ ↑ I  
 
Abbreviations: 
N: Number; Exp: Experimental group or period; Contr: Control group or period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; LE: Level of Evidence; CS: Conduct score; RCT: 
Randomized Controlled Design; SSRD: Single Subject Research Design; X: mean; SD: Standard Deviation; y: years; mo: months; PT: Physical Therapy; NDT: Neurodevelopmental Treatment; GMFM: Gross Motor Function 
Measure; MAS: Modified Ashworth Scale; PEDI: Pediatric Evaluation of Disability Inventory; ROM:  Range of Motion; syst review: systematic review; AACPDM: American Academy of Cerebral Palsy and Developmental 
Medicine 
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Table M (continued). Studies using Neurodevelopmental Treatment or Bobath therapy – subjects, interventions, evaluation, results, level of evidence and conduct scores 
 Author Design Subjects Method Results 
ICF 
LE 
(CS) 
  
N (exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int 
(weeks) 
Duration  
follow-up 
(weeks) 
Freq 
(*/week) 
Evaluation Exp 
Cont
r 
Exp 
vs 
cont 
2002, Knox
26
 
  
repeated 
measures 
15 - X=7y4mo quadriplegia (9) Exp phase(phase  B):  NDT,75 
min/session 
6 18 3 self care skills/caregiver 
assistance (PEDI) 
↑ = ↑ A/P III 
(8/14)   range 2-12y diplegia (4)        
 ABA   athetoid (1) Control phase (phase A): usual 
therapy 
   gross motor function (GMFM) ↑ = ↑ A  
  SSRD    ataxia (1)    Parent Questionnaire 
(individual goals)  
↑ = ↑ A  
       GMFCS I - V           
2002, 
Trahan
27
 
Pro-
spective  
5 - X=33mo GMFCS IV-V Phase A: baseline, conv PT, 
2*/week, 8 to 20 weeks 
4 - 4 gross motor function (GMFM) ↑ ↑ ↑ A II 
(10/14)             
 SSRD 
ABAB 
  range10-
37mo 
spastic 
quadriplegia 
Phase B:PT4 weeks, 4*/week 
altered with 8 weeks no PT(total 24 
weeks, ABAB design) 
         
            
                 
2004, 
Tsorlakis
28
 
RCT 17 17 X=7y3mo hemiplegia (10) Exp: 16 weeks NDT, 2*/week 16 - 3 gross motor function (GMFM) ↑ ↑ ↑ A II (5/7) 
Smaller 
RCT 
  range 3-14y diplegia (12) Contr: 16 weeks NDT, 5*/week         
    tetraplegia (12)            
        GMFCS I-III            
2006,  
Bar-Haim
29
 
RCT 12 12 group 
1:X=8,3y 
group 2:8,1y 
GMFCS II-IV Exp: Adeli suit  4 39 5 gross motor function (GMFM) ↑ ↑ = A II (6/7) 
Smaller 
RCT 
  diplegia (11) Contr: NDT    Mechanical Efficiency Index 
during stairclimbing 
↑ ↑ ↑ I 
    Quadri (12) 4 weeks, 2h/day, 5*/week         
2007, 
Cherng
30
 
ABA or 
AAB 
4 4 3,5-6,3y GMFCS I-III Group 1: ABA, Group 2:AAB 12 6 2,5 gait (GaitRite) ↑ =  I/A II 
(8/14) 
  X=4y spastic diplegia Contr: Reg PT, 2-3*/week NDT    Gross Motor Function (GMFM) ↑ =  I/A 
  SSRD      Exp: BWST, 2-3*/week+regular PT    muscle tone (MAS) = =  I  
  selective motor control (SMC) = = 
2008, 
Christansen 
31
 
  
RCT 10 14 med 3 y spastic CP  Exp: intermittent 4 weeks 4*/week 
followed by 6 weeks no therapy  
30 - 3 gross motor function (GMFM) ↑ ↑ = A II (5/7) 
smaller 
RCT 
  range 1y-
8y1mo 
  
GMFCS I -V          
    Contr: continuous training, 1*/week           
2001, 
Butler
32
 
Syst 
Review 
21 
studies 
- NDT studies - Medline, Healthstar, ClinPSYCH, CINAHL, Cochrane; until 2000/2001 AACPDM level of evidence    - II (8) 
   keywords: neurodevelopmental treatment, NDT, Cerebral Palsy         
2001, 
Brown
33
 
  
Syst 
Review 
17 
studies 
- 
 
NDT studies - Medline, CINAHL, Cochrane, Cochrane Library, EMBASE, Eric, 
Healthstar, PsychInfo, Medline, Sociofile 
Jadad scale    - II (7) 
       
    keywords: neuromuscular fascilitation, NDT, Bobath, motion therapy, 
exercise therapy, therapeutic exercises, kinetic chain exercises, 
psychomotor and therapeutic touch 
 Sacket levels of evidence 
    
            
            
Abbreviations:N: Number; Exp: Experimental group or period; Contr: Control group or period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; LE: Level of Evidence; CS: 
Conduct Score; RCT: Randomized Controlled Design;  SSRD: Single Subject Research DesginX: mean; SD: Standard Deviation; y: years; mo: months; PT: Physical Therapy; NDT: Neurodevelopmental Treatment; GMFM: 
Gross Motor Function Measure; MAS: Modified Ashworth Scale; PEDI: Pediatric Evaluation of Disability Inventory; ROM:  Range of Motion; syst review: systematic review; AACPDM: American Academy of Cerebral Palsy 
and Developmental Medicine  
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Table N. Overview of the studies using conductive education – subjects, interventions, evaluation, results, levels of evidence and conduct scores 
 
Author Design Subjects Method Results 
ICF 
LE 
(CS) 
  
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int 
(weeks) 
Duration 
follow-up 
(weeks) 
Freq 
(*/week) 
Evaluation Exp Contr 
Exp 
vs 
cont 
1995, 
Coleman
34
 
prospective 
intervention 
11 9 19-69 mo quadriplegia (11) Exp: conductive education 26  not 
reported 
parental perception and coping 
(questionnaire on Resources 
and Stress(QRS-F) 
  = I/A III 
(2/7)   X=45 mo diplegia (7) Contr: traditional early intervention       
   athetoid (1)         
  non-
randomized 
CT 
    hemiplegia (1)  6 months    areas of development (Vulpe 
Assessment Battery) 
  = I/E  
              
                
1995, 
Catanese
35
 
prospective 
intervention 
17 17 4 y - 
7y1mo 
mild (10) Exp: conductive education 26  no 
reported 
areas of development (Vulpe 
Assessment Battery) 
  = I/A III 
(3/7)  matche
d 
moderate (18)        
      severe (6) Contr: traditional early intervention   parental perception and coping 
(questionnaire on Resources 
and Stress (QRS-F) 
  = I/E 
 non-
randomized 
CT 
    6 months         
                
             standardized cognitive test    = I  
1997, Hur
36
 prospective 
intervention 
19 17 3,5-4,5y severe Exp: Conductive education 156   skills for independence 
(Vineland Adaptive Behavior 
Scales) 
↑ ↑ = I/A/P III 
(2/7)     mild Contr: British Special Education 
Program 
       
  non-
randomized 
CT 
   moderate        
          child functional level 
(Development Profile 2) 
↑ ↑ = A  
                
1998, 
Reddihough 
37
 
  
  
RCT 32 34 12-36 mo diplegia (11) Group 1(randomized): CE 
(2,8h/week) 
26   areas of development (Vulpe 
Assessment Battery) 
↑ ↑ = I/A II 
(4/7) + matching   X=22mo3
wks 
quadriplegia (42)        
   ataxia (2) Group 2(randomized): NDT 
(2,9h/week) 
   gross motor function (GMFM) ↑ ↑ = A  
         language development 
(Reynell Dev Lang Scale 
↑ ↑ = I  
        Group 3(non-randomized): CE 
(3.2h/week) 
        
           parental coping and stress 
(Parent Stress Index)  
= = = E  
  Smaller 
RCT 
     Group 4(non-randomized):NDT 
(2.2h/week) 
        
1999, 
Woolfson
38
 
prospective 
intervention   
    conductive education+NDT 52  not 
reported 
Semistructured interviews with 
the parents on perception of 
child remediation, parental re-
education and redefinition 
=   I IV 
(2/7)           E 
  
   
  
 
      P 
  Case-series       
  
 
  
 
     
Abbreviations;  
N: Number; Exp: Experimental group or period; Contr: Control group or period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; LE: Level of Evidence; CS: Conduct Score; 
RCT: Randomized Controlled Design; X: mean; SD: Standard Deviation; y: years; mo: months; PT: Physical Therapy; OT: Occupational Therapy; ST: Speech Therapy; GMFM: Gross Motor Function Measure; PEDI: 
Pediatric Evaluation of Disability Inventory; PDMS: Peabody Developmental Motor Scales; GAS: Goal Attainment Scale; SRIGM: Self-Reported Individualized Goal Measure; ROM:  Range of Motion  
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Table N (continued) Overview of the studies using conductive education – subjects, interventions, evaluation, results, levels of evidence and conduct scores 
 
Author Design Subjects Method Results 
 ICF 
LE 
(CS) 
 
 
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int 
(weeks) 
Duration 
follow-up 
(weeks) 
Freq 
(*/week) 
Evaluation Exp Contr 
 
Exp 
vs 
cont 
 
2003, 
Stiller
39
 
  
RCT 7 12 2y5mo-9y2mo hemi (2) Exp: CE(6h/day, 5*/week) 5  6h/day gross motor function (GMFM) = ↑ (1) = A II 
(5/7)     Group 1: X=76mo 
SD=21 
diplegia (22) Contr 1: intensive therapy 
(PT,OT,ST) 5h/day, 5*/week) 
   fine motor function (PDMS) = = = A 
        functional abilities (PEDI) = ↑(1) = A/P  
  Smaller 
RCT 
  
  Group 2=X=48mo 
SD21mo 
quadri (14) Contr 2: special 
education(6h/day, 5*/week) 
         
             
    Group 3:X=47mo 
SD 24mo 
             
              
2005, 
Wright
40
 
Pro-
spective  
9 - Year 1 X:6,5y, 
SD=0,8 
GMFCS III-V 8 months intensive CE class 8  5*/week gross/fine motor function (GMFM, 
PDMS, QUEST, PEDI, GAS) 
↑   A/P IV 
(3/7) 
 
  diplegia 3         
     Year 2:X=4y6mo 
SD=1 
quadri 1     self concept  ↑   A 
  Case 
series 
       participation at school  ↑   P  
          Family stress  ↑   E  
2005, 
Odman
41
 
Pro-
spective  
30 24 3-16y GMFCS I-V Exp: CE(move &walk) 2 52 Exp:4-
5*/week 
gross motor function (GMFM) ↑ ↑ ↓ A III 
(3/7) 
 
    diplegia 30 2-4h/day, 4-5*/week, 15 days   functional activities (PEDI-Functional 
Measures) 
= ↑ = A 
  repeated 
measures 
    hemiplegia 4 Contr: Traditional Health Care 
(learning motor skills) 
  Contr:4* 
/week 
     
      tetraplegia 5          
  control 
group 
    dyskinetic 13 3h/day, 4*/week;14 days           
      ataxic 2            
2006, 
Odman
42
 
Pro-
spective  
30 24 3 - 16 y GMFCS I-V Exp: CE (move&walk), 2-
4h/day, 4-5 days/week 
2  Goup 1: 
4-
5*/week 
gross motor function (GMFM) ↑ ↑ ↓ I III 
(3/7) 
    diplegia 30   functional activities (Pedi-Functional 
Measures) 
= ↑ = A 
  repeated 
measures 
    hemiplegia 4 Contr: Traditional Health Care 
(Lemo), 3h/day, 4*/week 
       
      tetraplegia 5   Group 2: 
4*/week 
individualized goals (SRIGM) ↑ ↑ = A/P  
  control 
group 
    dyskinetic 13           
      ataxic 2           
2009, 
Odman
43
 
Pro-
spective 
15 - 4-17y GMFCS I-V intensive group training, 4 
weeks, 2-4h/day, 3-5*/week 
4  3-
5*/week 
semistructured interview with the 
parents 
* no stats  I/E 
 
IV 
(1/7) 
 
    di (2) tetra (2)   
 Case 
series 
    hemi (6)           
Abbreviations: N: Number; Exp: Experimental group or period; Contr: Control group or period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; LE: Level of Evidence; CS: 
Conduct Score; CT: Randomized Controlled Design; X: mean; SD: Standard Deviation; y: years; mo: months; PT: Physical Therapy; OT: Occupational Therapy; ST: Speech Therapy; CE: Conductive education; GMFM: 
Gross Motor Function Measure; PEDI: Pediatric Evaluation of Disability Inventory; PDMS: Peabody Developmental Motor Scales; GAS: Goal Attainment Scale; SRIGM: Self-Reported Individualized Goal Measure; 
ROM:  Range of Motion   
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Table N (continued) 
 
Author type N Intervention Evaluation LE (CS) 
1999, Woolfson
44
 Syst Review 10 studies Medline, ERIC, PsychLit, Social Science Citation Index 
- II (4) 
 
  
       No time limitatons 
 
  
2000, Pedersen
45
  Syst Review 9 studies 
Medline, ERIC, PsychINFO  - II (3) 
no time limitations, studies using control groups 
 
  
     
keywords: conductive education 
 
  
2004, Darrah
10
  Syst Review 88 studies Medline (1966-2001), HealthSTAR (1975-2000), Cinahl (1982-
2001), EMBASE (1988-2001), ERIC (1966-2001), AMED (1985-
2001), Psychinfo (1984-2001) 
 - II (8) 
    
  
      
 
  
 
Abbreviations:  
LE: Level of Evidence; CS: Conduct Score; Syst Review: Systematic Review 
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Table O. Overview of the studies evaluating the effectiveness of sensory integration and Votja therapy - subjects, interventions, evaluation, results, levels of evidence and 
conduct scores 
 
Author Design Subjects Method Results 
 ICF 
LE 
(Cs) 
  
  
  
 
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int 
(weeks) 
Duration 
follow-
up 
(weeks) 
Freq 
(*/week) 
Evaluation Exp Contr 
Exp 
vs 
cont 
Sensory integration 
2001, 
Bumin
15
 
  
  
RCT 32 9 Group 
1&2:X=7.06y 
spastic 
diplegia 
  
Group 1 (n=16):SMP 14 no follow-
up 
3 Ayers Southern California Sensory 
Integration Test 
↑ 
(1+2) 
= (3)  I/A II (3) 
   Group 2 (n=16):SMP, group training       
Smaller 
RCT 
  Group 3:X=7y   Group 3 (n=9): home programme    Physical Ability Test  ↑ 
(1+2) 
= (3)  A  
       SMP: 3*/week, 1,5h/session, 3 months          
          SMP= sensory training, vestibular training, 
balance and postural reactions, bimanual 
activities and motor planning 
          
               
                    
Vojta therapy 
2004, 
Kanda
46
 
  
RCT 5 5 1m-3m spastic 
diplegia 
Group 1(n=5): Vojta 52 months, 
30min/session, 90-120 sessions/month 
208 3y 90-120 
sessions/
month 
 
Highest motor developmental level     ↑ I/A II (2) 
smaller 
RCT 
      
  
     
        Group 2 (n=2): no treatment     
 
        
          Group 3 (n=3): insufficient therapy      
 
        
 
Abbreviations 
N: Number; Exp: Experimental group or period; Contr: Control group or period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; LE: Level of Evidence; CS: Conduct Score; RCT: 
Randomized Controlled Design; X: mean; SD: Standard Deviation; y: years; mo: months; SMP:  Sensory Perceptual Motor Training 
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Table P: Overview of the studies using functional and task-oriented training- subjects, interventions, evaluation, results, levels of evidence and conduct scores 
 Author Design Subjects Method Results 
 
ICF 
LE 
(CS) 
  
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int 
(weeks) 
Duration 
follow-up 
(weeks) 
Freq 
(*/week) 
Evaluation Exp Contr 
Exp 
vs 
cont 
2001, 
Ketelaar
5
 
RCT 28 27 Group 2: X=54, 
SD=20 
mild or moderate Exp: Practicing functional 
activities 
78 - Exp: 3,4 gross motorfunction (GMFM) ↑ ↑ = A II 
(6/7) 
 
   hemiplegia (32)   Contr 3,8 functional performance (PEDI) ↑ ↑ ↑ A/P 
 Smaller 
RCT 
 
  Group 1: X=56, 
SD=20 
di plegia (11) Contr: Training based on 
normalization and quality of 
movement 
        
   quadri plegia(12)          
    2-7y            
2005, 
Ekström
6
 
  
  
prospective  14 - 1y6mo-6y GMFCS II-V functional, goal oriented training 21,7 13 2-25 individual goals (GAS) ↑ 
  
A IV 
(2/7) 
 
No control   X=3y7mo  2*/day to 25*/day (varying)    gross motor function (GMFM) ↑ 
  
A 
Case-
series 
          functional perfomance (PEDI) ↑ 
  
A/P  
            Measure of Process Care  ↑ 
  
E  
2005, 
Schalow
47
  
prospective 
intervention 
case-series 
8 - X=15y not reported Low intensity coordination 
dynamics therapy: crawling, 
treadmill walking, jumping, 
exercising on a special board) 
13 - 4 motor programs (EMG) = 
  
I IV 
(1/7) 
 
  7-27y     coordination =   A 
          
  
 
       
2007, 
Crompton 
48
 
RCT 8 7 6-14y spastic diplegia Exp: LL training (circuit trainig: 
closed kinetic chain, strength, 
balance,coordination, stretching; 
70% of max work rate) 
6 6 2 gross motor function (GMFM)  = = = A II 
(5/7) 
 
   group 1: X=9,9y 
SD=2,5y  
GMFCS I-III    Timed Up and Go ↓ = = A 
 Smaller 
RCT 
  
      Uptime (mean uptime hours) ↑ ↑ = A 
  group 
2:X=11,2y 
SD=1,9 
    10 min walk test  = = = A  
     Contr :UL dexterity training 
(stretching, games and task 
requiering manipulation and 
dexterity, inhand-manipulation) 
   strength LL/UL (dynamometer) =,=  , ↑ = I  
          hand tasks (BOT) = ↑ ↓ A  
           gross manual dexterity = ↑ = A  
           Handwriting Speed test ↑ = = A  
         + usual therapy (0-2*/week)    rapid hand manipulation  ↑ = ↓ A  
2009, 
Salem
49
 
RCT 5 5 range 4,9-10,2y GMFCS I - III Contr: walking and balance; 
facilitation and normalization of 
movement patterns. 
5 - 2 Timed Up and Go ↑ = ↑ A II 
(5/7) 
 
   X=6,53y, 
SD=1,8Y 
diplegia (8)    gross motor function (GMFM) ↑ = ↑ A 
 Smaller 
RCT 
  quadri (2)         
      Exp:  task-oriented training;      
   
  
2010, 
Löwing
50
  
prospective 
intervention 
ABA design 
SSRD 
22 - X=46 mo GMFCS I-IV phase B:  goal directed functional 
acitivites (learning new skills in 
daily life) 
12 12 in ADL Gross Motor Function (GMFM) ↑ = 
 
A IV 
(8/14) 
 
  SD=16mo    7 individual functional goals (GAS) ↑ = 
 
A 
 
        pROM (goniometer) ↑ = 
 
I 
        Phase A: Follow-up    selectivity (selective motor control) ↑ = 
 
I  
          spasticity (MAS) ↓ =  I  
Abbreviations: N: Number; Exp: experimental group/period; Contr: control group/period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; LE: Level of Evidence; CS: Conduct 
Score; RCT: Randomized Controlled Design; SSRD: Single Subject Research Design; X: mean; SD: Standard Deviation; y: years; mo: months; GMFCS: Gross Motor Classification System; GMFM: Gross Motor Function 
Measure; PEDI: Pediatric Evaluation of Disability Inventory; GAS: Goal Attainment Scale; LL: Lower Limb, UL: Upper Limb; BOT: Bruininks-Oseretsky Test of Motor Proficiency; MAS: Modified Ashworth Scale, pROM: 
Passive Range of Motion  
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Table Q: Overview of the studies using goal-setting procedures- subjects, interventions, evaluation, results, levels of evidence and conduct scores 
 
 Author Design Subjects Method Results 
ICF 
LE 
(CS) 
  
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int 
(weeks) 
Duration 
follow-
up 
(weeks) 
Freq 
(*/week) 
Evaluation Exp 
Cont
r 
Exp 
vs 
cont 
1996, 
Bower 
13
 
  
RCT 22 22 X group 
1=6.3y 
spastic  
quadriplegia 
Group 1: usual PT based on general aims 2 - 7 gross motor 
function (GMFM) 
  ↑ 
(3+4) 
A II 
(4/7) 
 
2*2 
factorial 
  Group 2: intensive PT (1h/day) based on general aims        
 smaller 
RCT 
  X group 
2=5.5y 
 Group 3: usual PT based on specific goals         
      Group 4: intensive PT (1h/day) based on specific goals         
     Xgroup 
3=5.8y 
  2 weeks           
       selection of goals/aims based on GMFM           
    Xgroup 
4=5.6y 
  treatment type was mixed (eclectic)           
                   
2001, 
Bower 
51
 
  
RCT 28 28 X=5.9 GMFCS III-V Group 1(n=15):  PT based on general aims (12h/6 months) 26 26 7 gross motor 
function (GMFM 
and GMPM) 
  = A II 
(7/7) 
 
     Group 2 (n=13): intensive PT (1h/day) based on general aims         
2*2 fact   range 3-12y spastic 
diplegia 
Group 3 (n=13): PT based on specific goals(12h/6months)      = A 
  ABA     Group 4 (n=15): intensive PT (1h/day) based on specific goals    Measure of 
Process Care 
Questionnaire 
     
  smaller 
RCT 
    spastic 
quadriplegia 
ABA design: 6 mo baseline observation, 6 mo intervention, 6 mo 
follow-up 
      E  
              
2009, 
Löwing
52
 
Pro-
spective 
22 22 X=4y1mo  
SD =1y5mo 
GMFCS I-IV Exp: goal directed therapy (group training and day-to-day 
practice, 1*/week, individual goals) 
12 - 1 functional abilities 
(PEDI) 
↑ = ↑ A/P II 
(4/7) 
 
  unilateral 17        
Multi-
centre 
    bilateral 27 Contr: activity directed therapy (1*/week,  based on general 
aims) 
   gross motor 
function (GMFM) 
↑ = ↑ A  
  non-
random-
ized CT 
             
               
                  
 
Abbreviations 
 
N: Number; Exp: Experimental group or period; Contr: Control group or period; Freq: Frequency; Int: Intervention group; Vs: Versus; ICF: International Classification of Functioning; LE: Level of Evidence; CS: Conduct Score; RCT: 
Randomized Controlled Design; X: mean; SD: Standard Deviation; y: years; mo: months; GMFCS: Gross Motor Classification System; GMFM: Gross Motor Function Measure; GMPM: Gross Motor Performance Measure; PEDI: 
Pediatric Evaluation of Disability Inventory 
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Table R: Overview of the studies using hydrotherapy or aquatic therapy- subjects, interventions, evaluation, results, levels of evidence and conduct scores 
 
Author Design Subjects Method Results 
ICF 
LE 
(CS) 
  
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int 
(weeks) 
Follow-
up 
(weeks) 
Freq 
(*/week) 
Evaluation 
 
Exp 
 
Contr 
Exp 
vs 
cont 
1998a,  
Hutzler 
53
  
RCT 23 23 5-7y hemiplegia (17) Group 1: swimming sessions+ physical 
activity at gym 
26 - 2 Lung function (spirometer)   ↑ I II 
(1/7) smaller 
RCT 
  Group 1: 
X=5,7y SD 1 
diplegia (19)    Water Orientation Score ↑   I/A 
  quadriplegia (6) Exp: NDT; 30 min, 4*/week          
      Group 2: 
X=5,5 SD 0,9 
ataxia/athetosis (4)           
                   
1998 b, 
Hutzler 
54
   
RCT 23 23 5-7y diplegia (19) Exp:  movement and swimming 
program (3*/week,30min) + group 
movement+NDT 
26 - 3 Water Orientation Score ↑   I/A II (2/7) 
    x=507y hemiplegia (17)    Selfperception (Martinek-
Zaichkowsky Self Concept 
Scale)  
 =  I  
smaller 
RCT 
    quadriplegia (6)         
      ataxia/athetosis (4) Contr: NDT 30 min, 4*/ week         
2005, 
Thorpe 
55
  
Pro-
spective 
intervention 
7 - 7-13y spastic diplegia (6) phase A: Individual aquatic exercise 
sessions, 45 min 
10 11 3 leg strength (handheld 
dynamometer) 
= =  I IV 
(8/14)    spastic hemiplegia 
(1)  
       
  X=9,7y phase B: usual therapy    gait velocity(3min walking 
test) 
= =  A  
    SD=1,8y           
  SSRD 
AB 
  
         energy expenditure (Resting 
Heart Rate) 
= =  I  
              
            gross motor function (GMFM) ↑ =  A  
             functional mobility (TUG) ↓ =  A  
2007, 
Ozer
56
 
prospective 
intervention 
13 10 Exp: X=8,1y SD 
1,5y 
not described Exp: 14 weeks swimming training + trad 
PT  
14 26 3 Child Behaviour Check List:    I II (3/7) 
       body awareness ↑     
  smaller 
RCT  
  Contr:X=8,9y SD 
1,5y  
  
   Contr : traditional PT only    competence =     
  
         problem behaviour =     
 
Abbreviations: 
 
N: Number; Exp: Experimental group or experimental period; Contr: Control group or control period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; LE: Level of Evidence; CS: 
Conduct Score; RCT: Randomized Controlled Design; SSRD: Single Subject Research Design; X: mean; SD: Standard Deviation; y: years; mo: months; NDT: Neurodevelopmental Treatment; VC: Vital Capacity; TUG: Timed Up 
and Go test; GMFM: Gross Motor Function Measure; GMPM: Gross Motor Performance Measure; PEDI: Pediatric Evaluation of Disability Inventory 
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Table S: Overview of the studies using therapeutic horse-riding subjects, interventions, evaluation, results, levels of evidence and conduct scores 
 
 Author Design Subjects Method Results 
ICF 
LE 
(CS) 
  
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int 
(weeks) 
Duration 
follow-up 
(weeks) 
Freq 
(* 
/week) 
Evaluation Exp 
Cont
r 
Exp vs 
cont 
1995 a, 
Mac 
Kinnon
57
  
  
RCT  10 9 4 - 12y mild Exp: usual PT+ 1h/week riding 
classes 
26 - 1 gross and fine motor function (GMFM, 
PDMS) 
=  = A II 
(5/7) 
    X=6,5y moderate     posture (bertoti) =  = I/A 
smaller 
RCT 
  SD=6,5y independent 
sitting 
functional riding skills, basic 
horse and stable knowledge, 
games on horseback) 
   BOT - UL speed and dexterity ↑  ↑ A  
         ADL (Vineland Adaptive Behaviour Scales) =  = I  
         self perception (Harter Self Perception Scale) ↑  = I  
              child behaviour (Child Behaviour Checklist) ↑  ↑ I  
      Contr: waiting list + usual PT    Qualitative questionnaire of performance ↑  = A  
1998, 
Quint
58
 
  
prospective 13 13 9-16y spastic 
quadriplegia 
Exp: BABS (powered saddle 
imitating a walking horse) 10 
times, 10 min 
4 - 2 pelvic tilt in sitting (photographic 
measurement) 
    II 
(5/7) matched         ↑ = ↑ I/A 
 Non-
random- 
ized CT 
             
        Contr: static saddle, 10 times, 
10 min 
         
                  
1998, Mc 
Gibbon
59
 
prospective  5 - X=9y6m independent 
walking 
Phase A: usual PT 8 - 2 gross motor function (GMFM) ↑ =  A IV 
(9/14
) 
repeated 
measures 
    Phase B: usual PT +  30 min 
hippotherapy (muscle 
elongation and relaxation, 
optimal postural alignment and 
independent sitting) 
   energy expenditure (heart rate) ↓ =  I 
    diplegia (4)    stride length, cadence and velocity =,=,= =,=,=  I/A 
  SSRD     hemiplegia (1)          
  AB design                
                  
1999, 
Kuczyns
ki
60
  
prospective 
intervention 
25 - 3-10y tetra (12) 20 min microprocessor 
controlled saddle riding 
13 - 2 postural sway (centre of pressure 
measurement) 
↓   I/A IV 
(1/7)   X=6,3y diplegia (4)        
case 
series 
  SD=1,7y hemiplegia (9)      functional abilities (PEDI) =   A/P  
               
1999, 
Haehl
61
  
prospective 
intervention 
2 - subject 
1:9,6y 
Spastic/athetoid 
quadriplegia 
hippotherapy: slow to medium 
walking speed; movements 
anw walking, forward sitting, 
minimum hands-on 
12 - 1 posture and postural control (markers) ↑   I IV 
(3/7)          
  case 
series 
  subject 2: 
4y 
spastic diplegia          
             
Abbreviations: 
N: Number; Exp: Experimental group or period; Contr: Control group period; Freq: Frequency; Int: Intervention; Vs: Versus; ICF: International Classification of Functioning; RCT: LE: Level of Evidence; CS: Conduct Score; 
RCT: Randomized Controlled Design; SSRD: Single Subject Research Design; X: mean; SD: Standard Deviation; y: years; mo: months; GMFM: Gross Motor Function Measure;  BOT: Bruininks-Oseretsky Test of Motor 
Proficiency; MAS: Modified Ashworth Scale; PEDI: Pediatric Evaluation of Disability Inventory  
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Table S (continued): Overview of the studies using therapeutic horseriding- subjects, interventions, evaluation, results, levels of evidence and conduct scores 
 Author  Design Subjects Method Results 
 ICF 
LE 
(CS) 
  
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Int 
(weeks) 
Follow-
up 
(weeks) 
Freq 
(*/week) 
Evaluation Exp Contr 
Exp 
vs 
cont 
2002, 
Sterba
62
  
prospective 17 - X=9y10m diplegia (12) phase A : horse back riding therapy 
(exercises during riding, prone 
lying,…) 
18 6 1 gross motor function (GMFM) ↑ = ↑ A IV 
(10/ 
14) 
repeated 
measures 
   quadriplegia (3)    functional independence (WeeFIM) = = = A 
   SD = 10 mo hemiplegia (2)         
  SSRD   GMFCS I-V Phase B: usual PT         
  AB design                 
                     
2003, 
Benda
63
  
prospective 
intervention 
7 8 4-12y spastic Exp: 8 min of hippotherapy (rythmic 
multidimensional movement of the 
horse) 
1 session - - EMG of trunk, upper leg muscles 
during sitting, standing and walking 
   I/A II 
(4/7) 
 
    independent 
sitting, standing 
       
 control group       asymmetry score   ↓ I  
  smaller RCT      Contr: 8 min stationary barrel 
(neutral warmth for a fleece 
saddle,symmetrical forward sitting 
posture 
         
                   
               
               
2004, 
Cherng
64
 
prospective 
intervention 
14 - 3y1m-
11y5m 
quadriplegia (5) Exp: AB 16 16 2 gross motor function (GMFM) ↑ = ↑ A IV 
(10/1
4) 
 
  diplegia (7) Contr: BA    muscle tone of hip adductors 
(MAS) 
= = = I 
 repeated 
measures 
  group 1: 
X=92,3 m 
hemiplegia (2) phase A= PT only        
    ambulant phase B: usual PT + horseback 
riding therapy 40 min, 2*/week 
        
  AB design   group 
2:X=93 m   
non-ambulant           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
2004, 
Casady
65
 
prospective 10 - 2,3-6,8y spastic quadri (2) Phase B: 10 weeks, 1*/week 
hippotherapy 
10 10 1 functional abilities (PEDI) ↑ = ↑ A/P IV 
(6/ 
14) 
 
SSRD   X=4,1y spastic dipl (1)    gross motor function (GMFM) ↑ = ↑ A 
    SD=1,7 hemiplegia (3) Phase A: 20 weeks usual PT          
      athetosis (1)           
  ABA design     non-specified (11)             
2008, 
Zurek
66
 
prospective 
intervention 
16 - 14-16y spastic dipl (7) Hippotherapy: 15-35 min on saddle 
(1 session) 
-  - Limb skin surface temperature ↑   I IV 
(2/7)   X=9,3y spastic hem (5)         
  case series   SD=3,8y other (4)             
2009, 
Shurtleff
67
  
  
prospective 
intervention 
11 
CP 
8 
(non-
CP) 
 
5-13y diplegia Phase A: hippotherapy,45 min, + 
usual PT 
12 12 1 3D analysis of head/trunk stability ↑   A IV 
(4/7) X=8y      reaching/grasping ↑    
SSRD 
  
    Phase B: wash-out, usual PTonly          
  AB design         AB design           
Abbreviations: N: Number; Exp: Experimental group or period; Contr: Control group or period; Freq: Frequency; Vs: Versus; ICF: International Classification of Functioning; LE: Level of Evidence; CS: Conduct Score; RCT: 
Randomized Controlled Design; SSRD: Single Subject Research Design; X: mean; SD: Standard Deviation; y: years; mo: months; GMFM: Gross Motor Function Measure;  BOT: Bruininks-Oseretsky Test of Motor 
Proficiency; MAS: Modified Ashworth Scale; PEDI: Pediatric Evaluation of Disability Inventory  
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Table S (continued): Overview of the studies using hydrotherapy or aquatic therapy- subjects, interventions, evaluation, results, levels of evidence and conduct scores 
 
 Author Design Subjects Method Results 
ICF 
LE 
(CS) 
 
type 
N 
(exp) 
N 
(contr) 
Age Type Intervention 
Duration 
int 
(weeks) 
Duration 
follow-
up 
(weeks) 
Freq 
(*/week) 
Evaluation Exp 
Cont
r 
exp 
vs 
contr 
2009, 
McGibbon 
68
 
RCT  25 22 
Group 1: 
X=8y5mo 
GMFCS I-IV Phase 1: 10 minutes hippo (group 1) 
/10minutes barrel (group 2) 
12 
 
1 adductor spasticity (EMG) ↓ = 
 
I 
II 
(6/7) smaller 
RCT 
  diplegia (25)    
Gross motor function 
(GMFM) 
↑ = 
 
A 
  
Group 2: 
X=8y8mo 
quadriplegia (9) Phase 2: 12 weekly hippotherapy 
sessions 
   
self-perception (self-
perception profiles) 
=,=,= =,=,= 
 
I 
 
    
  
hemiplegia (7) 
        
    
  
  mixed (6)           
2009, 
Davis
69
 
RCT  50 49 4 to 12y GMFCS I-III Exp: therapeutic horseriding, 30-40 min 10  
1 gross motor function (GMFM) 
  
= A II 
(6/7)   
  
Exp: 
X=7y8mo 
  Contr: usual activities 
   
health status (CHQ) 
  
= I/P 
 smaller 
RCT 
       quality of life (CP QoL, 
KIDSCREEN) 
= QoL    
  
  Contr: 
X=8y2mo 
         
  
 
               
2009, 
Debuse
70
 
  
retrospectiv
e 
17 - 4-63y 
GMFCS I-V 
6 weeks to several years not 
reported 
not 
reported 
not 
reported 
Semistructured interviews 
   
I IV 
(1/7) 
qualitative  
   
  hippotherapy 
    
A 
  multicenter 
   
    
       
P 
 
  case-series 
  
         
  
   
E 
 
1995b, 
Mac 
Kinnon
71
 
syst review 
 
11 
studies 
- - - - - - - - 
    
II (0) 
2007, 
Sterba
72
 
  
syst review 11 
studies 
- - - Cochrane library, Dare, Medline, CINAHL 
Critical Review Form (Law et 
al 1998) 
    II (8) 
 
    keywords: HBRT, hippotherapy, developmental riding therapy, equine-
movement therapy, riding for disabled, therapeutic horse-riding therapy, 
therapeutic riding, cerebral palsy, exercise therapy, horrseback riding, 
horses, physical therapy techniques, recreational therapy, rehabilitation, 
therapeutic exercise 
    
  
 
    
     
            
            
2007, 
Snider
73
 
syst review 
9 
studies 
- - - Pedro, Medline, CINAHL, ERIC, HealthSTAR levels of evidence according 
to Sacket 
    II (8) 
  
 
    keywords horse, riding, hippotherapy,horseback riding 
    
    
 
    equine movement therapy Pedro      
    
  
    ,,,,-2005  PICO format          
Abbreviations; 
N: Number; Exp: Experimental group or experimental period; Contr: Control group or control period; Int: intervention; Freq: Frequency; Vs: Versus; ICF: International Classification of Functioning; LE: Level of Evidence; CS: 
Conduct Score; RCT: Randomized Controlled Design; X: mean; SD: Standard Deviation; y: years; mo: months; GMFCS: Gross Motor Classification System; GMFM: Gross Motor Function Measure; CHQ: Child Health 
Questionaire; MAS: Modified Ashworth Scale; PEDI: Pediatric Evaluation of Disability Inventory 
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Appendix T. List of main problems 
 
 
 
 
 
Primary problems Problem nr 
Muscle tone 
 Hypertonia 1 
 Hypotonia 2 
 Fluctuating muscle tone 3 
Postural control 
 Static alignment 4 
 Dynamic alignment 5 
 Insufficient co-activation 6 
 Laxity 7 
Movement patterns 
 Extension pattern 8 
 Flexion pattern 9 
 Asymmetric Tonic Neck Reflex (ATNR) 10 
 Other pattern 11 
Muscle strength 12 
Secondary problems  
Muscle lenght 13 
Bony deformities 14 
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Appendix U: Lists of individual goals from clinical examination 
 
 
  
ROM and muscle length 
ROM1 Hip extension deficit (Thomas test) 
ROM3 ROM hip abduction (Knee and hip flexed) 
ROM4 ROM hip abduction (Knee and hip extended) 
ROM5 Knee extension deficit 
ROM6 Popliteal angle 
ROM7 Ankle ROM dorsiflexion (knee flexed) 
ROM8 Ankle ROM dorsiflexion (knee extended) 
ROM9 Varus deformity  
ROM10 Valgus deformity  
ROM11 Rectus femoris length 
ROM12 Length of tensor fasciae latae 
Spasticity 
SP1 Spasticity of hip flexors (Modified Ashworth) 
SP2 Spasticity of hip adductors (Modified Ashworth) 
SP3 Spasticity of hamstrings (Modified Ashworth) 
SP4 Spasticity of Rectus Femoris (Duncan Ely) 
SP5 Spasticity of soleus (Modified Ashworth) 
SP6 Spasticity of gastrocnemius (Modified Ashworth) 
SP7 Spasticity of tibialis posterior (Modified Ashworth) 
Strength and selectivity 
STR1 Strength abdominal muscles 
STR2 Strength hip abductors 
STR3 Strength hip extensors (manual testing) 
STR4 Strength knee extensors (manual testing) 
STR5 Strength knee flexors (manual testing) 
STR6 Strength ankle dorsiflexors (manual testing) 
STR7 Strength ankle plantar flexors (manual testing) 
Bony deformities 
BD 1 Patella alta 
BD 2 Femoral Anteversion 
BD 3 Tibio-femoral angle 
BD 4 Bimalleolar Angle 
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Appendix V: List of goals from three-dimensional gait analyis 
Time and distance parameters 
TD1 Walking speed 
TD1 Timing of toe off 
TD2 Cadence 
TD3 Step length 
TD4 Endurance 
TD5 Step width 
TD6 Energy consumption 
Pelvis 
P1 Mean pelvic anterior tilt 
P2 Range of pelvic motion in sagittal plane 
P3 Range of pelvic motion in coronal plane 
P4 Range of pelvic motion in transverse plane 
P5 Pelvis asymmetry 
Hip  
H1 Maximum hip extension in stance 
H2 Total sagittal hip range of motion 
H3 Maximum hip flexion in swing 
H4 Peak hip abduction in swing 
H5 Mean hip rotation in stance 
H6 Maximum hip rotation in stance 
H7 Timing of '0' sagittal hip moment in stance  
H8 Maximum hip extension moment in stance 
H9 Maximum hip flexion moment in stance 
H10 Hip adduction in stance 
H11 Hip angle at IC 
Knee 
K1 Knee angle at initial contact 
K2 Maximum knee extension in stance 
K3 Range of knee motion in stance 
K4 Maximum knee flexion in swing 
K5 Timing of maximum knee flexion in swing 
K6 Maximum knee extension moment in stance 
K7 Maximum knee flexion moment in stance 
K8 Phasic activity of rectus femoris  
Ankle 
A1 Ankle angle at initial contact 
A2 Maximum dorsiflexion in stance 
A3 Ankle angle at midswing 
A4 Ankle ROM during push-off 
A5 Ankle moment at loading response 
A6 Maximum ankle plantar flexion moment at preswing 
A7 Maximum ankle power absorption in loading response and midstance 
A8 Maximum ankle power generation at preswing 
A9 Phasic activity of tibialis anterior 
A10 Phasic activity of gastrocnemius  
A11 2nd ankle rocker  
A12 Max. DF in swing 
A13 Ankle rotation during stance 
A14 1st ankle rocker 
Foot  
F1 Mean foot progression angle 
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Appendix W: List of goals from Gross Motor Function Measure (GMFM-88)  
Dimension A Lying and rolling 
GMFM 1 Supine, head in middle, turns head with extremities symmetrical 
GMFM 2 Supine, brings hands to midline, fingers one with the other 
GMFM 3 Supine, lifts head 45° 
GMFM 4 Supine, flexes right hip and knee through full range 
GMFM 5 Supine, flexes left hip and knee through full range 
GMFM 6 Supine, reaches out with right arm, hand crosses midline 
GMFM 7 Supine, reaches out with left arm, hand crosses midline 
GMFM 8 Supine, rolls to prone over right side 
GMFM 9 Supine, rolls to prone over left side 
GMFM 10 Prone, lift head upright 
GMFM 11 Prone on forearms, lifts head upright, elbows extended, chest raised 
GMFM 12 Prone on forearms, weight on right forearm, fully extends opposite arm forward 
GMFM 13 Prone on forearms, weight on left forearm, fully extends opposite arm forward 
GMFM 14 Prone, rolls to supine over right side 
GMFM 15 Prone, rolls to supine over left side 
GMFM 16 Prone, pivots to the right 90°, using extremities 
GMFM 17 Prone, pivots to the left 90°, using extremities 
Dimension B Sitting 
GMFM 18 Supine, hands grasped by examiner, pulls self to sitting with head control 
GMFM 19 Supine, rolls to right side, attains sitting 
GMFM 20 Supine, rolls to left side, attains sitting 
GMFM 21 Sit on mat, supported at thorax by therapist, lifts head in midline, maintains 3 sec 
GMFM 22 Sit on mat, supported at thorax by therapist, lifts head in midline, maintains 10 sec 
GMFM 23 Sit on mat, arms propping, maintains 5 seconds 
GMFM 24 Sit on mat, maintains arms free, 3 seconds 
GMFM 25 Sit on mat with small toy in front, leans forward, touches toy, re-erects without arms propping 
GMFM 26 Sit on mat, touches toy placed 4 ° behind child’s right side, returns to start 
GMFM 27 Sit on mat, touches toy placed 4 ° behind child’s left side, returns to start 
GMFM 28 Right side sit, maintains arms free, 5 seconds 
GMFM 29 Left side sit, maintains arms free, 5 seconds 
GMFM 30 Sit  on mat, lowers to prone with control 
GMFM 31 Sit on mat with feet in front, attains 4 point over right side 
GMFM 32 Sit on mat with feet in front, attains 4 point over left side 
GMFM 33 Sit on mat, pivots 90° without arms assisting 
GMFM 34 Sit on bench, maintains arms and feet free, 10 seconds 
GMFM 35 Standing, attains sit on a small bench 
GMFM 36 On the floor, attains sit on a small bench 
GMFM 37 On the floor, attains sit on a large bench 
Dimension C Crawling and kneeling 
GMFM 38 Prone, creeps forward 1.8 m (6’) 
GMFM 39 4 point, maintains weight on hands and knees, 10 seconds 
GMFM 40 4 point, attains sit arms free 
GMFM 41 Prone, attains 4 point, weight on hands and knees 
GMFM 42 4 point, reaches forward with right arm hand above shoulder 
GMFM 43 4 point, reaches forward with left arm hand above shoulder 
GMFM 44 4 point, crawls or hitches forward 1.8 m (6’) 
GMFM 45 4 point, crawls reciprocally forward, 1.8 m (6’) 
GMFM 46 4 point, crawls up 4 steps on hands and knees or feet 
GMFM 47 4 point, crawls backwards down 4 steps on hands and knees or feet 
GMFM 48 Sit on mat, attains high kneeling using arms, maintains, arms free, 10 seconds 
GMFM 49 High kneeling, attains half kneeling on right knee using arms, maintains arms free, 10 seconds 
GMFM 50 High kneeling, attains half kneeling on left knee using arms, maintains arms free, 10 seconds 
GMFM 51 High kneeling, walks forward on knees 10 steps, arms free 
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Appendix W (continued): List of goals from Gross Motor Function Measure (GMFM-88)  
 
Dimension D Standing 
GMFM 52 On the floor, pulls to stand at large bench 
GMFM 53 Standing, maintains arms free, 3 seconds 
GMFM 54 Standing, holding on to large bench with one hand, lifts right foot, 3 seconds 
GMFM 55 Standing, holding on to large bench with one hand, lifts right foot, 3 seconds 
GMFM 56 Standing, maintains arms free, 20 seconds 
GMFM 57 Standing, lifts left foot, arms free, 10 seconds 
GMFM 58 Standing, lifts right foot, arms free, 10 seconds 
GMFM 59 Sit on small bench, attains standing without using arms 
GMFM 60 High kneeling, attains standing through half kneeling on right knee, without using arms 
GMFM 61 High kneeling, attains standing through half kneeling on left knee, without using arms 
GMFM 62 Standing, lowers to sit on the floor with control, arms free 
GMFM 63 Standing, attains squat, arms free 
GMFM 64 Standing, picks up object from floor, arms free, returns to stand 
Dimension E: Walking, running, and jumping 
GMFM 65 Standing, 2 hands on large bench, cruises 5 steps to the right 
GMFM 66 Standing, 2 hands on large bench, cruises 5 steps to the left 
GMFM 67 Standing, 2 hands held, walks forwards 10 steps 
GMFM 68 Standing, 1 hand held, walks forwards 10 steps 
GMFM 69 Standing, walks forward 10 steps 
GMFM 70 Standing, walks forward 10 steps, stops, turns 180°, returns 
GMFM 71 Standing, walks backward 10 steps 
GMFM 72 Standing, walks forward 10 steps, carrying a large object with 2 hands 
GMFM 73 Standing, walks forward 10 consecutive steps between parallel lines 20 cm (8” apart) 
GMFM 74 Standing, walks forward 10 consecutive steps on a straight line 2 cm (3/4”) wide 
GMFM 75 Standing, steps over stick at knee level, right foot leading 
GMFM 76 Standing, steps over stick at knee level, left foot leading 
GMFM 77 Standing, runs 4.  m (1 ’), stops and returns 
GMFM 78 Standing, kicks ball with right foot 
GMFM 79 Standing, kicks ball with left foot 
GMFM 80 Standing, jumps 30 cm (12”) high, both feet simultaneously 
GMFM 81 Standing, jumps forward 30 cm (12”) high, both feet simultaneously 
GMFM 82 Standing on right foot, hops on right foot 10 times with a 60 cm (24”) circle 
GMFM 83 Standing on left foot, hops on left foot 10 times with a 60 cm (24”) circle 
GMFM 84 Standing, holding 1 rail, walks up 4 steps, alternating feet 
GMFM 85 Standing, holding 1 rail, walks down 4 steps, alternating feet 
GMFM 86 Standing, walks up 4 steps, alternating feet 
GMFM 87 Standing, walks up 4 steps, alternating feet 
GMFM 88 Standing on 1  cm (6”) step, jumps off, both feet simultaneously 
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Appendix X: Item analysis evaluating the agreement between the live-and video-ratings rated by PT1 
 
Item GMFM Ƙ PA 
Dimension A: Lying and rolling 
Item 1  Supine, head in middle, turns head with extremities symmetrical 1,000 1,00 
Item 2 Supine, brings hands to midline, fingers one with the other 1,000 1,00 
Item 3 Supine, lifts head 45° 0,490 0,96 
Item 4 Supine, flexes right hip and knee through full range 0,703 0,92 
Item 5 Supine, flexes left hip and knee through full range 0,611 0,90 
Item 6 Supine, reaches out with right arm, hand crosses midline 1,000 1,00 
Item 7 Supine, reaches out with left arm, hand crosses midline 1,000 1,00 
Item 8 Supine, rolls to prone over right side 1,000 1,00 
Item 9 Supine, rolls to prone over left side 1,000 1,00 
Item 10 Prone, lift head upright 1,000 1,00 
Item 11 Prone on forearms, lifts head upright, elbows extended, chest raised  0,98 
Item 12 Prone on forearms, weight on right forearm, fully extends opposite arm forward 1,000 1,00 
Item 13 Prone on forearms, weight on left forearm, fully extends opposite arm forward 1,000 1,00 
Item 14 Prone, rolls to supine over right side 1,000 1,00 
Item 15 Prone, rolls to supine over left side 1,000 1,00 
Item 16 Prone, pivots to the right 90°, using extremities  0,98 
Item 17 Prone, pivots to the left 90°, using extremities  0,98 
Dimension B: Sitting 
Item 18 Supine, hands grasped by examiner, pulls self to sitting with head control 1,000 1,00 
Item 19 Supine, rolls to right side, attains sitting 1,000 1,00 
Item 20 Supine, rolls to left side, attains sitting 0,851 0,98 
Item 21 Sit on mat, supported at thorax by therapist, lifts head in midline, maintains 3 sec 1,000 1,00 
Item 22 Sit on mat, supported at thorax by therapist, lifts head in midline, maintains 10 sec 1,000 1,00 
Item 23 Sit on mat, arms propping, maintains 5 seconds 1,000 1,00 
Item 24 Sit on mat, maintains arms free, 3 seconds 1,000 1,00 
Item 25 Sit on mat, small toy in front, leans forward, touches toy, re-erects without arms propping 1,000 1,00 
Item 26 Sit on mat, touches toy placed 4 ° behind child’s right side, returns to start 1,000 1,00 
Item 27 Sit on mat, touches toy placed 4 ° behind child’s left side, returns to start  0,98 
Item 28 Right side sit, maintains arms free, 5 seconds 0,587 0,84 
Item 29 Left side sit, maintains arms free, 5 seconds 0,545 0,84 
Item 30 Sit  on mat, lowers to prone with control 1,000 1,00 
Item 31 Sit on mat with feet in front, attains 4 point over right side  0,98 
Item 32 Sit on mat with feet in front, attains 4 point over left side -0,0101 0,96 
Item 33 Sit on mat, pivots 90° without arms assisting 0,714 0,86 
Item 34 Sit on bench, maintains arms and feet free, 10 seconds 1,000 1,00 
Item 35 Standing, attains sit on a small bench 0,686 0,90 
Item 36 On the floor, attains sit on a small bench 0,879 0,96 
Item 37 On the floor, attains sit on a large bench 0,798 0,92 
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Appendix X (continued): Item analysis evaluating the agreement between the live-and video-ratings 
rated by PT1 
 
Dimension C: Crawling and kneeling 
Item 38 Prone, creeps forward 1.8 m (6’) -0,010 0,96 
Item 39 4 point, maintains weight on hands and knees, 10 seconds  0,98 
Item 40 4 point, attains sit arms free -0,020 0,92 
Item 41 Prone, attains 4 point, weight on hands and knees  0,96 
Item 42 4 point, reaches forward with right arm hand above shoulder  0,94 
Item 43 4 point, reaches forward with left arm hand above shoulder  0,94 
Item 44 4 point, crawls or hitches forward 1.8 m (6’)  0,98 
Item 45 4 point, crawls reciprocally forward, 1.8 m (6’) 0,310 0,96 
Item 46 4 point, crawls up 4 steps on hands and knees or feet 0,601 0,82 
Item 47 4 point, crawls backwards down 4 steps on hands and knees or feet 0,593 0,82 
Item 48 Sit on mat, attains high kneeling using arms, maintains, arms free, 10 seconds 0,527 0,84 
Item 49 High kneeling, attains half kneeling on right knee using arms, maintains arms free, 10 sec 0,627 0,68 
Item 50 High kneeling, attains half kneeling on left knee using arms, maintains arms free, 10 sec 0,641 0,68 
Item 51 High kneeling, walks forward on knees 10 steps, arms free 0,694 0,86 
Dimension D: Standing 
Item 52 On the floor, pulls to stand at large bench 0,740 0,96 
Item 53 Standing, maintains arms free, 3 seconds 0,704 0,86 
Item 54 Standing, holding on to large bench with one hand, lifts right foot, 3 seconds 0,440 0,82 
Item 55 Standing, holding on to large bench with one hand, lifts right foot, 3 seconds 0,564 0,86 
Item 56 Standing, maintains arms free, 20 seconds 0,811 0,88 
Item 57 Standing, lifts left foot, arms free, 10 seconds 0,747 0,84 
Item 58 Standing, lifts right foot, arms free, 10 seconds 0,792 0,86 
Item 59 Sit on small bench, attains standing without using arms 0,692 0,76 
Item 60 High kneeling, attains standing through half kneeling on right knee, without using arms 0,745 0,68 
Item 61 High kneeling, attains standing through half kneeling on left knee, without using arms 0,813 0,74 
Item 62 Standing, lowers to sit on the floor with control, arms free 0,799 0,76 
Item 63 Standing, attains squat, arms free 0,774 0,80 
Item 64 Standing, picks up object from floor, arms free, returns to stand 0,974 0,98 
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Appendix X (continued): Item analysis evaluating the agreement between the live-and video-ratings 
rated by PT1 
 
 
Dimension E: Walking, jumping and running 
Item 65 Standing, 2 hands on large bench, cruises 5 steps to the right 0,490 0,96 
Item 66 Standing, 2 hands on large bench, cruises 5 steps to the left 0,490 0,.96 
Item 67 Standing, 2 hands held, walks forwards 10 steps  0,98 
Item 68 Standing, 1 hand held, walks forwards 10 steps 0,556 0,96 
Item 69 Standing, walks forward 10 steps 0,824 0,90 
Item 70 Standing, walks forward 10 steps, stops, turns 180°, returns 1,000 1.00 
Item 71 Standing, walks backward 10 steps 1,000 1.00 
Item 72 Standing, walks forward 10 steps, carrying a large object with 2 hands 0,855 0,94 
Item 73 Standing, walks forward 10 consecutive steps between parallel lines 20 cm (8” apart) 0,892 0,86 
Item 74 Standing, walks forward 10 consecutive steps on a straight line 2 cm (3/4”) wide 0,825 0,82 
Item 75 Standing, steps over stick at knee level, right foot leading 0,799 0,74 
Item 76 Standing, steps over stick at knee level, left foot leading 0,855 0,80 
Item 77 Standing, runs 4.  m (1 ’), stops and returns 0,739 0,68 
Item 78 Standing, kicks ball with right foot 0,951 0,96 
Item 79 Standing, kicks ball with left foot 0,936 0,94 
Item 80 Standing, jumps 30 cm (12”) high, both feet simultaneously 0,815 0,82 
Item 81 Standing, jumps forward 30 cm (12”) high, both feet simultaneously 0,824 0,78 
Item 82 Standing on right foot, hops on right foot 10 times with a 60 cm (24”) circle 0,911 0,94 
Item 83 Standing on left foot, hops on left foot 10 times with a 60 cm (24”) circle 0,769 0,88 
Item 84 Standing, holding 1 rail, walks up 4 steps, alternating feet 0,657 0,66 
Item 85 Standing, holding 1 rail, walks down 4 steps, alternating feet 0,695 0,70 
Item 86 Standing, walks up 4 steps, alternating feet 0,709 0,72 
Item 87 Standing, walks up 4 steps, alternating feet 0,731 0,74 
Item 88 Standing on 1  cm (6”) step, jumps off, both feet simultaneously 0,813 0,78 
 
Abbreviations: 
Ƙ: Weighted Kappa Coefficients of 0,00-0,39 were considered as weak, 0,40-0,75 as moderate and 0,76-1,00 as very strong. 
PA: proportion of positive agreement calculated as the proportion of scores with positive agreement divided by the total number 
of scores. 
The blank cells represent the cells where Ƙ could not be calculated.  
The green cells represent the items with very good  agreement. (Ƙ >0,81) 
The orange cells represent the items with moderate to good agreement. (Ƙ > 0,61 < 0,81) 
The red cells represent the items with poor to fair agreement. (Ƙ < 0,40)  
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Appendix Y. The general program 
 
 
* More difficult, only for children with GMFCS I 
  
Aim Position Repetitions 
Stretching   
mm.hamstrings 
m.Gastrocnemius 
m.Psoas 
 
Long-sitting 
Standing 
Prone lying 
3*(30 sec) 
  
Pelvic & trunk control     
hip extension  (bridging) supine, knee-extension with hip adduction 3*20 
hip extension (briding) supine, knee-extension with hip abduction 3*20 
sidewards sitting knee-standing 2*20 
trunk rotation prone lying, hips extended, thighs on bal 5*10 
pelvis anteversion/retroversion* hands&knees 20 
Strengthening   
plantar flexor muscles 
m.Obliq Abd 
m.Glut Max 
m.Rectus Femoris&Vastii 
 
m.Glut Max 
 
toe standing, knees extended 
supine, rolling against resistance 
prone lying, hip extension 
supine, knee extension 
squatting 
prone lying, hip extension 
 
3*20 
Sit to stand Sitting, 90° hip, knee & ankle flexion 20 
Standing balance     
anteroposterior direction standing, feet closed (throwing &catching balls) 20 
  standing, hips abducted (idem) 20 
lateral  standing, feet together  (resistance against pelvis) 20 
one leg standing one-leg standing 20 
Gait training     
sidewards walking sidewards walking against a wall 20 steps 
backwards walking backwards walking 20 steps 
pelvic control shoulders externally rotated, walking between lines 20 steps 
Jumping*     
forwards standing, feet closed 5 
backwards standing, feet closed 5 
sidewards standing, feet closed 5 
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Appendix Z.  Example of an individually defined training program 
 
 
 
 
 
Goal 1: E. has improved knee extension at initial contact Position Rep 
Exercise 1:  Length mm.Hamstrings 
 
Supine lying 
Dynamic stretch in standing 3*20 s 
Exercise 2: Strengthening m.Rectus Femoris &Vastii Long sitting, knees in extension 3*15  
Exercise 3: Active hip extension  Long sitting, hips abducted, knees extended  20* 
 
Standing, hips and knees extended 5 min 
Exercise 4: Walking exercises to improve knee ext Walking  
Goal 2: E. has improved hip extension during gait Position Rep 
Exercise 1:  Stretching m.Psoas Prone lying, knees flexed, hip extension 20*5s 
Exercise 2:  Active hip extension Prone lying, knees flexed, hip extension 20*5 
Exercise 3:  Hip extension during gait Backwards walking, guiding hip extension 5 min 
Goal 3: E. can stand on one leg (L&R) for 4s Position Rep 
Exercise 1: Weightshift  Standing  
Exercise 2: Pelvic stability exercises   
Exercise 3: Single-leg stance exercises   
Goal 4: E. can climb15 steps of the stairs, carying backpack (school) Position Rep 
Exercises 1-3: Preparatory exercises: goal 1+2   
Exercise 4:  Small step-up exercises (sidewards, backwards)   
Exercise 5: Guided stair climbing, progression towards climbing with backpack (for school) using support 
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Appendix AA. Quality assessment form 
 
 
Type Position Repetitions Duration/intensity Feedback 
Hands on/off 
Attention to 
compensations 
 
Exercise 1  /2 /2 /2 /2 /2  
Exercise 2  /2 /2 /2 /2 /2  
Exercise  3  /2 /2 /2 /2 /2  
Exercise 4  /2 /2 /2 /2 /2  
Exercise 5  /2 /2 /2 /2 /2  
Exercise 6  /2 /2 /2 /2 /2  
Exercise 7  /2 /2 /2 /2 /2  
Exercise 8  /2 /2 /2 /2 /2  
Exercise 9  /2 /2 /2 /2 /2  
Exercise 10  /2 /2 /2 /2 /2  
Total 
 …/… …/… …/… …/… …/… …./…. 
= …/50 
Analytical versus functional training:   …/50 
Total quality score …/100 
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Appendix AB. Session form  
 
Session  ° … 
Date:  ……………………  from  …………… to ……………. (therapy time: ………. minutes) 
 
IMPAIRMENT LEVEL 
 
Joint mobility and muscle length   (total …. minutes) 
Muscle group Position 
Duration 
of stretch 
Repetitions  
M.Gastrocnemius stance/prone/supine/sitting 12 sec 3 Active/Passive/Activopassivo/Inhibition 
 stance/prone/supine/sitting   Active/Passive/Activopassivo/Inhibition 
 stance/prone/supine/sitting   Active/Passive/Activopassivo/Inhibition 
 stance/prone/supine/sitting   Active/Passive/Activopassivo/Inhibition 
 stance/prone/supine/sitting   Active/Passive/Activopassivo/Inhibition 
 stance/prone/supine/sitting   Active/Passive/Activopassivo/Inhibition 
 
 
Strength:       (total …. minutes) 
Muscle group Position Resistance Repetitions  
M.Gastrocnemius stance/prone/supine/sitting Body weight 3*15 Analytical/ Global 
 stance/prone/supine/sitting   Analytical/ Global 
 stance/prone/supine/sitting   Analytical/ Global 
 stance/prone/supine/sitting   Analytical/ Global 
 stance/prone/supine/sitting   Analytical/ Global 
 stance/prone/supine/sitting   Analytical/ Global 
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ACTIVITY LEVEL 
 Functional exercises  (total ….. minutes) 
Describe the exercise and specific points of attention.  
 
 Description Attention points 
Lying 
 
 
  
Sitting 
 
 
  
Standing 
 
 
  
Gait 
 
 
  
Transfer 
 
 
  
Trunk control 
 
 
  
Arm-and hand function 
 
 
  
Others 
 
 
  
 
 
PARTICIPATION LEVEL: participation to social activities (total time ….minutes) 
Specific preparation for social activities: 
- Home: 
- School: 
- Sports: 
- Others: 
 
REMARKS 
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Appendix AC Citations from Mr and Mrs Bobath 
 
‘The Bobath concept is a problem-solving approach to the assessment and treatment of individuals 
with disturbances of function, movement and postural control due to a lesion of the central nervous 
system. The concept provides a way of observing, analysing and interpreting task performance. It 
takes into account that Cerebral Palsy and allied conditions comprise a group of symptoms in which 
there is a large variety. Therefore, treatment needs to be flexible and needs to be adapted to the many 
needs and the variety of the individual child. No standardized set of exercises will be adequate to the 
needs of all children.’  
  ‘ … We learned that the background for normal children’s growing ability to move against gravity and 
for their great variety of movement and skills was the development of righting and equilibrium 
reactions.  This helped us towards a more dynamic treatment, i.e. facilitation of sequences of 
automatic movements.  We found a way of using key points of control from where inhibiting of 
abnormal activity could be done simultaneously with facilitation of normal activity.  We started to use 
‘reflex inhibiting’ dynamic patterns rather than ‘static reflex inhibiting postures’.  
 (Mrs Bobath, Development of neurodevelopmental treatment, 1992) 
 
‘There needs to be opportunity for practice for learning/ re-learning to occur, either by the individual or 
with the help of carers.  ‘ 
’Goals need to be realistic according to the client's potential and appropriate to the environment 
encountered during daily life. These principles integrate with the main ideas of motor learning theory, 
which requires the active participation of the client. This is not new. Bobath in the 1960s stated that 
"unless you stimulate or activate your patient in the way in which new activities are possible, you have 
done nothing at all. So the handling techniques as such are only the very first step in treatment, 
though they are very important’ 
(Bobath B. Bobath K. 1975. Motor development in the different types of cerebral palsy. Heinneman Medical 
Books, London).  
 
